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Abstract
ABSTRACT
Cytochrome oxidase is the terminal proton pumping enzyme of the respiratory chain, 
catalysing the reduction of oxygen to water. This complex enzyme is composed of up to 
thirteen subunits of both nuclear and mitochondrial genetic origin, but the order in 
which they assemble is not fully understood. To investigate assembly I utilised blue 
native gel electrophoresis to analyse Saccharomyces cerevisiae strains with mutations in 
cytochrome oxidase causing assembly defect. I identified novel subcomplexes incuding, 
for the first time, a subcomplex containing mitochondrially encoded subunits.
The respiratory chain is a target of the free radical nitric oxide (NO), which reversibly 
inhibits cytochrome oxidase through competition with oxygen at its active site. NO also 
has a myriad of other targets, and many of its actions are mediated through reactive 
nitrogen species (RNS) formed on reaction of NO with other species. NO is released as 
part of the immune response to infection and has antimicrobial action. Here, I found that 
prolonged incubation of yeast with an NO donor inhibited growth and caused a decrease 
in cytochrome oxidase content in dividing cells, which may be due to NO interfering 
with the assembly of the enzyme. I have also analysed gene expression in yeast after 
short NO exposure, to gain insight into the stress sensed by the cell and the transcription 
factors involved. The data suggest that NO causes a general stress response, in addition 
to specific effects such as repression of respiratory chain genes and activation of 
antioxidant/detoxification systems. Many genes known to be regulated by Haplp were 
repressed, suggesting that NO might interfere with this transcription factor.
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1. Introduction
In this thesis I began by studying the assembly of the respiratory chain enzyme 
cytochrome oxidase, using the yeast Saccharomyces cerevisiae as a model system. I 
next moved on to assess the effect of nitric oxide (NO), an inhibitor of cytochrome 
oxidase, on the respiratory chain and on the growth of yeast. This then led me to 
investigate the antimicrobial action of NO, again using yeast as a model.
1.1. MITOCHONDRIA AND THE RESPIRATORY CHAIN
In eukaryotic cells, mitochondria occupy a central position in the extraction of energy 
from nutrients and its trapping as adenosine triphosphate (ATP). Each cell can contain 
hundreds of mitochondria, spread throughout the cytosol. The organelle is enclosed by 
an outer membrane (OMM) which, together with the highly convoluted inner membrane 
(IMM) encloses the intermembrane space (IMS). The OMM is permeable due to the 
presence of porin, which allows solutes of less than 10 kDa molecular weight (most ions 
and metabolites, but not proteins) to pass, hence the composition of the IMS is similar 
to that of the cytosol. The IMM holds the components of the respiratory chain (Figure
1.1) and surrounds the mitochondrial matrix, containing the mitochondrial DNA 
(mtDNA) alongside a multitude of enzymes involved in the citric acid cycle, /?- 
oxidation of fatty acids, and the final steps of degradation of other nutrients. The 
mtDNA encodes several polypeptides which form part of the respiratory chain 
complexes, in addition to mitochondrial rRNAs and tRNAs. In yeast, these polypeptides 
are Coxlp, Cox2p, Cox3p, cytochrome b, Atp6p, Atp8p and Atp9p.
1.1.1. The chemiosmotic hypothesis
Controlled oxidation of nutrients begins in the cytosol and terminates in the 
mitochondria, converging in the formation of mitochondrial acetyl coenzyme A (acetyl 
CoA). The citric acid cycle, in which acetyl CoA is oxidised, is the final common 
pathway for the oxidation of fuel molecules. The electrons released during these 
processes are transferred to the molecules NAD+ and FAD, which carry the electrons to 
the mitochondrial respiratory chain (Figure 1.1). Respiratory chains are found in 
biological systems from mammals to bacteria and plants, and play a major role in the 
generation of energy, through ATP synthesis, by aerobic cells.
The essential premise of the respiratory chain is that electron flow through the 
respiratory chain complexes leads to proton pumping from the matrix to the IMS, 
generating a gradient of protons which return to the matrix through the ATP synthase, 
with the concomitant generation of ATP from ADP and inorganic phosphate (Figure
1.1). This is known as the chemiosmotic hypothesis (Mitchell and Moyle, 1967). The
14
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components of the respiratory chain are arranged roughly in order for electron flow 
from compounds with low redox potential to compounds with higher redox potential. 
The proton electrochemical gradient, or proton motive force, generated has two 
components: the A ph caused by different concentrations of protons across the 
membrane, and the A  ^due to the difference in electrical potential. Establishment of the 
proton gradient relies on the impermeability of the IMM to nearly all ions and polar 
molecules; movement across the IMM relies on specific ion and metabolite transporters, 
for example, the pyruvate produced in cytosolic glycolysis is transported from the 
intermembrane space to the matrix via a pyruvate carrier.
1.1.2. Components of the respiratory chain
In mammals, the respiratory chain comprises five enzyme complexes embedded in the 
IMM (Figure 1.1). Electrons from NADH are transferred to NADH dehydrogenase 
(complex I, NADH:ubiquinone oxidoreductase, EC 1.6.5.3). The soluble carrier 
ubiquinone transports electrons from NADH dehydrogenase and from the FADH2 
produced by succinate dehydrogenase (complex II, succinate:quinone oxidoreductase, 
EC 1.3.5.1), which is part of the citric acid cycle, to the bc\ complex (complex III, 
ubiquinol cytochrome c oxidoreductase, EC 1.10.2.2). Finally soluble cytochrome c 
transports electrons to cytochrome oxidase (complex IV, cytochrome c oxidase, 
ferrocytochrome c:O2 oxidoreductase, EC 1.9.3.1) where oxygen is reduced to water. 
NADH dehydrogenase, the bc\ complex and cytochrome oxidase pump protons across 
the IMM, and the ATP synthase (complex V, Fi-ATPase, EC 3.6.3.14) utilises these to 
generate ATP.
In S. cerevisiae the system is slightly different in that there are not one but three 
NADH dehydrogenases, none of which span the membrane or pump protons, but which 
are exposed to either the cytosolic or the matrix side of the IMM. Yeast succinate 
dehydrogenase is composed of four subunits and contains three iron-sulfur clusters, 
FAD and cytochrome b. The yeast bc\ complex contains three catalytic subunits which 
include cytochrome b, cytochrome c\ and an iron-sulfur centre, together with seven 
other non-catalytic subunits. The yeast ATP synthase contains 16 subunits. The 
structure of cytochrome oxidase is reviewed below.
1.2. CYTOCHROME OXIDASE
The cytochrome c oxidases are members of a large family of terminal oxidases present 
in prokaryotes and eukaryotes, all of which contain heme and copper. Cytochrome 
oxidase catalyses the reduction of oxygen to water using electrons from cytochrome c,
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and the multisubunit enzyme is the terminal proton pumping component of the 
respiratory chain.
1.2.1. Structure of cytochrome oxidase
Mammalian cytochrome oxidase is composed of thirteen subunits, while yeast 
cytochrome oxidase is composed of eleven. Most of the yeast subunits have a 
mammalian counterpart (Taanman and Capaldi, 1992; Taanman 1997), as detailed in 
Table 1.1. The crystal structure of Paracoccus denitrificans cytochrome oxidase was 
determined by Iwata in 1995 (Iwata et al., 1995), and that of bovine heart cytochrome 
oxidase by Tsukihara in 1996 (Tsukihara et al., 1996) (Figure 1.2). Three subunits, 
Coxlp, Cox2p and Cox3p, form the core of the enzyme and are encoded by the mtDNA 
itself, while the remaining subunits are encoded by the nuclear genome. The core 
subunits are highly conserved, being found in both eukaryotic and bacterial oxidases. P. 
denitrificans cytochrome oxidase, for example, contains homologs to Coxlp, Cox2p 
and Cox3p, in addition to a further non-homologous subunit. Therefore it is not 
surprising that the catalytic site and the region thought to be involved in proton 
pumping are located in these mitochondrially encoded subunits. Cox3p does not appear 
to be involved in proton pumping or catalysis, but is conserved and may be required for 
assembly or stability of the enzyme (Haltia et al., 1989). The role of the nuclear subunits 
has not been clearly established, but they are believed to be involved in assembly or 
stability of the complex, or in allosteric modification of activity through nucleotide 
binding (Kadenbach et al., 1998); some of them exist as isoforms.
Cytochrome oxidase is embedded in the IMM. In the bovine structure the core 
Cox2p is comprised of a C-terminal ten-stranded ^-barrel globular domain protruding 
into the IMS, anchored to the IMM by two transmembrane helices (Tsukihara et al., 
1996) (Figure 1.2A). The globular domain contains the initial acceptor of electrons from 
cytochrome c, the binuclear Cua site. The transmembrane region of Cox2p associates 
with Coxlp, the largest subunit, having twelve membrane-spanning helices which 
contain the redox-active heme a and heme «3-Cub centres but no appreciable 
extramembrane region. Cox3p also associates with the transmembrane region of Coxlp, 
but does not make direct contact with Cox2p. Cox3p spans the membrane seven times 
and contains no prosthetic groups. The nuclear-encoded subunits are smaller and either 
have one transmembrane region or are extramembrane polypeptides (Table 1.1, Figure 
1.2B). Cytochrome oxidase operates as a dimer, and the total molecular weight of each 
monomer is around 200,000 kDa.
16
1. Introduction
In addition to the redox active cofactors mentioned above, other metal sites are 
also present (Tsukihara et al., 1995). A magnesium binding site (to which manganese 
can also bind) is located at the interface between Coxlp and Cox2p, and may be 
involved in the exit of water from the catalytic site (Schmidt et al., 2003). Another 
binding site, for a calcium or sodium ion, has also been identified in Coxlp (Ostermeier 
et al., 1997; Kirichenko et al., 1998). A zinc ion is located in mammalian COX5B, 
ligated by 4 cysteine residues. Substitution of some of the cysteine ligands in the 
corresponding Cox4p impairs assembly of the yeast enzyme (Lightowlers et al., 1991).
1.2.2. Catalysis and proton translocation
Cytochrome oxidase uses electrons from cytochrome c to reduce molecular oxygen to 
water. The overall reaction is:
O2 + 4e + 8H +,n 2H2O + 4H +out 
Protons for water formation are sourced from the matrix side of the IMM while 
electrons from cytochrome c originate from the IMS side, hence this creates a ApH and a 
Av over the IMM, which the active translocation of protons out of the matrix adds to. 
The transfer of electrons occurs in several steps. The docking site for cytochrome c is 
believed to be located primarily in the Cox2p C-terminal extramembrane domain, but 
may also involve residues in Cox3p and other subunits (Tsukihara et al., 1996). 
Docking is thought to involve mainly electrostatic interactions between acidic residues 
on cytochrome oxidase and lysine residues surrounding the heme crevice of cytochrome 
c. Optimisation of the interaction may then be mediated by hydrophobic interactions 
(Maneg et al., 2004). Electrons from cytochrome c enter the protein at the Cua site in 
the C-terminal region of Cox2p, which comprises two copper atoms and is located close 
to the cytochrome c docking site. Electrons move from here to heme a in Coxlp, then to 
the Coxlp heme aj-Cus site where the reaction with oxygen takes place.
The fully reduced heme 03-Cub site is known as the R species. Once this is 
formed, the iron of heme <33 binds oxygen to form the A species, then the 0 -0  bond 
breaks and dioxygen is reduced. Electron and proton transfer to the heme #3-Cub site 
forms the F state then the O state. Formation of the F and O species is associated with 
the translocation of two protons across the IMM. Finally, in the reductive part of the 
cycle, two molecules of water are released via the intermediate E, requiring two further 
protons and two electrons, to reform species R (see (Michel et al., 1998; Wikstrom, 
2000)). The mechanism by which this is coupled to proton translocation is still unclear. 
Two possible proton translocating pores, the D- and K-channels formed of hydrophilic
17
1. Introduction
residues linked by a network of water molecules, are located in Coxlp (Rich et al., 
1998; Wikstrom et al., 1998).
1.3. ASSEMBLY OF CYTOCHROME OXIDASE
Cytochrome oxidase is a large multisubunit complex. Its assembly is complicated first 
by the fact that its composite polypeptides are synthesised in two separate cellular 
compartments (mitochondria and cytosol), and second by the requirement for 
incorporation of metal groups and cofactors. An array of nuclear encoded assembly 
proteins are required to coordinate assembly. These factors are involved in all aspects of 
assembly, from processing of mRNAs, to insertion of polypeptides into the membrane, 
to recruitment of cofactors. Some of the assembly factors have a general function and 
are also involved in the biogenesis of other respiratory complexes, while some are more 
specifically required for cytochrome oxidase assembly. Many of the assembly factors 
were first identified in S. cerevisiae, and much of the functional analysis has been 
performed in yeast. Table 1.2 summarises current knowledge on the more specific 
assembly factors required, and in the following sections I will expand on some of the 
information in this table.
1.3.1. Import of nuclear encoded subunits into the mitochondria
The three core catalytic subunits are encoded by the mitochondrial genome, so the 
synthesis of these subunits utilises the mitochondrial replication system. The remaining 
subunits (ten in mammals, eight in yeast) are encoded by the nuclear genome, so are 
synthesised on cytosolic ribosomes and must be targeted to the mitochondria. 
Mitochondrial targeting sequences can be in the form of a cleavable N-terminal 
sequence or, for many IMM proteins, an internal non-cleavable sequence. Mammalian 
COX6 C, for example, contains several basic amino acids in its N-terminus, which is not 
cleaved after import (Otsuka et al., 1988). Proteins pass first through the OMM via the 
translocase of the outer membrane (TOM) complex. Passage across or insertion into the 
IMM is facilitated by the translocase of the inner membrane (TIM) complex. Two such 
complexes have been identified (Pfanner and Geissler, 2001). The first, known as the 
Timl7p-23p complex, is the more general one, and is used by proteins with an N- 
terminal targeting presequence. This complex requires the cooperation of Tim44p, the 
ATP-dependent chaperone Hsp70p and its cochaperone Mgelp. The second complex, 
Tim22p-54p, is used by a set of polytopic IMM proteins containing internal 
mitochondrial targeting sequences and requires the soluble IMS proteins Tim8p, 
Tim 1 Op, Timl2p and Timl3p. Some of those proteins whose final fate is to span the
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IMM can utilise their topogenic signal (normally an integral part of the protein, i.e. the 
transmembrane section, though sometimes a section of protein removed by the Imp 
peptidase complex of the IMS after sorting) to cause translocation arrest and allow 
lateral sorting into the membrane. This is known as the ‘stop transfer’ mechanism, and 
import of Cox5ap has been shown to follow this route (Miller and Cumsky, 1993). 
Other IMM proteins continue to the matrix where their N-terminal target sequence is 
cleaved by the mitochondrial processing peptide (MPP), before they are then exported 
to the IMM. Here, the mechanism of export converges with that used by the mtDNA- 
encoded proteins destined for the IMM (Hell et al., 1998).
1.3.2. Export of protein domains from the mitochondrial matrix
The export of Cox2p, synthesised on mitochondrial ribosomes in the matrix has been 
most widely studied. Cox2p becomes tethered to the IMM by two transmembrane 
helices, with its small N-terminal and large C-terminal domains protruding into the 
IMS. In yeast Cox2p is synthesised as a precursor with a 15 amino acid N-terminal 
presequence, although this leader sequence is not present in mammalian COX2 (Pratje 
et al., 1983). Assembly of Cox2p requires insertion of the hydrophobic membrane 
domains into the IMM, and translocation of the hydrophilic regions across to the IMS.
1.3.2.1. Subunit-specific membrane-bound translational activators
There is evidence to suggest that, in yeast at least, subunit insertion into the IMM is 
cotranslational, which would prevent aggregation of subunits in the matrix. mRNAs are 
thought to be recruited to the IMM by subunit-specific membrane-bound translational 
activators which interact with the 5’ UTR of transcripts. P e tlllp  is required for 
translation of COX2 mRNA (Mulero and Fox, 1993). Mss51p is required for COX1 
mRNA translation but, unusually, does not recognise the mRNA simply through its 5’ 
UTR (Perez-Martinez et al., 2003). Mss51p also physically interacts with the Coxlp 
polypeptide, and is required for insertion of Coxlp into the membrane. Pet309p is also 
involved in Coxlp translation (Manthey and McEwan, 1995). Cox3p translation 
requires Pet54p (Costanzo et al., 1986), Petl22p (Kloeckener-Gruissem et al., 1988) and 
Pet494p (Costanzo and Fox, 1986), all of which have been shown to interact with each 
other (Brown et al., 1994). Some of the translational activators for different subunits 
have also been shown to interact, suggesting that the synthesis of all three core subunits 
could be directed to occur at particular sites in the IMM, rather than the subunits 
diffusing freely until an interaction partner is found (Naithani et al., 2003).
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I.3.2.2. Oxalp
Translocation of Cox2p from the matrix to the IMS is mediated by the highly conserved 
protein Oxalp, which spans the membrane five times in an Nout-Cin orientation. A 
temperature-sensitive mutant of yeast Oxalp displayed accumulation of the precursor 
form of Cox2p in the matrix. Since the presequence is cleaved by enzymes in the IMS 
this indicated that Oxalp is essential for the insertion of Cox2p into the IMM (Bauer et 
al., 1994; Hell et al., 2001). Oxalp has been specifically implicated as essential in 
transfer of the N-terminal transmembrane domain of Cox2p. Export of the Cox2p C- 
terminal domain was also defective in the absence of Oxalp (Hell et al., 1997; He and 
Fox, 1997), however this could be due to a requirement for prior translocation of the N- 
terminal domain (Hell et al., 1998). Oxalp may facilitate membrane insertion of Cox2p 
by sandwiching the N-terminal region between its own transmembrane helices until 
stable integration with the lipid bilayer is attained, in a similar manner to mammalian 
TRAM (translocating chain-associating membrane protein) (Saint-Georges et al., 2001).
Though Cox2p has been identified as the polypeptide most highly dependent on 
Oxalp, the function of Oxalp appears to be not restricted to Cox2p, but to form part of 
a more general mitochondrial export machinery (Hell et al., 1998; Hell et al., 2001). 
When the yeast OXA1 gene is deleted the resulting strain is respiratory deficient due to a 
complete loss of cytochrome oxidase content, in addition to decreased cytochrome b 
content and bc\ complex activity, and diminished ATP synthase activity (Altamura et 
al., 1996). The temperature-sensitive Oxalp mutant mentioned above also had defects in 
the insertion of Coxlp, Cox3p, cytochrome b and Atp6p into the IMM, albeit to a lesser 
extent than Cox2p (Hell et al., 2001). Additionally, membrane insertion of Oxalp itself 
utilises Oxalp (Hell et al., 1998).
Crosslinking experiments by Hell et al. have demonstrated direct interaction of 
Oxalp with several substrates, both nascent mitochondrial polypeptide chains 
(including Coxlp, Cox2p, Cox3p and cytochrome b) and newly imported nuclear 
encoded proteins (Hell et al., 1998; Hell et al., 2001). The association with nascent 
mitochondrial polypeptides was enhanced in the presence of ribosomes. When 
puromycin (which causes premature release of the polypeptide chain from the 
ribosome) was used to inhibit protein synthesis, the number of nascent chains found 
associated with Oxalp decreased. However, when chloramphenicol (which stalls 
elongation of the polypeptide chain) was used this was not the case (Hell et al., 2001). It 
was suggested that membrane insertion may be cotranslational, and that Oxalp may 
make direct contact with the ribosomes themselves, or with translational activator
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proteins. A pool of Oxalp was found to copurify with mitochondrial ribosomes in 
sucrose gradient centrifugation, and the C-terminal matrix domain of Oxalp may 
interact with the ribosomes (Szyrach et al., 2003).
Oxalp was first thought to be involved in the export of only N-terminal regions, 
but several of its substrates contain IMS loops adjacent to two transmembrane regions, 
suggesting that it is not the location of a protein domain that determines the requirement 
for Oxalp in translocation, but the nature of that domain. Oxalp may be of particular 
importance in the translocation of transmembrane domains which have a high 
proportion of negatively charged residues, a feature of the N-terminal transmembrane 
domain of Cox2p (Saint-Georges et al., 2001; Herrmann and Bonnefoy, 2004). In the 
absence of Oxalp, mutations which introduced positively charged residues into the 
transmembrane region of cytochrome ci restored translocation of the Cox2p N-terminal 
transmembrane domain (Hamel et al., 1998). The introduction of a single positively 
charged residue into the transmembrane region of another be \ complex subunit Qcr9p 
had a similar effect (Saint-Georges et al., 2001). The authors of these studies propose 
that the positive charges promote interaction of cytochrome c\ or Qcr9p with negatively 
charged residues in Cox2p and allow coinsertion of Cox2p into the membrane. In 
another study the absence of the N-terminal presequence of Cox2p abolished assembly 
(Torello et al., 1997). However a suppressor mutant expressing Cox2p with its N- 
terminal presequence replaced by a large portion of cytochrome b was identified. In this 
fusion protein the N-terminus of Cox2p was required to be exported effectively as a 
hairpin loop adjacent to two transmembrane domains. The presence of Oxalp was 
essential for export of the fusion protein, suggesting that the specific properties (in 
particular net charge) of the domain to be transported, rather than its final topology, 
determines its dependence on Oxalp (Herrmann and Bonnefoy, 2004). Additionally, 
when the IMS domain of Atp9p was made more positively charged by mutagenesis the 
export of this protein did not subsequently require Oxalp (Herrmann and Bonnefoy, 
2004). The Cox2p N-terminal IMS domain is highly acidic, with a net charge of -5, as 
opposed to the loops in the other (less dependent) known substrates of Oxalp, which 
have net charges of -2 or -3. Other proteins, which insert into the membrane in the 
absence of Oxalp, are uncharged or have a positive net charge. Therefore the number of 
charged residues in a domain seems to determine its dependence on Oxalp (Herrmann 
and Bonnefoy, 2004).
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1.3.2.3. Mbalp
The extent of dependency of Oxalp substrates on Oxalp varies considerably. Cox2p 
displays a high requirement for Oxalp, while Coxlp, Cox3p, Atp6p and cytochrome b 
are less dependent and can insert into the membrane in the absence of Oxalp, albeit 
with lower efficiency (Hell et al., 2001). These substrates may be more easily able to 
spontaneously insert into the membrane, or may require another translocation 
machinery, perhaps of partially overlapping function with Oxalp, to mediate their 
insertion (Herrmann and Bonnefoy, 2004). Mbalp, an IMM protein, was isolated along 
with Oxalp as a multicopy suppressor of an AFG3 (encoding a mitochondrial protease) 
deletion mutant (Rep et al., 1996). Preuss et al. found that deletion of MBA1 caused a 
defect in Cox2p N-terminal export, and, like Oxalp, Mbalp interacted with Coxlp, 
Cox2p, Cox3p and cytochrome b during their synthesis (Preuss et al., 2001). However, 
Mbalp did not interact with Oxalp and is unlikely to be part of an Oxalp complex. 
Mbalp is partially dispensable and cannot replace Oxalp, but there seems to be some 
overlap in the function of the two proteins (Preuss et al., 2001). Mbalp has been 
suggested to be involved in export of protein domains less charged than those exported 
by Oxalp (Herrmann and Bonnefoy, 2004).
1.3.2.4. Removal o f the Cox2p N-terminal presequence
After translocation the Cox2p presequence is cleaved by the IMM Imp peptidase 
complex (Behrens et al., 1991; Bauer et al., 1994), containing at least two subunits, 
Implp and Imp2p (Nunnari et al., 1993). Cleavage is dependent on another protein 
Cox20p, since COX20 deletion leads to an accumulation of the precursor form of Cox2p 
with its N-terminus in the IMS (Hell et al., 2000). Cox20p was found in association 
with both the precursor and the mature form of Cox2p, therefore it has been proposed 
that Cox20p somehow presents Cox2p as a substrate to the Imp peptidase complex and 
then acts as a chaperone during subsequent assembly (Hell et al., 2000).
1.3.2.5. Coxl8p, Mss2p and Pntlp
Less is known about the protein components involved in transfer of the C-terminal 
domain of Cox2p. C-terminal extrusion, unlike N-terminal extrusion, is dependent upon 
IMM potential (He and Fox, 1997). Saracco and Fox demonstrated that Coxl8p is 
required for export of the C-terminal domain of Cox2p (Saracco and Fox, 2002). 
Coxl8p deficiency causes a lack of cytochrome oxidase but does not affect other 
components of the respiratory chain (Souza et al., 2000). The Neurospora crassa
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homologue of Coxl8p, Oxa2p, interacts with newly synthesised Cox2p and Cox3p and 
is not necessary for N-terminal extrusion, since in the absence of C oxl8p the targeting 
sequence of Cox2p was removed as normal (Funes et al., 2004). Coxl8p is an integral 
IMM protein with five predicted helices and a similar structure to Oxalp but a shorter 
C-terminal domain, and may act as a posttranslational translocase (Preuss et al., 2005).
Coxl8p immunoprecipitates with Mss2p and Pntlp (Saracco and Fox, 2002). 
Pntlp is an integral IMM protein. Its deletion in yeast did not affect respiratory growth, 
though less cytochrome oxidase was assembled (He and Fox, 1999). However, deletion 
of the homologous gene in the yeast Kluyveromyces lactis abolished cytochrome 
oxidase activity due to a defect in Cox2p C-terminal export and some decrease in N- 
terminal export (He and Fox, 1999). Mss2p is a matrix side peripherally bound IMM 
protein. Deletion of Mss2p caused respiratory deficiency through inhibiting export of 
the Cox2p C-terminal domain but not the N-terminal domain, and subsequent 
degradation of Cox2p and cytochrome oxidase (Broadley et al., 2001). Since Mss2p 
does not span the membrane and therefore is unlikely to be a translocase, the authors 
proposed that it may be involved in delivery of the Cox2p C-terminus to its 
translocation machinery, or in folding the C-terminal domain prior to export.
1.3.3. Recruitment and insertion of cofactors
1.3.3.1. Heme
Both hemes of cytochrome oxidase bind non-covalently to the transmembrane region of 
Coxlp. The difference between heme a and heme arises because of their different 
protein environments, and in particular because one coordination position of heme a3 is 
unoccupied to enable binding of oxygen. Heme a is low-spin, ligated with two histidine 
residues, while heme <23 is high-spin, and ligated by only one histidine residue 
(Tsukihara et al., 1995). Heme a is a modified form of the more common heme b, 
having a 15 carbon famesyl side chain instead of a vinyl at C-2, and replacement of the 
methyl group at C-8 of the porphyrin ring by a formyl group (Caughey et al., 1975). 
Heme a is formed from heme b in two steps. The famesyl transferase Cox 1 Op converts 
heme b to heme o (containing the famesyl side chain) (Tzagoloff et al., 1993) which is 
then oxidized at the methyl by a three component monooxygenase comprising the heme 
synthase Coxl5p, the ferredoxin Yahlp and the ferredoxin reductase Arhip (Barros et 
al., 2 0 0 1 ).
Since the hemes are located within the membrane domain of the core subunit 
Coxlp, it seems probable that their insertion would occur early on in assembly, prior to
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interaction of Coxlp with other subunits and likely during translation of Coxlp (Carr 
and Winge, 2003). Consistent with this, human COXIO mutant cells did not accumulate 
a subassembly containing COX1, COX4 and COX5A (mammalian numbering), thought 
to be an early assembly intermediate of cytochrome oxidase (Williams et al., 2004). In 
particular, the insertion is very likely to occur prior to interaction with Cox2p since the 
famesyl group of heme a?> is packed between the two subunits (Carr and Winge, 2003). 
SURF1, homologous to yeast Shylp, has recently been implicated in the insertion of 
heme a3 in Rhodobacter sphaeroides (Smith et al., 2005).
I.3.3.2. Copper
Copper insertion at the CuA site of Cox2p and the Cub site of Coxlp has been more 
widely investigated. In the crystal stmctures of bovine and P. denitrificans cytochrome 
oxidase, the two copper atoms at CuA are bridged by two cysteine residues and each 
atom is ligated by a pair of histidine sidechains and either a methionine residue or a 
main chain carbonyl oxygen (Tsukihara et al., 1995; Iwata et al., 1995). In yeast the 
copper atoms are likely to be bound in a similar manner. The single copper atom of the 
Cub site has three histidine ligands (Tsukihara et al., 1995), one of which is covalently 
cross-linked to a tyrosine residue (Ostermeier et al., 1997).
Assembly of both copper sites requires the soluble protein Coxl7p. Absence of 
Coxl7p was shown by Glerum et al. to cause respiratory deficiency in yeast due to a 
lack of cytochrome oxidase, and was rescued by the addition of high concentration of 
exogenous copper (Glerum et al., 1996a). The Coxl7p protein is small (8 kDa), has a 
CCXC consensus sequence allowing binding of up to three copper ions per monomer, 
and exists as a dimer or tetramer (Beers et al., 1997; Heaton et al., 2001). Coxl7p is 
found in the cytoplasm and the IMS, consistent with its proposed role as a shuttler of 
copper from the cytoplasm to the mitochondria (Beers et al., 1997). However, Maxfield 
et al. demonstrated that Coxl7p is functional even when its location is restricted to the 
mitochondria. Expression of a form of Coxl7p tethered to the IMM through fusion with 
the transmembrane domain of another protein Sco2p was sufficient to rescue respiratory 
growth in a COX17 deletion strain, even in a low copper environment. This suggests 
that Coxl7p does not function as a transporter and its presence in the cytosol may be 
simply due to poor uptake or retention by the mitochondria (Maxfield et al., 2004).
Coxl7p is thought to deliver copper ions to the CuA site of Cox2p and the Cub 
site of Coxlp via two different proteins, Scolp and Coxl lp, respectively. Scolp, along 
with the homologous Sco2p, was shown by Glerum et al. to be a high copy suppressor
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of COX17 mutations (Glerum et al., 1996b). Evidence for copper transfer from Coxl7p 
to Scolp has been provided by Homg et al. These authors showed that the luminescence 
of copper-bound Coxl7p was quenched in the presence of the soluble domain of Scolp, 
and that the Scolp recovered afterwards contained bound copper (Homg et al., 2004). 
Unlike deletion of COX17, deletion or mutation of yeast SCO1 is not rescued by high 
concentrations of copper in the growth medium (Glerum et al., 1996b).
Scolp consists of an IMS soluble domain tethered to the IMM by a single 
transmembrane helix (Balatri et al., 2003). Yeast Scolp has been shown to form 
homomers both in vitro and in vivo, and binds the C-terminal region of Cox2p (Lode et 
al., 2000). Homomer formation might allow the two copper atoms required by the Cua 
site to be delivered simultaneously (Nittis et al., 2001). Scolp has a CXXXC consensus 
in its IMS domain, similar to that found in the copper-binding site of Cox2p (Glemm et 
al., 1996b), and binds one copper ion per monomer through three ligands: the two 
cysteines and a conserved C-terminal histidine. Mutation of any of these residues 
produces non-functional cytochrome oxidase and leads to decreased levels of Cox2p 
(Nittis et al., 2001; Lode et al., 2000). Yeast also contain a homologous protein Sco2p, 
the role of which is still not understood. When SCOl is deleted cytochrome oxidase is 
not assembled (Krummeck and Rodel, 1990) but this is not the case for deletion of 
SC02  (Glemm et al., 1996b). Two human genes, SCOl and SC02 , show homology to 
both yeast SCOl and SC02  (Petruzzella et al., 1998; Paret et al., 1999). Both are 
required for cytochrome oxidase function, and pathogenic mutations have been 
identified in both genes (for example (Vesela et al., 2004)). Copper supplementation of 
cultured cells derived from such patients has been reported to rescue cytochrome 
oxidase activity and COX2 protein levels (Jaksch et al., 2001; Salviati et al., 2002).
Scolp is generally thought to act by accepting copper ions from Coxl7p and 
transferring them to Cox2p. However in addition to its copper binding motif Scolp has 
several conserved residues in its active site similar to those found in peroxiredoxins and 
thiol :disulfide oxidoreductases, and its secondary structure has a typical thioredoxin 
fold. Therefore it was suggested that it might act not as a copper carrier, but to facilitate 
reduction of the cysteine residues in the Cox2p copper binding site to allow concomitant 
transfer of copper directly from Coxl7p to Cox2p (Chinenov, 2004; Balatri et al., 
2003). However, human SC02, containing these conserved active site residues, did not 
reduce disulfide bridges in a thioredoxin assay (Jaksch et al., 2001).
The presence of the copper-binding region of Scolp in the IMS, and the binding 
of Scolp to the IMS region of Cox2p, suggest that Cua site formation occurs after
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translocation of the Cox2p C-terminal domain through the IMM. Dickinson et al. have 
suggested that Cua site assembly occurs after the cytochrome oxidase complex is 
formed, since the mutation S240F in yeast SCOl allows assembly of the enzyme, albeit 
with a selective decrease in Cox2p (Dickinson et al., 2000). Conflicting evidence in 
humans has been provided by Williams et al. who found that fibroblasts with a SCOl 
mutation did not form subassemblies containing both Coxlp and Cox2p, indicating that 
Cua assembly is a prior requirement for the interaction of Coxlp with Cox2p, at least in 
the mammalian system (Williams et al., 2004).
Delivery of copper to Coxlp requires Cox lip , identified by Tzagoloff 
(Tzagoloff et al., 1990). Deletion of the COX11 gene in R. sphaeroides led to 
diminished accumulation of the aa3 type cytochrome oxidase, which lacked Cub but 
contained Cua and both hemes (Hiser et al., 2000). Since the oxidase formed was 
relatively stable, Cub insertion may be a late step in enzyme assembly. However, on 
deletion of COX11 in yeast no stable cytochrome oxidase is present, perhaps reflecting 
the differing complexity of the two organisms (Tzagoloff et al., 1990). Coxl lp  has been 
shown to interact with mitochondrial ribosomes, indicating a possible cotranslational 
insertion of copper into the Cub site (Khalimonchuk et al., 2005), which would make 
sense since the site is located deep within the membrane. Coxl lp has a similar structure 
to Scolp and binds a single copper atom (Carr et al., 2002). Direct transfer of copper 
from Coxl7p to Coxl lp has been demonstrated in the same way as described for Scolp 
(Homg et al., 2004). Homg et al. provided evidence to suggest that Coxl7p utilised two 
different areas of its surface in binding to its two substrates Scolp and Coxl 1 p. 
However, no stable interaction has been identified between Coxl7p and either Scolp or 
Coxl 1 p.
1.3.4. Quality control systems
Quality control of the assembly of IMM proteins is essential, since potentially 
deleterious aggregates of mitochondrial translation products could otherwise form in the 
membrane, dismpting cellular function. The degradation of unassembled subunits or 
incompletely assembled complexes is an important part of the assembly machinery. In 
yeast, this degradation process has proven especially efficient, and cytochrome oxidase 
assembly in yeast is regarded as an all or nothing process, with the mitochondrial 
subunits in particular being rapidly degraded if assembly cannot proceed.
A family of highly conserved ATP-dependent proteases termed the AAA 
proteases (ATPases Associated with a variety of cellular Activities) are believed to be
26
1. Introduction
of major importance in the degradation of unassembled subunits. In yeast, two such 
complexes exist. Both are located in the IMM and are around 1000 kDa in mass. The 
first, /-AAA, is a homo-oligomeric complex of Ymelp which exposes its catalytic 
domain to the IMS. Ymelp has been implicated specifically in the degradation of 
Cox2p. Cytochrome c-deficient yeast mutants are deficient in cytochrome oxidase, and 
lack Coxlp, Cox2p and Cox3p. Pulse chase experiments revealed that Cox2p is rapidly 
degraded in vivo in such strains. However when YME1 was deleted the levels of Cox2p 
and Cox3p were seen by western analysis to be partially restored (Pearce and Sherman,
1995). Similarly, Cox2p is degraded in Cox4p-deficient yeast, but mutation of YME1 
partially restored Cox2p levels (though not, in this experiment, Cox3p levels, which 
were also decreased by Cox4p deficiency) (Nakai et al., 1995). The second complex, m- 
AAA, is a hetero-oligomer of Afg3p and Rcalp, with its catalytic site exposed to the 
matrix side. This complex has been implicated in the degradation of several cytochrome 
oxidase subunits. For example, disruption of the proteolytic domain of yeast Afg3p 
reduced degradation of Coxlp and Cox3p compared to the wild type (Guelin et al.,
1996).
There are two models currently under consideration to explain the mechanism of 
protein degradation by the Afg3p/Rcalp complex and the Ymelp complex (Leonhard et 
al., 2000). The ‘shedding’ model suggests that the exposed loops of membrane-bound 
proteins are cleaved, destabilising the membrane-spanning segments and allowing 
proteolytic attack from the surface of the membrane. The two complexes could work 
together in this model, one acting from the IMS side and the other from the matrix side. 
Alternatively, the ‘pulling’ model suggests that the proteases actively remove 
membrane-spanning proteins from their hydrophobic environment for degradation, this 
made possible by an ATP-dependent conformational change of the protease on binding 
of the target protein.
AAA proteases show similarity to chaperones, and it has been suggested that in 
addition to their proteolytic activity they may play a chaperone-like role. They interact 
specifically with unfolded proteins but not with their folded counterparts. The 
interaction of Ymelp with a correctly folded model protein and a counterpart in which 
the extramembrane C-terminal domain was only loosely folded was analysed in vitro by 
Leonhard et al. (Leonhard et al., 1999). Ymelp associated with and degraded only the 
incorrectly folded protein, and the AAA domain was crucial for binding. Additionally, 
the AAA domain prevented the aggregation of denatured dihydrofolate reductase, 
presumed by the authors to be due to mediation of refolding. Loss of Afg3p abolished
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respiratory growth by impairing activity of the yeast respiratory chain complexes, 
indicating its importance in the assembly of cytochrome oxidase (Tauer et al., 1994). 
The simultaneous absence of both Afg3p and Ymelp is lethal in yeast, but when the 
proteolytically inactive variant of Afg3p is present this is not the case, suggesting that a 
chaperone-like function is in operation (Lemaire et al., 2000).
The existence of proteolytic activities in the mitochondria other than those 
described above is highly likely. The sensitivity of cytochrome oxidase subunits to 
degradation appears to be variable. The steady state levels of subunits may reflect both 
their intrinsic stability and protective associations with other subunits or assembly 
factors. The soluble subunits Cox4p and Cox6p appear to have a higher intrinsic 
stability than some of the membrane-bound subunits; they are relatively stable in 
assembly-arrested mutants (Glerum and Tzagoloff, 1997).
1.3.5. Association of subunits
It is not clear whether individual subunits diffuse in the membrane to find each other, or 
whether they are inserted at particular membrane sites. As discussed earlier, membrane- 
bound translational activators may direct synthesis of mitochondrially-encoded subunits 
to particular membrane sites in yeast, but no homologues have been identified in 
mammals. There appears to be no regulatory system coordinating synthesis of nuclear 
and mitochondrial subunits of cytochrome oxidase, in humans at least. When 
mitochondrial protein synthesis was persistently inhibited no decrease in nuclear protein 
synthesis was observed, and instead the excess of nuclear subunits was dealt with by 
enhanced degradation (Nijtmans et al., 1995).
The temporal order of subunit interaction is still not well understood. As 
discussed above, unassembled or incompletely assembled subunits in yeast are rapidly 
degraded in the face of assembly problem, hence yeast has so far not proven useful in 
the identification of assembly intermediates. However, degradation of unassembled 
mammalian subunits seems less severe, and several intermediates have been identified 
in human cells. Nijtmans et al. blocked cytosolic protein synthesis with cycloheximide 
to deplete pools of nuclear-encoded subunits and cause the accumulation of assembly 
intermediates (Nijtmans et al., 1998). This strategy allowed the detection of two 
intermediates. The first was a subcomplex containing COX1 and COX4 (yeast Coxlp 
and Cox5p), while the second contained all subunits except COX6A and COX7A or B 
(yeast Cox6ap and Cox7p). Williams et al. took this further and looked for 
accumulation of subcomplexes in cells derived from patients with mutations in the
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assembly factors SCOl, SURF1 (homologous to yeast Shylp) and COX 10 (Williams et 
al., 2004). The previously identified subassemblies accumulated in these cells, and use 
of additional antibodies demonstrated that the first subcomplex contained COX5A 
(yeast Cox6p) in addition to COX1 and COX4. It seems therefore that an early 
assembly step involves formation of a complex between COX1, COX4 and COX5A 
(yeast Coxlp, Cox5p and Cox6p), and the peripheral polypeptides COX6A and COX7A 
or B (yeast Cox6ap and Cox7p) are added in a final step. Although assembly of 
mammalian cytochrome oxidase is believed to be a sequential process, this is not 
necessarily the case for lower organisms. Coxlp in R. sphaeroides can form a complex 
with either Cox2p or Cox3p, suggesting that several pathways may be possible (Hiser 
and Hosier, 2002).
Cytochrome oxidase exists as a dimer, and the presence of cardiolipin may be 
required for dimer formation (Sedlak and Robinson, 1999). There is also evidence to 
suggest that cytochrome oxidase associates with the be \ complex to form a 
supracomplex within the IMM, leaving little enzyme present in free form (Schagger and 
Pfeiffer, 2000; Cruciat et al., 2000). The supracomplex would consist of the bc\ 
complex together with either one or two cytochrome oxidase dimers, and is thought to 
allow cytochrome c to be channelled quickly from the bc\ complex to cytochrome 
oxidase, improving efficiency. However the association is not required for stability of 
either enzyme. The stability of such supracomplexes is also promoted by cardiolipin 
(Zhang et al., 2002; Pfeiffer et al., 2003).
1.3.6. Cytochrome oxidase disorders
The importance of the study of assembly of cytochrome oxidase lies partly in its 
relevance to human disease. Many of the assembly factors identified in yeast have 
human homologues. Mitochondrial disease is associated with a wide range of clinical 
presentations, even for mutation of a single gene, and phenotypes are commonly tissue- 
specific. Mammalian cells contain hundreds of mitochondria, and therefore thousands of 
copies of mtDNA; a cell can contain mutant mtDNA in addition to wild type mtDNA 
(heteroplasmy; this is not the case in yeast), and the relative proportions of these are 
likely to contribute to the tissue specificity. Those tissues with high energy demand 
(muscle, heart, brain) tend to be most affected. Phenotypes include myopathy, 
encephalomyopathy, MELAS (mitochondrial encephalopathy, lactic acidosis, and 
stroke-like episodes), LHON (Leber’s hereditary optical neuropathy) and Leigh
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syndrome (an early-onset fatal neurodegenerative disorder). Defects tend to be early- 
onset and prognosis is generally unfavourable.
Cytochrome oxidase deficiency is one of the most frequent causes of respiratory 
chain defect in humans (Barrientos et al., 2002). It can be caused by mutation in the 
mitochondrial genome (subunits of the enzyme or tRNA or rRNA mutations) or the 
nuclear genome. No mutation in any of the nuclear encoded subunits of cytochrome 
oxidase has ever been identified, although autosomal recessive mutations in several of 
the nuclear-encoded assembly factors required for synthesis have been found. Several 
mutations of the mitochondrial subunits have been reported, and their effects have been 
studied using the yeast and R. sphaeroides models (Meunier, 2001; Bratton et al., 2003).
1.4. NITRIC OXIDE
The second part of my thesis relates to nitric oxide (NO), a gaseous uncharged free 
radical which has intricate connections with the respiratory chain and in particular 
cytochrome oxidase. NO is synthesised from L-arginine by a family of NO synthase 
(NOS) enzymes (Alderton et al., 2001), and has several physiological and 
pathophysiological roles. NO can diffuse between cells (Lancaster, Jr., 1994), though its 
hydrophobicity means that it has a tendency to partition into membranes (Liu et al.,
1998). NO coordinates transition metals such as iron, manganese and copper (Henry et
• 9 4 - • •  • •al., 1993). Of particular importance, NO can easily bind Fe , either in free form, in iron 
sulfur centres, or in hemoproteins where the heme has a free ligand position (Cooper,
1999). In mammalian cells the main mechanism of NO breakdown is through its 
reaction with hemoglobin (Wennmalm et al., 1993).
1.4.1. Physiological functions of NO
NO has several physiological functions in mammalian cells. Its physiological 
importance was first recognised when it was identified as EDRF (endothelium derived 
relaxing factor), an intracellular messenger causing relaxation of smooth muscle 
(Palmer et al., 1987; Ignarro et al., 1987). NO produced in endothelial cells on 
activation with, for example, acetylcholine, diffuses to the smooth muscle to cause 
relaxation and dilation, part of the normal regulation of blood flow. NO is also produced 
post-synaptically by neurons, and is involved in neurotransmission and 
neuromodulation, particularly in memory formation (Susswein et al., 2004). 
Additionally, NO inhibits platelet aggregation and adhesion (Moncada et al., 1991). All 
of these physiological effects are primarily mediated through activation of the soluble 
guanylate cyclase: NO binds Fe2+ in the heme group of this enzyme, triggering the
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production of cGMP from GTP, which can then act on cGMP-dependent protein kinases 
or cGMP-gated ion channels (Denninger and Marietta, 1999). Yeast do not appear to 
have a homologue to the soluble guanylate cyclase. A further possible physiological 
role of NO in regulating respiration at the level of cytochrome oxidase is discussed 
below.
1.4.2. Reversible inhibition of cytochrome oxidase by NO
NO has been known for many years to bind cytochrome oxidase, and was widely used 
to study the effects of inhibition of cytochrome oxidase. NO competes with oxygen for 
the active site of cytochrome oxidase, binding reduced heme a3 or oxidised Cub (Sarti et 
al., 2003). However, only in recent years has the possibility that this might have 
biological relevance been considered. There is now increasing evidence to suggest that 
inhibition of cellular respiration through the action of NO on cytochrome oxidase may 
have a physiological role in mammalian cells. Several investigations have demonstrated 
that physiological concentrations of NO can rapidly and reversibly inhibit cell 
respiration at the level of cytochrome oxidase in mammalian cells.
In 1994, Cleeter et al. showed that NO inhibited respiration through inhibition of 
cytochrome oxidase activity in isolated mitochondria (Cleeter et al., 1994). 
Subsequently, Brown and Cooper demonstrated that sub-micromolar levels of NO, 
likely to be present in some physiological conditions, rapidly and reversibly inhibited 
respiration in rat brain synaptosomes and isolated bovine cytochrome oxidase, through 
competition with oxygen for the cytochrome oxidase active site (Brown and Cooper, 
1994). Brown et al. also showed that the addition of activated macrophages to a 
fibroblast or non-activated macrophage culture reversibly inhibited respiration in the 
second cell population, and that this was due to NO but did not involve the soluble 
guanylate cyclase (Brown et al., 1998), demonstrating that the inhibition of cytochrome 
oxidase could be caused by endogenously produced NO and was not confined to the 
NO-producing cell.
Brown has suggested that the acute reversible inhibition of cytochrome oxidase 
by NO may physiologically regulate mitochondrial respiration. NO increases the Km of 
cytochrome oxidase for oxygen, and could allow cytochrome oxidase to act as an 
oxygen sensor, regulating its consumption at the point where it is consumed (Brown, 
1995a). This has been suggested to lead to ‘metabolic hypoxia’, meaning that 
cytochrome oxidase cannot use the available oxygen, which could have 
pathophysiological consequences (Moncada and Erusalimsky, 2002). Additionally,
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since cytochrome oxidase is responsible for virtually all cellular oxygen consumption, it 
would result in increased cellular oxygen levels which could have implications for 
signalling pathways regulated by oxygen concentration (Moncada and Erusalimsky, 
2002).
1.4.3. Antimicrobial action of NO
In yeast there is no clear evidence for the existence of a NOS enzyme, therefore NO is 
unlikely to play any physiological role in this organism. However, NO is released in 
high concentrations by the macrophages of the mammalian innate immune system upon 
infection with pathogenic bacteria, viruses, parasites and fungi (Hibbs, Jr. et al., 1987; 
Marietta et al., 1988; MacMicking et al., 1997). Three NOS enzymes, eNOS 
(endothelial), nNOS (neuronal) and iNOS (inducible), as well as the controversial 
mtNOS (mitochondrial) have been described (Ghafourifar and Richter, 1997; Tatoyan 
and Giulivi, 1998; Alderton et al., 2001). In macrophages, NO is synthesised by the 
inducible iNOS (MacMicking et al., 1997). NO has cytotoxic and cytostatic properties 
against pathogens and, together with reactive oxygen species (ROS), which are also 
generated by cells of the immune system by the enzyme NADPH oxidase (Klebanoff, 
1971; Nathan and Root, 1977), provides a first line of defence against pathogen 
infection (Mastroeni et al., 2000). The release of NO by activated macrophages has also 
been implicated in mammalian pathology, including inflammatory diseases such as 
arthritis (McCartney-Francis et al., 1993) and neurodegenerative diseases such as 
Parkinson’s disease (Shergill et al., 1996).
The mechanism by which the NO produced by macrophages gives rise to 
antimicrobial action is unclear. At high concentrations and/or on prolonged exposure, 
NO can react with other molecules, including ROS, to form species collectively 
described as reactive nitrogen species (RNS), which can react with a wide variety of 
cellular targets. It is likely that such species contribute to the effect. In the next few 
sections I will discuss the formation of RNS, their targets, the formation of ROS, which 
may also be involved in the antimicrobial effect of NO, and the mechanisms of defence 
the cell employs against RNS and ROS.
1.5. REACTIVE NITROGEN SPECIES AND THEIR TARGETS
RNS are formed in the reaction of N O  with other species. N O  reacts slowly with oxygen 
to produce nitrogen dioxide (NO2), which can react with another N O  radical to generate 
dinitrogen trioxide (N2O3). These reactions are particularly prevalent within 
membranes, where N O  tends to accumulate (Liu et al., 1998). NO2 can nitrate several
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molecules, including tyrosine. Tyrosine nitration can cause protein dysfunction and has 
been identified in diseases such as atherosclerosis (Leeuwenburgh et al., 1997). A 
proteomic study of nitrated proteins after cytokine induction of iNOS in rat cells or 
tissues identified over forty nitrated proteins, and a third of these were mitochondrial, 
for example glutamate dehydrogenase, aconitase, creatine kinase, COX5 and ATP 
synthase (Aulak et al., 2001). N2O3 can nitrosate (add NO+ to) thiols or amines. 
Nitrosation of thiols generates S-nitrosothiols, and the NO+ group is directly 
transferable from one thiol to another, in a process called transnitrosation. S-nitrosation 
of cysteine thiols has been implicated in redox-based signalling, regulating a wide 
variety of pathways (Hess et al., 2005).
NO also reacts with the radical superoxide anion (O2") to produce peroxynitrite 
(ONOO ), a highly reactive oxidant and strong nitrating agent. Peroxynitrite has been 
implicated in many of the deleterious cellular actions of NO. It can mediate oxidation of 
deoxyribose (Beckman et al., 1990), methionine (Moreno and Pryor, 1992), thiols (Radi 
et al., 1991a), phospholipids (Radi et al., 1991b) and causes DNA strand cleavage (King 
et al., 1992). It can also nitrate tyrosine residues (Beckman et al., 1992).
1.5.1. Irreversible inhibition of respiratory chain enzymes by NO/RNS
The enzymes of the respiratory chain are perhaps the most widely studied targets of 
NO/RNS. Irreversible or persistent inhibition has been found to occur under high 
concentrations or on prolonged periods of incubation with NO, and evidence suggests 
that RNS rather than NO itself mediates the inhibition. The antimicrobial effect of NO 
could be partly mediated through inhibition of the respiratory chain, either irreversible, 
or reversible at cytochrome oxidase.
Using the NO donor DETA NONOate, Clementi et al. showed that prolonged 
exposure to NO causes persistent inhibition of NADH dehydrogenase (Clementi et al., 
1998). The inhibition was reversible by light and thiols (glutathione or DTT); S- 
nitrosation can be reversed by light or reduced thiols, so the mechanism of inhibition 
has been proposed to be via S-nitrosation of critical thiol residues (Clementi et al., 
1998). In support of this, the S-nitrosothiol NO donors SNAP and GSNO inhibit NADH 
dehydrogenase even in conditions where little NO is released, in a manner which is 
reversible by light or thiols (Borutaite et al., 2000). However, other evidence suggests 
that peroxynitrite might be involved. Addition of peroxynitrite causes NADH 
dehydrogenase inhibition and in some studies this is also partly relieved by light and 
thiols (Cassina and Radi, 1996; Borutaite et al., 2000; Riobo et al., 2001). Peroxynitrite
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scavengers were not found to prevent inhibition of respiration in the study by Clementi 
et al. (Clementi et al., 1998), but another study found partial prevention of the NO- 
induced NADH dehydrogenase inhibition (Riobo et al., 2001). Since peroxynitrite is a 
poor nitrosating agent this suggests that mechanisms other than S-nitrosation are 
involved. There is some evidence to suggest that peroxynitrite can nitrate tyrosines in 
NADH dehydrogenase (Yamamoto et al., 2002). As discussed earlier, S. cerevisiae does 
not contain a conventional NADH dehydrogenase, instead having three non-membrane- 
spanning NADH dehydrogenases. However, the above discussion serves to illustrate the 
complexity of the chemistry which can result in consequence of NO.
Succinate dehydrogenase and the bc\ complex, like NADH dehydrogenase, 
contain non-heme iron-sulfur centres. However, inhibition of these complexes has not 
been as consistently observed as has the inhibition of NADH dehydrogenase. Some 
studies have found that NO inhibits succinate dehydrogenase; both peroxynitrite 
(Cassina and Radi, 1996; Radi et al., 1994) and destruction of the iron-sulfur centres 
(Welter et al., 1996; Geng et al., 1992) has been implicated in this. Other authors find 
the bc\ complex but not succinate dehydrogenase inhibited (Poderoso et al., 1996; 
Pearce et al., 2001).
Bolanos et al. have reported irreversible inhibition of cytochrome oxidase in 
astrocytes after prolonged incubation (over 18 hours) with NO, with no change in 
NADH dehydrogenase or succinate dehydrogenase activity (Bolanos et al., 1994). This 
was suggested to be due to the peroxidation of cardiolipin, which has been shown to 
inhibit cytochrome oxidase activity (Heales et al., 1994; Paradies et al., 2000). 
Irreversible inhibition of cytochrome oxidase activity by RNS has also been associated 
with a decrease in steady state enzyme level (Sharpe and Cooper, 1998; Leary et al., 
2002; Ramachandran et al., 2004).
1.5.2. Other protein targets
Aside from the components of the respiratory chain, RNS are likely to have a myriad of 
other protein targets. Here, I review some of the major targets identified in mammalian 
cells. Mitochondrial aconitase, a component of the citric acid cycle catalysing the 
isomerisation of citrate to isocitrate, is inhibited in co-cultivated cells by activated 
macrophages (Drapier and Hibbs, 1986). The mechanism of inhibition may be through 
S-nitrosation of the aconitase iron-sulfur centre (Gardner et al., 1997) or disruption of 
the centre by peroxynitrite (Hausladen and Fridovich, 1994; Castro et al., 1998). 
Mitochondrial creatine kinase is involved in export of ATP from the mitochondrion.
34
1. Introduction
Inhibition of the kinase was observed in the presence of NO donor, and was reversible 
on addition of the reducing agent DTT, therefore the mechanism of inhibition was 
suggested to be through S-nitrosation of a critical active site cysteine (Gross et al., 1996; 
Wolosker et al., 1996). However, peroxynitrite can also inhibit creatine kinase activity, 
and oxidation of the critical thiol has also been proposed (Stachowiak et al., 1998; 
Konorev et al., 1998). The glycolytic enzyme GAPDH, catalysing the rate-limiting step 
in glycolysis, is also inhibited by NO (Dimmeler et al., 1992). Peroxynitrite can oxidise 
the active-site cysteine (Souza and Radi, 1998) and S-nitrosation of the same cysteine 
has also been implicated in the inhibition (Padgett and Whorton, 1995; Beltran et al., 
2000).
NO also causes reversible inhibition of catalase, the enzyme which converts 
hydrogen peroxide into water and molecular oxygen, probably by competitive inhibition 
with hydrogen peroxide at the active site heme (Brown, 1995b). This might be expected 
to lead to increased hydrogen peroxide levels and consequent cell damage. NO also 
inhibits glutathione reductase, via the formation of S-nitrosothiols (Butzer et al., 1999). 
This enzyme recycles oxidised glutathione (GSSG) to regenerate reduced glutathione 
(GSH) which, as will be seen later, is important in detoxification.
The cytochrome P450 superfamily contains heme iron, and NO has been found 
to decrease the activity of cytochrome P450 enzymes (Morgan et al., 2001). The 
inhibition can be both reversible at the heme iron of cytochrome P450, and irreversible, 
perhaps via modification of thiols or nitration of tyrosine residues by peroxynitrite 
(Minamiyama et al., 1997; Roberts et al., 1998; Quaroni et al., 2004). In yeast, 
cytochrome P450-containing enzymes are involved in the synthesis of ergosterol, an 
essential component of the fungal cell wall. Ribonucleotide reductase, the rate-limiting 
enzyme in DNA synthesis, is also inhibited by NO (Kwon et al., 1991). The enzyme 
catalyses the reduction of ribonucleotides to their corresponding deoxyribonucleotides, 
to be used as precursors in DNA synthesis. The inhibition may be due to S-nitrosation 
of one or more of the cysteine residues involved in electron transfer (Roy et al., 1995) 
and/or disruption of a stable tyrosyl free radical in the enzyme (Lepoivre et al., 1994; 
Lemaire et al., 1999).
1.5.3. DNA and lipid damage
RNS target other cellular components in addition to proteins. DNA damage has been 
reported, and is due to both deamination mediated by N2O3 and oxidation by 
peroxynitrite (Dedon and Tannenbaum, 2004). A yeast mutant deficent in DNA repair
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was more sensitive to NO-induced toxicity than wild type yeast (Tamir et al., 1996). 
Since peroxynitrite production is likely to be concentrated in the mitochondria, mtDNA 
may be particularly at risk of mutagenesis. mtDNA is also inherently less protected 
from such damage due to the absence of protective histones and the apparent 
incapability of mitochondria to perform nucleotide-excision repair (Yakes and Van 
Houten, 1997). Peroxynitrite has been shown to cause a higher level of damage to 
mtDNA than nuclear DNA (Ballinger et al., 2000).
Lipids are another target of RNS. Lipid peroxidation is initiated by free radicals, 
which remove hydrogen from unsaturated lipids to generate lipid radicals, which 
combine with oxygen and propagate a chain of lipid peroxidation. Peroxynitrite and 
NO2 can initiate this process (Pryor and Lightsey, 1981; Radi et al., 1991b; O'Donnell et 
al., 1997). As mentioned earlier, peroxidation of cardiolipin may be involved in the 
irreversible inhibition of cytochrome oxidase caused by NO.
1.5.4. Production of ROS by the respiratory chain
Inhibition of the respiratory chain by NO/RNS, whether reversible or irreversible, 
would lead to the respiratory chain being in a more reduced state. The respiratory chain 
is a major site of superoxide generation, and its inhibition by NO has been shown to 
increase the amount of superoxide generated (Poderoso et al., 1996). This might 
therefore be expected to increase peroxynitrite production (Packer et al., 1996). 
Synthesis of highly reactive peroxynitrite in close proximity to the respiratory chain is 
likely to further potentiate the action of NO (Moncada and Erusalimsky, 2002). It is not 
surprising that many of the enzymes identified to be inhibited by NO are located in the 
mitochondria, since this is where the formation of peroxynitrite will be at its highest.
When the respiratory chain is highly reduced, electrons can ‘escape’ and react 
with oxygen to form superoxide. Many of the redox centres of the electron transport 
chain are one electron carriers, so could potentially donate one electron to molecular 
oxygen, generating the superoxide radical. In particular, the oxidation of ubiquinol 
(UQH2) to ubiquinone (UQ) at the Q0 site of the bc\ complex takes place in two one- 
electron steps, allowing the transient formation of ubisemiquinone (UQH). The 
unpaired electron can be transferred to molecular oxygen (Boveris et al., 1976; Cadenas 
et al., 1977). When the respiratory chain is reduced the existence of ubisemiquinone will 
be prolonged, increasing the likelihood of reaction with oxygen. Additionally, 
superoxide is generated by NADH dehydrogenase at the flavin mononucleotide group, 
the first electron carrier of the complex (Turrens and Boveris, 1980; Liu et al., 2002).
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ROS include the superoxide anion, hydrogen peroxide (H2O2) and the hydroxyl 
radical (OH ). These are highly reactive and therefore transient species. Superoxide 
spontaneously dismutates to oxygen and hydrogen peroxide, a process which can be
1
accelerated by the enzyme superoxide dismutase. On reaction with Fe the hydroxyl 
radical is generated by hydrogen peroxide. This is a powerful oxidant, and can cause 
damage to proteins, lipids and DNA.
1.6. ROS/RNS DEFENCE IN YEAST
Microorganisms have developed numerous defence strategies, both enzymatic and non- 
enzymatic, to protect against damaging reactive species, involving both the 
detoxification of the reactive species themselves and the repair or removal of damaged 
cellular constituents. The defences against ROS have been well studied, however, 
defence mechanisms against RNS are less well defined. Below I review the major 
enzyme-based ROS and RNS defences.
1.6.1. Superoxide dismutase
One of the most important antioxidant activities in the cell is superoxide dismutase, 
which catalyses the conversion of one ROS (superoxide) into another ROS (hydrogen 
peroxide). The reaction can also proceed spontaneously in the absence of enzyme. Yeast 
contain a cytosolic copper,zinc superoxide dismutase encoded by the SOD1 gene and a 
mitochondrial manganese superoxide dismutase encoded by the SOD2 gene. When 
SOD2 is deleted the cell is sensitive to high oxygen levels (van Loon et al., 1986), and 
when SOD2 is mutated this causes severely increased sensitivity to conditions which 
enhance ROS production by the respiratory chain (Piper, 1999). Removal of superoxide 
would be expected to decrease the level of highly reactive peroxynitrite formed in the 
reaction between NO and superoxide, hence superoxide dismutase may protect against 
the actions of RNS in addition to its more obvious role in protection against ROS (De 
Groote et al., 1997).
1.6.2. Yhblp
In yeast, the main defence mechanism against NO is thought to be the NO 
oxidoreductase Yhblp, encoded by the YHB1 gene. This is part of the widely conserved 
flavohemoglobin family, which contain a globin element containing heme b and a 
reductase element with binding sites for FAD and NAD(P)H, and are widely distributed 
in bacteria and fungi (Poole and Hughes, 2000). Evidence suggests that bacterial 
flavohemoglobins act as oxygenases consuming NO to produce nitrate under aerobic
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conditions (Kim et al., 1999), and as NO reductases to form N2O under anaerobic 
conditions (Hausladen et al., 1998). The yeast Yhblp probably has the same function 
(Liu et al., 2000).
1.6.3. Glutathione
Glutathione (y-glutamylcysteinylglycine) is an abundant low molecular weight thiol. 
Synthesis of glutathione requires y-glutamylcysteine synthetase (Gshlp) and glutathione 
synthetase (Gsh2p). The peptide has many functions including free radical scavenging, 
mediated by the redox-active sulfhydryl group of the cysteine residue (Meister, 1988). 
Glutathione cycles between a reduced form (GSH) and an oxidised form (GSSG), in 
which two peptides are linked by a disulfide bond. Reduced glutathione (GSH) is 
oxidised by ROS/RNS, forming a disulfide bond with another GSH to generate oxidised 
glutathione (GSSG). Regeneration of GSH from GSSG requires NADPH and is 
catalysed by glutathione reductase (Glrlp). GSH may scavenge RNS or reverse the 
modifications they make to proteins. S-nitrosation of thiols, and thiol oxidation, will 
deplete the cellular pool of GSH, making damage to other cellular components more 
likely (Radi et al., 1991a). Inhibition of NADH dehydrogenase seems to be preceded by 
a drop in reduced glutathione levels (Beltran et al., 2000).
GSH can also form conjugates with compounds requiring excretion, including 
epoxides (Meister 1988), in a reaction catalysed by glutathione S-transferase (Gttlp, 
Gtt2p). The conjugates are then pumped out of the cytosol into the vacuole. In 
mammalian cells, this is achieved by the MRP (multidrug associated resistance protein) 
sub-family of ABC transporters. In yeast, the MRP-like Ycflp family carries out the 
function (Li et al., 1996).
1.6.4. Removal of peroxides
Several systems are in place for removal of hydrogen peroxide and other peroxides. 
Catalase catalyses the conversion of hydrogen peroxide into water and molecular 
oxygen. Yeast contain two catalases: catalase A (Ctalp) is peroxisomal and involved in 
removal of hydrogen peroxide formed during fatty acid oxidation (Hiltunen et al., 
2003), while catalase T (Cttlp) is cytoplasmic and plays a more general antioxidant 
role. Mitochondrial cytochrome c peroxidase (Ccplp) also degrades hydrogen peroxide, 
using electrons from cytochrome c. Expression of this enzyme increases during 
respiratory growth and on treatment with hydrogen peroxide (Kwon et al., 2003). 
Interestingly, expression also increases in the presence of peroxynitrite, suggesting a 
possible role in detoxification of RNS (Kwon et al., 2003).
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Glutathione peroxidases use GSH as a reductant to break down both hydrogen 
peroxide and larger peroxides. Phospholipid hydroperoxide glutathione peroxidases 
differ functionally from classical glutathione peroxidases in that they are able to 
additionally break down lipid hydroperoxides, and are therefore involved in the repair 
of lipid peroxidation. Yeast does not contain any classical glutathione peroxidases, but 
contains three phospholipid hydroperoxide glutathione peroxidases, encoded by the 
genes GPX1, GPX2 and GPX3 (Avery and Avery, 2001).
Glutaredoxins also use GSH as a reductant. Like the glutathione peroxidases 
they reduce hydroperoxides, so have overlapping function (Collinson et al., 2002; 
Collinson and Grant, 2003). S. cerevisiae has two glutaredoxins (GRX1 and GRX2) 
containing two redox active cysteines in the active site, and three glutaredoxin-related 
proteins (GRX3, GRX4 and GRX5), each containing one active site cysteine. The 
glutaredoxins were also shown to have glutathione S-transferase activity (Collinson and 
Grant, 2003).
Peroxiredoxins, or thiol peroxidases, also scavenge peroxides. S. cerevisiae has 
five peroxiredoxins (Park et al., 2000). There are two types, 1-Cys peroxiredoxins and 
2-Cys peroxiredoxins. When oxidised the 2-Cys variety forms an intramolecular 
disulfide bridge which requires thioredoxin for reduction. The regeneration of 
thioredoxin is, in turn, mediated by thioredoxin reductase. Tsalp and Tsa2p, 2-Cys 
peroxiredoxins, both detoxify hydrogen peroxide, while Tsa2p can additionally 
scavenge peroxynitrite (Wong et al., 2002).
1.6.5. Transcription factors involved in the response to stress
ROS and RNS, as we have seen, interact with multiple cellular components, which will 
give rise to cellular stress. This will induce a response at the transcriptional level to 
enable the cell to adjust to the stress sensed. Three transcription factors which may be 
relevant in the cellular response to NO/RNS treatment are Msn2p, Msn4p and Yaplp. 
Msn2p and Msn4p are homologous zinc finger transcription factors which bind 
specifically to stress response elements (STREs; C4T) to activate genes (Estruch and 
Carlson, 1993; Schmitt and McEntee, 1996). Their intracellular location is sensitive to 
environmental stress, and in conditions of stress the proteins accumulate in the nucleus. 
These transcription factors mediate the general response to stress (Schmitt and 
McEntee, 1996; Martinez-Pastor et al., 1996). Yaplp, a member of the AP-1 group of 
transcription factors, containing a bZIP (leucine zipper) domain, is specifically involved 
in the response to oxidative stress (Rodrigues-Pousada et al., 2004). Like Msn2/4p,
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regulation of Yaplp takes place at the level of subcellular localisation. In conditions of 
oxidative stress the protein accumulates in the nucleus where it activates the 
transcription of oxidative stress response genes (Kuge et al., 1997). Another 
transcription factor Skn7p was identified in a screen of mutants sensitive to oxidative 
stress (Krems et al., 1996). Like Yaplp, it has been shown to regulate the transcription 
of several genes involved in the response to oxidative stress (Morgan et al., 1997; Lee et 
al., 1999).
1.7. AIMS OF THIS THESIS
1.7.1. Cytochrome oxidase assembly
Chapter 3 attempts to provide more information on the pathway of synthesis of 
cytochrome oxidase, using yeast as a model system. The structure of cytochrome 
oxidase of the yeast S. cerevisiae closely resembles that of its mammalian counterpart 
(see Table 1.1) (Taanman, 1997). Full genomic sequence data has been available for 
yeast since 1996, and yeast is amenable to genetic manipulation. Yeast are facultative 
anaerobes, so can ferment the pyruvate produced in glycolysis. This means that the 
organism is viable in the absence of a functional respiratory chain, allowing study of 
mutant strains. Unlike mammalian cells, yeast cells can tolerate only one type of 
mtDNA, hence manipulation of yeast mtDNA allows creation of homoplasmic cells and 
mutations in the mtDNA-encoded respiratory chain subunits can also be studied. Yeast 
has proven extremely useful in deciphering the roles of particular subunits and residues 
in the function of cytochrome oxidase, and in the identification of nuclear proteins 
involved in the cytochrome oxidase assembly process. However, as discussed earlier, 
when there is a defect in cytochrome oxidase assembly, unassembled subunits in yeast 
are rapidly degraded by mitochondrial proteases. Consequently the use of yeast to 
investigate the sequential assembly process of cytochrome oxidase has been limited 
because of the absence of partially assembled intermediates, and to date there is only 
one report of cytochrome oxidase subassemblies identified in yeast (Church et al., 
2005).
I screened yeast strains with mutations in the COX2 gene to identify assembly- 
defective strains. This was achieved by analysing the UV-Vis spectrum of the cells and 
assessing the concentration of cytochrome oxidase present as determined by absorbance 
of heme aa$. I then characterised those strains with assembly defects. Two strains 
which, unusually, contained partially assembled cytochrome oxidase, were further 
analysed using blue native electrophoresis to investigate the presence of assembly
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complexes, providing information on the sequential process of assembly of cytochrome 
oxidase.
1.7.2. Antimicrobial action of nitric oxide
Much research has concentrated on the physiological actions of NO occurring in 
mammalian cells in the presence of low concentrations of the gas. However, the 
antimicrobial actions of NO on pathogenic bacteria, viruses, parasites and fungi, 
resulting from its release in higher concentrations by macrophages, has been less well 
characterised. Here, I used S. cerevisiae as a model system to study the antimicrobial 
action. The action is likely to be mediated by RNS, formed on reaction of NO with other 
molecules such as molecular oxygen or the superoxide radical. Several studies have 
shown that the NO oxidoreductase Yhblp is likely to be the main protective mechanism 
against NO in some microorganisms, including S. cerevisiae, limiting the exposure of 
cellular targets to damaging RNS (Liu et al., 2000; Hromatka et al., 2005; 2005; Sarver 
and DeRisi, 2005). Consequently, to detect other proteins contributing to the defence 
against NO/RNS, I analysed the effect of NO/RNS on yeast strains lacking the YHB1 
gene.
In Chapter 4 I characterised the effect of NO/RNS on yeast cell proliferation and 
viability, and on the components of the respiratory chain. In Chapter 5 I used a genomic 
approach to determine the systems/proteins which are targeted by RNS stress, and the 
strategies used by the cells to withstand the stress. I identified those genes which had 
altered expression on treatment with NO/RNS, and analysed the data in such a way as to 
exclude the contribution of the general stress response. I also studied the roles of the 
transcription factors Msn2/4p and Yaplp in the gene expression response to RNS 
treatment.
The formation of RNS and their actions in the cell involve complex chemistry, 
and I did not attempt to distinguish between NO and RNS involvement in the 
antimicrobial action. However, I did assess the contribution of the respiratory chain to 
the growth inhibition and gene expression changes. This provides information about the 
role of respiratory chain inhibition (both reversible and irreversible) in the stress sensed 
by the cell. Additionally, since the respiratory chain is the major source of ROS 
production, it gives clues as to whether ROS have a major involvement in the stress.
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Figure 1.1. The respiratory chain.
Electron flow through the respiratory chain complexes leads to pumping of protons from the matrix to the 
IMS, generating a gradient of protons which return to the matrix through the ATP synthase (complex V), 
accompanied by the generation of ATP. UQ, ubiquinone.
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Figure 1.2. Structure of bovine cytochrome oxidase.
The atomic structure is from the bovine enzyme (PDB lOCC) and bovine numbering is used. A. Structure of the core subunits COX1, COX2 and COX3. 
B. Structure of the entire cytochrome oxidase monomer.
1. Introduction
Table 1.1. Yeast cytochrome oxidase subunits and their mammalian counterparts. aData obtained 
from the Saccharomyces Genome Database (www.yeastgenome.org). bData obtained from (Taanman, 
1997). cData obtained from the bovine structure (Tsukihara et al., 1996).dSize of full length transcript. 
6Interchangeable isoforms (Cumsky et al., 1985): Cox5ap is expressed at high oxygen tension, Cox5bp at 
low oxygen tension (Poyton and Burke, 1992). fYeast Cox7ap also shows some homology to mammalian 
C0X8. Yeast subunits corresponding to mammalian C0X7B have not been identified.
Yeast
subunit
Gene
name8
Mammalian
counterpart6
Interacts
withc
Molecular
weight
(kDa)d
Location0 Disruption of 
fungal gene
Coxlp C0X1 C0X1 C0X2
C0X3
C0X4
C0X7C
58.8 IMM Assembly defect 
(Lemaire et al., 
1998)
Cox2p C0X2 COX2 C0X1
C0X6B
C0X6C
28.6 IMM Assembly defect 
(Slonimski and 
Tzagoloff, 1976; 
Lemaire et al., 
1998)
Cox3p C0X3 COX3 COX1
C0X4
COX6A
C0X6B
C0X7A
30.4 IMM Assembly defect 
(Haltia et al., 
1989; Lemaire 
et al., 1998)
Cox4p C0X4 COX5B C0X1
C0X3
17.1 Matrix
extrinsic
Assembly defect 
(Dowhan et al., 
1985)
Cox5ap/
Cox5bpe
C0X5
A/B
C0X4 C0X5A
COX7B
C0X8
17.1/17.2 IMM Assembly defect 
(McEwan et al., 
2004)
(Glerum and 
Tzagoloff, 1997)
Cox6p C0X6 C0X5A C0X4
COX6C
17.3 Matrix
extrinsic
Assembly defect 
(Glerum and 
Tzagoloff, 1997)
Cox6ap C0X13 C0X6A C0X3
COX1
(other
monomer)
15.0 IMM Altered activity 
(dependent on 
ionic strength) 
(Taanman and 
Capaldi, 1993)
Cox6bp C0X12 C0X6B COX2
COX3
COX6B
(other
monomer)
9.8 IMS
extrinsic
Partial assembly 
defect
(LaMarche et 
al., 1992)
Cox7p C0X7 C0X7A COX3 6.9 IMM Assembly defect 
(Aggeler and 
Capaldi, 1990; 
Calder and 
McEwen, 1990)
Cox7ap C0X9 C0X6Ct COX2
COX5A
7.0 IMM Assembly defect 
(Wright et al., 
1986)
Cox8p C0X8 C0X7C C0X1 8.9 IMM Diminished
activity
(Patterson and 
Poyton, 1986)
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Table 1.2. Accessory proteins involved in cytochrome oxidase assembly. Assembly factors 
specifically involved in the assembly of cytochrome oxidase are shown. Yeast nomenclature is used.
Protein Function Location Reference
Arhip Heme a biosynthesis IMM (Barros et al., 2001)
CoxlOp Heme a biosynthesis IMM (Tzagoloff etal., 1993)
Coxl 1 p Delivery of copper to Coxl p IMM (Hiser et al., 2000)
Cox14p Unknown IMM (Glerum etal., 1995)
Cox15p Heme a biosynthesis IMM (Barros et al., 2001)
Cox16p Unknown IMM (Carlson et al., 2003)
Cox17p Delivery of copper to Sco1 p and 
Coxl 1 p
Cytosol; IMS (Glerum etal., 1996a)
Cox18p Translocation of Cox2p C-terminus 
into IMS
IMM (Saracco and Fox, 2002)
Cox19p May be involved in copper insertion; 
has homology to Cox17p
Cytosol; IMS (Nobrega et al., 2002)
Cox20p Required for Cox2p N-terminal 
presequence cleavage
IMM (Hell etal., 2000)
Cox23p May be involved in copper insertion; 
has homology to Cox17p
IMS (Barros et al., 2004)
Cox24p Translation of COX1 mRNA IMM (Barros et al., 2006)
Implp,
Imp2p
Cleavage of Cox2p N-terminal 
presequence
IMM (Behrens et al., 1991) 
(Bauer et al., 1994)
Mbalp Translocation of subunits IMM (Preuss et al., 2001)
Mia40p Import of metal-containing proteins IMS (Chacinska et al., 2004; 
Terziyska et al., 2005)
Mss2p Translocation of Cox2p IMM (Broadley et al., 2001)
Mss51p Translation of COX1 mRNA; insertion 
of Coxlp into the IMM
IMM (Perez-Martinez et al., 
2003)
(Siep et al., 2000)
Oxalp Translocation of Cox2p N-terminus 
into the IMS
IMM (Hell etal., 2001)
Pet54p Translation of COX3 mRNA IMM (Costanzo et al., 1986)
Pet1 OOp Matrix incorporation of a subcomplex 
containing Cox7p, Cox7ap and 
Cox8p
IMM (Church et al., 1996) 
(Church et al., 2005)
Pet111 p Translation of COX2 mRNA IMM (Mulero and Fox, 1993)
Pet117p Unknown IMM (McEwen et al., 1993)
Pet122p Translation of COX3 mRNA IMM (Kloeckener-Gruissem et 
al., 1988)
Pet191p Unknown IMM (McEwen et al., 1993)
Pet309p Translation of COX1 mRNA IMM (Manthey and McEwan, 
1995)
Pet494p Translation of COX3 mRNA IMM (Costanzo and Fox, 1986)
Pntlp Translocation of Cox2p IMM (He and Fox, 1999)
Scolp Delivery of copper to Cox2p IMM (Glerum et al., 1996b)
Sco2p May have similar function to Sco1 p IMM (Lode etal., 2002)
Shylp May be involved in heme a3 insertion IMM (Smith et al., 2005)
Yahlp Heme a biosynthesis matrix (Barros et al., 2001)
Ymelp Degradation of unassembled 
subunits
IMM (Pearce and Sherman, 
1995)
Afg3p,
Rcalp
Degradation of unassembled 
subunits
IMM (Guelin et al., 1996)
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2.1. CELL BIOLOGY
2.1.1. Yeast growth
The yeast strains used in this study are listed in Table 2.1. Media components were 
obtained from Sigma or Becton Dickinson unless otherwise stated. YPDA (1% (w/v) 
yeast extract, 2% (w/v) peptone, 3% (w/v) glucose, supplemented with 10 mg/L 
adenine) was the standard growth medium. Adenine was omitted to allow detection of 
Ade' auxotrophs. To assess respiratory competence glucose was replaced with glycerol 
(YPG). For the experiments involving nitric oxide, glucose was replaced with galactose 
and the medium was supplemented with 800 mg/L of CSM-Ura (complete supplement 
mixture minus uracil, BIO 101 systems) and 20 mg/L uracil (YPGal). In the presence of 
glucose mitochondrial functions are repressed, so cells rely only on fermentation for 
energy production. This repression of genes involved in metabolising other carbon 
sources is lifted in the absence of glucose. Glycerol cannot be fermented so cells 
growing in YPG must rely only on respiration for growth, allowing detection of 
respiratory deficient strains. Galactose can be used by the cell for both fermentation and 
respiration. For selective growth of diploids a minimal medium (0.7% (w/v) yeast 
nitrogen base, 3% (w/v) glucose or galactose, 2% (w/v) agar) was used. For the 
selection of auxotrophs, minimal medium containing 800 mg/L of CSM-(component) 
was used. Transformation medium (0.7% (w/v) yeast nitrogen base, 3% (w/v) glucose, 
1M sorbitol, 800 mg/L CSM-Ura) was used for site-directed mutagenesis. 2% (w/v) 
agar was added for solid media, and all media were autoclaved at 121°C for 15 minutes 
prior to use.
Growth on solid medium was overnight at 28°C or at room temperature for 2-3 
days. Growth in liquid culture was at 28°C with shaking at 170 rpm, routinely in 10 ml 
medium in 100 ml flasks. Cells were stored in the short term at 4°C on solid media. For 
long term storage at -80°C cells were resuspended in 50% YPDA, 25% glycerol.
2.1.2. Bacterial growth
Bacterial strains were grown in LBA medium (0.5% sodium chloride, 0.5% yeast 
extract, 1% tryptone, 100  pg/ml ampicillin added after autoclaving) with 2 % agar added 
for solid media. Growth on solid medium was overnight at 37°C or at room temperature 
for 2-3 days. Growth in liquid culture was at 37°C with shaking at 170 rpm. Cells were 
stored in the short term at 4°C on solid media, or for long term storage in 50% LBA, 
25% glycerol at -80°C.
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2.1.3. Crossing yeast strains
Cells were grown on YPDA then physically mixed on a fresh YPDA plate. 
Alternatively when many clones were tested, they were resuspended in water in a 96- 
well plate and a replicator used to lay drops onto a YPDA plate spread with a lawn of 
the second strain. After 2 days growth plates were replicated on minimal medium and 
incubated for 2 days for selection of diploids.
2.1.4. Generation of p° (mtDNA-less) cells
Cells were subcloned then subjected to successive rounds of growth on YPDA 
supplemented after autoclaving with 1 mg/L ethidium bromide. Absence of mtDNA was 
confirmed by inability to grow on YPG.
2.1.5. Mapping mutations to the COX2 gene
Haploid mutants were crossed with the respiratory deficient rho‘ tester strain CKDS 302 
containing only COX2 in its mitochondrial genome. Respiratory growth of the diploids 
formed indicated that recombination had occurred to introduce wild type COX2 into the 
mutant mitochondrial genome and that the mutation must therefore be present in the 
COX2 gene, while respiratory deficiency indicated that COX2 recombination did not 
affect the mutation, which must therefore be located elsewhere (Figure 2.1). Since the 
COX2 sequence present in the tester strain contained some sequence outside (upstream 
and downstream) of the COX2 non-coding sequence, the existence of mutations outside 
the COX2 coding region was excluded by crossing with W303-lB/pBM2, a rho' strain 
containing only the COX2 coding region. This tester strain was constructed in our lab by 
biolistic transformation of W303-1B rho0 (see 2.2.6) with the pBM2 plasmid generated 
in our lab by PCR cloning, using the product of amplification of the COX2 gene with 
the primers PL32 and PL27 (see Table 2.2 and Figure 2.4.) and the Stratagene PCR- 
Script cloning kit.
2.1.6. Cytoduction
The respiratory deficient mutations were generated in the BM1/1-16 strain by moderate 
mutagenesis with 8 mM of the mtDNA mutagen manganese chloride. The strain 
harbours the opl mutation which affects the adenine nucleotide carrier of the IMM 
(Meunier et al., 1993). The opl mutation is lethal in combination with a rho0 or rho' 
(complete deletion or large deletion of mtDNA) mutation, hence only mit' (point) 
mutants accumulated. Since the opl mutation itself causes respiratory deficiency,
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screening for mit' mutants required diploids (OP I opl)', mit' mutants were identified by 
the inability of diploids to grow on respiratory medium (YPG) (Meunier et al., 1993).
Due to the opl mutation causing respiratory deficiency, further genetic analysis 
of the respiratory deficient mutants required transfer of the mtDNA to another nuclear 
background. This was done in a two step manner. The BM1/1-16 mutants were used for 
cytoduction of the mitochondrial genome into the recipient strain JC8/56 rho0, carrying 
the mutation karl-1 required for cytoduction (Conde and Fink, 1976). 12 hours after 
crossing single colonies were generated on YPD, the aim being to terminate crossing at 
the point where zygotes with mixed cytoplasm but unfused nuclei can be selected. After 
2 days growth BM 1/1-16 haploid colonies (auxotroph for adenine) appeared red due to 
the absence of adenine. Blockage of the adenine biosynthetic pathway due to the adel 
or ade2 mutations causes accumulation of P-ribosylaminoimidazole, a pink intermediate 
of the adenine biosynthetic pathway. Diploids appeared as large white colonies. The 
smaller white colonies (Ade+) present were either JC8/56 rho0 or JC8 rho+ mit’ (i.e. with 
mitochondrial genome but mutation in COX2) mutant haploids, and these were 
transferred by toothpick onto YPD. To distinguish between them, colonies were crossed 
with the respiratory deficient rho' tester strain W303-lB/pBM2 containing only COX2 
in the mitochondrial genome. The resultant diploids were replicated onto YPG medium 
to select for respiratory competent colonies (derived from JC8 rho+ m if mutant 
haploids).
The corresponding haploids were selected and crossed with W303-1B rho0 as 
described for the initial crossing. This time the red (Ade') colonies were selected and 
crossed with the respiratory deficient tester strain CKDS 302 to distinguish between 
W303-1B rho0 and W303-1B mutant haploids. Haploid strains corresponding to the 
resultant respiratory competent diploids were used for subsequent analyses.
2.1.7. Generation of revertants
The mutant strain was subcloned on YPDA, then subclones were resuspended in 50 pi 
of sterile water, spread on YPG, and incubated for 1-2 weeks. Respiratory competent 
clones arising were then subcloned on YPDA, and subclones were replicated on YPG to 
confirm respiratory competence. In cases where few respiratory competent clones arose
n
the procedure was repeated with the initial subclones (approx. 10 cells per ml) first 
incubated overnight in YPDA containing 8 mM manganese chloride to increase the 
frequency of mutagenesis.
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Secondary mutations may arise at any location, in the nuclear as well as in the 
mitochondrial genome. To determine the mitochondrial or nuclear heredity of a 
reversion, the rho0 was generated from the revertant, and crossed with the parent mutant 
of the correct mating type. Growth of the resultant diploid on YPG indicated a nuclear 
dominant reversion, while absence of growth indicated a nuclear recessive or 
mitochondrial mutation. To distinguish between the latter two possibilities the revertant 
was crossed with the rho0 form of the parent mutant, and growth of the diploid on YPG 
indicated mitochondrial reversion (Figure 2.2).
2.1.8. Incubation with nitric oxide donor
The nitric oxide (NO) donor used was (Z)-l-[2-(2-aminoethyl)-N-(2- 
ammonioethyl)amino]diazen-l-ium-l,2-diolate (DETA NONOate), obtained from 
Alexis Biochemicals and dissolved to form a 500 mM aqueous solution. NO is released 
from DETA NONOate in a temperature- and pH-dependent manner, with higher 
temperature and lower pH resulting in quicker decomposition. The half life of DETA 
NONOate is 20 hours at 37°C and 57 hours at 24°C at pH 7.4 (Hrabie and Klose, 1993). 
The experiments described here were carried out at 28°C. Prior to culture the pH of 
YPGal media was approximately 5.85. Yeast growth caused media pH to drop, and 
DETA NONOate was added to cultures when a pH of around 5.6 was reached.
In Chapter 4, two culture conditions were used. In both cases, a 10 ml starter 
culture was grown in a 100 ml Erlenmeyer flask for 6 hours at 28°C with shaking at 170 
rpm, and used to inoculate new YPGal cultures to A6oonm = 0.015 (or 0.05 for FY1679 
Ayhbl Asodl). For the first condition, after 15.5 hours growth the A6oonm of the cultures
n
was measured to be around 2 , a density of approximately 6 .10  cells per ml (late 
exponential phase). Cultures were divided into 10 ml aliquots in new 100 ml flasks, and 
treatment was given immediately afterwards. For the second condition, cells were 
allowed to grow for a further 6 hours to allow early stationary phase (A6oonm around 10, 
approximately 3.108 cells per ml) to be reached prior to splitting and treatment.
0.1, 1 or 3 mM final concentration of DETA NONOate was added to the 
cultures. Where myxothiazol (Sigma) was added, the stock was 20 mM in ethanol and 
the final concentration was 8 pM. An ergosterol (Sigma) stock was 30 mg/ml in ethanol 
and the final concentration was 15, 50 or 120 pg/ml. In cases where both ergosterol and 
NO donor were required, ergosterol was added immediately prior to NO donor. Cultures 
were returned to the incubator for up to 26 hours and cell density was monitored by 
measuring absorbance at 600 nm. Cells were harvested for characterisation as required.
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To harvest, cells were pelleted by centrifugation at 1,780 g at 4°C for 4 minutes, washed 
twice with ice-cold water, then resuspended to around 100 mg cells per ml in water (for 
oxygen consumption measurements) or 5% Ficoll pH 7.5 (for spectroscopy).
In the experiment involving carbon monoxide, the gas was bubbled slowly 
through a 120 ml aliquot of cells in a closed Erlenmeyer flask at a rate of approx. 1 
bubble/8s; compressed air was also bubbled through at a faster rate to ensure the culture 
was aerobic. The experiment took place at room temperature with moderate stirring and 
the cells were harvested after 6.5 hours
2.1.9. Methylene blue staining
80 pi of a 0.1% solution of methylene blue was added to 5 pi of cells, which were then 
immediately visualised at 40x magnification with a light microscope. As positive 
control, cells were treated with 100% ethanol in a 1:1 (v/v) ratio for 5 minutes prior to 
the methylene blue addition. The numbers of blue and white cells were counted, for a 
sample size of at least 300.
2.1.10. Fluorimetry
The dyes tested were: dihydrorhodamine 123, dihydroethidium, 2',7'-
dichlorodihydrofluorescein diacetate (carboxy-^DCFDA), all dissolved in DMSO. 
Excitation/emission spectra of the corresponding active fluorophores are shown in 
Figure 2.3. Assays were performed with minimal exposure to light. Yeast starter 
cultures were used to inoculate new 20 ml YPGal cultures so that after 17 hours of
• c  o
growth they reached an A6oonm of 1-2. The volume of cells required to give 3.10 -2.10 
cells per well of a 96-well plate was calculated and placed in an eppendorf. Preliminary 
experiments showed that YPGal medium had significant autofluorescence (due to 
peptone and yeast extract), so assays were carried out in PBS rather than YPGal. Cells 
were harvested at 1,780 g for 2 minutes, washed with 1 ml PBS then centrifuged again 
at 1,780 g for 2 minutes. Cells were resuspended to a volume of 95.7 pl/well in PBS, 
aliquoted into wells, then 2-250 pM dye was added as required. Reactions were 
incubated for 1 hour at 28°C in the dark. Alternatively, dye was added directly to an 
aliquot of culture with enough cells for 5 wells. After 1 hour incubation cells were 
harvested by 1,780 g centrifugation for 2 minutes, then washed twice in water and twice 
in PBS before resuspension in 500 pi PBS, then 100 pi was aliquoted into wells. 
Fluorescence was measured in a plate reader using filters allowing excitation at 485 nm 
and emission detection at 535 nm. Negative controls were: addition of DMSO in place 
of dye; assay with no cells. The positive control was incubation with 5 mM hydrogen
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peroxide for 15 minutes at 28°C with 170 rpm shaking in the dark, before addition of 
dye (and corresponding negative control).
2.1.11. Confocal microscopy
Cultures were grown as described in 2.1.10 then a culture volume equating to 2.108 cells 
was removed and the volume made up to 5 ml. 2 pM dye (see above) or DMSO 
(control) was added and the cells were incubated at 28°C degrees for 1 hour with 
shaking at 170 rpm. Where antimycin was used this was added immediately prior to dye 
or DMSO. Cells were harvested by 1,780 g centrifugation for 2 minutes, then washed 
twice in water and twice in PBS before resuspension in 500 pi PBS. Varying volumes 
were mounted onto slides and visualised with a Leica confocal microscope at 40x and 
63x magnification. Fluorophores were excited at 488 nm (dihydrorhodamine 123 and 
carboxy-F^DCFDA) and 543 nm (dihydroethidium). Emission was measured at >500 
nm for dihydrorhodamine 123 and carboxy-F^DCFDA and >560 nm for 
dihydroethidium.
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2.2. MOLECULAR BIOLOGY
2.2.1. DNA extraction
Cells were resuspended in 0.5 ml of a solution of 0.1 M Tris pH 8 , 50 mM EDTA then 
approximately 0.25 ml glass beads (425-600 micron, Sigma) was added. 0.5 ml of 
phenol:chloroform:isoamyl alcohol (25:24:1) pH 8.0 was added and the mixture 
vortexed for 2 minutes then centrifuged for 5 minutes at 16,000 g. The upper aqueous 
phase containing the DNA was removed to a new tube and centrifuged again, then this 
step was repeated to remove all residual phenol. 50 pi of 3 M sodium acetate pH 5.5 and 
1 ml of ethanol was added prior to incubation at -20°C for 30 minutes. The precipitated 
DNA was pelleted by 5 minute centrifugation at 16,000 g, washed with 70% ethanol 
then allowed to air dry. Finally, DNA was resuspended in 100 pi water and stored at - 
20°C.
2.2.2. PCR
Primer oligonucleotides were obtained from Sigma Genosys and resuspended to 10 pM. 
Routinely, PCR reactions were set up in a total volume of 50 pi containing IX Taq 
buffer (Promega; 50 mM potassium chloride, 10 mM Tris-HCl pH 9, 1.5 mM 
magnesium chloride, 0.1% Triton X-100), dNTPs at 200 pM each, forward and reverse 
primer at 200 nM each, 0.5 pi of template DNA (prepared as in 2.2.1) and 5U of Taq 
DNA polymerase (Promega), in water. The primers routinely used are listed in Table 
2.2 and the primer sites in the COX2 gene are indicated in Figure 2.4. The standard PCR 
parameters used were 94°C for 2 minutes, then 35 cycles of 94°C for 1 minute, 35°C for 
1 minute and 70°C for 1 minute, then 70°C for 20 minutes. For amplification of OXA1 
and COX12 annealing was carried out at 45°C.
To confirm amplification a 5 pi aliquot of reaction product was mixed with 3 pi 
of PCR loading buffer (Sigma) and resolved alongside 5 pi of DNA ladder (Sigma; 50- 
2000 bp) on agarose gel (1% (w/v) agarose, 0.5 pg/ml ethidium bromide). Bands were 
visualised under UV light.
2.2.3. Sequencing
PCR products were purified using the Qiagen PCR Purification kit, according to the 
manufacturer’s instructions. Purified product was quantified using a NanoDrop 
Technologies spectrophotometer and diluted to 4-8 fmoles/pl in water. Sequencing was 
performed by an in-house service using primers at 4 pmol/pl dilution.
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Sequences were analysed with the aid of BioEdit (Ibis Therapeutics), and ClustalW 
(http://www.ebi.ac.uk/clustalw/) was used for alignments.
2.2.4. Bacterial transformation
SoloPack Gold Ultracompetent cells (Stratagene) were transformed with plasmid 
according to the manufacturer’s protocol. For the site-directed mutagenesis 5 pi of 
digested PCR product (see 2.2.6) was used to transform XL 10-Gold Ultracompetent 
cells (Stratagene) according to the manufacturer’s protocol. To isolate plasmids from 
transformed bacteria, overnight LBA cultures (5 ml) were pelleted at 16,000 g for 1 
minute then processed using the Qiagen Plasmid Miniprep kit, according to the 
manufacturer’s instructions. The success of isolation was determined by resolving 5 pi 
of plasmid on agarose gel (see 2 .2 .2 ).
2.2.5. Yeast transformation (see 2.2.6 for biolistic transformation)
The method used was based on the Gietz and Woods protocol (Gietz and Woods, 2002). 
Briefly, cells were pelleted, resuspended in 1 ml of 100 mM lithium acetate, incubated 
at 28°C for 5 minutes, pelleted, then the supernatant removed. On top of the cell pellet 
was placed 240 pi of 50% (w/v) polyethylene glycol, 36 pi of 1 M lithium acetate, 50 pi 
of 2 mg/ml ssDNA, 5 pi of plasmid DNA and 20 pi of water. The pellet was vortexed 
well then incubated at 42°C for 40 minutes. Cells were then harvested and resuspended 
in 200 pi water for plating onto synthetic drop out medium (MinGlu-Ura).
2.2.6. Site-directed mutagenesis
The plasmids pJM2 (obtained from T. Fox (Mulero and Fox, 1993)) and pBM2, 
containing the COX2 gene (from our lab, obtained by PCR cloning using the Stratagene 
PCR-Script cloning kit), were subjected to PCR-based mutagenesis to introduce the 
amino acid changes D41N and F45K, with the point mutations GAT -> AAT and TTT 
AAA, respectively. PCR reactions were set up in a total volume of 50 pi containing 
IX reaction buffer (Stratagene; 10 mM potassium chloride, 20 mM Tris-HCl pH 8 .8 , 10 
mM ammonium sulfate, 2 mM magnesium sulfate, 0.1% Triton X-100, 0.1 mg/ml 
nuclease-free BSA), dNTPs at 200 pM each, forward and reverse primer at 200 nM 
each, 0.5 pi plasmid, 2.5U Pfu Turbo high fidelity polymerase (Stratagene), in water. 
The primers used for introduction of D41N were 5 aaggtattttagaattacataataatattat (fwd) 
and 5 atatatttattatgtaattctaaaatacctt (rev). Primers used for introduction of F45K were 
5 gataatattatgaaatatttattagttattttagg (fwd) and 5 cctaaaataactaataaatatttcataatattatc (rev).
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The standard PCR parameters used were 94°C for 3 minutes, then 18 cycles of 94°C for 
30 seconds, 35°C for 1 minute, 68°C for 14 minutes, then 68°C for 20 minutes. 1 pi of 
Dpnl was added to the reaction mixture, which was then incubated at 37°C for 1 hour to 
degrade the template at methylated GATC sites. Success of the amplification was 
checked by resolving a 10 pi aliquot of reaction product on agarose gel (as described in 
2 .2 .2 ); high molecular weight bands corresponding to plasmid should still be present 
after Dpnl treatment. PCR product was used to transform bacterial cells as detailed in
2.2.4. Transformants were subcloned and plasmids were isolated from 12 subclones as 
described in 2.2.4. The COX2 gene was fully sequenced to identify clones with only the 
required mutation. Bacterial transformant containing the correct plasmid was used to 
prepare more plasmid stock, which was then concentrated with an Amicon Microcon 
ultrafiltration device (Millipore), according to the manufacturer’s instructions, for use in 
biolistic transformation.
3 pg of plasmids containing the mutated COX2 and 0.5 pg of YEp352 plasmid 
containing the URA3 gene (allowing selection of Ura+ nuclear transformants) were 
mixed with 50 pi of 60 mg.ml' 1 0.7 pm tungsten particles, and the particles coated with 
DNA according to the manufacturers protocol (BioRad). Aliquots were used for 
transformation of the recipient strain W303-1B rho0, on transformation medium 
(selective for Ura+ transformants). Particle bombardments were performed with a 
Biolistic PDS-1000/He Particle Delivery System (BioRad) at 1,300 psi. Plates were 
incubated for 4-5 days after which time Ura+ transformants (which have received the 
YEp352 plasmid) arose from cells which were amenable to transformation. Screening 
the colonies arising from only this type of cell increases the likelihood of identifying 
mitochondrial transformants.
To identify the mitochondrial transformants, more than 1000 Ura+ colonies were 
crossed with the tester strain CKL3 containing the complete mitochondrial genome but 
with the mutations COX2 A189V and A220V, which cause respiratory deficiency and 
are far away from the sites of site-directed mutagenesis. On crossing, high frequency 
homologous recombination will occur if the modified pJM2 or pBM2 plasmid is 
present, producing diploid wild type (respiratory competent), diploid CKL3 (respiratory 
deficient) and diploid COX2 mutant (respiratory competence unknown) (Figure 2.5). If 
the plasmid is absent no respiratory competent diploids will arise. Therefore selecting 
for respiratory competence allows identification of colonies transformed with the pJM2 
or pBM2 plasmid.
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Forty haploids corresponding to respiratory competent diploids were subcloned 
and approx. 100 subclones of each crossed again with the tester strain. Two of the 
resulting respiratory competent diploids were subcloned again and the COX2 gene of 24 
subclones sequenced. If sequences are all wild type this indicates that recombination 
leading to the mitochondrial mutation probably causes respiratory deficiency. In this 
case, the mutated gene was introduced into a rho+ genome by crossing the 
corresponding haploids with the wild type CKWT, then the diploids diluted and plated 
on YPD (approx. 1000 colonies) then YPG to identify respiratory deficient diploids. 
These colonies may be either parental rho' or recombinant mit', so spectra were 
measured (see 2.3.1) to identify mit' colonies (rho' has no cytochrome b or aa3).
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2.3. BIOCHEMICAL METHODS
2.3.1. Preparation of mitochondrial membranes
400 ml YPDA cultures were grown for 48 hours, pelleted at 1,780 g for 5 mins at 4°C, 
washed with phosphate buffer (50 mM potassium phosphate, 5 mM EDTA pH 7.5), 
then resuspended in 5 ml of the same buffer. All subsequent steps were carried out at 
4°C. Glass beads (425-600 micron, Sigma) were added and cells broken by shaking at 
30 Hz for 10 minutes in a Retsch bead-mill. Debris and beads were removed by 
centrifugation at 6 ,0 0 0  g for 20  mins, and the supernatant, containing the membranes, 
was centrifuged at 800,000 g for 1.5 hours. The pelleted membranes were resuspended 
in 1 ml of phosphate buffer containing 10% (v/v) glycerol using a hand homogeniser 
and stored in aliquots at -80°C.
Membranes were scanned and concentrations of cytochromes were measured as 
described below. Protein concentration of mitochondrial membrane preparations was 
determined with a modified Lowry method (Peterson, 1977) using the Protein Assay kit 
from Sigma, and a typical concentration was 20-40 mg per ml for wild type. A typical 
standard curve is shown in Figure 2.6.
2.3.2. Spectroscopy
Optical spectra of both cell suspensions and mitochondrial membranes were measured 
using a spectrophotometer built in house. Spectra were generated by scanning in the 
visible range with a single beam instrument built in-house. Cells were grown on YPDA 
plates for 48 hours then resuspended in 5% Ficoll pH 7.5 to around 100 mg cells per ml, 
or grown in YPGal liquid medium for up to 26 hours, pelleted and resuspended (as 
described in 2.1.8). For cell suspensions, a baseline was recorded using diluted milk, 
samples were reduced with sodium dithionite as required, and cytochrome contents 
were estimated from the dithionite reduced spectra. Alternatively, mitochondrial 
membranes were diluted up to 5 times in phosphate buffer and dithionite reduced minus 
ferricyanide oxidised spectra were used for cytochrome estimation. These were 
generated by first scanning oxidised sample, then adding dithionite to reduce the 
sample, and scanning again, then reduced minus oxidised spectra were computer­
generated. Cytochrome contents were measured using the following formulae: 
cytochrome oxidase at 604-(594-614)/2 nm using an extinction coefficient of 14 mM ' 1 
cm'1; cytochrome b at 562-575 nm, 6=28.5 mM ' 1 cm'1; cytochromes c + c\ at 550-542 
nm, 6=18 mM ' 1 cm' 1 (van Gelder and Slater, 1962; Meunier and Rich, 1998).
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2.3.3. Oxygen consumption/cytochrome oxidase activity
Oxygen consumption was measured with an oxygen electrode at 25°C. To measure 
cytochrome oxidase activity, mitochondrial membrane samples were diluted to 10 nM 
cytochrome oxidase in phosphate buffer containing 10 mM ascorbate and 50 pM 
TMPD. Consumption of oxygen by cytochrome oxidase was initiated by the addition of 
varying concentrations of cytochrome c and rates of oxygen consumption were 
measured as a function of cytochrome c concentration, and used to produce 
Lineweaver-Burk (1/V vs 1/[S]) plots from which Km (cyt c) and Vm values were 
derived.
To measure oxygen consumption of whole cells, cells were harvested from 
liquid culture, resuspended to around 100 mg cells per ml in water, then added to YPGal 
containing 2 pM FCCP at a concentration of approximately 10 mg cells per ml. 
Respiratory activity is presented relative to the amount of cells or the amount of 
cytochrome oxidase present. Since the respiratory chain is the major site of oxygen 
consumption in yeast cells it was not necessary to add a respiratory chain inhibitor to 
measure the proportion of oxygen consumption due to cytochrome oxidase.
2.3.4. Nitric oxide detection
Cells were grown to an A6oonm of around 2, as described in 2.1.8, then a 1 ml aliquot 
was removed and placed in the chamber of an NO electrode (World Precision 
Instruments). The culture was stirred and was open to air. 3 mM DETA NONOate was 
added and the concentration of NO in the culture was measured over 24 hours.
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2.4. WESTERN BLOTTING
2.4.1. Denaturing electrophoresis
2.4.1.1. Gel preparation
Denaturing SDS gels were prepared using the BioRad Mini-PROTEAN 3 
electrophoresis system. 10% to 20% resolving gels were prepared as described in Table 
2.3A. Urea was added to gel solutions since this assists in ensuring complete 
denaturation, resulting in sharper bands, and prevents aggregation. Gels were overlayed 
with 100 pi of water whilst setting to produce a uniform upper edge. After approx. 30 
minutes gels were overlaid with stacking gel (Table 2.3A). 10-well combs were encased 
in stacking gel and removed once the gel had set.
2.4.1.2. Sample preparation
Analyses were performed on crude mitochondrial membranes, prepared as described in
2.3.1. Samples were diluted in dissociation buffer (Table 2.4) to give 2 pg/pl protein, as 
determined by Lowry assay (see 2.3.1), then incubated at 37°C for 30 minutes. 
Incubation at a low temperature for a long period prevents formation of aggregates. To 
assess quantities to load, an initial gel was loaded with 10 pg protein of each sample, 
blotted and probed with an antibody against porin. Signal intensities were quantified 
and a graph of intensity against wild type dilution plotted (Figure 2.7). Mutant signal 
intensities were compared to the graph allowing the percentage error in the Lowry assay 
to be determined. Sample preparations were subsequently adjusted by the dilution 
factors calculated, so that between 10 and 20  pg of total protein, as determined by 
Lowry assay, was loaded in each lane to represent 100% sample. Unused dissociated 
sample was stored at -80°C for up to one month.
2.4.1.3. Gel running and processing
For estimation of molecular mass, 5 pi of Precision Protein Standards (10-250 kDa, 
BioRad) was loaded. Protein was electrophoresed in running buffer (Table 2.4) at 100V, 
then 200V after samples had stacked, for around 1 hour depending on the percentage of 
acrylamide. After electrophoresis, protein was electroblotted onto PVDF membrane 
(Amersham Biosciences, pore size 0.45 pm) with the BioRad Mini Trans-Blot cell, as 
follows. The gel was placed on Whatman 3MM paper resting on a sponge piece. PVDF 
was placed on top and the sandwich was completed with further pieces of filter paper 
and sponge. The sandwich was placed inside the blotting cassette and protein transfer
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was for 1 hour at 100V, in Towbin’s buffer (Table 2.4). After blotting the membranes 
were allowed to dry completely overnight and were rewetted in methanol prior to 
immunodetection.
2.4.2. Blue native electrophoresis
2.4.2.1. Gel preparation
Native gels were prepared using Hoeffer gradient gel pouring apparatus connected to a 
Watson Marlow 4 way peristaltic pump. As with denaturing gels, the BioRad Mini- 
PROTEAN 3 electrophoresis system was used. Gels were prepared as described in 
Table 2.3B. To pour 8-16% gradient gels the 16% solution was allowed to flow about 
10 cm towards the pump before the 8% solution was released from its chamber. After 
pouring the gels were overlaid with 100 pi of water-saturated butanol and allowed to set 
for around 30 minutes. After the stacking gel had been set around 10-well combs, gels 
were wrapped in clingfilm and stored at 4°C overnight for use within 24 hours. Gels 
were assembled with cathode buffer filling the inner chamber and anode buffer in the 
outer chamber, and wells were rinsed thoroughly with cathode buffer immediately prior 
to loading of samples (Table 2.4).
2.4.2.2. Sample preparation
Sample volume equating to one lane (approx. 60 pg protein) was mixed with 15 pi of 
solubilising solution containing 1 pg/ml leupeptin, 1 pg/ml pepstatin and 1 pM PMSF. 
5 pi of 10% (w/v) laurylmaltoside was added to solubilise and the mixture was left on 
ice for 15 mins, then centrifuged for 20 minutes at 16,000 g. The supernatant was 
removed and 2.5 pi of loading buffer was added to it. Samples were prepared in 
multiples and either loaded directly onto 8-16% gradient gel or stored at -80°C for up to 
one month. Since large volumes were loaded, any empty lanes were loaded with an 
appropriate volume of loading mix (solubilising solution, 10% laurylmaltoside and 
loading buffer, 6 :2 :1) to avoid distortion during electrophoresis.
2.4.2.3. Gel running and processing
5 pi of HMW Native Markers 66-669 kDa (Amersham Biosciences) were used for 
estimation of molecular mass. Gels were run at 100 V until the dye front had migrated 
well into the stacking gel, then run at 8 mA fixed current (for 2 gels; 4 mA for 1 gel) for 
the remainder of the electrophoresis. Gels were electroblotted as described in 2.4.1.3.
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Prior to immunodetection the Serva blue G was removed from membranes by short 
incubation in three changes of methanol.
2.4.3. Two-dimensional native/denaturing electrophoresis
Samples were prepared and separated on 8-16% polyacrylamide blue native gels as 
described above. Single sample lanes were excised and protein was dissociated by 
incubation in 1% /?-mercaptoethanol, 1% SDS for 15 minutes, before washing twice for 
10 minutes in 50 mM Tris-HCl pH 6 .8 , 1% SDS with gentle shaking, to remove /?- 
mercaptoethanol, an inhibitor of polymerisation. The gel slice was placed horizontally 
between two glass plates, in the region where stacking gel would usually be poured. 
Resolving gel (20% polyacrylamide for detection of Cox8p, 15% polyacrylamide for 
detection of other subunits, Table 2.3 A) was poured below it (Figure 2.8).
When resolving gel had set the native gel slice was encased in stacking gel, with 
a marker well created adjacent to it. A common problem in two-dimensional 
electrophoresis is streaking, in which bands merge and individual complexes are 
difficult to identify. The use of agarose as stacking gel has been suggested to overcome 
this problem and to be a more efficient method than using an acrylamide stacking gel, 
since proteins in the gel slice can be dissociated by adding agents to the agarose gel 
rather than in separate steps as described above, which allow substantial leaching of 
protein.(Brookes et al., 2002). I initially attempted to use a stacking gel of 0.7% (w/v) 
agarose, 0.5% (w/v) SDS and 15 mM /?-mercaptoethanol, heated to 60°C and poured 
around the untreated gel slice. However, I did not find that this method prevented 
streaking, and instead obtained better results by dissociating the protein as initially 
described and using a 3% polyacrylamide stacking gel (Table 2.3A). The stacking gel 
had a tendency to reduce in volume prior to setting, so was topped up at regular 
intervals during the setting period. Also, residual //-mercaptoethanol occasionally 
impaired the setting process; this was remedied where necessary by placing the gel at 
40°C for up to 30 minutes. Once set, electrophoresis apparatus was assembled and run 
as described in 2.4.1.3.
2.4.4. Immunodetection
Non-specific protein binding sites on the PVDF membranes were blocked by 1 hour 
incubation with gentle shaking in 10% (w/v) non-fat milk (Marvel) in PBS then the 
membranes were incubated with subunit-specific primary antibodies for 2 hours. After 
three 10 minute washes in PBST, membranes were incubated with HRP-conjugated 
secondary antibody for 1 hour. Where tertiary PAP (peroxidase anti-peroxidase)
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antibody was used a further two 10 minute washes were performed and membranes 
were incubated with PAP antibody for 1 hour. Finally three 10 minute washes in PBST 
were carried out, plus a final 5 minute wash in PBS. Western Lightning 
Chemiluminescence Reagent Plus (Perkin Elmer) in conjunction with Hyperfilm ECL 
film (Amersham Biosciences) was used to visualise proteins.
Subunit-specific mouse monoclonal antibodies against the yeast cytochrome 
oxidase subunits Coxlp, Cox2p, Cox3p, Cox4p, Cox5p, Cox6p, Cox6ap and Cox8p, 
and porin were used, in addition to a polyclonal rabbit antiserum recognising the co- 
migrating subunits Cox7p and Cox7ap (Table 2.5). All these antibodies were generated 
in the laboratory of Prof. R. A. Capaldi (Institute of Molecular Biology, Eugene, OR) 
and are described in (Taanman and Capaldi, 1993); most of them are commercially 
available (Molecular Probes Inc., Eugene, OR). The polyclonal antiserum against 
cytochrome c\ was generously supplied by Prof. B. L. Trumpower (Dartmouth Medical 
School, Hanover, NH, USA). HRP-conjugated anti-mouse secondary antibodies were 
obtained from BioRad, DakoCytomation and Jackson ImmunoResearch. Anti-rabbit 
secondary antibody was obtained from BioRad. Monoclonal mouse PAP tertiary 
antibody was obtained from DakoCytomation.
Some of the antibodies used gave rise to more than one strong band on blots 
from denaturing gels. To determine which of the bands corresponded to the cytochrome 
oxidase subunit the antibody was raised against, and to confirm the identity of single 
bands detected, the band pattern in wild type mitochondrial membrane preparations was 
compared to that of purified yeast cytochrome oxidase (kindly provided by J.-W. 
Taanman, isolated according to (Taanman and Capaldi, 1992)). Here, purified yeast 
cytochrome oxidase was mixed with an equivalent volume of 2x dissociation buffer 
then 4 times the volume of lx dissociation buffer, before incubation at 37°C for 30 
minutes, and 10 pi was loaded in each lane of a denaturing gel adjacent to wild type 
mitochondrial membrane preparation and molecular weight marker (Figure 2.9).
2.4.5. In situ cytochrome oxidase activity assay
An 8-16% native gel was prepared, loaded and run as described above, then a single gel 
strip was removed and destained with anode buffer for 10 minutes before being rinsed 
in water. The strip was incubated in staining solution (50 mM sodium phosphate buffer 
pH 7.4 containing 0.5 mg.ml' 1 diaminobenzidine, 1 mg.ml’1 cytochrome c and 2 pg.ml' 1 
catalase) at 37°C with gentle shaking overnight, then the reaction was stopped and
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excess strain removed by replacing staining solution with 10% acetic acid and 40% 
methanol for several hours. The assay detects a colour change.
2.4.6. Electroelution
Blots derived from native gels exhibited a Coxlp-containing band running at 
approximately the level that Coxlp itself should be found. To determine the identity of 
the band I needed to resolve isolated Coxlp adjacent to the membrane sample on native 
gel. Purified yeast cytochrome oxidase was available but could not be simply 
dissociated then run on native gel as the SDS would diffuse and/or be drawn into the 
rest of the gel.
Prior to isolation of Coxlp from purified yeast cytochrome oxidase, the 
preparation was checked for purity. 20 pi was dissociated in 4 pi of a solution of 5x 
dissociation buffer at 37°C for 30 minutes. The entire dissociated sample was loaded on 
15% denaturing gel adjacent to molecular weight markers, and the gel was run as 
described in 2.4.1.3. The gel was subsequently stained with Coomassie blue for 5 hours, 
then destained in water for approx. 24 hours to allow optimal band visualisation. A large 
band of the correct molecular weight for Coxlp was present, and contaminating bands 
(i.e. not components of cytochrome oxidase) were absent.
Another denaturing gel (10%, to allow good separation of bands) was prepared, 
with one large well of 67 mm width. Purified yeast cytochrome oxidase was prepared as 
above, but sample volume was scaled up by a factor of 14 and 250 pi sample was 
loaded into the well, adjacent to a molecular weight marker. The gel was run as normal, 
then the two edges were removed and stained as described above to determine the 
migration of Coxlp, while the central portion of the gel was wrapped in clingfilm and 
stored at -20°C. After staining, the edges were aligned and the Coxlp band excised from 
the central portion of the gel. This was placed in an electroelution tank with running 
buffer, glycerol and a few grains of bromophenol blue. Protein was eluted at 4 mA until 
all the dye had transferred to the positive terminus, and elution was allowed to continue 
for 30 minutes subsequent to this to ensure completion. Running buffer was carefully 
removed by pipette, then the protein solution was collected and the chamber rinsed 
twice with running buffer to collect residual protein.
To determine the correct quantity of purified Coxlp to load onto native gel a 
dilution series of purified yeast Coxlp was loaded onto 10% denaturing gel. One lane 
was excised and Coomassie-stained to confirm the absence of contaminating bands. The
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remainder of the gel was blotted and probed with Coxlp antiserum, and 16x dilution of 
purified yeast Coxlp was judged the best signal.
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2.5. GENE EXPRESSION
2.5.1. Microarray
The microarray strategy employed was as follows. mRNA was isolated from yeast cells 
(2.5.1.1 and 2.5.1.2) then reverse transcribed using a modified oligo(dT) primer with a 
T7 RNA polymerase promoter sequence in the first strand cDNA synthesis (2.5.1.3). 
Second strand cDNA synthesis was RNase H-mediated. Double-stranded cDNA was 
purified and used as template for in vitro transcription from T7 RNA polymerase 
promoters (in the presence of T7 RNA polymerase and a biotinylated nucleotide 
analog/ribonucleotide mix) for antisense cRNA amplification and biotin-labelling 
(2.5.1.4). Single stranded biotinlyated cRNA targets were fragmented (to 200 
nucleotides or less) and hybridised to Affymetrix GeneChip expression arrays (2.5.1.5). 
The arrays contain several 25-mer DNA probes for each gene present on the chip (ORFs 
from the Yeast Genome Database (www.yeastgenome.org)), each present in hundreds 
of copies. Use of cRNA rather than cDNA targets results in improved target binding 
avidity, and better sensitivity as the melting temperature of RNA-DNA hybrids is 
higher; also the target population does not self-hybridise. Arrays are scanned to 
determine fluorescence of each probe, relating to the number of copies of labeled cRNA 
present.
2.5././. RNA extraction
YPGal starter cultures which had been allowed to grow for 18 hours were used to 
inoculate 30 ml cultures of YPGal media to A6oonm = 0.08 in 250 ml Erlenmeyer flasks. 
After 8 hours incubation at 28°C with shaking at 170 rpm the cultures reached an A6oonm 
of around 0.5 (mid exponential phase), and 0.1, 1 or 3 mM DETA NONOate was added. 
Cultures were incubated for a further 10, 30, 60 or 120 minutes, then cells were 
harvested at 1,780 g for 4 minutes at 4°C. Control cells were not treated with NO donor 
but were harvested immediately. Pellets were washed with ice-cold water than flash 
frozen in liquid nitrogen and stored at -80°C. Cells were resuspended in 1.2 ml of AE 
buffer (50 mM sodium acetate, 10 mM EDTA pH 5.3) and RNA was extracted by a hot 
phenol method (Schmitt et al., 1990). Briefly, 1/10 volumes of 10% SDS and 1 volume 
of phenol were added and incubated at 65 °C for 10 minutes, then tubes were rapidly 
chilled in a dry ice/ethanol bath before centrifugation at 16,000 g for 2 minutes. The 
aqueous phase was removed and an equal volume of phenol:chloroform:isoamyl alcohol 
(25:24:1) pH 6.6  added before centrifugation for 5 minutes at 16,000 g. The aqueous
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phase was again removed, and 1/10 volumes of 3 M sodium acetate pH 5.3 and 2.5 
volumes of 100% ethanol were added before precipitation at 65 °C for 30 minutes. RNA 
was pelleted by 5 minute centrifugation at 16,000 g then washed in 80% ethanol and 
resuspended in 150 pi water. All steps involving RNA were carried out using RNase- 
free reagents and equipment. Absorbance at 260 and 280 nm of samples diluted in 10 
mM Tris pH 7.5 was used for quantification and purity control (A260/A280 ratio of 1.9- 
2.1 for pure RNA), and RNA integrity was assessed using the Agilent Technologies 
2100 Bioanalyser. An example trace is shown in Figure 2.10.
2.5.1.2. mRNA isolation
Poly(A) mRNA was enriched in a single round using the Qiagen Oligotex mRNA kit, 
using the Batch protocol, according to the manufacturer’s instructions. After analysis of 
mRNA quality with the Agilent Technologies 2100 Bioanalyser (Figure 2.10) and 
mRNA quantitation, mRNA was concentrated by precipitation as described in the 
Affymetrix GeneChip Expression Analysis Technical Manual (www.affymetrix.com). 
After air-drying the pellet was resuspended in 10 pi (for 0.2-1 pg mRNA) or 9 pi (for 1- 
2 pg mRNA) water and samples were stored at -20°C.
2.5.1.3. Synthesis o f double-stranded cDNA
Double-stranded DNA was made from mRNA using the Superscript II Reverse 
Transcriptase kit (Invitrogen) and a modified oligo(dT) primer with a T7 RNA 
polymerase promoter sequence (GeneChip), according to instructions given in the 
Affymetrix GeneChip Expression Analysis Technical Manual (www.affymetrix.com), 
but with incubations at 42°C taking place at 37°C instead. cDNA cleanup protocol was 
also as described in this manual.
2.5.1.4. In vitro transcription
In vitro transcription was performed, using the entire template, with T7 RNA 
polymerase and biotinylated ribonucleotides (BioArray High Yield RNA Transcript 
Labelling Kit, Enzo Diagnostics), according to the manufacturer’s instructions. The 
biotinylated cRNA obtained was purified with the Affymetrix GeneChip Sample 
Cleanup Module, absorbance of samples at 260 and 280 nm was used for quantification 
and purity control, and RNA integrity was assessed using the Agilent Technologies 
2100 Bioanalyser. The cRNA was fragmented using the GeneChip Sample Cleanup 
Module.
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2.5.1.5. Hybridisation and initial analyses
Hybridisation and initial analyses were performed by an in-house service. 15 pg of 
fragmented cRNA was hybridized onto Affymetrix GeneChip Yeast Genome S98 arrays 
in a rotating hybridization oven at 45°C for 16 hours. This was followed by staining and 
washing on a GeneChip Fluidics Station 450, and scanning on a GeneChip Scanner 
3000 with autoloader. Arrays were stained with streptavidin phycoerythrin and 
fluorescence was amplified by addition of biotinylated goat anti-streptavidin antibody 
(plus goat IgG), then restaining. Acquisition and quantification of array images as well 
as primary data analysis was performed using the GeneChip Operating System (GCOS) 
software version 1.2 from Affymetrix.
2.5.1.6, Data analysis
Microsoft Excel was used for further statistical analyses. Triplicate samples 
(independent cell preparations) were prepared for untreated control cells (W303-1B 
Ayhbl), and duplicates for cells treated for 10, 60 or 120 minutes with 3 mM NO donor. 
For all other tests, one sample was prepared. Transcript number in treated cells was 
compared to transcript number in untreated cells, and fold change values (or average 
fold change values) at each time point were calculated relative to the gene expression 
(or average gene expression) in the respective strain without treatment. The transcript 
level was assumed significantly increased or decreased for a specific gene when its Z- 
score was higher than 1.96 compared with all the genes designated as present by the 
Affymetrix software. Replicates were compared with the average value for the time 
point and changes in expression of over 2-fold were noted. Categorisation of genes was 
performed using the Yeast Genome Database (www.yeastgenome.org). The genomic 
expression profiles were created using the software Cluster and Tree View 
(rana.lbl.gov/EisenSoftware.htm).
2.5.2. Quantitative real-time PCR
(RT)q-PCR allows quantitation of starting DNA because it measures PCR amplification 
during the exponential phase of a PCR reaction rather than using the less precise end­
point measurement, which displays significant variability even with the same starting 
concentration of DNA. Total RNA extraction, mRNA purification and cDNA synthesis 
were carried out as described above. Where the effect of the heme precursor 
deuteroporphyrin IX (dpIX) was assessed, this was added to cells immediately prior to 
the NO donor. Quantitative PCR was performed using the ABI Prism 7700 Sequence
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Detection System (Applied Biosystems). The primers used are listed in Table 2.6, and 
were designed using Primer Express version 2.0 software within the guidelines given by 
the supplier (Applied Biosystems). Reactions were carried out in a 25 pi mixture 
containing 24 pg/pl of cDNA, lx  SYBR Green PCR Master Mix (Applied Biosystems; 
containing SYBR green I dye, AmpliTaq Gold DNA polymerase, dNTPs with dUTP 
and optimised buffer components) and 300 nM of each primer. PCR parameters used 
were 50°C for 2 minutes, 95°C for 10 minutes (for optimal DNA polymerase 
activation), then 40 cycles of 90°C for 15 seconds, 60°C for 1 minute. Accumulation of 
PCR products was detected by monitoring the increase in fluorescence of the reporter 
dye SYBR green I.
The mean of the background fluorescence for all the tested wells measured 
between cycles 3 and 10 was recorded and used to set the baseline with Sequence 
Detector software version 1.7a. (Applied Biosystems). The threshold for amplification 
was set by drawing a line intersecting the exponential phase of the logarithmic 
amplification curves (fluorescence vs cycle number); a threshold of 0.04 was used in all 
assays. The cycle number at which the threshold line intersects the linear curve for each 
sample was used to determine the threshold cycle ( C t )  value. Dissociation curves 
(change in fluorescence with time vs temperature) were run to confirm absence of 
contaminating products. All subsequent data analysis was performed in Excel. (RT)q- 
PCR products generated using primers amplifying the ACT I (actin) gene were used as 
endogenous control since ACT1 expression did not alter between treatments in the 
microarray analysis. The quantity of mRNA of each gene of interest in each sample, 
indicated by the threshold cycle ( C t ) ,  was therefore normalised by the level of ACT1 
RNA: C t g ene o f interest - C U c t i  =  A C t .  Relative quantification of mRNA between treated 
and untreated cells was performed using the comparative C t  ( A A C t )  method ( A C t sampie -  
A C t reference =  A A C t ;  relative quantity = 2'AACt), as suggested by the manufacturer 
(Applied Biosystems). This method is valid if amplification efficiencies of the target 
genes and the endogenous control gene are equivalent, as demonstrated in Figure 2.11 
(Livak and Schmittgen, 2001). Each sample was assayed at least in triplicate, and each 
assay contained duplicates or triplicates. The exception was dpIX treatment, where only 
one assay (in duplicate) was performed.
2.5.3. /?-Galactosidase assay
STRE-LacZ or CYCl?-LacZ cells were grown in YPGal media as described for the 
microarray analysis. For the assays involving CTT1 overexpression YPG was used, and
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for the SOD1 overexpression plasmid MinGal-Trp was used for induction and MinGlu- 
Trp for control. Where anaerobic cultures were required these were placed in closed 
tubes with no shaking. After 8 hours of growth cells were treated with 3 mM NO donor 
or 8 pM myxothiazol and incubated for 10, 60 or 120 minutes. Where deuteroporphyrin 
IX (dpIX) was required this was also added after 8 hours, and immediately prior to NO 
donor. Cells were harvested at 1,780 g at 4°C for 4 minutes (this step was not required 
for anaerobic cultures). The pellet was washed with ice-cold water then resuspended in 
ice-cold Z buffer (60 mM disodium hydrogen phosphate, 40 mM sodium dihydrogen 
phosphate, 10 mM potassium chloride, 1 mM magnesium sulfate, 50 mM./?- 
mercaptoethanol, pH 7), then the A6oonm was measured. One drop of 0.1% SDS and two 
drops of chloroform were added, and the mix was equilibrated at 28°C for 15 minutes. 
o-Nitrophenyl-/?-D-galactopyranoside was added to a final concentration of 0.64 mg.ml" 
1 and, after incubation at 28°C for 15 minutes, the mix was centrifuged at 2,330 g at 
room temperature for 2 minutes, and the A420nm and Assonm of the supernatant were 
measured. /?-galactosidase activity was expressed in Miller units, calculated as follows: 
1000 x [A420nm -  (1.75 x A550nm)] / (15 min x culture volume used in the assay in ml x 
A6oonm). Experiments were repeated five times for the STKE-LacZ Ayhbl assay, three 
times for the overexpression assays, and twice for the CYClp-LacZ assays.
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A. Mutation in COX2
©  < /  CKDSRespiratorydeficient Respiratorydeficient
B. Mutation in another gene
0 2KDS \  _v!°VRespiratorydeficient Respiratorydeficient
diploid
Respiratory
competent
Respiratory
deficient
Figure 2.1. Mapping of mutations to the COX2 gene.
Mitochondrial DNA is shown. CKDS 302 is a respiratory deficient rho’ strain and its mtDNA contains 
only the COX2 gene, illustrated in red. The respiratory deficient mit' strain contains mutation in the COX2 
gene (red) or another gene (green). Mutations are indicated by a cross. If  the mit' mutation is present in 
COX2 homologous recombination will allow formation of respiratory competent diploids (A), while if 
present in another gene respiratoiy deficient diploids will be formed (B).
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A. Reversion in mtDNA
mit'mit'
Respiratory
deficient
Respiratory
deficient
Respiratory
deficient
mit'
Respiratory
deficientRespiratorycom petent
Respiratory
com petent
B. Nuclear recessive reversion
mit"mit'
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deficient
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deficient
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deficient
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deficient
C. Nuclear dominant reversion
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Figure 2.2. Mapping of reversions.
Two crosses were performed for each revertant to determine the genetic origin of the suppressor 
mutation, (i) Rho0 revertants, in which mtDNA had been removed, were crossed with the corresponding 
original mutants, (ii) The revertants were crossed with a wild type rho0 strain. Nuclear DNA is indicated 
by a solid line and mtDNA by a circle. The COX2 gene is illustrated in red, and mutations by a cross 
(black = primary mutation causing respiratory deficiency; green = secondary mutation restoring 
respiratory competence).
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Figure 2.3. Excitation/emission spectra.
Spectra for the active fluorophores from A. dihydrorhodamine 123 (rhodamine 123) B. carboxy- 
H2DCFDA (2',7'-dichlorofluorescein) and C. dihydroethidium (ethidium), obtained from Invitrogen 
(http://probes.invitrogen.com/resources/spectraviewer/). Excitation lasers used in confocal imaging are 
indicated.
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a t a t t a t a a a t a g a c a a a a g a g t c t a a a g g t t a a g a t t t a t t a a a  pPL32
1 a t g t t a g a t t t a t t a a g a t t a c a a t t a a c a a c a t t c a t t a t g a a t  
M L D L L R L Q L T T F I M N  
4 6 g a t g t a c c a a c a c c t t a t g c a t g t t a t t t t c a g g a t t c a g c a a c a  
D V P T P Y A C Y F Q D S A T  
91 c c a a a t c a a g a a g g t a t t t t a g a a t t a c a t g a t a a t a t t a t g t t t  
P N Q E G I L E L H D N I M F  
136 t a t t t a t t a g t t a t t t t a g g t t t a g t a t c t t g a a t g t t a t a t a c a  
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181 a t t g t t a t a a c a t a t t c a a a a a a t c c t a t t g c a t a t a a a t a t a t t  
I V M T Y S K N P I A Y K Y I  
22 6 a a a c a t g g a c a a a c t a t t g a a g t t a t t t g a a c a a t t t t t c c a g c t  
K H G Q T I E V I W T I F P A  
271 g t a a t t t t a t t a a t t a t t g c t t t c c c t t c a t t t a t t t t a t t a t a t  
V I  L L I  I A F P S F I L L Y  
316 t t a t g t g a t g a a g t t a t t t c a c c a g c t a t a a c t a t t a a a g c t a t t  
L C D E V I S P A M T I K A I  
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G Y Q W Y W K Y E Y S D F I N  
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D S G E T V E F E S Y V I P D  
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S M V V P V D T H I R F V V T  --- ► SH02
541 g c ^ g c t g a t g t t a t t c a t g a t t t t g c t a t c c c a a g t t t a g g t a t t  
A A D V I H D F A I P S L G I  
58 6 a a a g t t g a t g c t a c t c c t g g t a g a t t a a a t c a a g t t t c t g c t t t a  
K V D A T  P G R L N Q V S A L  
631 a t t c a a a g a g a a g g t g t c t t c t a t g g g g c a t g t t c t g a g t t g t g t  
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721 t t a c c t a a a t t t t t g ^ a a t g a t t a a a t g a a c a a t a a t t a a t a t t t  pPL27 
L P K F L E W L N E Q *  
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Figure 2.4. Annealing sites of primers used in the amplification of the S. cerevisiae COX2 gene.
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Figure 2.5. Screening of transformants.
The Ura+ transformants were screened for the presence of the COX2 plasmid. Recombination can occur 
between the mutated COX2 gene in the tester strain CKL3 and the COX2 plasmid if present in the Ura+ 
transformant. Some of the rho+ progeny will be respiratory competent. However, if no plasmid is present 
respiratory competent colonies will not arise. The COX2 gene is shown in red, and mutations are 
indicated with a cross.
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Figure 2.6. Typical standard curve used to determine protein concentration of membrane 
preparations.
The standard curve was generated using BSA standards ranging from 50 to 400 pg/ml, processed in 
duplicate.
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Figure 2.7. Porin signal intensities of a wild type dilution series.
Anti-porin antiserum was used to probe a blot of mutant samples loaded at 10 pg per well according to 
results of Lowry assay, and a wild type dilution series. Signal intensity was measured. All mutant signal 
intensities fell between 5 and 15 and the chart was used to calculate dilution factors for subsequent 
sample preparation.
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Figure 2.8. Assembly of two-dimensional native/denaturing gels.
A single gel slice was excised from a blue native gel, treated to dissociate protein, then placed 
horizontally between two glass plates. Resolving gel was poured beneath the slice before its enclosure in 
stacking gel.
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Figure 2.9. Determining band identity in denaturing gels.
Samples of purified yeast cytochrome oxidase (C) were electrophoresed adjacent to wild type 
mitochondrial membrane samples (M) and molecular weight markers. A. Subunits resolved on 15% gel.
B. Subunits resolved on 10% gel. C. Subunits resolved on 12.5% gel.
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Figure 2.10. RNA integrity assessed by the Agilent Technologies 2100 Bioanalyser.
Example traces of total RNA (A), mRNA (B) and cRNA (C) are shown.
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Figure 2.11. Relative efficiency plots to assess suitability of primer pairs for analysis using the comparative Ct (AACt) method.
Standard curves of ACt (using ACT1 as endogenous control) for serial dilutions of DNA were drawn and linear regression lines calculated. Amplification efficiencies of target 
gene and endogenous control gene are judged equivalent, and therefore suitable for analysis using the comparative Ct (AACt) method, if gradient is <0.1 (Applied Biosystems).
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Table 2.1. Yeast strains used in this study.
Strain Genotype Source
Strains used in Chapter 3
BM 1/1-16 MATa adel op1 [eryl oli1 intronless] Our lab
JC8/56 rho° M ATaleuI kar1-1 [rho°]a Our lab
W303-1B rho° MATa ura3-1 his3' leu2-3 ade2-1 trp1-1 [rho°] Our lab
CKDS 302 MATa Ieu1 kar1-1 [rho' COX2]b Our lab
W303-1 B/pBM2 MATa ura3-1 his3' leu2-3 ade2-1 trp1-1 [rho COX2] Our lab
CK L3 MATa Ieu1 kar1-1 [COX2 A189V A220V] c Our lab
CK WT MATa Ieu1 kar1-1 Our lab
Strains used in Chapters 4 and 5
BY4741 MATa his3A1 leu2A0 met15A0 ura3A0 Euroscarf
BY4741 Ayhbl MATa his3A1 leu2A0 met15A0 ura3A0 yhb1::kanMX4 Euroscarf
BY4741 Ayhbl rho° MATa his3A1 leu2A0 met15A0 ura3A0 yhb1::kanMX4 [rho0] Euroscarf1
FY1679 Ayhbl MATa his3-A200 ura3-52 Ieu2-A1 trp1-A63 yhb1::LEU2 Our labe
FY1679 Ayhbl MATa his3~A200 ura3-52 Ieu2-A1 trp1-A63 sod1:.kanMX4 Our lab®
Asodl yhb1::LEU2
FY1679 Ayhbl MATa his3-A200 ura3-52 Ieu2-A1 trp1-A63 sod2::kanMX4 Our lab®
Asod2 yhb1::URA3
FY1679 Ayhbl Accpl MATa his3-A200 ura3-52 Ieu2-A1 trp1-A63 ccp1::kanMX4 
yhb1::LEU2
Our lab®
FY1679 Ayhbl Actt1 MATa his3-A200 ura3-52 Ieu2-A1 trp1-A63 ctt1::kanMX4 
yhb1::URA3
Our lab®
BY4741 A ndel MATa his3A1 leu2A0 met15A0 ura3A0 nde1::kanMX4 Euroscarf
BY4741 A nde2 MATa his3A1 leu2AO met15A0 ura3A0 nde2::kanMX4 Euroscarf
BY4741 A ndil MATa his3A1 leu2AO met15A0 ura3A0 ndi1::kanMX4 Euroscarf
BY4741 A sdh1 MATa his3A1 leu2A0 met15A0 ura3A0 sdh1::kanMX4 Euroscarf
BY4741 Asdh2 MATa his3A1 leu2A0 met15A0 ura3A0 sdh2::kanMX4 Euroscarf
BY4741 A cat5 MATa his3A1 leu2A0 met15A0 ura3A0 cat5::kanMX4 Euroscarf
CWL65 MATa ura3-1 his3' leu2-3 ade2-1 trp1-1 [CYTB T46K] Our lab
CWAF MATa ura3-1 hisJ leu2-3 ade2-1 trp1-1 [COX3 AF94-F98] Our lab
W303-1B MATa ade2-1 hisJ Ieu2-3,112 trp1-1 ura3-1 URA3-STRE-LacZ P. Piper
W303-1B Ayhbl MAT a ade2-1 his3' Ieu2-3,112 trp1-1 ura3-1 URA3-STRE-LacZ Our lab®
yhb1::LEU2
W303 Ayhbl MAT a ade2-1 his3’ Ieu2-3,112 trp1-1 ura3-1 URA3 STRE-LacZ Our lab®
Amsn2/4 yhb1::LEU2 msn2::HIS3 msn4::TRP1
W303 Ayhbl Ayapl MAT a ade2-1 his3' Ieu2-3,112 trp1-1 ura3-1 yhb1::LEU2 Our lab®
yap1::TRP1
Our labd®W303 Ayhbl rho° MAT a ade2-1 his3~ Ieu2-3,112 trp1-1 ura3-1 URA3-STRE-LacZ
yhb1::LEU2 [rho0]
Our labfSOD1ICSS1 W303-1B Ayhbl transformed with a centromeric plasmid
overexpression containing the SOD1 and CCS1 genes under the control of the
ADH2 promoter
Our labfCTT1 overexpression W303-1B Ayhbl transformed with an insertional vector pRS403 
containing the CTT1 gene under the control of the ADH2
promoter
Our lab9BY4741 Ayhbl BY4741 Ayhbl transformed with a multicopy vector containing
C Y C f-LacZ the LacZ gene under the control of the CYC1 promoter
arho° mutation is the complete loss of mtDNA
brho' mutation involves a large deletion of mtDNA, with amplification of the remaining sequence 
cmif mutation is a point mutation in a gene encoded by the mtDNA 
drho° produced by ethidium bromide treatment
&Ayhbl strains obtained through PCR-mediated gene deletion from the strains given by P. Piper
fplasmid from P. Piper (Harris et al, 2003; Harris et al., 2005)
plasmid from B. Guiard (Guarente and Ptashne, 1981; Ramil et al, 2000)
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Table 2.2. Primers used for amplification of mitochondrial and nuclear genes.
Gene Forward primer(s) Reverse primer(s)
COX1 PL50 atg gta caa aga tga tta tat tea ac PL51 tta aga ttg tac age tgg tgt att aaa tg
COX2 PL32 att ata aat aga caa aag agt c PL27 att gtt cat tta ate att c
SH02 tat tag att cgt tgt aac age t SH01 ata taa ggt gat tga ata gaa t
PL30 age tgt tac aac gaa tct aat a
COX3 BM09 tag aaa gaa gta gac ate aac BM10 cct cat caa taa aat agt acg
COX12 Cox6bF tea caa ata gga aca age ac Cox6bR agg eta agt gca cat tact a
COX9 Cox7aF gat att tgc aaa eta eta ac Cox7aR ata aga ata taa tgc gaa aa
OXA1 OXA1F atg ttc aaa etc ace tct eg OXA1R aat gaa gtt tga ttt gtg aa
SC01 scof ggg aaa cag aaa aaa cag caa scor aca aga acg ggt tat age gtt
Table 2.3. Gel recipes.
A. Denaturing gel. B. Native gradient gel. Prior to addition of ammonium persulfate and TEMED gel 
solutions were filtered through 0.2 pm Millipore filters to remove dust. Ammonium persulfate and 
TEMED were added immediately prior to gel pouring. Quantities given are sufficient to pour 2 
denaturing gels or 4 native gradient gels. 40% acrylamide was obtained from BioRad. Acrylamide-bis 
solution contained 48% acrylamide, 1.5% bisacrylamide (49.5%T 3%C) and was cleaned with Amberlite 
MB-1 resin overnight prior to first use. 3x gel buffer contained 1.5 M 6-aminocaproic acid and 150 mM 
bistris pH 7.
A Stacking gel
3%
Resolving gel
10% 12.5% 15% 20%
3.75 M Tris pH 8.6 - 920 pi 920 pi 920 pi 920 pi
0.5 M Tris pH 6.8 500 pi - - -
40% Acrylamide (37:5:1) 450 pi 2.5 ml 3.1 ml 3.7 ml 4.9 ml
20% (w/v) SDS 25 pi 46 pi 46 pi 46 pi 46 pi
Urea 1.8 g 3.25 g 3.25 g 3.25 g 3.25 g
ddH20 3.25 ml 4.1 ml 3.5 ml 2.9 ml 1.7 ml
10% (w/v) Ammonium persulfate 25 pi 44 pi 44 pi 44 pi 44 pi
TEMED 3 pi 6 pi 6 pi 6 pi 6 pi
B Stacking gel Resolving gel
4% 8% 16%
Acrylamide-bis 0.5 ml 1.98 ml 3.25 ml
3x Gel buffer 2.0 ml 3.96 ml 3.3 ml
Glycerol - - 1.98 g
ddH20 3.5 ml 5.86 ml 1.7 ml
10% (w/v) Ammonium persulfate 50 pi 70 pi 35 pi
TEMED 5 pi 7 pi 3.5 pi
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Table 2.4. Solutions used in western blotting.
Dissociation buffer 50 mM Tris-HCI pH 6.8 
12% (w/v) glycerol 
4% (w/v) SDS 
2% (v/v) j3-mercaptoethanol 
0.01% (w/v) bromophenol blue
Running buffer 25 mM Tris 
192 mM glycine 
1% (w/v) SDS
Towbin’s buffer 25 mM Tris-base 
192 mM glycine 
20% (v/v) methanol
Cathode buffer 50 mM tricine 
15 mM bistris
0.02% (w/v) Serva blue G pH 7.0
Anode buffer 50 mM bistris pH 7.0
Solubilising solution 1 M 6-aminocaproic acid 
50 mM bistris
Loading buffer 1 M 6-aminocaproic acid 
5% (w/v) Serva blue G
PBS 0.01 M phosphate buffered saline pH 7.4 
0.138 M sodium chloride 
00027 M potassium chloride
PBST 0.01 M phosphate buffered saline pH 7.4 
0.138 M sodium chloride 
00027 M potassium chloride 
0.3% (v/v) Tween 20
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Table 2.5. Antibodies.
All the antibodies are monoclonal and raised in the mouse, except the polyclonal rabbit antiserum against Cox7p/Cox7ap and the polyclonal antiserum against cyt cx. 
aAntibodies were diluted in PBST. bThe exposure time required for two-dimensional blots was slightly longer than that stated, detection of Cox8p on two-dimensional 
blots additionally required the tertiary antibody PAP at 1:600 dilution.
Antigen Primary antibody 
Name Dilution3 SDS gel (%)
Exposure time 
SDSb Native
Secondary antibody 
Name Dilution3
Coxlp 111D8-B7 1:400 10 2 min 15s BioRad 1:4000
Cox2p 4B12-A5 1:4000 12.5 1 min 4 min Dako 1:2000
Cox3p DA5 1:4000 12.5 30s 15s Dako 1:2000
Cox4p 1A12-A12 1:20,000 12.5 30s 2 min BioRad 1:4000
Cox5p 13E2-F5 1:1000 15 30s 4 min Dako 1:2000
Cox6p 11D11-H6 1:250 15 15s 30s BioRad 1:4000
Cox6ap 7E3 1:2000SDS; 
1:400 native
15 1 min 4 min Dako 1:2000
Cox7p/7ap 1:500 15 10s 15s BioRad rabbit 1:4000
Cox8pc 20B5 1:10 15 30s 1 min BioRad 1:4000
Cyt Ci 1:6000 12.5 30s - BioRad 1:4000
Porin 16G9-E6 1:20,000 12.5 10s - BioRad 1:4000
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Table 2.6. Primers used for amplification in (RT)q-PCR
Gene Forward primer Reverse primer
CYC7 tcc gag tac ttg acg aac cca tcc ttt tcc ttc ttc aac ccg
CTT1 aga aag agt tcc gga gcg tg tct ggt atg gag egg cgt at
GPM2 gca age aca cca tcc aat gt get tag cgt caa tcc aac cac
HSP26 tgt tcc cat ctg gtt teg gt acc agg aac cac gac ttt caa
GTT2 tgc ctt ggc tga gaa gaa ca ctt ctt gtg etc tcc ctt cca
OYE3 tgg tea gcg tgc tea aag ac cga cct get cat cag acc aa
ACT1 ttg gat tcc ggt gat ggt gt cga ttc tea aaa tgg cgt ga
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SUBCOMPLEXES OF CYTOCHROME OXIDASE
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3.1. INTRODUCTION
3.1.1. Temporal pathway of cytochrome oxidase assembly
While much is known about the array of assembly factors involved in the various stages 
of cytochrome oxidase assembly, relatively little is known about the order in which the 
subunits of cytochrome oxidase join together to form the fully assembled enzyme. 
Assembly of mammalian cytochrome oxidase is believed to occur in an ordered 
sequence. Work by Nijtmans et al. (Nijtmans et al., 1998) and Williams et al. (Williams 
et al., 2004) has outlined the temporal pathway of assembly in human cells. In yeast, 
there is only one previous report of cytochrome oxidase subassemblies (Church et al., 
2005), but no subassembly containing any of the core subunits Coxlp, Cox2p or Cox3p 
has yet been identified.
3.1.2. Aims
The aim of this work was to gain more information on the assembly of cytochrome 
oxidase, in particular the order of subunit assembly, using yeast as a model system. I 
used a random mutagenesis approach to generate respiratory deficient mutants of the 
COX2 gene, encoding the core subunit Cox2p. In addition to mutations which 
completely abolished cytochrome oxidase assembly I was able to identify mutants in 
which assembly was impaired but not completely abolished. I characterised these 
mutants and their subunit composition and identified novel cytochrome oxidase 
subcomplexes.
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3.2. RESULTS 
3.2.1. Selection and initial characterisation of the mutant strains
The strain BM1/1-16 had been previously subjected to moderate mutagenesis by 
overnight incubation with 8 mM of the mtDNA mutagen manganese chloride (Meunier 
et al., 1993). 29 mutants had previously been mapped to the COX2 gene, by crossing of 
the haploid with a COX2 rho' strain (large deletion of mtDNA, amplification of the 
remaining sequence) (see 2.1.5). I confirmed the mapping using the same method and 
identified the mutations by sequencing (see 2.2.3). The majority were stop or ffameshift 
changes, but nine strains with one or more missense mutation in the COX2 coding 
region were identified, as in the example shown in Figure 3.1. The mutants chosen for 
further study were transferred via cytoduction (see 2.1.6) into the W303-1B nuclear 
background to facilitate genetic analysis, since the BM1/1-16 strain contains the opl 
mutation in the major ADP/ATP carrier of the IMM, causing respiratory deficiency.
All the mutations were located in the C-terminal globular domain of Cox2p 
(Figure 3.2A). Three mutants harboured double mutations (Table 3.1). To determine 
which mutation caused the respiratory defect, I isolated revertants from the double 
mutants and identified any reversion mutations in COX2 (Table 3.1) (see 2.1.7). 
Revertants are colonies which have acquired secondary mutations restoring competency 
to grow on respiratory medium. For two of the double mutants (Y146N + M232K and 
D162N + V169M), analysis of the reversions showed that only one of the double 
mutations was causing the respiratory defect (M232K or D162N). The second mutation 
by itself (Y146N or V169M) had little effect on the respiratory growth competence. The 
third double mutant, C221W + L245W, failed to yield reversion in COX2, suggesting 
that both mutations conferred respiratory deficient phenotype. For the remaining 
mutants, except G156E and R159K, reversion to wild type at each mutated site was 
identified, confirming that the mutation was responsible for the respiratory deficiency. 
The exception was P170H which failed to yield any mitochondrial reversions.
3.2.2. Analysis of cytochrome oxidase assembly by optical spectroscopy
The effect of the mutations on cytochrome oxidase content of whole cells was analysed. 
In yeast, unassembled subunits, especially the core subunits Coxlp, Cox2p and Cox3p, 
are rapidly degraded by AAA proteases (Nakai et al., 1995; Pearce and Sherman, 1995; 
Guelin et al., 1996). So in the absence of assembly the optical spectrum of the yeast 
cells alters, and the characteristic absorbance peak at 603 nm due to the heme aa^ of
87
3. Subcomplexes o f cytochrome oxidase
Coxlp is absent (Tzagoloff and Dieckmann, 1990; Brown et al., 1993; Meunier and 
Rich, 1998). Heme aa3 signal was absent in seven of the nine mutants: Y146N + 
M232K, D162N + V169M, P170H, R213M, G219E, C221W + L245W and G226E (see 
2.3.2). Therefore in these seven strains, mutation in COX2 abolished assembly of 
cytochrome oxidase. The optical spectrum of the double mutant C221W + L245W is 
shown in Figure 3.3.
However, two COX2 mutants, strain G156E (not shown) and R159K (Figure 
3.3), showed a significant amount of cytochrome oxidase present in optical spectra 
although they were unable to grow on respiratory medium. For both mutants the 
amplitude of heme aa^ signal was reduced to around 50% of the wild type level. In 
addition, the absorbance peak was shifted from 603 nm to 599 nm, indicating a 
perturbation of the heme environment. The phenotype of these two mutants was unusual 
since normally an assembly defect in yeast leads to a complete absence of aa3 signal. 
The mutants were therefore investigated in further detail to establish what interesting 
information on cytochrome oxidase assembly they could provide.
3.2.3. Activity of cytochrome oxidase in the mutants R159K and G156E
Cytochrome oxidase activity was determined to see whether the mutations impaired 
enzyme function as well as its assembly. Varying concentrations of reduced cytochrome 
c were supplied to mitochondrial membranes and oxygen consumption was measured 
(see 2.3.3). Data obtained were used to construct Lineweaver-Burke plots from which 
Vm and Km values were determined (Figure 3.4). Both mutants showed a decreased Vm 
and increased Km for cytochrome c (Table 3.2). The increase in Km is suggestive of a 
weakened interaction between the reaction partners, probably arising from a distortion 
of the binding site for cytochrome c on the surface of Cox2p.
3.2.4. Reversion mutations in the copper-binding domain of Cox2p
To understand the molecular nature of the effects of the mutations, I generated 
revertants which partially compensated the defects caused. As described in 2.1.7., the 
revertants were classified according to their mitochondrial or nuclear origin. For 
R159K, 9 nuclear and 6 mitochondrial revertants were identified and candidate genes 
were amplified and sequenced: COX1, COX2 and COX3 for mitochondrial reversions; 
COX12 (coding for Cox6bp) and COX9 (coding for Cox7ap) due to the close proximity 
of Cox6bp and Cox7ap to Cox2p, OXA1 and SCOl for nuclear reversions. No 
reversions were identified in genes other than COX2. For both G156E and R159K, 
revertants were obtained with secondary mutations at residues D187 or S222 of Cox2p
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(Table 3.1 and Figure 3.2B). These residues are located 25-30A from the primary sites 
and are in the copper-binding domain. This might suggest that the Cua site is perturbed 
in the mutants and that the reversions restore its correct structure. The revertants R159K 
+ D187N and R159K + S222Y were further studied. These reversion mutations restored 
respiratory growth yield to around half of wild type level and increased cytochrome 
oxidase content, though this was still lower than in the wild type (Table 3.2). 
Furthermore, cytochrome oxidase activity was closer to wild type; Vm was restored to 
wild type value and Km (cyt c) was lower than in the mutant (Table 3.2).
3.2.5. No evidence for a role of Oxalp or Scolp in the suppression of the defect 
caused by R159K.
The assembly chaperone Oxalp is required for export of the N-terminal region of 
cytochrome oxidase, and may also play a role in C-terminal export (Hell et al., 1997). It 
is possible that the mutation R159K might impair the interaction of Oxalp with Cox2p, 
preventing insertion of Cox2p into the membrane. In this case, overexpression of OXA1 
might re-establish the membrane insertion of Coxlp. The R159K mutant was 
transformed with an OXA1 overexpression plasmid (obtained from A. Tzagoloff, see 
2.2.5). Growth of the resultant strain on respiratory medium did not differ from that of 
the parent R159K mutant, indicating that Oxalp could not suppress the defect in the 
R159K mutant. However, the level of Oxalp overexpression was not determined, 
therefore it cannot be ruled out that a concentration-dependent effect may be in 
operation and a higher level of Oxalp expression may have elicited a growth difference. 
However, since the R159K mutation is located in the C-terminal region of Cox2p it 
seems unlikely that it would have an effect on Oxalp function. Moreover, no nuclear 
revertants of the R159K strain were found to contain OXA1 mutation.
More likely is that the mutation could interfere with the action of the copper 
chaperone Scolp, which binds to the C-terminus of Cox2p to deliver copper to the Cua 
site (Lode et al., 2000; Glerum et al., 1996b). Since R159K is located in the C-terminal 
region a distortion here could easily be imagined to impair the interaction between 
Cox2p and Scolp. Addition of copper to the growth medium might be expected to 
relieve problems caused by impaired interaction of Scolp, since supplementation of 
copper to human cells deficient in the homologous SC02 rescued their cytochrome 
oxidase deficiency (Jaksch et al., 2001; Salviati et al., 2002). To test this, growth 
medium (both respiratory and non-respiratory) was supplemented with copper (50-200 
pM copper chloride) and growth of the R159K strain was monitored. No differences in
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growth were observed in the presence of copper, which was not deleterious to wild type 
growth. Again, no nuclear revertants of R159K could be assigned to the SCOl gene.
3.2.6. Steady state subunit levels
The mutants G159E and R159K, and the revertants R159K + D187N and R159K + 
S222Y, were further investigated through western blotting analysis to determine the 
nature of the assembly failure (see 2.4.1 and 2.4.4). Mitochondrial membrane samples 
of the mutants and revertants were compared to serial dilutions of wild type membranes 
on denaturing gels to allow estimation of steady state enzyme content as a percentage of 
wild type (Figure 3.5). The mutant C221W + L245W, lacking heme aa3 signal, was also 
used for comparison. Antibodies raised against several cytochrome oxidase subunits 
were used and an antibody against porin was employed as a control for equal loading of 
mitochondrial protein; the concentration of porin should not be affected by alteration in 
cytochrome oxidase level (Taanman et al., 1997).
Characteristic of the phenotype of yeast mutants with impaired assembly of 
cytochrome oxidase, C221W + L245W lacked most of the cytochrome oxidase subunits 
assessed, with the exception of Cox4p. Cox4p is a matrix-side extrinsic polypeptide 
which has been shown to be present in soluble form when assembly is disrupted, 
suggesting that it is relatively stable compared to other subunits (Glerum and Tzagoloff, 
1997). Furthermore, in a yeast Cox3p point mutant the level of Cox4p was decreased to 
a lesser extent than most other subunits (Meunier and Taanman, 2002). The levels of 
each subunit compared to wild type could reflect partly the intrinsic stability of the 
subunit, and partly the content of that subunit in the misassembled complex. A small 
amount of Cox7p and/or Cox7ap (the antiserum detects both co-migrating subunits) 
could also be seen, since the signal was very strong; however, there was still less than 
10% of this subunit present. Surprisingly, the mutant contained a small amount of 
Cox2p, though less than 10% of wild-type level.
In the mutants G156E and R159K the levels of the core subunits Coxlp and 
Cox3p were around 25% of the wild type level, the amount of Cox5p was between 25 
and 50%, and the levels of Cox6p, Cox6ap, Cox7p and/or 7ap, and Cox8p were around 
50% of wild type level. The amount of Cox4p was higher, at 75-100% of wild type 
level. Cox2p level in these mutants was exceptionally low, at less than 10% of wild type 
levels, clearly lower than the level of the other core subunits.
In the revertants R159K + D187N and R159K + S222Y the level of each subunit 
increased compared to the mutant, but was still lower than in the wild type, with the
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exception of Cox4p which remained at high levels. Unexpectedly, the amount of Cox2p, 
while greater than in the mutant, remained at less than 10% of wild type levels. It might 
have been expected that Cox2p content in the revertants should have been similar to the 
levels of the other subunits, since enzyme activity was closer to the wild type rate 
(Table 3.2).
The level of cytochrome c\ in the strains was also assessed (Figure 3.5). This 
was found to be at 50% of wild type level or higher in all mutants and revertants except 
C221W + L245W, containing less than 10% of wild type level. Since the amount of bc\ 
complex seems affected by a decrease in cytochrome oxidase content, this may provide 
further evidence for the existence of a supracomplex containing both bc\ and 
cytochrome oxidase (Schagger and Pfeiffer, 2000; Cruciat et al., 2000).
3.2.7. Subcomplexes of cytochrome oxidase
To investigate further the specific decrease in Cox2p, I performed western analysis of 
blue native gels, which allow isolation of membrane protein complexes (Schagger and 
von Jagow, 1991) (see 2.4.2 and 2.4.4). The neutral detergent laurylmaltoside extracts 
proteins from the membrane, and Serva blue G dye confers a negative charge on the 
proteins. Mitochondrial membrane samples were subjected to native electrophoresis and 
the same antibodies as above were used to detect any complexes or subcomplexes 
(resulting from assembly or degradation) of cytochrome oxidase (Figure 3.6).
3.2.7.1. Major subcomplexes present in the wild type
In the control wild type two bands were detected by most of the antibodies tested. The 
upper band, denoted a, was assumed to correspond to the monomeric holoenzyme 
complex due to it being the highest molecular weight band (migrating close to the 232 
kDa marker). In-gel staining for cytochrome oxidase activity showed that both bands a 
and b represented active forms of the enzyme (Figure 3.7). The lower band b seems 
likely to be a partially degraded complex lacking Cox6ap, since it was not detected on 
probing with the antibody raised against this subunit. The relative proportions of bands 
a and b were not equal, and complex b tended to be present at higher levels. This 
suggests that Cox6ap is only loosely associated with the enzyme complex and that 
subtle variations in sample treatment prior to loading on the gel can alter the extent of 
Cox6ap attachment. Several lines of evidence in the literature corroborate this. 
Solubilisation of yeast cytochrome oxidase with Triton X-100 removes Cox6ap and 
Cox6bp (Taanman and Capaldi, 1992). Furthermore, chromatography (FPLC) of the 
purified bovine enzyme demonstrated that in various buffers containing 1 mM
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laurylmaltoside and 400 mM salt the enzyme eluted from columns as two major peaks; 
a fully assembled 13-subunit form and an 11-subunit form lacking COX6A and COX6B 
(Liu et al., 1995). This suggests that loss of the homologous yeast subunits Cox6ap and 
Cox6bp (which I did not probe for) may occur during sample preparation for blue native 
gel electrophoresis. Finally, in humans, an assembly complex has been identified in 
which COX6A and COX7A are absent (Nijtmans et al., 1998; Williams et al., 2004).
Surprisingly, although Cox4p was present in band b it did not appear to be 
present in band a (Figure 3.6). This may be because the Cox4p epitope is not accessible 
to the anti-Cox4p antibody in the fully assembled monomer due to shielding by Cox6ap. 
In the bovine enzyme the N-terminus of COX5B, equivalent to yeast Cox4p, is in close 
vicinity to the N-terminal region of COX6A, the yeast Cox6ap counterpart (Figure 3.8). 
The N-terminal sequence of yeast Cox4p is extended by 25 amino acids compared to 
COX5B, while the region N-terminal of the membrane-spanning a-helix in Cox6ap is 
35 amino acids compared with 12 in COX6A. The folding of these extended N-terminal 
sequences is unknown. However, it is quite possible that the extended N-terminal region 
of Cox4p is shielded by the extended Cox6ap N-terminal region. The location of the 
Cox4p epitope recognised by antibody has not been determined, but if it lies in the N- 
terminal region it may be inaccessible to antibody and thus not identified in the 
monomeric holoenzyme. It is well recognised that antibodies raised against 
polypeptides are not necessarily useful in detection of the natively folded protein.
3.2.7.2. Subcomplex c identified only in the mutants and revertants
No complexes were detected in the mutant C221W + L245W, as would be expected on 
consideration of the denaturing western blot (Figure 3.5). The mutants G156E and 
R159K contained less than 10% of wild type levels of complexes a and b. However, a 
faster migrating band c, not detectable in the wild type, was present. Band c was not 
detected by antibodies raised against Cox2p, Cox4p, Cox6ap, Cox7p and Cox7ap, or 
Cox8p, suggesting that these subunits were absent from subcomplex c. The band 
comprised Coxlp, Cox3p, Cox5p and Cox6p. The revertants contained band c in 
addition to bands a and b. Revertant R159K + S222Y had about 25-50% the level of 
bands a and b as the wild type, while revertant R159K + D187N appeared to have less 
than 10% of bands a and b compared to wild type. There is some difficulty in estimating 
this since the relative contributions of a and b to the assembled enzyme population vary 
with each sample, possibly due to subtle variations in sample treatment, as suggested 
earlier. However, both revertants seem to contain more of complexes a and b than the
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parent mutant R159K. The quantity of band c in the revertants seems to be similar or 
slightly less than that in the mutants. Therefore the secondary mutations increase the 
content of fully assembled enzyme.
3.2.7.3. Other subcomplexes
Four other subcomplexes were identified in all wild type, mutant (except C221W + 
L245W) and revertant samples tested. Three faster migrating bands were identified 
separately by antibodies raised against Cox7p and Cox7ap (band d), Cox8p (band e) and 
Coxlp (band j ). Additionally, a slower migrating band was identified by the Cox8p 
antibody (band z). Band d  appeared less prominent in the mutants, while bands e and /  
were more prominent in the mutants and revertants than in the wild type.
As mentioned earlier, antibodies which work well in the detection of denatured 
proteins do not necessarily work well in detecting native protein. Non-specific binding 
may occur (Williams et al., 2004). To determine whether the detection of the bands d, e, 
f  and z was specific and whether they did indeed represent subcomplexes containing 
Cox7p and/or Cox7ap, Cox8p and Coxlp (and also to confirm specificity of bands a, b 
and c), I ran two-dimensional gels, native in the first dimension then denaturing in the 
second dimension (Figure 3.9) (see 2.4.3 and 2.4.4). This allowed the components of 
each of the bands identified in the one-dimensional native blots to be determined. I used 
the revertant R159K + S222Y in this analysis since this strain contained high levels of 
all the bands detected.
When the two-dimensional blots were probed with antiserum against Cox3p, 
three spots corresponding to bands a, b and c were clearly visible at the correct 
migration for Cox3p, indicating that the detection was specific (Figure 3.9A). To 
determine whether band /  was specific, two-dimensional blots were probed with the 
antibody raised against Coxlp. Four spots corresponding to bands a, b, c and /  were 
detected, all migrating at the same rate on the second dimension denaturing gel, and the 
remainder of the blot was clear (Figure 3.9A). This suggests that bands a, /?, c and/ all 
contained Coxlp and that the bands were not non-specific signals. Band/runs on native 
gel between 66  and 140 kDa, therefore it was possible that it might in fact represent 
unassembled Coxlp. To determine whether this was the case, Coxlp was isolated from 
purified yeast cytochrome oxidase (see 2.4.6) and electrophoresed alongside the R159K 
+ S222Y revertant on native gel (Figure 3.10). Band/ co-migrated with purified Coxlp, 
therefore represents unassembled Coxlp. However, it is not clear why band/ should be 
absent in the mutant C221W + L245W.
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It can be noted that both Coxlp and Cox3p appear to migrate on two- 
dimensional gels at a faster rate than might be expected due to their molecular weight. 
This is most likely due to the difficulty in assembling these gels and ensuring that 
molecular weight marker is aligned correctly with the native gel slice. Lower molecular 
weight complexes tend to be more difficult to resolve on second dimension denaturing 
gel. On probing two-dimensional blots with Cox7p/Cox7ap antiserum, spots 
corresponding to bands a and b could be distinguished, migrating at the correct 
molecular weight for Cox7p/Cox7ap. However, the signal then extended in a streak, 
making identification of further spots problematic. The absence of any other spots 
corresponding to the migration of band d, though, suggests that band d  is indeed a 
subcomplex containing Cox7p and/or Cox7ap. Band d  was not identified by any of the 
other cytochrome oxidase antibodies tested, suggesting that it represents a subcomplex 
containing Cox7p and/or Cox7ap along with other unidentified proteins.
The final two bands, e and z, were both identified only by the Cox8p antibody. 
On probing the two-dimensional blot, two spots were present corresponding to bands a 
and b (Figure 3.9B). No spot corresponding to band c was visible, in accordance with 
the absence of band c in the one-dimensional native blot (Figure 3.6). Spots 
corresponding to bands e and z were also identifiable, but these did not co-migrate with 
spots a and b, indicating that the recognition of bands e and z by the Cox8p antibody 
was due to non-specific binding. In addition to the spots, several smears were present on 
the blot. Detection of spots with the Cox8p antibody required use of a tertiary antibody 
since the signal was weak. Incubation of a companion blot with only secondary and 
tertiary antibody demonstrated that the smears were due to non-specific reaction of the 
tertiary antibody used in conjunction with Cox8p antiserum.
3.2.8. Membrane insertion of the Cox2p N-terminal domain by Oxalp
In parallel to this work I attempted to investigate possible involvement of the assembly 
factor Oxalp in translocation of charged residues across the IMM. Oxalp has been 
suggested to facilitate translocation of negatively charged regions, including the Cox2p 
N-terminal transmembrane domain, while more neutral regions position themselves in 
the membrane by other means (Saint-Georges et al., 2001; Herrmann and Bonnefoy, 
2004).
I attempted the construction of two strains in which the N-terminal 
transmembrane domain of Cox2p would lose part of its negative charge. First, a strain 
with the mutation D41N in COX2, i.e. replacement of a negatively charged residue with
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an uncharged polar residue in the N-terminal transmembrane domain of Cox2p. Second, 
a strain with the nearby mutation F45K, i.e. replacement of an uncharged residue with a 
positively charged residue. A human mutation (M29K) causing myopathy was found at 
an equivalent residue, though there is poor sequence conservation in this region 
(Rahman et al., 1999). I aimed to determine whether Oxalp was still required for the 
insertion of Cox2p into the membrane when its N-terminal transmembrane domain was 
less negatively charged. In the absence of Oxalp cytochrome oxidase cannot be 
assembled (Altamura et al., 1996). I planned to introduce the mutated COX2 gene into a 
strain with deletion of the OXA1 gene and see whether cytochrome oxidase could still 
be assembled in the mutants. Of course, this was subject to the mutations not causing 
assembly problem due to structural changes. For example, the crystal structure of 
bovine cytochrome oxidase suggests that residue D25 (equivalent to yeast D41) could 
form a salt bridge with an conserved arginine 2.5A away on bovine COX6C (yeast 
Cox7ap) (Figure 3.11). Disruption of this would prevent neutralisation of the arginine 
charge, so assembly may be affected. Furthermore, D41 could be involved in tethering 
the transmembrane domain in place.
I attempted to generate the mutant strains through biolistic transformation as 
described in 2.2.6. Unfortunately I was not successful in generating the mutants. 
However the D41N mutant, but not the F45K mutant, was later successfully made by 
another member of our lab. The mutant did not have a respiratory deficient phenotype, 
suggesting that the D41 residue was not required for assembly of cytochrome oxidase. 
In another lab D41N was introduced into a mutant with temperature-sensitive Oxalp 
function (see (Bauer et al., 1994; Hell et al., 2001)). Accumulation and degradation of 
Cox2p was studied after incubation at the permissive temperature of 28°C and non- 
permissive temperature of 34°C. No difference was observed between the control D41 
and mutant D41N, and the work has not been pursued further (G. Dujardin, personal 
communication).
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3.3. DISCUSSION
Nine strains containing mutations in the COX2 gene have been analysed. All the 
mutations are located in the C-terminal globular domain of Cox2p. In yeast, 
unassembled subunits, especially the core subunits Coxlp, Cox2p and Cox3p, are 
rapidly degraded by AAA proteases, hence in the absence of assembly the characteristic 
peak at 603 nm due to the heme aa^ of Coxlp is absent. In seven of the mutants an 
absence of heme aa3 signal was observed in optical spectra. Therefore in these seven 
strains the COX2 mutation(s) abolished assembly of cytochrome oxidase, explaining the 
respiratory growth deficiency observed. Two mutant strains, G156E and R159K, had an 
unusual optical spectrum: heme aa3 signal was diminished but not abolished, and the 
absorbance peak was blue shifted to 599 nm. In these mutants, unusually, assembly was 
impaired but not abolished.
3.3.1. COX2 mutations abolishing cytochrome oxidase assembly
In the absence of cytochrome oxidase assembly unassembled subunits are normally 
rapidly degraded. One of the seven mutants with no heme aa^ signal (C221W + 
L245W) was analysed by western blotting and was found to contain less than 10% of 
wild type levels of all cytochrome oxidase subunits tested, except Cox4p, known to be a 
relatively stable subunit.
As shown in Figure 3.2A, some of the mutations are located close to the Cua 
centre. C221 is a copper ligand, and it has been shown previously that replacement of 
the copper ligands resulted in an assembly failure and absence of heme aa3 signal 
(Speno et al., 1995). Residues M232, G219 and G226 are also in the CuA-binding 
domain. Mutation at these residues may abolish or diminish copper binding through 
alteration of the backbone fold or sidechain packing at the /Miairpin structure of the Cua 
site. The mutations could also hinder the metallation of the Cua site by impairing the 
interaction between Cox2p and copper chaperones through distorting the binding 
surface. Failure to bind copper is likely to result in degradation of Cox2p and therefore 
prevent complex assembly.
The remaining five deleterious residues are located away (> 20  A) from the Cua 
site. The corresponding residue to P I70 initiates a /Mum in the bovine cytochrome 
oxidase, so mutation to histidine is likely to disrupt this. The corresponding bovine 
residue to D162 (E l37) is likely to be involved in a stabilising sidechain ionic 
interaction with R122 (bovine numbering) in COX4 (yeast Cox5p) (Figure 3.12). 
However, since there is poor sequence conservation between the bovine and yeast
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enzymes in this region of Cox2p no firm predictions can be made about the situation in 
yeast. R213 is located in a loop connecting ^-strands in the bovine Cox2p structure, so 
mutation to methionine is likely to alter sidechain packing in this region. All these 
mutations are likely to disrupt the native fold of Cox2p.
Alteration of Cox2p metallation and/or folding is likely to be the cause of the 
assembly failure in these mutants. Unassembled Cox2p is a substrate of the AAA 
protease Ymelp (Nakai et al., 1995; Pearce and Sherman, 1995). The enzyme senses the 
folding state of solvent-exposed domains and degrades unfolded membrane proteins 
(Leonhard et al., 1999). It is probable that Cox2p is rapidly proteolytically degraded and 
consequently cannot associate with Coxlp to stabilise the nascent complex. This would 
result in degradation of the subunits and absence of a heme aa3 signal.
3.3.2. COX2 mutations allowing partial cytochrome oxidase assembly
The optical spectra of the mutants G156E and R159K showed the presence of a 
significant amount (approx. 50% wild type level) of cytochrome oxidase, despite the 
respiratory deficiency of the mutants (Table 3.2). However, the signal peak was shifted, 
indicating perturbation of the heme environment. The enzyme also had decreased 
activity and increased Km for cytochrome c, suggesting a weakened interaction. 
Revertant mutations in the CuA-binding domain partially restored respiratory 
competence and cytochrome oxidase assembly. Interestingly, in a mutant of Scolp, a 
copper chaperone which provides copper atoms to the Cua site, the optical spectrum 
also exhibited a blue-shifted and diminished heme aa3 signal (Dickinson et al., 2000). It 
can be hypothesised that the primary mutations might have a long-range effect on 
folding of the Cua site, and the reversion mutations would alter the folding such that the 
enzyme can still be assembled. In the two R159K revertants analysed Vm was also 
restored, while Km (cyt c) was still high but closer to wild type level. So the reversions 
increase the functionality of the cytochrome c binding site even in the presence of the 
mutation R159K. This might be expected since replacement of arginine with lysine is a 
semi-conservative structural change.
Analysis of subcomplexes of the cytochrome oxidase present in the mutant 
strains showed that a large proportion of the cytochrome oxidase is present as a newly 
identified subcomplex c. A total of five complexes or subcomplexes could be identified 
by blue native electrophoresis. The wild type contained a, the monomeric holoenzyme; 
b, the monomeric holoenzyme lacking Cox6ap; d, containing Cox7p and/or Cox7ap but 
none of the other cytochrome oxidase subunits tested; and f  unassembled Coxlp. The
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mutant strains contained lower levels of a and b but additionally contained high levels 
of the faster migrating c, lacking Cox2p, Cox4p, Cox6 ap, Cox7p, Cox7ap and Cox8p, 
but containing Coxlp, Cox3p, Cox5p and Cox6p. I did not probe with an antibody 
against Cox6bp. The revertants contained c in addition to levels of a and b intermediate 
between those observed in the wild type and mutants. The absence of Cox2p in the 
major population of cytochrome oxidase in the mutants would explain the perturbation 
of the heme environment observed in optical spectra. It could also help to explain the 
high Km for cytochrome c, since part of the binding site for cytochrome c is located in 
Cox2p (Bisson et al., 1982; Lappalainen et al., 1995; Witt et al., 1995; Zhen et al., 
1999). Km would be closer to wild type in the revertants due to an increased proportion 
of enzyme containing Cox2p.
3.3.3. Origin of band c
There are several possibilities regarding the identity of band c:
3.3.3.1. Degradation product
Band c could represent a degradation product of the fully or partially assembled 
cytochrome oxidase. The G156E and R159K mutations may allow assembly of the 
complex. However, the mutations would alter the Cox2p structure such that it would be 
rendered unstable and especially susceptible to proteases. Cox2p would be 
proteolytically degraded and the attachment of some of the peripheral subunits would be 
weakened, while some of the remaining subunits (Coxlp, Cox3p, Cox5p and Cox6p) 
remained attached to each other in a stable subcomplex. It is not clear whether the entire 
Cox2p polypeptide would be extracted from the complex, or whether only the soluble 
extramembrane domain might be affected. Although the exact location of the Cox2p 
antibody epitope is not known, it is most likely to be in the exposed C-terminal region.
3.3.3.2. Assembly intermediate
Alternatively, band c could be an assembly intermediate accumulating due to the 
absence of Cox2p, rapidly degraded because of its mutations, but required in a 
subsequent assembly step. It is quite possible that Coxlp could interact with the core 
subunit Cox3p before interacting with Cox2p, since in the less complex cytochrome 
oxidase of R. sphaeroides Coxlp can associate with either of these subunits first (Hiser 
and Hosier, 2002). However, since c does not accumulate in the double mutant C221W 
+ L245W this suggests that its formation requires the presence of Cox2p. Furthermore, 
the absence of heme aaj, in the other Cox2p mutants suggests that Cox2p is required at
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least for the formation of a heme-containing subcomplex. It seems unlikely that band c 
represents a simple assembly intermediate.
3.3.3.3. Partially degraded assembly intermediate
Instead, band c could represent a degradation product of an assembly intermediate 
containing Cox2p. Initial folding of Cox2p may be comparatively normal in the G156E 
and R159K mutants, allowing the formation of an assembly intermediate containing 
Coxlp, Cox2p, Cox3p, Cox5p and Cox6p (Figure 3.13). Assembly would halt at this 
point, perhaps due to an inability of nuclear subunits to bind the altered Cox2p, or an 
unstable interaction with a chaperone protein. Cox2p would be unprotected and 
susceptible to proteases, so it would be removed (either fully or partially) from the 
assembling complex, the rest of which remains stable and intact but cannot proceed with 
assembly in the absence of Cox2p. Hence band c would represent an assembly 
intermediate which has undergone processing to remove Cox2p. In the other COX2 
mutants the folding defect would be too severe to allow the transient assembly of Cox2p 
and formation of a stable subcomplex.
A small proportion of the Cox2p-containing assembly intermediate would 
escape proteolysis and persist to form fully assembled enzyme (Figure 3.13). In the 
revertants R159K + D187N and R159K + S222Y there are significantly higher levels of 
complex a and subcomplex b compared to the mutants (Figure 3.6), suggesting that the 
secondary mutations increase the stability of the Cox2p-containing assembly complex 
so that the proportion of fully assembled enzyme would increase. However, this does 
not seem in agreement with the data obtained using denaturing electrophoresis. The 
amount of Cox2p detected by this method was less than 10% of wild type level for both 
mutants and revertants. However, sample treatment prior to denaturing electrophoresis 
is harsher than that required for native electrophoresis. The stability of the revertant 
Cox2p is likely to be intermediate between that of the parent mutant and the wild type, 
so a high degree of Cox2p degradation may occur in the revertants during denaturing 
sample preparation, but not during native sample preparation. The mitochondrial 
membrane samples used were not treated with protease inhibitors during extraction, and 
in denaturing gel electrophoresis multiple bands were present beneath the Cox2p bands 
of the mutants and revertants but to a lesser extent in the wild type (Figure 3.5). These 
most likely represent Cox2p degradation products.
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3.3.4. Band d
The other interesting subcomplex, d, containing Cox7p and/or Cox7ap, was detected in 
all samples except the mutant C221W + L245W. This may be a subassembly complex 
containing Cox7p and/or Cox7ap together with other as yet undetermined proteins. 
Recently, Church et. al. used sucrose gradient fractionation to identify a yeast 
cytochrome oxidase subcomplex containing Cox7p and Cox7ap in addition to Cox8p 
and the assembly factor PetlOOp (Church et al., 2005). My analysis did not reveal the 
presence of Cox8p in subcomplex d, however, it would be interesting to know whether 
PetlOOp was associated with the band.
3.3.5. Conclusions
This is the first instance of detection of the cytochrome oxidase subassemblies 
described, and only the second report of detection of subassemblies in yeast (see 
(Church et al., 2005)). The subassembly c is particularly interesting since it contains two 
of the core subunits of cytochrome oxidase. These results provide interesting data on the 
cytochrome oxidase assembly pathway and will aid understanding of the temporal order 
of subunit interaction. The work demonstrates that yeast, which has been invaluable in 
detecting assembly factors involved in assembly, can also be useful in delineating the 
sequential pathway of cytochrome oxidase assembly. It would be interesting now to 
analyse further yeast mutants in the same way.
The next chapter considers the effect of the cytochrome oxidase inhibitor and 
antimicrobial agent NO on yeast. A severe decrease in cytochrome oxidase content was 
observed after treatment with NO/RNS, suggesting that these substances can interfere 
with the assembly of cytochrome oxidase.
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Figure 3.1. The R159K mutation in COX2.
The amino acid change arginine to lysine caused by mutation of guanine to adenine at nucleotide position 
476 of the COX2 cDNA is highlighted. A. Coding sequence (primer PL32). B. Reverse sequence (primer 
PL27).
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Figure 3.2. Location of Cox2p mutations and reversions.
A. Cox2p only is shown. The locations of all the missense mutations identified in the respiratory deficient 
mutants are indicated. B. Coxlp and Cox2p only are displayed. The locations of the mutations G 156E and 
R159K are indicated, together with the reversion positions 187 and 222. The atomic structure is from the 
bovine enzyme (PDB lOCC), but residues are identified by yeast numbering. Copper atoms are shown in 
orange and heme groups in pink.
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Figure 3.3. Cytochrome levels in mutant and wild type cells.
Optical spectra of fully reduced whole cell suspensions were obtained as described in 2.3.3. c, 
cytochrome c, b, cytochrome b, a, cytochrome oxidase (heme aa3).
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Figure 3.4. Cytochrome oxidase activity in mutants and wild type.
Lineweaver-Burke plots were constructed after measuring oxygen consumption by mitochondrial membranes supplied with varying concentrations of cytochrome c.
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Figure 3.5. Steady state levels of cytochrome oxidase subunits in mutants and revertants.
Steady state subunit levels in mutants and revertants were compared to serial dilutions of the wild type on 
denaturing western blots loaded with 10-20 pg of protein, by probing with antibodies specific for 
cytochrome oxidase subunits Coxlp, Cox2p, Cox3p, Cox4p, Cox5p, Cox6p, Cox6ap, Cox7p and Cox7ap 
(Cox7/7ap), and Cox8p, and the 6cr complex subunit cytochrome c\ (see 2.4.1 and 2.4.4). An antibody 
specific for porin was used as control for equal loading.
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Figure 3.6. Subcomplexes of cytochrome oxidase in wild type and Cox2p mutants and revertants.
Immunoblots of native gels loaded with 60 (ig of protein from mutants, revertants and wild type were probed with subunit-specific antibodies 
against Coxlp, Cox2p, Cox3p, Cox4p, Cox5p, Cox6p, Cox6ap, Cox7p and Cox7ap (Cox7/7ap), and Cox8p, to determine the existence and 
composition of subcomplexes. Equal loading was confirmed by denaturing western blot probed with antiserum against porin. Bands a-z represent 
possible complexes or subcomplexes of cytochrome oxidase. Molecular weight markers are shown on the right hand side.
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Figure 3.7 Cytochrome oxidase activity of complexes a and b in the wild type.
Wild type protein (60 pi) was resolved on blue native gel then stained for cytochrome oxidase activity, as 
described in 2.4.5.
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Figure 3.8. Proximity of the N-terminal regions of COX6A and COX5B.
The atomic structure is from the bovine enzyme (PDB lOCC). The core subunits are shown in white, 
COX6A (yeast Cox6ap) is shown in red and COX5B (yeast Cox4p) is shown in yellow. In yeast, the 
Cox4p N-terminal sequence is extended by 25 amino acids and the Cox6ap N-terminal sequence by 23 
amino acids.
108
3. Subcomplexes o f cytochrome oxidase
232k 140k 66k
T T T native
top a b e d  f   »
▼ i l l !
C o x lp  
Cox3p  
Cox7/7ap
C o x lp
Cox3p
Cox7/7ap
450k
425k
415k
410k
450k
O)
c
TO 
C
"O
410k
232k 140k 
▼ ▼
top z a b e
▼ I I I I
66k
native
Cox8p
4k Z*
Cox8p m*
ab
450k
425k
O)c
TO
415k i  I  
410k
B
Figure 3.9 Subunit composition of cytochrome oxidase subcomplexes in the R159K + S222Y 
revertant verified by two-dimensional electrophoresis.
Blue native gel strips loaded with 60 pi protein were electophoresed then mounted horizontally and 
resolved by denaturing electrophoresis, before immunoblotting (see 2.4.3). Other gel strips from the same 
native gels were directly immunoblotted and are shown above the two-dimensional blots to aid 
identification of spots. A. The upper two-dimensional blot was probed with antibodies specific to Coxlp 
and Cox3p, while the lower blot was probed with antiserum recognising Cox7p and Cox7ap. In both 
cases, 15% denaturing gels was used. B. The two-dimensional blot, from a 20% denaturing gel, was 
probed with antibody raised against Cox8p.
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Figure 3.10. Identity of band/
Coxlp was isolated from purified yeast cytochrome oxidase and electrophoresed adjacent to the R159K + 
S222Y revertant on native gel, then the blot was incubated with antiserum against Coxlp.
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Figure 3.11. Possible salt bridge between Cox2p and Cox7ap.
The atomic structure is from the bovine enzyme (PDB lOCC). Bovine residue D25 in COX2 (yeast 
Cox2p D41) may form a salt bridge with residue R43 in COX6C (yeast Cox7ap).
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Cox2p
COX4
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Figure 3.12. Possible stabilising sidechain interaction between Cox2p and Cox5p.
The atomic structure is from the bovine enzyme (PDB 10CC). Bovine residue E l37 in COX2 (yeast 
Cox2p D162) could interact with R 122 in COX4 (yeast Cox5p).
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Figure 3.13. Formation of a partially degraded assembly intermediate of cytochrome oxidase.
Initial folding of Cox2p would be comparatively normal, allowing formation of an assembly intermediate 
containing Coxlp, Cox2p, Cox3p, Cox5p and Cox6p. However, Cox2p would be unstable and 
proteolytically degraded, while the remaining subunits remain attached. Some assembly intermediate 
would escape degradation of Cox2p and persist to form fully assembled cytochrome oxidase.
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Table 3.1. Mutations and reversions in COX2.
Reversion mutations were generated by manganese chloride treatment. Mutations were identified by 
sequencing the entire COX2 gene.
Mutation Reversion(s)
Y146N + M232K Y146N + K232M
G156E G156E + D187N/G
G156E + S222Y/F
R159K R159K + D187N
R159K + S222Y
D162N + V169M N162D +V169M
P170H -
R213M Wild type
G219E Wild type
C221W+ L245W -
G226E Wild type
Table 3.2. Cytochrome oxidase content and activity in mutants and revertants.
aThe cells were incubated in YPG, and the optical density of the culture was determined after 3 days. bThe 
cytochrome oxidase (CcO) content was determined from the amplitude of the heme aa3 optical spectra of 
dithionite-reduced whole cell suspensions (see 2.3.2). cThe cytochrome oxidase activity of membrane 
samples was measured using an oxygen electrode. Initial rates were measured as a function of 
cytochrome c concentration, and Vm and Km values were derived from Lineweaver-Burke plots as in 
Figure 3.4. (see 2.3.3).
Mutation Growth yielda 
(% wild type)
CcO content5 
(nmol.g cells'1)
CcO activity0 
Vm (s'1) Km (pM cyt c)
Wild type 100 0.8 625 7.4
G156E <5 0.4 47 53
R159K <5 0.4 208 43
R159K + D187N 60 0.6 650 14
R159K + S222Y 40 0.5 580 16
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Chapter 4
EFFECT OF NO/RNS ON CELL PROLIFERATION 
AND THE RESPIRATORY CHAIN
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4.1. INTRODUCTION
4.1.1. Antimicrobial activity of nitric oxide
On infection with pathogenic bacteria, viruses, parasites and fungi, the mammalian 
immune system releases high levels of nitric oxide (NO), an effective antimicrobial 
agent (MacMicking et al., 1997). However the specific cellular targets of this 
antimicrobial activity are not well understood. NO reversibly inhibits cytochrome 
oxidase by high affinity binding at the active site. At high concentrations and/or on 
prolonged exposure NO reacts with other molecules to form species collectively 
described as reactive nitrogen species (RNS). These species have varying reactivity and 
stability, and extend the range of targets which NO can affect to include thiols, 
tyrosines, DNA and lipids. RNS have also been shown to irreversibly inhibit respiration. 
RNS, together with reactive oxygen species (ROS), form the first line of host cell 
defence against pathogens, and their breadth of targets would account for the broad 
spectrum antimicrobial activity observed.
4.1.2. Aims
The aim of the work described in this chapter, in conjunction with the work described in 
Chapter 5, was to assess the nature of the antimicrobial effect of NO and the responses 
it elicits in the cell, using the model Saccharomyces cerevisiae. My aim has not been to 
distinguish between the various RNS which could be involved, rather to study the 
effects of the collective RNS to which pathogens may be exposed. I have used the NO 
donor DETA NONOate as a source of NO, since it releases NO over an extended period 
of time (Hrabie and Klose, 1993). In this chapter I have considered the effects of 
prolonged NO exposure of yeast cells on cell proliferation and on the cytochromes of 
the respiratory chain. Since NO and RNS have been demonstrated to inhibit several 
respiratory chain enzymes it seems likely that part of their antimicrobial action could be 
achieved through disruption of respiration. I have also assessed the involvement of 
oxidative stress defence genes in the sensitivity of yeast cells to the growth inhibition to 
determine the involvement of ROS in the antimicrobial action.
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4.2. RESULTS
4.2.1. Inhibition of yeast respiration by NO donor
NO is well known to inhibit mammalian respiration at sub-micromolar concentrations 
by reversibly inhibiting cytochrome oxidase. However yeast contain a very efficient NO 
oxidoreductase encoded by the YHB1 gene, and Yhblp is likely to be the main 
protective mechanism against NO in some microorganisms (Gardner et al., 2000; Liu et 
al., 2000). It might then be expected that the presence of Yhblp would prevent 
inhibition of respiration by NO.
In Figure 4.1 cells were grown to late exponential phase (approx. 6.107 cells per 
ml) then resuspended in fresh growth medium before addition of the NO donor DETA 
NONOate, and oxygen consumption was measured (see 2.3.3). NO donor had only a 
mild effect, even at high concentration (3 mM), on respiration of wild type yeast, 
reducing oxygen consumption from 77 to 56 pM O2 per second. However in a strain 
with deletion of YHB1 (Ayhbl) oxygen consumption was severely inhibited by 0.1 mM 
DETA NONOate, from 75 to 3 pM O2 per second. So yeast respiration can be inhibited 
by NO, but the presence of Yhblp is sufficient to defend against respiratory inhibition 
by even high concentrations of NO donor.
4.2.2. Inhibition of yeast proliferation by NO donor
The efficacy of Yhblp in the removal of NO is also demonstrated by comparing the 
growth of wild type and Ayhbl yeast in the presence of DETA NONOate. In all 
experiments cells were grown in galactose medium (YPGal) since this carbon source 
can be used for either respiration or fermentation by yeast cells, and induces much 
lower levels of repression of respiratory chain gene expression and mitochondrial 
biogenesis than glucose (Lagunas, 1986). At late exponential phase (approx. 6.107 cells 
per ml) cultures were divided into aliquots and varying concentrations of DETA 
NONOate added, then cell density was monitored for a period of 12 hours until 
stationary phase was attained (the experimental detail is described in 2 .1.8).
Figure 4.2A shows that high concentration of DETA NONOate had no effect on 
the growth of wild type yeast. In the absence of DETA NONOate growth of the Ayhbl 
mutant was similar to the wild type, confirming that the Ayhbl mutation itself did not 
affect yeast growth. However proliferation of these cells was sensitive to NO donor. 
Addition of 0.1 mM DETA NONOate had no effect on growth, but the presence of 3 
mM resulted in severe growth repression (Figure 4.2B). Control cultures underwent
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between 3 and 4 doublings during 12 hours while 3 mM DETA NONOate-treated cells 
reached only between 2 and 3 doublings within the same time frame, to reach less than 
half the cell density of control cells. When 1 mM DETA NONOate was added, the 
effect was not so severe and the culture underwent more than 3 doublings. With this 
concentration cell proliferation decreased to a similar level to that observed on 
incubation with 8 pM myxothiazol (Figure 4.2C). Myxothiazol is a specific inhibitor of 
the bc\ complex, and the concentration used here has been previously demonstrated to 
be sufficient to fully inhibit respiratory function (Bourges et al., 2005).
The effect of high concentration of DETA NONOate on proliferation of Ayhbl 
cells which had already been allowed to reach early stationary phase (approx. 3.108 cells 
per ml) was also assessed (Figure 4.2B). Incubation with 3 mM DETA NONOate 
caused cells to undergo less than one doubling before reaching a plateau compared to 
between one and two doublings in the control, and the culture appeared as if in a 
premature stationary phase after about 4 hours. As with the late exponential phase cells, 
density after 12 hours of 3 mM NO donor treatment was approximately half that 
observed in the control.
These data clearly demonstrate that the YHB1 gene is effective at removal of 
NO, and highlight the importance of flavohemoglobins as a protective mechanism 
against NO in some microorganisms. The objective of this study was to assess the 
antimicrobial action of NO, comprising the nature of the stresses sensed by the cell and 
the response of the cell to these stresses. Since Yhblp is so remarkably efficient at 
protecting against NO/RNS I have performed all the experiments described 
subsequently in strains with deletion of the YHB1 gene, to detect other proteins that 
contribute to the defence against NO/RNS.
To verify that NO and/or RNS, rather than another degradation product of 
DETA NONOate, was causing the inhibition of growth, the effect on cell proliferation 
of DETA NONOate which had been allowed to decompose for varying lengths of time 
was assessed (Figure 4.3). After one day of decomposition 3 mM DETA NONOate had 
a similar effect to fresh DETA NONOate. After 4 and 6 days decomposition the 
proliferation of treated cells became progressively closer to that observed in untreated 
cells. However, after 6 days decomposition the growth was still only about 70% of that 
observed in the untreated cells. The half life of DETA NONOate is 20 hours at 37°C 
and 57 hours at 24°C at pH 7.4 (Hrabie and Klose, 1993), so some DETA release might 
still be expected even after 6 days. Nevertheless, it is still possible that some of the 
deleterious effect on growth observed could be due to compounds other than NO and
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RNS. However, when wild type cells were treated with 3 mM DETA NONOate which 
had been allowed to decompose for 4 days the cell proliferation observed was similar to 
that observed with 3 mM fresh DETA NONOate (Figure 4.3). Since the substrate for 
Yhblp is NO, this data suggests that the growth inhibition in Ayhbl cells is not due to 
an unknown degradation product of DETA NONOate.
To estimate the concentration of NO which causes the severe decrease in cell 
proliferation I used an NO electrode to measure NO release from 3 mM DETA 
NONOate (see 2.3.4). Cells were grown to late exponential phase in YPGal, then an 
aliquot was removed and placed in the chamber of the NO electrode. 3 mM DETA 
NONOate was added and NO concentration measured over the following 24 hours 
(Figure 4.4). NO levels rose to 15-18 pM rapidly after addition of DETA NONOate, 
and remained at around this level for 4 hours. The concentration then decreased to 10- 
12 pM after 6 hours then to 3 pM after 12 hours, after which it remained steady. In the 
experiments described in this chapter I have worked at 28°C and an initial pH of around
5.6, therefore the half life of NO donor might be expected to be less than the 20 hours 
recorded at 37°C and pH 7.4. Since the conditions in the NO electrode chamber were 
not identical to those used when monitoring cell growth (different stirring speed due to 
use of magnetic stirrer used instead of platform shaker; different oxygen concentration 
due to different surface area exposed to air) the results can only be an approximation of 
the concentrations sensed by the cells.
4.2.3. NO donor at 3 mM does not impair cell viability
Having established that 3 mM DETA NONOate exerts an antimicrobial effect on Ayhbl 
yeast, I assessed cell survival to determine the nature of the inhibition of cell 
proliferation. Since RNS can act on a wide variety of targets incubation with DETA 
NONOate is likely to cause damage to several cellular components, which could lead to 
lethality. The viability stain methylene blue does not stain viable yeast cells since it is 
rapidly metabolised to a colourless product, but in non-living cells the stain appears 
blue. Comparison of methylene blue stained cells under the light microscope showed no 
differences between DETA NONOate-treated and control cell populations after 12 
hours (see 2.1.9). Although the methylene blue stain has been reported to overestimate 
yeast viability (O'Connor-Cox et al., 1997), almost no stained cells could be identified. 
The efficacy of the assay was confirmed by the high proportion of cells staining after 
short ethanol incubation.
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To further confirm the absence of lethality the percentage of cells able to form 
colonies after treatment with 3 mM DETA NONOate was monitored. After 12 hours 
treatment cell density was measured then cultures were diluted to 3000 cells per ml and 
aliquots were plated onto YPGal medium, then after 2 days incubation the colonies were 
counted. Viability of NO donor-treated cells was 77 ± 9% (n = 2) compared to the 
control. As a final test, I assessed the effect of replacing the growth medium after 12 
hour treatment with NO donor. I took a culture which had been treated with NO donor, 
harvested the cells, washed them twice with water, and used resuspended cells to 
inoculate a new YPGal culture to A6oonm = 0.05. After 13 hours of growth the new 
culture reached late exponential phase. Growth was then monitored for a further 7.5 
hours, after which time density of the culture derived from treated cells had reached 
about 80% of the density of a control culture treated in the same way (Figure 4.5). The 
small amount of growth inhibition observed may be due to residual NO donor, NO or 
RNS which had not been effectively washed from the cells, or a cytotoxic effect of 
DETA NONOate on a small proportion of the cells used to inoculate the culture. When 
this set of results is combined it seems that NO, at least at 3 mM, has a cytostatic rather 
than a cytotoxic effect on yeast.
4.2.4. NO donor does not cause rho' accumulation
I also evaluated the mutagenic effect of DETA NONOate. Deletions in mtDNA are 
called rho’ mutations, and accumulation of rho' mutations reflects the mutagenic effect 
of a compound on mtDNA. Such mutations occur spontaneously in cultures at a 
frequency of around 0.1%. ROS are mutagenic: treatments which enhance ROS 
production or diminish yeast cell defences against ROS (such as disruption of SOD2) 
increase the frequency of rho' accumulation (Piper, 1999). mtDNA is particularly 
susceptible to the mutagenic effects of endogenous ROS production, and its location 
close to the respiratory chain, lack of protective histones and the apparent incapability 
of mitochondria to perform nucleotide-excision repair probably contribute to this 
(Yakes and Van Houten, 1997).
It seems possible that RNS could also have a mutagenic effect on mtDNA. Since 
the mtDNA encodes components of the respiratory chain, rho' mutations cause 
respiratory deficiency. The plates used in colony counting (see 4.2.3) were replicated 
onto respiratory medium (YPG) and the number of colonies unable to grow (respiratory 
deficient) was recorded. No respiratory deficient colonies were present, consequently it 
seems that RNS do not have a mutagenic effect on the mtDNA.
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4.2.5. ROS do not appear to be involved in the effect of NO donor on cell 
proliferation
The respiratory chain is the major source of endogenous ROS production in yeast. 
Inhibition of the respiratory chain by NO acting on cytochrome oxidase will impede the 
flow of electrons, making the respiratory chain more reduced and increasing the 
likelihood of superoxide formation (Poderoso et al., 1996). Superoxide can combine 
with NO to form highly reactive peroxynitrite, which has a wide range of targets and 
may contribute to the antimicrobial action of NO. To determine the involvement of ROS 
in the observed response to NO donor, the effect of NO donor on proliferation of strains 
with deletion of genes involved in the oxidative stress response was monitored. The 
genes deleted were SOD1 (cytosolic superoxide dismutase), SOD2 (mitochondrial 
superoxide dismutase), CCT1 (cytosolic catalase T) and CCP1 (cytochrome c 
peroxidase). The superoxide dismutases are of particular interest since they are thought 
to perform one of the most important antioxidant activities in aerobic cells.
Cell density in the presence of 3 mM DETA NONOate was monitored over a 12 
hour period from late exponential phase. The inhibitory effect of NO donor on growth 
of the deletion strains was not significantly different to that observed in the control 
(Figure 4.6A). The Asodl strain did appear slightly less sensitive than the control. 
However, this is likely due to the comparatively slow growth of this strain in the 
absence of DETA NONOate; it seems that deletion of the cytoplasmic superoxide 
dismutase is in itself deleterious, as has been reported previously (Longo et al., 1996). 
The data did not provide any evidence to suggest involvement of ROS in the cytostatic 
effect of NO donor.
4.2.6. The NO donor has a deleterious effect on cell proliferation in the absence of 
a respiratory chain
NO is a potent inhibitor of cytochrome oxidase. Additionally, RNS have been 
demonstrated to damage several components of the respiratory chain. Therefore it seems 
possible that the antimicrobial action of NO could be a consequence of deleterious 
action on the respiratory chain. To investigate whether a respiratory chain was required 
for the cytostatic effect I assessed the effect of DETA NONOate on cells with impaired 
respiratory function: cells treated with 8 pM myxothiazol immediately prior to addition 
of DETA NONOate (intact but inhibited respiratory chain); and rho0 cells (absent 
respiratory chain). In both cases growth before addition of NO donor was decreased by 
around 25% compared to the control, since the cells could rely only on fermentation.
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When 3 mM DETA NONOate was added growth was further inhibited by 30-35% after 
12 hours, while 1 mM DETA NONOate had little or no effect (Figure 4.6B). These data 
suggest that at a high concentration, the NO donor has an inhibitory effect on yeast 
growth independently of a functional respiratory chain. However, at lower concentration 
this does not seem to be the case. The apparent weaker cytostatic effect of 3 mM NO 
donor observed in cells with impaired respiratory function might be due to their slower 
growth prior to NO donor addition, mirroring the situation with the Asodl strain 
described in 4.2.5. Slower growing cells could be less sensitive to NO/RNS damage, 
perhaps due to their having more time in each cell cycle to repair the damage.
4.2.7. Sites of ROS production in yeast
Although I did not find evidence to implicate ROS in the antimicrobial action of DETA 
NONOate, it was interesting to attempt to determine the main sites of ROS production 
in yeast, with a view to determining the effect of NO on ROS production. To this end, I 
used a number of yeast strains with deletion of components of various respiratory 
complexes: the internal NADH dehydrogenase, the two external NADH
dehydrogenases, succinate dehydrogenase, the bc\ complex and cytochrome oxidase, in 
addition to a strain with deletion of CAT5, involved in quinol biosynthesis. The strains 
were exposed to probes (dihydrorhodamine 123, carboxy-H2DCFDA, dihydroethidium) 
designed to fluoresce when in contact with ROS. Dihydrorhodamine 123 and carboxy- 
H2DCFDA both detect hydrogen peroxide and peroxynitrite. Carboxy-^DCFDA also 
detects peroxyl radicals (ROO), and dihydroethidium detects superoxide. Quantitation 
of fluorescence was attempted by fluorimetry and confocal microscopy (as described in 
2 .1.10 and 2 .1.11).
In fluorimetry, a low cell number (3.105 cells) per assay exhibited a similar 
fluorescence to no cells, with any concentration of probe used. Increasing the cell 
number resulted in higher signals, especially if a high concentration of probe was used, 
but fluorescence was not strikingly higher, indicating that the cells may be quenching 
the fluorescence. The yeast cells had a high degree of natural fluorescence, measured by 
both fluorimetry and confocal analysis, which varied with strain. Such autofluorescence 
has been observed previously in yeast and was suggested to be due to sources including 
reduced nicotinamide nucleotides and oxidised flavins (Knight et al., 1999; Billinton 
and Knight, 2001). Fluorescence in the presence of probe often did not therefore 
increase above that observed in the absence of probe. Use of higher concentrations of 
probe served to increase the autofluorescence, so did not alleviate the problem.
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Additionally, replicates were variable and results were not comparable between 
different experiments. Significant error was likely to be introduced through washing the 
cells, but this was required to remove the growth medium, which itself fluoresced. To 
assess whether this error was important I corrected results for cell density of the 
resuspended cells, but the variations observed could not explain the results.
To determine whether the small increases in fluorescence observed in the 
presence of probe were due to ROS, antimycin, well documented to increase ROS 
production (for example (Boveris and Cadenas, 1975; Rasmussen et al., 2003)), was 
added to wild type cells. However, antimycin caused an increase in autofluorescence, 
again allowing only small changes in fluorescence on addition of probe. In conclusion, I 
was not able to show that it was ROS which were measured by the fluorescence changes 
on addition of probe, differences in fluorescence were very small anyway, and the 
results were highly variable. Therefore I did not pursue this line of research further.
4.2.8. Prolonged treatment with NO donor severely decreased cytochrome oxidase 
content
Prolonged incubation of mammalian cells with NO, especially at high concentrations, 
causes irreversible damage to respiratory function (see for example (Clementi et al., 
1998)). To further investigate the effect of NO donor on the yeast respiratory chain, 
cytochrome levels were assessed after prolonged incubation with DETA NONOate. 
Firstly, as a control, the variations in cytochrome (c + c\, b, a + a3) levels and oxygen
• 7consumption were assessed at stages of growth from late exponential phase (9.10 cells
o  o
per ml) through early stationary phase (3.10 cells per ml) to stationary phase (8.10 
cells per ml), in the absence of DETA NONOate. Cells were grown in the same way as 
described previously, and at several time points were harvested and washed. 
Cytochrome content was assessed by spectroscopy (see 2.3.2) and oxygen consumption 
was assessed with an oxygen electrode (see 2.3.3). The results are shown in Table 4.1. 
Levels of all the cytochromes measured had a tendency to increase over growth. The 
overall oxygen uptake of the cells seemed reasonably constant, but cytochrome oxidase 
activity decreased after cells had reached stationary phase, falling from around 500 to 
around 330 electrons per second.
To test the effect of prolonged NO donor incubation on the respiratory chain, 
cells were cultured from late exponential phase in the presence of 3 mM DETA 
NONOate, then harvested for analysis at intervals over the next 12 hours. Pellets were 
washed thoroughly to remove any residual NO reversibly bound to cytochrome oxidase.
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The change in cytochrome level with duration of treatment is shown in Figures 4.7A 
and B. Cytochrome level (pmol per 106 cells) was compared with that measured 
immediately prior to addition of NO donor. The NO donor had a differential effect on 
the cytochromes. By 4 hours of DETA NONOate treatment (approx. one cell division) 
the levels of all the cytochromes measured had decreased to around 50% of their 
original levels. After this, cytochromes b and c + c\ levels began to increase and 
recovered to their original levels after 12 hours (approx. two cell divisions). In contrast, 
cytochrome oxidase exhibited a further dramatic decrease to just 10% of the original 
level.
The effect of different concentrations of DETA NONOate on cytochrome 
oxidase was also assessed (Figure 4.7C). Addition of 0.1 mM DETA NONOate had no 
effect on cytochrome oxidase levels after 12 hours. After 12 hour treatment with 1 mM 
NO donor the concentrations of cytochromes c + c\, b and a + were 0.30, 0.18 and 
0.04 pmol per 106 cells, respectively. This is compared to 0.29, 0.21 and 0.01 pmol per 
106 cells in 3 mM-treated cells, indicating a less severe effect on cytochrome oxidase.
The analysis was repeated with another strain, FY1679 Ayhbl. The growth rate 
of this strain showed a similar sensitivity to NO donor as BY4741 Ayhbl (Figure 4.8, 
compare to Figure 4.2B). However the effect on cytochrome oxidase content was more 
rapid, and cytochrome oxidase was completely abolished after 6 hours incubation 
(Figure 4.9). By this point no oxygen consumption could be measured. Cytochrome c 
level in this strain was 0.08 pmol per 106 cells compared to 0.15 pmol per 106 cells in 
untreated cells after 6 hours, which may reflect the decrease observed after 6 hours in 
the BY4741 Ayhbl strain. Cytochrome b level, however, did not appear to be sensitive 
to NO donor treatment after 6 hours.
4.2.9. The decrease in cytochrome oxidase content is specific to NO donor
Since NO donor inhibits respiration, the dramatic effect on cytochrome oxidase content 
might have been caused in some way by blockage of the respiratory chain. If this were 
the case it might be expected that a similar effect would be observed if the respiratory 
chain was blocked by another means. To test this the effect of carbon monoxide, which 
acts specifically at the active site of cytochrome oxidase, on late exponential phase cells 
was monitored (see 2.1.8 for experimental detail). Cytochrome content was not 
diminished. After 6.5 hour incubation cytochrome levels increased: c + c\ from 0.29 to 
0.62; b from 0.16 to 0.40; a + a3 from 0.05 to 0.13 pmol per 106 cells. However, in this 
experiment the concentration of carbon monoxide was not measured, so it is not clear
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whether the amount of carbon monoxide supplied to the cells was sufficient to inhibit 
respiration, or to what degree respiration was inhibited. Additionally, the experimental 
conditions differed slightly from those used in the other experiments described in this 
chapter (see 2 .1.8), so the results may not be directly comparable.
As a further test, late exponential phase cells were treated with an inhibitory 
dose (8 pM) of the bc\ complex specific inhibitor myxothiazol (see Figure 4.2C) and 
cytochrome content was measured after 6 and 12 hours of incubation (Table 4.2). 
Although yeast growth rate was decreased to around that observed on incubation with 1 
mM DETA NONOate, levels of all the cytochromes increased throughout growth, as 
observed in the control (Table 4.1). Taken together, these data suggest that the decrease 
in cytochrome oxidase observed after treatment with NO donor is specifically due to 
NO/RNS, and not simply due to an inhibition of respiration.
4.2.10. NO donor has little effect on cytochrome content in stationary phase cells
In 4.2.8 I showed that NO donor had a severe effect on cytochrome oxidase level when 
added to rapidly dividing cultures in late exponential phase. I wanted to determine 
whether the same was true for slowly dividing cultures. The analysis was therefore
o
repeated for cells which had been grown to early stationary phase (approx 3.10 cells 
per ml) prior to addition of NO donor. As shown in Figure 4.2B, these cultures undergo 
only one doubling before reaching stationary phase. The results are presented in Table
4.3. In contrast to the late exponential phase cells, the levels of all the cytochromes 
measured remained steady, even after 26 hours of treatment with NO donor. The 
activity of cytochrome oxidase fell from 591 to around 300 electrons per second after 6 - 
12 hours treatment, mirroring the decrease in activity observed in untreated cells: when 
cells were grown from a density of about 3.108 to about 8.108 cells per ml (6  hours) in 
the absence of NO donor, cytochrome oxidase activity decreased from 591 to 333 
electrons per second. This indicates that in early stationary phase cells NO donor does 
not irreversibly inhibit cytochrome oxidase, at least after 6-12  hours of incubation. 
However NO does seem to arrest cell proliferation and the accumulation of 
cytochromes; as untreated cells progress through stationary phase an increase, almost a 
doubling, in the levels of all the cytochromes is observed (Table 4.1), but this is not 
seen in NO donor-treated cells (Table 4.3). Additionally, cellular oxygen consumption 
progressively decreased over the 26 hours of NO donor treatment. This is likely due to 
the lower amount of cytochrome oxidase present per cell when compared to untreated 
cells.
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4.3. DISCUSSION
4.3.1. Inhibitory effect of NO on cell proliferation
Proliferation of yeast cultures was inhibited by DETA NONOate, but only in the 
absence of the YHB1 gene (Figure 4.2A). 3 mM DETA NONOate was required to elicit 
a severe growth repression, while 1 mM caused slight repression and 0.1 mM had no 
effect (Figure 4.2B).
However, the oxygen electrode data showed that a low concentration (0.1 mM) 
of NO donor was sufficient to completely inhibit respiration in Ayhbl cells added to 
fresh medium in the oxygen electrode chamber (Figure 4.1). It might therefore have 
been expected that this concentration of NO donor would have had some deleterious 
effect on yeast growth. In galactose, when respiration is abolished, the growth rate 
should decrease as demonstrated by the effect of an inhibitory concentration of 
myxothiazol, a specific inhibitor of the bc\ complex (Figure 4.2C). However, 0.1 mM of 
NO donor did not affect growth rate. It seems that the two systems, growth curve and 
oxygen electrode, give rise to differing sensitivities to NO donor. The ratio of cells to 
DETA NONOate was four times higher at the beginning of the growth curve
7 6experiment than in the oxygen consumption assay (approx. 2.10 compared to 5.10 
cells per pmol DETA NONOate). This might help to explain why cells in the growth 
assay appear less sensitive to NO donor. Another possibility is that, due to harvesting 
and resuspension, cells are more stressed when they are placed in the oxygen electrode 
chamber, which may mean that defence systems are not able to deal adequately with the 
NO supplied. Furthermore, it is difficult to be sure that the concentration of NO released 
in the two systems is the same. The pH of the media used in growth curves at the point 
of NO donor addition was lower than that of the fresh media in the electrode chamber, 
since cells had already been growing in it (see 2.1.8). Therefore NO release might have 
been expected to be higher in the growth assays. However, the growth assay media may 
have been modified in such a way by metabolic products that NO release by DETA 
NONOate, or the concentration of NO/RNS sensed by the cells, was lower than in the 
fresh media. In addition to this, the oxygen consumption was measured during the first 
few minutes after NO inhibition, while the cell proliferation was monitored over a much 
longer time frame. It may be that initially respiration is completely inhibited by 0.1 mM 
NO donor, but the cells respond to this in such a way that the repression is relieved, 
perhaps by upregulating defence systems involved in removal of NO or RNS, as will be 
discussed in the following chapter.
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I did not find evidence to suggest that DETA NONOate has a cytotoxic effect on 
S. cerevisiae, rather a cytostatic effect seems to be in operation. In addition to this NO 
donor did not appear to exert any mutagenic effect on the mtDNA. In this study I did 
not attempt to distinguish between NO and NO-derived RNS, but was interested in the 
overall effect of NO as an antimicrobial agent. However, I did assess the involvement of 
ROS in the antimicrobial effect. I monitored the effect of the NO donor on proliferation 
of strains with deletion of genes involved in oxidative stress defence (Figure 4.6A) and 
found no evidence to suggest involvement of ROS in the observed deleterious effect. 
Moreover, in the absence of a respiratory chain, the main site of ROS production, 
inhibition of cell proliferation still occurred with 3 mM NO donor (see next paragraph), 
further suggesting no major ROS involvement.
Since NO is a powerful inhibitor of cytochrome oxidase, and RNS have been 
demonstrated to damage respiratory chain components, the inhibition of yeast 
proliferation could be a consequence of adverse action on the respiratory chain. 
However, the effect of 3 mM DETA NONOate cannot be exclusively due to this since a 
deleterious effect was observed even when the respiratory chain was absent or 
compromised (Figure 4.6B). In contrast, 1 mM DETA NONOate failed to cause further 
decrease in growth from that due to the respiratory deficiency. It may be that at lower 
concentrations DETA NONOate inhibits the respiratory chain to cause an antimicrobial 
effect, while at high concentrations the growth inhibition is due to the combined effects 
of inhibition of the respiratory chain and further deleterious effects on other targets. 
Inhibition of the respiratory chain, whether reversible or irreversible, cannot solely 
account for the observed cytostatic effect on yeast.
4.3.2. Possible mechanisms for the inhibition of proliferation
NO has two particular targets, which are well characterised: the heme of the soluble 
guanylate cyclase, and the binuclear centre of cytochrome oxidase. It is feasible that NO 
could target other heme-containing enzymes. However RNS have a much wider range 
of targets. In similar conditions to those used here, it was shown that Ayhbl yeast grown 
for an hour in the presence of 3 mM DETA NONOate had a ten-fold higher level of 
nitrosylation of multiple high mass complexes than wild type yeast treated in the same 
way (Liu et al., 2000). Since cells in my experiments were exposed to NO donor for a 
much longer time period, it seems likely that high levels of protein nitrosylation could 
be occurring in these experiments. Additionally, Ramachandran et al. showed that 
prolonged exposure of bovine endothelial cells to DETA NONOate caused an increase
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in the levels of cysteine S-nitrosothiols and other nitrosated species (e.g. iron nitrosyl 
compounds, N-nitrosamines) (Ramachandran et al., 2004). NO and RNS could 
conceivably react with many targets to impair essential cellular activities and lead to 
cell growth inhibition.
Ribonucleotide reductase, the rate-limiting enzyme in DNA synthesis, has been 
documented as a target of NO/RNS. NO generated by macrophages caused growth 
arrest in tumour cells partly through inhibition of ribonucleotide reductase (Kwon et al., 
1991). Such inhibition could be implicated in the inhibition of yeast growth. Another 
possibility could be inhibition of enzymes involved in ergosterol biosynthesis. 
Ergosterol is a vital fungal cell wall constituent, and the ergosterol biosynthetic pathway 
is a major target of antifungal drugs (Lupetti et al., 2002). Several enzymes in the 
ergosterol biosynthesis pathway contain cytochrome P450, which is known to be 
inhibited by NO (Minamiyama et al., 1997; Roberts et al., 1998; Quaroni et al., 2004). 
DETA NONOate has been shown to inhibit steroid hormone synthesis in mammalian 
cells by inhibiting activity of several cytochrome P450-containing enzymes (Hanke et 
al., 1998). Effects of NO on other targets will be further discussed in the following 
chapter.
4.3.3. Severe decrease in cytochrome oxidase level after NO donor exposure
Prolonged exposure of late exponential phase cells to high concentrations of NO donor 
caused a severe decrease in cytochrome oxidase content, as judged by the heme aa3 
signal (Figure 4.7). The same effect was not observed for cytochromes b and c + c\. The 
severe decrease could be due to a dissociation or degradation of cytochrome oxidase 
induced by DETA NONOate. Alternatively NO donor may be hampering synthesis of 
new cytochrome oxidase. As discussed in the previous chapter, failure to assemble 
cytochrome oxidase results in rapid degradation of subunits, in particular the core 
subunits Coxlp, Cox2p and Cox3p, resulting in an absence of the heme aa^ signal.
There have been several reports in the literature regarding NO/RNS-induced loss 
of cytochrome oxidase. Ramachandran et al. showed that in bovine endothelial cells 
prolonged exposure to 0.5 mM DETA NONOate resulted in a decrease of NADH 
dehydrogenase, succinate dehydrogenase and cytochrome oxidase protein levels and 
activities (Ramachandran et al., 2004). The decrease in activity was reversible for 
succinate dehydrogenase and cytochrome oxidase when NO was removed (NADH 
dehydrogenase was not assessed), but in the case of cytochrome oxidase this 
reversibility was dependent on new protein synthesis.
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Prolonged incubation of smooth muscle cells with azide caused an irreversible 
loss of cytochrome oxidase activity and loss of heme aa3 signal (Leary et al., 2002). No 
decrease in mRNAs encoding several cytochrome oxidase subunits was observed, and 
steady state subunit levels were unaltered. However, significant pools of unassembled 
mitochondrial subunits were detected on blue native gels and cytochrome oxidase 
content as determined by absorbance spectra was decreased. The authors suggested that 
the treatment caused structural damage, likely around the heme groups, and dissociation 
of existing cytochrome oxidase (Leary et al., 2002).
Additionally, Sharpe and Cooper demonstrated that peroxynitrite treatment 
caused irreversible inhibition of purified cytochrome oxidase. This was associated with 
loss of the Cua absorption band and, at higher peroxynitrite concentrations, loss of 
hemes a and a3 (Sharpe and Cooper, 1998).
4.3.4. Possible disruption of cytochrome oxidase synthesis
In the data presented here, cytochrome oxidase levels only decreased on DETA 
NONOate treatment of late exponential phase cells, and not early stationary phase cells. 
In this discussion, to simplify, I will refer to late exponential phase cells as ‘dividing 
cells’ and early stationary phase cells as ‘non-dividing cells’. Even after 26 hours of 
exposure to DETA NONOate no decrease in cytochrome oxidase content was observed 
in non-dividing cells. Therefore it seems unlikely that the low level of cytochrome 
oxidase in dividing cells after NO donor treatment could be solely due to degradation of 
existing enzyme. It is more likely that the decreased cytochrome oxidase content is due 
to a lower synthesis of the enzyme in the presence of NO donor. In dividing cultures 
there is both a higher energy demand and a requirement for new enzymes for daughter 
cells, hence respiratory complex synthesis will be higher than in non-dividing cultures. 
Therefore the effects of NO donor on cytochrome oxidase levels would be more evident 
in this type of culture. Decreased synthesis of cytochrome oxidase could be brought 
about through various mechanisms including alteration of mRNA synthesis or stability, 
or a defect in the process of subunit assembly (involving cytochrome oxidase subunits 
or one of the many assembly factors).
4.3.4.1. mRNA changes
Several studies have reported specific modifications in mRNA levels of 
mitochondrially-encoded proteins as a result of NO treatment. Gou et al. and Wei et al. 
showed that on prolonged treatment of macrophages with LPS (which induces iNOS 
synthesis) the levels of cytochrome b and Coxlp mRNA and protein decreased (Gou et
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al., 2001; Wei et al., 2002). This was not due to repressed transcription, rather to 
increased mRNA degradation, which the authors suggested was perhaps to be expected 
since the mitochondrial genes are transcribed as polycistronic precursor RNAs. 
However, Nicoletti et al. showed that LPS induction of iNOS in mixed cortical and 
astroglial cultures caused an increase in mRNAs for Coxlp, Cox2p and Atp6p (Nicoletti 
et al., 1998). This was reversed by addition of superoxide dismutases and catalase, 
indicating an involvement of ROS. The authors proposed that the cells were attempting 
to compensate for the accumulation of damaged subunits of the respiratory chain. In a 
study using the NO donor DEA NONOate, Lehrer-Graiwer et al. also showed that 
macrophage Coxlp mRNA and protein levels increased after short treatment (Lehrer- 
Graiwer et al., 2000). There seems to be no consensus on the effect of NO on mRNA 
levels, and observations may depend on the length of treatment and system used.
In the following chapter I describe the effect of short DETA NONOate exposure 
on genomic expression profiles. After 60 minutes the treatment resulted in a decrease in 
expression of a number of genes encoding subunits of respiratory chain complexes, and 
levels remained low even after 2 hours (Table 4.4). Subunits or assembly factors of all 
respiratory chain complexes were repressed in the analysis. The repression was not 
specific to cytochrome oxidase subunits: components of the bc\ complex, for example, 
were repressed to a similar, if not more severe, extent. This repression may therefore 
account for the decrease in levels of cytochromes c + cu b and a + <33 after 2 to 6 hours 
of DETA NONOate treatment, but is unlikely to be the cause of the further severe 
decrease in cytochrome oxidase content after prolonged exposure. However, mRNA 
levels were followed over only a 2 hour period, so the possibility remains that 
transcription of genes encoding cytochrome oxidase subunits could remain suppressed 
over a longer period, while genes encoding subunits of other respiratory complexes 
could have an increased expression later on, helping to restore levels of these enzymes 
in the cell. While it is possible that alterations in mRNA expression or stability may 
cause a specific decrease in cytochrome oxidase levels, the evidence does not point in 
favour of this.
4.3.4.2. Alterations in cytochrome oxidase assembly
The differential effect of DETA NONOate on the cytochrome oxidase level in dividing 
and non-dividing cells might be explained by its interfering with the physical assembly 
of cytochrome oxidase. Assembling enzyme might be particularly susceptible to 
interference by NO or RNS as potentially reactive sites could be more accessible.
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Insertion of the heme or copper centres into the enzyme may be subject to interference. 
NO and RNS have been shown to react with protein-bound metal centres, with thiols 
and with tyrosines. There are therefore several possible targets in cytochrome oxidase 
for NO and its derivatives.
One target could be the cysteine ligands of the Cua site. The copper atoms of the 
P. denitrificans and bovine enzymes are bridged by two cysteine residues of Cox2p 
(Iwata et al., 1995; Ostermeier et al., 1997; Tsukihara et al., 1996) and in yeast they are 
likely to be bound in a similar manner. Sharpe and Cooper demonstrated that 
peroxynitrite treatment caused irreversible inhibition of purified cytochrome oxidase 
associated with irreversible loss of the Cua signal. It was suggested that peroxynitrite 
reacts with the Cua site, through oxidation of the thiol ligands (Sharpe and Cooper, 
1998). It is possible that RNS may react with these cysteines in the nascent enzyme, and 
S-nitrosation or oxidation of the thiol groups is likely to hinder the binding of copper in 
the assembling enzyme. In Chapter 3, I showed that mutations in the Cua site caused 
assembly of cytochrome oxidase to be abolished. It can be suggested that in these 
mutants formation of the Cua site is impaired, hindering the folding of Cox2p, and 
leading to impaired enzyme assembly and consequent degradation of cytochrome 
oxidase subunits. The cysteine ligands may be particularly vulnerable to S-nitrosation in 
the nascent enzyme but protected in the assembled enzyme.
A second possibility is reaction with radical tyrosines to form nitrotyrosine. 
Coxlp contains several tyrosine residues which are conserved between yeast, human 
and cow (yeast residues 18, 130, 232, 245, 262, 304, 371, 372, 379 and 443). 
Peroxynitrite has been shown to induce formation of nitrotyrosine in other proteins 
(Ischiropoulos, 1998), so tyrosine residues could be targets of RNS in cytochrome 
oxidase. A highly conserved residue of particular interest is the redox-active tyrosine 
245 (yeast numbering), which forms a radical tyrosyl in a catalytic intermediate of 
cytochrome oxidase (Proshlyakov et al., 2000). NO is likely to be very reactive with this 
radical. The equivalent residue tyrosine 244 in the bovine enzyme is close to the heme 
fl3-CuB centre, and is covalently linked to histidine 240 (yeast H241), a ligand of CuB 
(Ostermeier et al., 1997) (Figure 4.10). Site-directed mutagenesis of the equivalent 
tyrosine residue (Y288) in the Escherichia coli cytochrome bo?, ubiquinol oxidase, part 
of the heme-copper oxidase superfamily, demonstrated that it was essential for the 
assembly of the CuB site (Thomas et al., 1994). Mutants Y288A/F/H/S had an inactive 
enzyme, assembled hemes b and 03, but had a highly disrupted environment around 
heme 0 3  and a loss of CuB. Y288F was also studied in R. sphaeroides by optical and
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Raman spectroscopy. The enzyme was again inactive, and found to have hemes a and a3 
present but Cub absent (Das et al., 1998). So, alteration of this tyrosine causes the 
structure of the binuclear centre to be severely disrupted. It was postulated that in 
Y288F, the cross-link between Y288 and the histidine could not form, and that this 
cross-link holds the heme <Z3-Cub structure in the correct configuration to allow catalytic 
activity (Das et al., 1998). It is possible that RNS may nitrate tyrosine 245 during 
assembly of cytochrome oxidase, impairing Cub binding. This is likely to cause 
disruption of assembly of the heme «3-Cub centre and consequent disruption of enzyme 
assembly.
4.3.5. Conclusions
Prolonged incubation with high concentration of NO/RNS had a severe inhibitory effect 
on growth of yeast with deletion of the YHB1 gene encoding the highly efficient NO 
oxidoreductase Yhblp. However, the treatment was not cytotoxic and did not cause 
mtDNA mutation. The effect on cell proliferation did not seem to involve ROS, and was 
still observed when the respiratory chain was absent or compromised by myxothiazol, 
indicating that it was not simply due to inhibition of the respiratory chain. The levels of 
respiratory chain complexes were, however, altered by NO/RNS treatment, and in 
particular the assembly of cytochrome oxidase seemed to be compromised. To further 
characterise the antimicrobial activity of NO/RNS on yeast, alterations in gene 
expression caused by NO donor were next assessed.
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Figure 4.1. Effect of NO donor on oxygen consumption by yeast cells.
Wild type BY4741 cells and BY4741 Ayhbl cells lacking the NO-scavenging enzyme Yhblp were grown 
to late exponential phase and oxygen consumption measured. DETA NONOate (concentrations indicated) 
was added and the effect on oxygen consumption monitored.
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Figure 4.2. Effect of NO donor on yeast proliferation.
A. Wild type BY4741 and mutant BY4741 Ayhbl cells were grown to late exponential phase then 
incubated with 0 or 3 mM DETA NONOate for 12 hours. B. BY4741 Ayhbl cells were grown to late 
exponential (E) or early stationary (S) phase then incubated with 0, 0.1, 1 or 3 mM DETA NONOate for 
12 hours. C. BY4741 Ayhbl cells were grown to late exponential phase then incubated untreated 
(control), or with 1 mM DETA or 8 pM myxothiazol (a specific inhibitor of the bc\ complex) for 12 
hours. Cell density was measured at intervals. The graphs are representative of at least 3 independent 
experiments.
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Figure 4.3. Effect of decomposed NO donor on yeast proliferation.
Growth of wild type and Ayhbl cells after 12 hours incubation with 3 mM decomposed DETA NONOate 
was compared to growth of untreated cells. 0, 1, 4 and 6 denote the number of days DETA NONOate was 
allowed to decompose at 37°C prior to addition to cultures.
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Figure 4.4. NO released upon addition of 3 mM DETA NONOate to the culture medium.
Cells were grown to late exponential phase, an aliquot was transferred to the NO electrode chamber, and 
3 mM DETA NONOate was added. The concentration of NO was monitored for 24 hours. The graph is 
representative of two experiments.
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Figure 4.5. Viability of yeast cells after NO donor exposure.
Cultures were grown in the presence of 0 or 3 mM DETA NONOate for 12 hours. Cells were harvested, 
washed twice with water, then resuspended cells were used to inoculate fresh YPGal media to A60onm = 
0.05. After 13 hours growth the new cultures reached late exponential phase, and cell density was 
monitored over the 7.5 hours following this.
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Figure 4.6. Effect of NO donor on the growth of cells with a non-functional respiratory chain, and 
on cells lacking components of the oxidative stress response system.
A. Cells were grown to late exponential phase then incubated with 0 or 3 mM DETA NONOate for 12 
hours, and cell density measured at intervals. Density of NO donor-treated cultures is shown at two time 
points for several Ayhbl strains lacking components of the oxidative stress response system: 1, FY1679; 
2, FY1679 Acttl; 3, FY1679 Asodl; 4, FY1679 Asod2; 5, FY1679 Accpl. B. BY4741 Ayhbl and 
BY4741 Ayhbl rho° cells were grown to late exponential phase. 8 pM myxothiazol was added to the 
BY4741 cells then 0, 1 or 3 mM DETA was added to both BY4741 and BY4741 rho° cells. Cell density 
was monitored over 12 hours, and density of cultures treated with 1 mM (white) or 3 mM (grey) NO 
donor compared to untreated cells after 12 hours is shown. Where error bars are shown these represent ± 
the standard deviation from at least two independent experiments.
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Figure 4.7. Change in cytochrome content on NO donor treatment of cells in late exponential phase.
A. 3 mM DETA was added to BY4741 Ayhbl cells at 9.107 cells per ml density and spectra were taken at several points over the following 12 hours. The 
spectra were normalised for cytochrome b signal. Data are representative of 5 experiments. B. Content (pmol per 106 cells) of cytochromes c + C\ (c), b and a 
+ a3 (aa3) after addition of 3 mM NO donor is expressed as a ratio compared to control values obtained prior to DETA NONOate addition. C. Varying 
concentrations of DETA NONOate were added to cells at 9.107 cells per ml density and cytochrome content was measured after 12 hours. The spectra were 
normalised for cytochrome b signal.
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Figure 4.8. Effect of NO donor on FY1679 proliferation.
FY1679 wild type and Ayhbl cells were grown to late exponential phase then incubated with 0 or 3 mM 
DETA NONOate for 12 hours. The graphs are representative of two independent experiments.
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Figure 4.9. Cytochrome levels after NO donor treatment of FY1679 Ayhbl.
3 mM DETA NONOate was added to exponential phase cells and spectra were taken after 6 hours 
incubation.
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Coxlp
Figure 4.10. Tyrosine 244 in bovine COX1.
The atomic structure is from the bovine enzyme (PDB lOCC), and residues are identified using the 
bovine numbering. CuB is shown in orange and hemes a and a3 in pink.
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Table 4.1. Variation in cytochrome levels and oxygen consumption in control cells.
BY4741 Ayhbl cells were grown in YPGal and harvested at several growth stages. Cytochrome content 
and oxygen consumption were determined as described in 2.3.2 and 2.3.3. Time points represent hours 
from late exponential phase (0 = late exponential, 6 = early stationary, 12 = stationary phase). Data are 
representative o f three experiments.
Time (hours) 0 6 12
Density (x108 cells ml"1) 0.9 2.6 7.8
Cytochrome content
c + c1 (pmol.106 cells"1) 0.29 0.20 0.39
b (pmol.106 cells'1) 0.16 0.14 0.27
a + a3 (pmol.106 cells"1) 0.05 0.04 0.09
Oxygen consumption
pmoles e".106 cells'1.s'1 23 23 30
e'.cytochrome oxidase"1.s'1 458 591 333
Table 4.2. Cytochrome levels after myxothiazol treatment.
BY4741 Ayhbl cells were grown until late exponential phase. 8 pM myxothiazol was added to aliquots of 
the culture and cytochrome content was measured after 6 and 12 hours (see 2.3.2).
Hours after myxothiazol addition 0 6 12
Density (x108 cells ml"1) 0.9 2.3 5.6
Cytochrome content
c + c-i (pmol.106 cells'1) 0.29 0.34 0.34
b (pmol.106 cells"1) 0.16 0.20 0.23
a + a3 (pmol.106 cells'1) 0.05 0.11 0.14
Table 4.3. Change in cytochrome content on NO donor treatment of cells in early stationary phase.
BY4741 Ayhbl cells were grown to early stationary phase then split into aliquots and 3 mM DETA 
NONOate added. Cells were incubated then harvested and washed at intervals, and cytochrome content 
and oxygen consumption assessed. Data are representative of 3 experiments.
Hours after NO donor addition 0 2 4 6 12 26
Density (x108 cells.ml'1) 2.6 3.9 5.5 5.3 5.2 5.6
Cytochrome content 
c + Ci (pmol.106 cells'1) 0.20 0.31 0.28 0.29 0.30 0.26
b (pmol.106 cells'1) 0.14 0.21 0.20 0.20 0.20 0.17
a + a3 (pmol.106 cells'1) 0.04 0.04 0.03 0.03 0.03 0.04
Oxygen consumption
pmoles e'.106 cells'1.s"1 23 20 15 10 9 3
e'.cytochrome oxidase'1.s'1 591 557 459 354 277 58
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Table 4.4. Gene expression changes after treatment with 3 mM DETA NONOate.
BY4741 tsyhbl cells at exponential phase (cell density around 1.5 x 107 cells per ml) were incubated with 
3 mM DETA NONOate for 10 to 120 minutes before RNA isolation and microarray analysis (as 
described in 2.5.1). Gene expression is represented as fold change compared to values obtained prior to 
treatment.
Complex Gene Description 10 min 30 min 60 min 120 min
NADH NDE1 External dehydrogenase 0.67 0.15 0.42 0.67
dehydrogenase NDI1 Internal dehydrogenase 1.10 0.25 0.12 0.08
Succinate SDH1 Flavoprotein subunit 0.74 0.21 0.12 0.09
dehydrogenase SDH2 Iron-sulfur protein 0.71 0.14 0.10 0.08
SDH3 Cytochrome b 0.81 0.27 0.15 0.11
SDH4 Membrane anchor subunit 0.85 0.35 0.17 0.14
Cytochrome c CYC1 Isoform 1 0.79 0.05 0.02 0.01
CYC7 Isoform 2 2.36 0.52 0.19 0.41
bci complex CYT1 Cytochrome c^ 0.50 0.17 0.08 0.07
RIP1 Rieske iron-sulfur protein 0.75 0.21 0.13 0.14
COR1 Core subunit 0.77 0.38 0.27 0.18
QCR2 40 kDa subunit 0.86 0.29 0.17 0.14
QCR6 17 kDa subunit 0.64 0.29 0.17 0.17
QCR9 7.3 kDa subunit 0.75 0.42 0.32 0.35
QCR10 8.5 kDa subunit 0.75 0.33 0.28 0.34
Cytochrome COX4 Subunit 4 0.72 0.42 0.35 0.28
oxidase COX5A Subunit 5a 0.62 0.22 0.21 0.17
COX6 Subunit 6 0.67 0.50 0.34 0.37
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Chapter 5
TRANSCRIPTIONAL CHANGES INDUCED BY
NO/RNS
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5.1. INTRODUCTION
Reactive nitrogen species (RNS) have multiple targets and are likely to have a wide 
range of actions on the cell. In Chapter 4 I characterised the effect of prolonged 
exposure to nitric oxide (NO) donor on cell proliferation and on the cytochromes of the 
respiratory chain. NO donor had a cytostatic effect and caused a specific decrease in the 
level of cytochrome oxidase.
5.1.1. Aims
To gain more information on the stresses sensed by the cell on NO/RNS treatment, and 
the responses to these stresses, I used microarray technology to perform a genome-wide 
analysis of expression changes in response to short NO donor treatment. I monitored 
gene expression during the first two hours of exposure since the major alterations in 
gene expression are expected to be observed within this time frame. I measured the 
time-course effect of 3 mM DETA NONOate, a concentration which significantly 
inhibited growth of late exponential phase cells. I also assessed the response to varying 
concentrations of DETA NONOate. Additionally I used the transcriptional response of 
Ayhbl rho° cells to determine the involvement of the respiratory chain in the gene 
expression changes caused by NO donor. The transcription factors Msn2/4p and Yaplp 
have been implicated in the general and the oxidative stress responses, respectively, so I 
investigated their involvement in the regulation of the genes altered by NO donor. I 
compared the results of the time-course analysis with those obtained from a study of the 
effect of the respiratory chain inhibitor myxothiazol on gene expression (Bourges et al., 
2005) to enable identification of genes specifically altered in response to NO donor. 
Finally, several of the genes identified are known to be regulated by the transcription 
factor Haplp, so I attempted to assess possible involvement of Haplp in the NO donor- 
induced changes in gene expression.
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5.2. RESULTS
5.2.1. W303-1B Ayhbl sensitivity to NO donor
The strain used for the majority of the microarray analysis was W303-1B Ayhbl, rather 
than BY4741 Ayhbl used in Chapter 4. A previous microarray analysis in our lab, 
designed to investigate the effect of the bc\ complex inhibitor myxothiazol on gene 
expression (Bourges et al., 2005), had been performed using this strain, and I wanted to 
be able to reliably compare my results with this study. To confirm that NO donor had 
the same deleterious effect on growth of the W303-1B Ayhbl strain I incubated cells 
from late exponential phase with 3 mM NO donor (see 2.1.8). Growth was severely 
inhibited by the addition of 3 mM DETA NONOate, while the control wild type strain 
was not affected (Figure 5.1), mirroring the effect observed on BY4741 and FY1679 
(Figure 4.2A and Figure 4.8)
5.2.2. Time-course response to NO donor treatment
After growth to mid exponential phase cells were incubated for a period of 10, 30, 60 or 
120 minutes with 3 mM DETA NONOate, harvested, then their RNA was extracted and 
used to prepare labelled cDNA for hybridisation to Affymetrix GeneChip expression 
arrays. The experimental procedure is described in 2.5.1. Control samples to which NO 
donor was not added were harvested at time zero. Data was analysed as described in
2.5.1.6. Of a total of about 6,400 nuclear genes (plus around 600 other targets including 
putative ORFs and mitochondrial genes) represented on the array, expression of 731 
genes (after exclusion of chromosomes, TY elements and non-annotated SAGE ORFs) 
was altered after treatment at at least one time point compared to the control. These 
were categorised into 14 functional groups, and the number of genes altered in each 
group is shown in Table 5.1. Treatment with NO donor resulted in an increased number 
of transcripts for approximately half of these genes, with the remainder having fewer 
transcripts after treatment. The full set of expression data is available at 
http://www.ebi.ac.uk/arrayexpress/ and can be retrieved using the accession number E- 
MEXP-580.
Overall, the maximum repression of genes was usually observed early on, after 
10 or 30 minutes of treatment. Analysis of the complete set of data showed that around 
40% of the 385 repressed genes had a lowest expression after 10 minutes of treatment, 
and around 33% after 30 minutes. Induction of genes was more evenly spread, with
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30% of the 346 overexpressed genes having maximum induction at 10 minutes, 20% at 
30 minutes, 12% at 60 minutes and 38% at 120 minutes of NO donor incubation.
Many genes showed a time-course response similar to that induced by several 
environmental changes: immediately after the shift to stressful environment, cells 
respond with large changes in the expression of genes, and after a while the transcripts 
return to normal levels (Gasch et al., 2000). This type of transient response is typical of 
the environmental stress response. The most striking feature apparent from Table 5.1 is 
that a large number of genes (195) belonging to the category “DNA structure, 
replication, transcription and translation” are repressed on NO donor treatment. More 
than 75% of these are involved in transcription and translation. These genes typify the 
transient response, with repression early on in the time course and expression restored 
closer to control levels after 60 minutes (Figure 5.2A and B). For the overexpressed 
genes, such transient change was most clearly seen in the category “Protein folding and 
modification”. Between 10 and 30 minutes of NO exposure, the expression increased 2 
to 20 fold depending on the gene. Later, between 30 and 60 minutes of treatment, the 
expression decreased to a level closer to that observed in untreated cells. (Figure 5.2C).
Other genes showed a very different pattern of expression. For instance, the 
expression level of genes in the category “Response to oxidative stress” increased 
during the 30 minutes after NO donor addition, but transcript levels did not return to 
normal during the remainder of the time-course (Figure 5.2C). Similarly, expression of 
genes of the category “Electron transfer and ADP/ATP translocator” showed a 
prolonged increase (Figure 5.2C). Further analysis of transcriptional changes have been 
performed after 60 minutes treatment with NO donor, to obtain more information on the 
longer-lasting effects of NO/RNS.
5.2.3. Validation of microarray results by (RT)q-PCR
To independently validate the results of the microarray I prepared fresh cDNA from 
untreated cells and from cells incubated for 60 minutes with 3 mM NO donor. The 
samples were subjected to (RT)q-PCR analysis to determine the relative expression 
levels of six genes after treatment, as described in 2.5.2. The genes selected were chosen 
to represent the range of signal strengths and expression changes observed in microarray 
analysis. They were CYC7, repressed by 5-fold after 60 minutes; CTT1, repressed by 2- 
fold after 60 minutes; and GPM2, HSP26, OYE3 and GTT2, induced by between 10 and 
37-fold after 60 minutes. ACT1 was used as a reference since it did not alter in any 
microarray experiment. The (RT)q-PCR data are presented in comparison to the
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microarray data in Table 5.2. Although the extent of repression or upregulation 
observed by (RT)q-PCR is not identical to that observed by microarray analysis, the 
pattern of expression seen is alike.
5.2.4. Effect of different concentrations of NO donor on gene expression
The concentration of DETA NONOate used in these experiments was 3 mM, that 
required to significantly inhibit yeast growth (Figure 5.1). It was also interesting to 
determine what effect a lower inhibitory dose (1 mM) or a sub-inhibitory dose (0.1 mM) 
(see Figure 4.2B) had on gene expression, and whether such treatment caused a 
different type of response. The microarray analysis was repeated on cells incubated for 
60 minutes in the presence of 1 mM and 0.1 mM DETA NONOate. When cells were 
treated with 3 mM NO donor, 291 genes had a significantly altered expression after 60 
minutes. Of these genes, only 172 were also altered at 1 mM NO donor, and just 83 at 
0.1 mM (Figure 5.3A). The average fold change in expression of the 291 genes was 
closer to 1 the lower the concentration of NO donor used (Figure 5.3B). WOien all the 
genes which showed alteration at any time point after 3 mM NO donor treatment, or 
after 60 minute treatment with 1 or 0.1 mM NO, were considered, 1 mM NO donor 
appeared to elicit a stronger response than 3 mM NO donor in just 48 genes of a total of 
869. There were only three genes which had an altered expression level at 0.1 mM 
DETA but did not show a significant change at 1 or 3 mM. It seems therefore that the 
extent of the modification of gene expression increases with increasing concentration of 
NO donor, and that a novel pattern of gene expression is not observed at a sub- 
inhibitory dose of DETA NONOate.
5.2.5. Dependence of NO donor-induced gene expression on the respiratory chain
To assess whether the changes in gene expression observed after 3 mM DETA 
NONOate treatment were dependent on the respiratory chain, the strain W303-1B 
Ayhbl rho°, lacking mtDNA, was incubated for 60 minutes with 3 mM NO donor and 
the microarray analysis repeated. When the 291 genes altered after 60 minutes treatment 
in the control strain were analysed, the average fold change of gene expression between 
treated and untreated samples was closer to 1 in the rho° strain than in the control (3.74 
versus 5.29 for the overexpressed genes, 1.19 versus 1.85 for the repressed genes), 
suggesting that NO donor elicited a weaker response in the rho° cells. The ratio “fold 
change in rho° / fold change in control” (Ri) was calculated and genes were categorised 
according to the impact the presence of a respiratory chain had on their expression 
(Table 5.3A).
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An Rj value of <0.25 (for overexpressed genes) or >4 (for repressed genes) 
represents a clear dependence on the respiratory chain. 35 genes of the total 291 altered 
in the control after 60 minutes treatment fell into this category. However 14 of these 
genes were already overexpressed or repressed in the untreated rho° compared to the 
untreated control; the absence of the respiratory chain caused expression change, which 
was not further altered by NO donor exposure. Therefore only 21 genes (7%, the 
majority belonging to the categories “Glycolysis, gluconeogenesis, carbohydrate storage 
pathway” and “Unknown genes”) were found to be heavily dependent on the respiratory 
chain for modulation of expression. The expression change of these genes could be due 
to the inhibition of the respiratory chain by NO, or an indirect effect of a respiratory 
chain product such as ROS. The dependency of 7% of genes could not be clearly 
assigned to a category, while the expression of 26% of genes was clearly not affected by 
the absence of the respiratory chain. 161 genes (55%) had some weak reliance on the 
respiratory chain (Ri value between 0.25 and 0.75). The data suggests that the overall 
transcriptional change is not simply due to inhibition of the respiratory chain by NO.
5.2.6. Comparison with transcriptional changes induced by myxothiazol treatment
A similar microarray analysis of the effect of an inhibitory concentration of 
myxothiazol, a respiratory chain inhibitor acting specifically on the bc\ complex, on 
gene expression was recently performed in our lab (Bourges et al., 2005). Wild type 
W303-1B cells were treated with 8 pM myxothiazol for 2 to 120 minutes and the 
experiment was conducted using the same culture medium, conditions and method of 
analysis as those described here. The strain used in the myxothiazol study did not have 
deletion of the YHB1 gene. To determine whether absence of YHB1 caused significant 
modification of basal gene expression, I compared gene expression in untreated Ayhbl 
cells to expression in the untreated wild type cells. Only 17 genes exhibited a greater 
than two-fold alteration in expression between the two samples, hence it is still possible 
to make reliable comparison between the studies. After 2-120 minute treatment with 
myxothiazol, 879 genes, compared to 731 genes after 10-120 minute of NO donor 
treatment, were altered (Table 5.1). The larger number is probably due to the additional 
two minute time point. To identify those alterations in gene expression after NO donor 
exposure which could be classified as due to a general stress response induced by 
inhibition of the respiratory chain, and those which were more specific to NO donor 
treatment, I compared the two data sets.
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5.2.6.1, Genes commonly altered by NO donor and myxothiazol
Most (477) of the 731 genes altered after DETA NONOate treatment were common to 
both NO donor and myxothiazol treatments (Table 5.1). For most categories, over 50% 
of the genes altered after DETA NONOate treatment were also altered after 
myxothiazol treatment. In general, the expression changes of these genes were transient 
on both NO donor and myxothiazol treatment (Figure 5.4A). This was particularly 
evident in the category “DNA structure, replication, transcription and translation”, 
where 8 8% of the genes repressed in response to NO donor were also repressed by 
myxothiazol treatment (Figure 5.4B). Many of these genes have previously been 
observed to be repressed in response to several environmental changes (Causton et al., 
2001). Most of the genes are involved in transcription and translation, and their transient 
repression represents a response to sudden environmental change associated with 
transient growth arrest. Similar transient responses were also observed in categories 
such as “Protein folding and modification” (Figure 5.2C) and “Glycolysis, 
gluconeogenesis and carbohydrate storage pathway” (Figure 5.2D).
5.2.6.1. Genes specifically altered in response to NO donor
265 genes were induced by NO donor incubation but not by myxothiazol incubation. 
The analysis of gene expression was repeated with another strain, BY4741 Ayhbl, after 
60 minutes exposure to 3 mM DETA NONOate, and results were similar to those 
observed in W303-1B Ayhbl cells. Combining the results from both strains, 117 genes 
had a clearly altered expression after NO donor treatment, while their expression was 
not altered, or was altered in a different manner (induced rather than repressed), after 
myxothiazol treatment (Table 5.4). These 72 repressed and 45 induced genes could 
therefore be considered to be altered specifically in response to the NO donor and not 
due to a general respiratory chain inhibition stress. The expression change of none of 
these genes was heavily dependent on the respiratory chain (Table 5.3A).
In contrast to the pattern observed for the genes altered in response to both 
myxothiazol and NO donor, the modification of expression of the NO-specific genes 
generally persisted over the course of the experiment; overall, expression is altered in 
the first 10 to 30 minutes and does not return to control levels during the 2 hours 
assessed (Figure 5.5). This is especially striking in the category “Electron transfer and 
ADP/ATP translocator” (Table 5.4). 24 genes of this category were repressed 
specifically after NO donor treatment, half of them by 10-fold or more, and transcript
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levels tended to progressively decrease over time. The overexpressed categories 
“Response to oxidative stress” and “Transporter and targeting” also typify the response.
5.2.7. Role of the transcription factors Yaplp, Msn2p and Msn4p
The transcription factor Yaplp is involved in the response to oxidative stress 
(Rodrigues-Pousada et al., 2004). Therefore it is possible that Yaplp might be involved 
in the regulation of gene expression by NO donor. The redundant transcription factors 
Msn2p and Msn4p have been shown to regulate genes of the general stress and 
environmental stress response (Martinez-Pastor et al., 1996; Schmitt and McEntee, 
1996; Causton et al., 2001). Since several genes altered after NO donor exposure show 
the characteristic expression pattern of these responses, Msn2p and Msn4p are two more 
candidate transcription factors.
To test the involvement of Yaplp and Msn2/4p in the regulation, microarray 
data was obtained after 60 minutes of 3 mM DETA NONOate treatment of a strain with 
deletion of the YAP1 gene (W303-1B Ayhbl Ayapl) and a strain with double deletion of 
MSN2 and MSN4 (W303-1B Ayhbl Amsn2/4). The ratios “fold change in Ayapl or 
Amsn2/4 / fold change in control” (R2 and R3, respectively) were calculated for each of 
the 291 genes altered after 60 minutes of 3 mM NO donor treatment of the control, and 
genes were assigned to one of five categories depending on the transcription factors 
found to regulate their induction or repression (Table 5.3B). Alteration of gene 
expression was considered to be dependent on a transcription factor when R was lower 
than 0.75 (for up-regulated genes) or higher than 1.33 (for repressed genes). Yaplp was 
found to be involved in the regulation of 67 genes (23%) and Msn2/4p in the regulation 
of 77 genes (26%). Varying levels of reliance were exhibited, for example R values for 
overexpresssed genes varied from 0.05 (highly dependent) to 0.75 (weak dependence). 
Regulation was not able to be clearly assigned for 3.4% of the genes, and more than 
55% of the genes were regulated by neither Yaplp nor Msn2/4p. Of the highly 
dependent genes (R < 0.5 for upregulated genes and R > 2 for repressed genes), sixteen 
(AAD6, YKL071W, YOL155C, YNR064C, YLL056C, CYB2, HMX1, SUE1, HMG1, 
UBX6, HPA2, YBR056w-a, FLR1, CTA1, PCS60 and YBR242W) were specifically 
altered in response to NO/RNS and appear in Table 5.4.
A similar study was carried out to assess dependence of myxothiazol-induced 
gene expression changes on these transcription factors (Bourges et al., 2005). 301 genes 
with altered expression after 10 minutes of 8 pM myxothiazol treatment were assessed. 
Yaplp was found to be involved in the regulation of 30% of these genes, a similar
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situation to that observed with NO donor. Msn2/4p had a much clearer involvement, 
being required for regulation of 84% of the genes, in combination or not with Yaplp. It 
might be that the regulators involved in responding to myxothiazol and NO donor stress 
are different.
To further investigate the involvement of Msn2/4p in the NO donor-induced 
response, I monitored the translational changes of an MSN2/4-dri\en LacZ reporter gene 
in the strain W303-1B Ayhbl. Msn2/4p bind to the stress response element (STRE) to 
activate transcription (Estruch and Carlson, 1993; Schmitt and McEntee, 1996). /?- 
galactosidase activity was measured in untreated cells and in 3 mM DETA NONOate- 
treated cells over 2 hours (Figure 5.6). A background /^-galactosidase activity of 15-20 
Units was observed in the untreated cells at time zero; this was also seen in the 
untreated control and in the NO donor-resistant wild type W303-1B after 120 minutes 
of treatment. After 10 minutes of incubation, no alteration of /^-galactosidase activity 
was observed. However, after 60 and 120 minutes the activity almost doubled, to reach 
a level close to that observed after heat shock and after 120 minute treatment with 8 pM 
myxothiazol. When the strain W303-1B Ayhbl Amsn2/4 containing the reporter gene 
was monitored no /^-galactosidase activity was observed. These results mirror those 
obtained in the same experiment using the wild type strain to assess the transcription 
factors involved in myxothiazol-induced stress (Bourges et al., 2005). It seems therefore 
that DETA NONOate does induce the activation of STRE by Msn2/4p.
I also planned to assess the involvement of ROS in the Msn2/4p-regulated 
response to NO donor, using strains with inducible overexpression of SOD1 (in addition 
to the Sodlp assembly factor CSS1, which is required for activity of overexpressed 
Sodlp (Harris et al., 2005)) or CTT1. SOD1 overexpression resulted in a high basal 
level of /?-galactosidase activity. This was not due to the presence of the vector since 
when expression was not induced the basal /^-galactosidase level was low. This basal 
stress could be due to high levels of hydrogen peroxide produced by Sodlp which 
cannot be removed quickly enough by cells. Consequently the overexpression strain 
could not be used to assess whether increased Sodlp decreased the magnitude of 
response to NO donor. Overexpression of CTT1 required growth in glycerol, but the /?- 
galactosidase assay gave variable results using cells grown in glycerol, so the effect of 
NO donor in this strain could also not be assessed.
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5.2.8. Role of the transcription factor Haplp
Haplp is an oxygen-responsive zinc finger transcription factor which regulates 
expression of genes of the respiratory chain, and heme, sterol and fatty acid synthesis. 
Its activity is regulated by heme levels. Since many genes of the respiratory chain, and 
involved in the synthesis of sterols and fatty acids, were repressed on NO donor 
exposure (Table 5.4) a potential involvement of Haplp in the transcriptional response to 
NO donor was investigated. It seems possible that Haplp could be inactivated on 
exposure to NO donor. One possibility is that NO/RNS could interfere with the heme 
synthesis pathway, resulting in a lower level of heme available for the activation of 
Haplp. Supplying heme to the cells might result in re-activation of Haplp.
To investigate this, I wanted to show in an independent assay that a reporter 
gene driven by Haplp is repressed by NO donor, and use this assay to test compounds 
(heme, or precursors of heme) that might alleviate the Haplp inactivation by NO donor. 
To this end, I monitored translational changes using a LacZ reporter gene under the 
control of the CYC1 promoter (Guarente and Ptashne, 1981). CYC1 is known to be 
induced by Haplp. In the microarray analysis, CYC1 was repressed by up to 100-fold. 
In the absence of NO donor, /^-galactosidase activity was high at around 170 Units when 
cells were grown aerobically, but no activity was detected under anaerobic conditions 
(see 2.5.3), as expected since HAP1 expression requires heme, the synthesis of which 
requires oxygen. Addition of 3 mM NO donor to aerobically grown cells caused a 
decrease in ^ -galactosidase activity of around one quarter after one hour, a much milder 
decrease than that observed by microarray (Figure 5.7). One possible reason for this 
could be that the assay was measuring a decreased level of protein. This would require 
degradation of existing /^-galactosidase protein, which might be expected to take longer 
than the 1 hour period tested. The assay was repeated after 12 hours incubation of cells 
with NO donor, and this time a 5-fold decrease in /^-galactosidase activity was observed. 
This could be interpreted to mean that RNS inhibits new synthesis of /^-galactosidase 
but since the enzyme is very stable only mild effects on activity are observed. 
Alternatively, the turnover of the enzyme may be quick but the expression of /?- 
galactosidase would be only partially inhibited by NO donor. When the assays were 
repeated with 8 pM myxothiazol similar effects on ^-galactosidase activity were noted 
(Figure 5.7). However, myxothiazol was shown by microarray not to affect CYC1 
expression (Bourges et al., 2005). Therefore the decrease in /^-galactosidase activity is 
likely to be due to a more general stress, for example the inhibition of respiration, and 
not specifically due to NO/RNS. It seems that the stability of the enzyme is most likely
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the problem, and enzyme activity is not a sensitive probe for repression of transcription. 
To circumvent this problem, another possibility was to add NO donor to an anaerobic 
culture and assess the recovery of /^-galactosidase activity. However the recovery 
proved very slow in control cells, with activity beginning to appear only after 8 hours of 
aerobic growth, so this approach was not experimentally feasible. In conclusion, this 
assay was not useful in assessing the involvement of the transcription factor Haplp in 
transcriptional changes induced by NO donor.
In the next experiment, I used (RT)q-PCR to monitor CYC 7 gene expression and 
the effects of deuteroporphyrin (dpIX), a stable analogue of protoporphyrin, precursor 
of the final step of heme synthesis (heme itself cannot be used since it cannot pass the 
cell wall). Exogenously supplied dpIX has been shown to activate Haplp (Hon et al., 
2003). In the microarray analysis CYC7 was repressed by up to five-fold after NO donor 
treatment. I treated cells for 60 minutes with 200 pg per ml of dpIX in the presence of 3 
mM NO donor, then prepared cDNA and analysed expression of the gene CYC 7 using 
(RT)q-PCR. As a control I used cells treated with dpIX alone. The relative quantity of 
the CYC7 gene after addition of NO donor was 0.053, while in the presence of dpIX the 
relative quantity was 0.020. Hence dpIX did not appear to relieve the NO donor-induced 
repression of CYC7. However, I did not show that a strain defective in heme synthesis 
could be rescued with the concentration of dpIX used, so the results do not allow 
complete rejection of the possibility of NO interfering with the heme level.
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5.3. DISCUSSION
5.3.1. Overview of results
After 10-120 minutes treatment with an inhibitory dose of DETA NONOate the 
transcript levels of 731 genes were altered compared to the untreated control. 
Alterations of transcript levels may be due to alteration in the expression of genes (the 
number of mRNAs produced), or to a modification of the stability of mRNAs. Changes 
in stability of mRNAs can vary according to the cellular environment. In particular, as 
discussed in 4.3.4.1, studies have shown that induction of NO synthesis in mammalian 
cells led to specific decreases in levels of some respiratory chain mRNAs which were 
caused by an increase in mRNA degradation rather than a decrease in their expression 
(Gou et al., 2001; Wei et al., 2002).
At lower concentrations of DETA NONOate the extent of alteration of 
expression was decreased, and it seems that NO donor elicits a concentration-dependent 
effect. The requirement for a respiratory chain in the gene expression changes observed 
was assessed and the expression of most genes was found to have no reliance or only a 
weak reliance on the presence of a respiratory chain, indicating that the gene expression 
changes are not due simply to inhibition of the respiratory chain. This would also 
suggest that ROS do not play a major role in the gene expression changes, since the 
respiratory chain is the main site of ROS production.
The data was compared to that obtained in a similar analysis of the effects of 
myxothiazol on gene expression, and the majority of the genes (477 of 731) were found 
to be altered after both DETA NONOate and myxothiazol treatment. These genes 
tended to be expressed in a transient manner, with expression being highly altered at 
early time points but returning to control levels later on; this is the signature of the 
general stress response induced to allow cells to adapt to their new environment. Similar 
induction of the general stress response has been seen before in Saccharomyces 
cerevisiae (Sarver and DeRisi, 2005).
117 genes were clearly altered in response to NO donor but not myxothiazol 
treatment (Table 5.4). These generally exhibited a more prolonged response, with 
expression levels staying altered until the end of the two hour time course. Analysis of 
these genes might provide useful information on the nature of the stresses sensed by the 
cell and the responses induced by it. Cellular damage by ROS is prevented by 
antioxidant defences that neutralise ROS and detoxification defences which repair 
damage or remove damaged cellular components. When the cell is stressed so that
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levels of ROS exceed the antioxidant capacity of the cell, it must respond to this. It is 
likely that a similar system exists to defend against RNS. At least 50% of the genes 
clearly upregulated by DETA NONOate but not by myxothiazol were also upregulated 
by hydrogen peroxide (Gasch et al., 2000; Causton et al., 2001), suggesting that RNS 
stress shares some features with oxidative stress.
5.3.2. Activation of antioxidant/detoxification enzymes
5.3.2.I. Yhblp
The first line of defence against RNS in yeast seems to be the NO oxidoreductase 
Yhblp, product of the YHB1 gene, which consumes NO very efficiently (Gardner et al., 
2000; Liu et al., 2000; Sarver and DeRisi, 2005). In recent microarray studies using S. 
cerevisiae and Candida albicans, YHB1 was found to be highly induced on exposure to 
RNS (Sarver and DeRisi, 2005; Hromatka et al., 2005). Since I have utilised a strain 
with deletion of YHB1, no changes in the expression of the gene are observed in this 
study, allowing other less dominant defences to become apparent.
53.2.2. Superoxide dismutase, catalase and cytochrome c peroxidase
The first line of defence against ROS would be upregulation of genes encoding enzymes 
such as superoxide dismutase, catalase and cytochrome c peroxidase, which detoxify 
ROS (Moradas-Ferreira et al., 1996). The SOD1, SOD2, CTT1 and CCP1 genes were all 
upregulated in the presence of hydrogen peroxide (Gasch et al., 2000; Causton et al., 
2001). However, none of these genes were induced on NO donor exposure. Instead, 
CCP1 encoding cytochrome c peroxidase and CTA1 encoding catalase A were in fact 
repressed, suggesting that ROS are not significantly involved in the NO donor-induced 
stress.
5.3.2.3. Glutathione
Glutathione is the most abundant thiol peptide in cells and is involved in many 
processes including detoxification of ROS. Glutathione forms S-conjugates with a wide 
range of toxins which can then be transported out of the cytosol to the vacuole. Two 
genes of this system, GTT2 and YCF1, were upregulated. GTT2 encodes glutathione S- 
transferase which catalyses conjugate formation, and was highly overexpressed, even in 
the presence of 0.1 mM DETA NONOate. It shares some functional overlap with GTT1, 
and GRX1 and GRX2 which encode glutaredoxins, however none of these genes had 
altered expression. YCF1, encoding a glutathione conjugate transporter, was upregulated
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by 10-fold. GSH1, required for the synthesis of glutathione, was upregulated by 3-fold 
after NO donor incubation, but was not significantly altered in the BY4741 strain. In C. 
albicans several genes of the glutathione system, such as YCF1, GTT1 and GLR1 
(glutathione reductase) were also overexpressed on nitrosative stress (Hromatka et al., 
2005). In total, about a quarter of the clearly NO-specific overexpressed genes 
(including SSU1, OYE3, GSH1, YNL134C, DRE2, FRE5, FLR1, ARN1, DDR48) were 
upregulated in this organism.
5.3.2.4. Peroxiredoxins
Yeast contain five peroxiredoxins, a family of conserved antioxidant enzymes which 
use thioredoxin to scavenge hydrogen peroxide and alkyl hydroperoxides (Chae et al., 
1994; Netto et al., 1996). The peroxiredoxin Tsa2p was found to have peroxynitrite 
reductase activity, and its expression was induced on exposure to peroxynitrite or a NO 
donor (Wong et al., 2002). Tsa2p was suggested to cooperate with Tsalp, the major 
cytosolic thioredoxin peroxidase, to remove ROS and RNS. Here, TSA2 was 
upregulated by around 4-fold by both NO donor (even at 0.1 mM) and myxothiazol, and 
the mitochondrial peroxiredoxin Prxlp, encoded by PRX1, was induced 3-fold in the 
W303-1B strain (but not in the BY4741 strain). On exposure to oxidants, cysteine- 
sulfinic (Cys-SOH) acid groups form in the 2-Cys peroxiredoxins Tsalp, Tsa2p and 
Ahplp. In most cases these groups are attacked by a cysteine residue of the other 
subunit of the homodimer to form a disulfide bond, but sometimes the cysteine-sulfinic 
acid is further oxidised to sulphinic acid (Cys-S0 2 H). Sulfiredoxin, encoded by SRX1, 
reduces sulfinic acid groups in Tsalp and Tsa2p, and facilitates formation of the 
disulfide bond (Biteau et al., 2003). SRX1 was induced by up to 25-fold after DETA 
NONOate treatment. These data suggest that the cells may be exposed to hydrogen 
peroxide or peroxynitrite, and are attempting to remove these reactive molecules.
5.3.2.5. Lipid peroxidation
Lipid peroxidation is a major type of oxidative damage, and several genes involved in 
the repair of such damage were induced after exposure to NO donor. Phospholipid 
hydroperoxide glutathione peroxidases reduce hydrogen peroxide and larger 
hydroperoxides, including lipid peroxides. Oxidation of polyunsaturated lipids occurs 
by an autocatalytic process to produce fatty acid hydroperoxides. These undergo 
fragmentation to highly reactive epoxides, aldehydes and alkanes, which can cause 
further damage to the cell by reaction with proteins and DNA. Phospholipid 
hydroperoxides are central intermediates in the lipid peroxidation chain reaction,
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therefore phospholipid hydroperoxide glutathione peroxidases are considered a main 
line of defence against oxidative damage to membranes. Three such enzymes have been 
identified in yeast; one of them, GPX2, was upregulated by around 4-fold after NO 
donor exposure. This gene was shown by Inoue et. al. (Inoue et al., 1999) to be under 
the control of Yaplp, but I did not observe this. The homologous gene GPX1 was 
upregulated by about 4-fold by both NO donor and myxothiazol. Both genes were 
induced even at low (0.1 mM) concentration of NO donor.
The gene YNR064C was upregulated by up to 70-fold after NO donor treatment. 
This protein has characteristics of an epoxide hydrolase belonging to the a/p hydrolase 
fold family (Elfstrom and Widersten, 2005). Such enzymes inactivate reactive epoxides 
which might otherwise alkylate proteins and DNA. A microarray study showed that 
exposure to the DNA alkylating agent methyl methanesulfonate (MMS) caused 30-fold 
overexpression of the gene, suggesting that it may indeed function as an epoxide 
hydrolase (Jelinsky and Samson, 1999). In fact, many of the genes mentioned here were 
induced on MMS treatment of yeast. Exposure to an alkylating agent will bring into 
force a program to eliminate, repair or replace alkylated components from the cell.
Three putative aryl alcohol dehydrogenases, AAD4, AAD6 and AAD16, were 
highly induced, between 11 and 40-fold, after DETA NONOate exposure. These share 
high sequence homology with the aryl alcohol dehydrogenase from the lignin-degrading 
fungus Phanerochaete chryosporium, which converts aromatic aldehydes arising from 
oxidation of lignocellulose into aromatic alcohols (Delneri et al., 1999a). The protein 
products may be involved in removing the damage done to lipids by peroxidation. 
However, function has not yet been assigned since deletion of the seven AAD genes did 
not reveal a phenotype (Delneri et al., 1999b). Overexpression of three of the seven 
genes suggests that they play an important role in the response to NO donor-stress. All 
seven genes were also found to be upregulated in oxidative stress caused by transfer to 
growth in oleate (Groot Koerkamp et al., 2002). Several of the AAD genes (3, 6 , 10, 14 
and 15) were overexpressed on transfer from fermentative to respiratory growth in the 
presence of a YAP1 overexpression plasmid compared to a control strain, and it was 
suggested that the AAD genes might play an important protective role during oxidative 
stress (DeRisi et al., 1997). The promoter regions of AAD4 and AAD6 contain Yaplp 
control elements, and AAD6 expression was found to be regulated by Yaplp (Groot 
Koerkamp et al., 2002). Here, I found AAD6 to be clearly under the control of Yaplp, 
though AAD4 was not. Finally, another alcohol dehydrogenase, YNL134C, was also 
upregulated, by around 5-fold, on exposure to NO donor.
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5.3,2.6. DNA repair system
Oxidation of nucleic acids leads to damage such as base modification, single strand 
breaks and DNA-protein crosslinks. Two genes encoding proteins involved in the repair 
of DNA damage were upregulated after NO treatment. HUG1 was not initially 
overexpressed, but expression had increased by 65-fold after 2 hours (26-fold in 
BY4741 after 1 hour). Huglp is involved in the Meclp-mediated checkpoint pathway 
that responds to DNA damage or replication arrest, and its transcription is induced by 
DNA damage (Basrai et al., 1999). DDR48 encodes a DNA damage responsive protein 
and was induced by 4-fold after DETA NONOate treatment. Its expression was also 
increased after MMS treatment. The cells may be sensing DNA damage caused by 
exposure to RNS. However, this would appear to be limited since in 4.2.5 I 
demonstrated that even long exposure to DETA NONOate did not increase rho‘ 
(deletion in mtDNA) production.
5.3.3. Modification of iron homeostasis
Several genes involved in iron homeostasis were upregulated after exposure of yeast to 
NO donor. 75772, encoding a conserved mitochondrial matrix protein which performs a 
scaffolding function during iron-sulfur cluster assembly and is required for the synthesis 
of iron-sulfur proteins (Schilke et al., 1999), was upregulated by up to 20-fold on NO 
donor exposure. NFU1 and ISA2, with similar function (Schilke et al., 1999; Pelzer et 
al., 2000), were also upregulated, albeit to a lesser extent. FRE5 encodes a putative 
ferric reductase, is part of a family of nine homologous genes thought to be involved in 
iron uptake, and is induced during iron depletion through the iron-regulated 
transcription factor Rcslp. FRE5 underwent a 6 -fold increase in expression after NO 
donor exposure. The homologous FRE7 was also upregulated, but not so clearly in the 
BY4741 strain. ARN1 and ARN2, members of the ARN family of transporters that 
specifically recognize siderophore-iron chelates (Yun et al., 2000), were upregulated. 
CCC1, involved in transporting iron for storage in the yeast vacuole (Li et al., 2001), 
was repressed after NO donor exposure.
This data suggests that cells are attempting to acquire more iron. Possibly the 
iron already available in the cell is not in a ‘free’ form available for use. Superoxide 
radicals oxidise iron-sulfur clusters in proteins, releasing iron from the cluster and 
inactivating the enzyme. Despite having high levels of iron, SOD1-deficient mutants are 
iron-deficient, suggesting that the iron released accumulates in a form that cannot be 
used for the biosynthesis of new clusters (De Freitas et al., 2000; Srinivasan et al.,
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2000). Genes encoding iron acquisition proteins were also shown to be upregulated in 
Histoplasma capsulatum (Nittler et al., 2005) and C. albicans (Hromatka et al., 2005) 
after exposure to NO donors. Increased iron demand may reflect the efforts of the cell to 
reconstitute iron-sulfur cluster-containing proteins to replace those which have been 
inactivated by RNS.
5.3.4. Induction of transporters
ARR2 was also highly induced after NO donor exposure. The arsenate reductase Arr2p 
converts arsenate to arsenite, which can then be exported from the cell (Mukhopadhyay 
and Rosen, 1998). The reason for upregulation of this gene is unclear, however, the 
equivalent of ARR3, encoding an arsenite transporter, was found to be upregulated in a 
microarray study of the effect of nitrosative stress on C. albicans (Hromatka et al., 
2005). Several other transporters were also upregulated after NO donor exposure: FLR1 
(multidrug transporter), MCH4 (monocarboxylic acid transporter), YHR048W and SSU1 
(sulfite transporter). SSU1 was also upregulated after nitrosative stress in another S. 
cerevisiae study, and was suggested to transport RNS metabolites out of the cell (Sarver 
and DeRisi, 2005). A similar function could be suggested for the other transporters.
5.3.5. Repression of fatty acid and sterol synthesis
Eight genes involved in the synthesis of fatty acids and sterols were repressed on DETA 
NONOate treatment. ERG7 encodes lanosterol synthase which catalyses cyclisation of 
squalene 2,3-epoxide, in ergosterol biosynthesis; HMG1 encodes an isozyme of HMG- 
CoA reductase which catalyses a rate-limiting step in sterol biosynthesis; MVD1 
encodes mevalonate pyrophosphase decarboxylase, essential for sterol biosynthesis; 
ATOl encodes an acetate transporter. FAS2 encodes a subunit of fatty acid synthetase, 
OLE1 encodes a fatty acid desaturase, and CYB5 is involved in both sterol and fatty acid 
synthesis. The number of genes increases to 15 if those genes which were not clearly 
also repressed in the BY4741 strain are included. In contrast, only one gene promoting 
lipid biosynthesis was repressed by both NO donor and myxothiazol. Most striking was 
the overexpression by a factor of more than 200  (the highest upregulation observed for 
any gene) of FRM2, encoding a protein of unknown function involved in the fatty acid 
signaling pathway. FRM2 mutation prevented repression of OLE1 by unsaturated fatty 
acids (McHale et al., 1996). A similar upregulation of FRM2 was also observed on 
nitrosative stress in the S. cerevisiae study mentioned earlier (Sarver and DeRisi, 2005). 
As discussed in 4.3.2, a decrease in sterol synthesis might be expected to have a severe 
effect on cell proliferation, since ergosterol is essential for cell viability. However,
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addition of ergosterol to the growth medium of NO donor-treated cells did not appear to 
relieve the inhibition of proliferation (although appropriate controls were not carried 
out).
5.3.6. Severe repression of respiratory chain genes
One of the most striking effects of NO donor exposure was the severe repression of 
many genes encoding respiratory chain subunits or involved in the assembly of 
respiratory complexes. A large majority of these genes were repressed by NO donor but 
not myxothiazol. Four cytochrome oxidase genes (three subunits), seven bc\ complex 
genes (six subunits), four succinate dehydrogenase genes and one NADH 
dehydrogenase gene were repressed. This was in addition to three genes relating to 
cytochrome c and one gene required for ubiquinone biosynthesis. Repression reached as 
high as 100-fold. More than a third of these genes were also repressed after NO donor 
treatment of C. albicans (,SDH1, SDH2, CYC1, RIP1, YOR356W, COX4, QCR1, 
COX5A, QCR2), along with several other respiratory chain genes which were not 
observed here (Hromatka et al., 2005). It seems that repression of the respiratory chain 
is of great importance in the response of cells to NO donor-induced stress. In the recent 
study of nitrosative stress in S. cerevisiae, repression of respiratory chain genes was 
observed in rich medium but not in synthetic medium (Sarver and DeRisi, 2005).
Nine respiratory chain genes (CYT1, SDH2, AD/7, SDH1, QCR6, SDH4, QCR2, 
COX5A, COX1, ATP9) were repressed by more than 3-fold in the untreated rho° strain 
compared to the untreated control. Downregulation of respiratory chain genes in the 
absence of mtDNA has been observed before (Epstein et al., 2001).
NO is a potent inhibitor of the respiratory chain, and blockage of the respiratory 
chain would be expected to increase production of ROS. If lowering transcription of 
respiratory chain genes leads to a decrease in levels of respiratory chain proteins the 
cells might be expected to produce less ROS, thus this could represent a strategy to 
protect the cells from further oxidative damage. However, when I monitored cell growth 
and gene expression in the absence of a respiratory chain, or cell growth in strains 
lacking components of the ROS defence system, I found no major role for ROS or the 
respiratory chain in the NO donor induced stress. Therefore it seems unlikely that this is 
a plausible rationale for decreased expression of respiratory chain genes.
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5.3.7. Transcription factors involved in the genomic response to NO/RNS
5.3.7.L Haplp
Haplp is a zinc finger transcription factor involved in regulating the transcriptional 
changes induced by altered oxygen tension. It is localised in the nucleus where its 
activity is controlled by heme, which in turn is dependent on oxygen level. Two steps in 
the heme biosynthetic pathway use oxygen as a substrate (enzymes Heml3p and 
Heml4p), while the final step in the pathway (enzyme Heml5p) has been shown to be 
faster in the presence of oxygen (Hon et al., 2003). In anaerobiosis heme is absent and 
Haplp is bound to other proteins to form a high molecular weight complex (HMC) 
(Fytlovich et al., 1993; Zhang and Guarente, 1994; Zhang et al., 1998). In aerobic 
conditions, heme is synthesised and liberates Haplp from the HMC, allowing Haplp to 
bind DNA and activate transcription of aerobic genes encoding proteins involved in 
respiratory chain, heme, sterol and fatty acid synthesis. Heme is also a component of 
many of these enzymes, providing an additional level of control.
17 of the 36 known or putative Haplp-regulated genes described in (Ter Linde 
and Steensma, 2002) were found to be repressed after NO donor treatment (Table 5.5). 
Most of the genes were unchanged on myxothiazol treatment, although 6 were 
overexpressed. One of the genes Haplp is known to induce is ROX1, encoding a 
transcription factor which represses hypoxic genes in aerobic conditions. Although 
ROX1 did not appear to be upregulated in my data, several of its known or putative 
target genes were upregulated (Table 5.5). This suggests that NO or RNS might be able 
to interfere somehow, directly or indirectly, with Haplp, to impair its activity. The 
mechanism of interference could be through several means. It may be that on NO donor 
exposure the cells sense conditions resembling low oxygen tension. I compared the 
pattern of gene expression observed in anaerobiosis (Ter Linde et al., 1999) to that 
observed on NO donor exposure. Of the genes clearly specifically altered in response to 
NO donor, only a few were also altered in a similar manner in anaerobiosis, and this 
was more obvious in the repressed genes than the overexpressed genes. Also, some of 
the RNS-specific upregulated genes were downregulated in anaerobiosis. Therefore it 
seems that rather than a general low oxygen tension being sensed, NO/RNS may alter 
Haplp activity more specifically. One possibility is inhibition of one of the enzymes 
involved in the heme synthesis pathway, resulting in decreased heme levels and 
therefore decreased Haplp activity. I attempted to investigate this using a reporter gene, 
however this assay did not work well. I then assessed repression of the CYC7 gene by
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(RT)q-PCR, and the heme precursor dpIX did not relieve the repression caused by NO 
donor exposure. However, this would need to be repeated with a proper control. In 
conclusion, I did not find evidence to support an involvement of heme level in the gene 
repression, and was also not able to directly demonstrate involvement of Haplp (since 
the reporter gene assay was unsuccessful). The possible role of Haplp is inferred from 
the microarray data and from previous results of other groups, therefore more work 
needs to be done.
5.3.7.2. Msn2/4p
Msn2p and Msn4p are mediators of the general response to stress. After both 
myxothiazol and NO donor treatment, a transient gene expression response 
characteristic of the general stress response was observed, therefore it might be 
expected that Msn2/4p could play a role. Indeed, 84% of the genes altered after 10 
minutes of myxothiazol treatment showed some dependence on Msn2/4p (Bourges et 
al., 2005). Gene expression after 60 minutes treatment with NO donor, however, was 
found to have only limited dependence on Msn2/4p, with 26% of genes showing 
dependency. However the involvement of transcription factors was assessed at different 
time points; 60 minutes for NO donor and 10 minutes for myxothiazol. To clarify this I 
assessed transcription of a LacZ reporter gene controlled by a STRE in the presence of 
NO donor. The /?-galactosidase activity displayed a similar pattern of response to that 
seen after myxothiazol treatment, suggesting that the involvement of Msn2/4p is largely 
an early event. No STRE activation is detected at 10 minutes, presumably because the 
early alterations of transcription have not yet resulted in changes at the protein level. 
However, after 60 minutes the early transcriptional changes will have become 
detectable at the protein level. It seems likely that Msn2/4p are involved early on in 
transient transcriptional regulation of a large set of genes. After 60 minutes of NO donor 
incubation this involvement will not be seen in microarray analysis. It would be 
interesting to assess involvement of Msn2/4p at an earlier time point to confirm this.
5.3.7.3. Yaplp
Yaplp is specifically involved in the response to oxidative stress. After 60 minutes of 
NO donor treatment 23% of genes were found to be regulated by Yaplp, a similar 
number to those regulated by Msn2/4p. The strain W303-1B used in the majority of the 
experiments described carries a mutation in the gene encoding Ybplp, which forms a 
stress-induced complex with Yaplp and influences its nuclear localisation in response 
to hydrogen peroxide (Veal et al., 2003). The mutation causes some loss of function and
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increased sensitivity to hydrogen peroxide. Possible inhibition of the Yaplp system 
might therefore have affected some of the results. However, in the analysis of Yaplp 
involvement in the gene expression response due to myxothiazol, the experiment was 
repeated using the YAP1 deletion in the BY4741 parent strain, which does not harbour 
the YBP1 mutation, and similar results were found. Additionally, when gene expression 
changes after NO donor treatment were measured in the BY4741 strain, similar results 
were obtained to those in the W303-1B strain. Therefore it is unlikely that the mutations 
in YBP1 affect the response to NO donor stress.
Interestingly, while the expression of YAP1 was not altered after NO donor 
treatment, YAP2 (another member or the AP-1 family) was induced on NO donor 
exposure. Yap2p has some overlapping function with Yaplp, but seems to be more 
involved in the control of genes involved in the stabilisation of proteins (Cohen et al., 
2002).
163
5. Transcriptional changes induced by NO/RNS
W303 0
7 W303Ayhb l 0 
W303 3E 6J2
a> 5 u
0  4
5 -  3 S'
1  2a>
TJ 1
,.A  W303Ayftb 1 3
0
0 2 4 6 8 10
tim e (hours)
Figure 5.1. Effect of NO donor on yeast proliferation.
W303-1B and W303-1B Ayhbl cells were grown in YPGal in the presence of 0 or 3 mM DETA 
NONOate. Growth was monitored by measuring cell density at 600 nm.
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Figure 5.2. Changes in gene expression after NO donor treatment.
Fold change values were calculated relative to untreated cells. A. average fold decrease and B. number of 
genes repressed at each time point in the category “DNA structure, replication, transcription and 
translation”. C. heat map showing overexpression of genes in the categories “Response to oxidative 
stress”, “Electron transfer and ADP/ATP translocator” and “Protein folding and modification”. The 
number of replicate chips for each time point is stated in 2.5.1.6.
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Figure 5.3. Effect of varying concentration of NO donor on gene expression.
W303-1B Ayhbl cells were incubated for 60 minutes in the presence of 3, 1 and 0.1 mM DETA 
NONOate. A. Fold change values were calculated relative to the relevant untreated strain and the number 
of genes significantly altered at each concentration of NO donor is shown. B. The average fold change of 
the 291 genes altered after 60 minute NO donor treatment was calculated at each concentration of NO 
donor. 3, 1 and 0.1 indicate the concentration of DETA NONOate in mM. Three replicate chips were 
examined for the 3 mM concentration, and one chip each for the 1 mM and 0.1 mM concentrations.
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Figure 5.4. Genes commonly altered by NO donor and myxothiazol.
Fold change values were calculated relative to the relevant untreated strain. A. Average fold changes in 
response to NO donor for all genes (211 overexpressed, 266 repressed) with expression altered by both 
NO donor and myxothiazol treatment. B, C, D. Expression profiles of 4 representative genes after NO 
donor (solid line) and myxothiazol (dashed line) treatment, for the categories “DNA structure, replication, 
transcription and translation” (B), “Protein folding and modification” (C) and “Glycolysis, 
gluconeogenesis and carbohydrate storage” (D). The number of replicate chips examined for each time 
point is stated in 2.5.1.6.
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Figure 5.5. Genes altered specifically by NO donor.
Fold change values were calculated relative to the untreated strain. A. Average fold changes in response 
to NO donor for all genes (45 overexpressed, 72 repressed) with expression altered by NO donor but not 
myxothiazol treatment. B. Number of genes altered at each time point. The number of replicate chips 
examined for each time point is stated in 2.5.1.6.
60
Omin 10 min 60 min 120 min C+ C- 120min120min
Ayhbl WT myxo
Figure 5.6. STRE activation by Msn2/4p induced by NO donor.
W303-1B Ayhbl cells harbouring the reporter gene LacZ under the control of a STRE-containing 
promoter were cultivated for 8 hours in YPGal at 28°C, then exposed to 3 mM NO donor for 10, 60 or 
120 min. The cells were harvested and the expression of the reporter gene was followed. Controls were as 
follows: after 8 hours growth at 28°C, W303-1B Ayhbl cells were cultivated without NO donor for 60 
min at 37°C (C+), or for 120 hours at 28°C (C') or with 8 pM myxothiazol for 120 min at 28°C; W303-1B 
cells, with an active Yhblp, were exposed to 3 mM NO donor for 120 min. The mean and standard 
deviation (±) of the values obtained for /^-galactosidase activity are shown.
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Figure 5.7. CYC1 repression in the presence of NO donor and myxothiazol.
W303-1B Ayhbl cells harbouring the reporter gene LacZ under the control of the CYC1 promoter were 
cultivated for 8 hours in YPGal at 28°C, then exposed to 3 mM NO donor or 8 pM myxothiazol for 1 or 
12 hours. The cells were harvested and the expression of the reporter gene monitored.
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Table 5.1. Number of genes with altered expression as a result of incubation with NO donor.
W303-1B Ayhbl cells were treated for 10-120 minutes with 3 mM DETA NONOate or for 2-120 minutes 
with 8 pM myxothiazol. For each gene, the number of transcripts in treated cells was compared to the 
number of transcripts in untreated cells and a fold change value calculated at each time point. The number 
of replicate chips examined for each time point is stated in 2.5.1.6. The over-expressed and repressed 
genes were grouped into functional categories. The table shows the number of genes in each functional 
category which had a fold change value judged significant at at least one time point (see 2.5.1.6). Of the 
genes altered after 3 mM DETA NONOate exposure, the number altered common to both treatments is 
indicated.
Category Overexpressed genes 
NO myxo common NO
Repressed genes
myxo common
Response to oxidative stress 15 6 4 4 2 2
Electron transfer and 
ADP/ATP translocator
4 8 2 31 4 5
Glycolysis, gluconeogenesis, 
carbohydrate storage pathway
48 68 40 13 11 9
Peroxisome, fatty acid and 
lipid metabolism
7 16 5 18 3 3
Amino acid metabolism, 
catabolism and transport
21 14 9 12 13 5
Ion homeostasis 7 4 1 4 3 2
Transporter and targeting 28 33 11 13 16 10
Protein folding and 
modification
13 13 10 3 2 2
Response to variable stress 8 6 5 1 3 1
Kinase, phosphorylase and 
signal transduction
9 24 7 1 3 1
Cellular organisation and 
biogenesis
33 61 19 27 33 13
DNA structure, replication, 
transcription and translation
14 28 9 195 251 171
Other 18 11 7 14 14 8
Unknown genes 121 154 82 49 75 34
Total 346 446 211 385 433 266
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Table 5.2. Validation of microarray results by (RT) qPCR analysis.
For six representative genes, fold change value obtained after 60 minutes NO donor treatment in 
microarray analysis is listed adjacent to relative quantity obtained in (RT)q-PCR analysis. Values were 
calculated as described in 2.5.1.6 and 2.5.2 and are the average of results from at least two independent 
cell preparations (microarray) or at least three separate assays with each sample processed in duplicate 
((RT)q-PCR).
Microarray 
signal TO signal T60 fold change
(RT)q-PCR 
relative quantity
CYC7 33 6.4 0.19 0.05
CTT1 6.5 3.5 0.54 0.23
HSP26 11 116 11 7.1
GPM2 7.6 93 12 9.8
OYE3 67 1173 18 44
GTT2 37 1378 37 55
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Table 5.3. Dependence of NO donor-induced changes in gene expression on the respiratory chain, 
and on the transcription factors Msn2/4p and Yaplp.
The gene expression in the mutants Ayhbl rho° (mtDNA-less), Ayhbl Amsn2/4 and Ayhbl Ayapl after 60 
minutes treatment with 3 mM NO donor was compared with gene expression in the control under the 
same conditions. 3 replicate chips were examined for the control and one chip for all other samples. The 
ratio “fold change in mutant / fold change in control” (R) was calculated for each gene. Assignment of 
genes into categories utilised the cut-off values for R indicated in the Table. R,, R2 and R3 are the ratios 
in, respectively, rho°, Ayapl and Amsn2/4. “Number of genes already altered in the untreated rho°. bThe 
genes exhibiting strong dependence on the respiratory chain are GPH1, MAL32, TSL1, GDB1, GLC3, 
SUC4, SUC2, HSP26, HSP24, GPG1, YPR013C, DCS2, YIL057C, YNR034w-a, YNR073C, YER067W, 
YCL042W, YFR017C (overexpressed), RK11, SPS4 and RPL7B (repressed); cYaplp dependent genes: 
AAD6, SRX1, EC M3 8, PRX1, GL04, OYE3, TDH1, GPH1, OSM1, GDH3, BDH1, GSY2, GLG1, SUC4, 
SUC2, SRY1, ATR1, HSP26, SN04, YGP1, WSC4, PKH2, HAP1, PH05, YGR287C, PH O ll, YKL071W, 
YCL042W, YFR017C, YR02, YLR047C (overexpressed), COX23, CBP6, ACOl, RKI1, HNM1, RPL7B, 
FMP10 and YFR026C (repressed); dMsn2/4p dependent genes: GTT2, TSA2, GSH1, NTH1, YNL274C, 
TSL1, GDB1, TPS2, LEU2, PAI3, TFS1, HSP31, GIP2, GPG1, HUG1, YOL155C, KTR2, DDR48, ANB1, 
YHR087W, YNR064C, SOL4, YLL056C, YMR090W, YLR346C (overexpressed), CYC1, CYB2, HMX1, 
CYC7, SUE1, SLS1, ADH1, JEN1, HXT2, HMG1, MVD1, ERG13, ERG25, IN02, PUT4, YMR009W, 
UBX6, SSA2, PTR2, TEC1, SST1, HPA2, RSM24 and YBR056w-a (repressed); eYaplp and Msn2/4p 
dependent genes: AAC3, YEL047C, MAL32, YHR048W, FLR1, YDR089W, YOL155C, YOL057W, GPM2, 
YPR013C, YNR034w-a, YNR073C, YER067W, YML131W, YER067c-a (overexpressed), CTA1, ADH2, 
FBP1, PCK1, ICL1, STL1, PXA2, ARG8, ADY2, MRPL1, PCS60, MSF1 and YBR242W (repressed).
A Effect of respiratory deficiency Number of genes
Strong0 (R, < 0.25) 30 (12a)
Overexpressed Weak (0.25 < R3 < 0.75) 115
genes None (0.9 ^ R0 32
Unclear (0.75 < R, < 0.9) 7
Strong (R3 £ 4) 5 (2a)
Repressed Weak (4> Ri > 1.33) 46
genes None (1.11 ^ Ri) 42
Unclear (1.33 > R3 > 1.33) 14
B Regulation Number of genes
Yaplp onlyc (R2 < 0.75; 0.9 < R3) 31
Overexpressed Msn2/4p onlyd (R3 < 0.75; 0.9 £ R2) 25
Yaplp and Msn2/4pe (R2 and R3< 0.75) 15
genes Other (R2 and R3> 0.9) 107
Unclear (0.75 ^ R2 and R3 < 0.9) 6
Yap1 p onlyc (R2 > 1.33; 1.11 £ R3) 8°
Repressed Msn2/4p only0 (R3 > 1.33; 1.11 > R2) 24°
Yaplp and Msn2/4pe (R2 and R3 > 1.33) 13°
genes Other (R2 and R3 < 1.11) 58
Unclear (1.11 < R2 and R3£ 1.33) 4
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Table 5.4. Genes with altered expression after NO donor treatment but not myxothiazol treatment.
Trancriptional responses to 3 mM DETA NONOate {Ayhbl strain) and 8 pM myxothiazol were compared in the W303-1B background. 265 genes were found to be altered by NO 
donor but not by myxothiazol. 117 genes which were clearly altered specifically in response to NO donor after comparison to results obtained using another strain (BY 1471 Ayhbl) 
are listed in the table together with the fold change values obtained in the W303-1B Ayhbl strain after 10-120 minutes treatment with DETA NONOate. aGene overexpressed after 
myxothiazol treatment. Numbers in parenthesis indicate the total number of genes in that category altered after NO donor treatment (see Table 5.1).
A. Genes overexpressed after NO donor treatment
Category Number of genes Gene Function 10 min
Fold change 
30 min 60 min 120 min
Response to 7(15) AAD4 Putative aryl-alcohol dehydrogenase 5.1 15.2 27.0 29.6
oxidative stress AAD6 Putative aryl-alcohol dehydrogenase 3.4 20.6 30.0 37.9
AAD16 Putative aryl-alcohol dehydrogenase 3.5 10.0 10.4 11.0
GPX2 Phospholipid hydroperoxide glutathione peroxidase 1.8 2.7 4.8 4.1
GTT2 Glutathione S-transferase 11.5 30.6 37.1 36.8
SRX1 Sulfiredoxin 4.1 9.0 13.8 24.1
YCF1 Glutathione S-conjugate transporter 5.3 10.9 10.7 9.3
Electron transfer and 1(4) OYE3 NADPH dehydrogenase 8.4 16.0 17.6 13.6
ADP/ATP translocator
Glycolysis, gluconeogenesis and 3(48) GDH3 Glutamate dehydrogenase 2.9 4.2 4.2 5.6
carbohydrate storage pathway YEL047C Fumarate reductase 1.5 3.0 5.7 9.3
YNL134C Alcohol dehydrogenase 3.6 5.9 5.4 4.6
Peroxisome, fatty acid 1(7) FRM2 Integration of lipid signaling pathways with cellular 136.1 206.5 226.0 224.6
and lipid metabolism homeostasis
Amino acid metabolism, 2(21) GCV1 Glycine decarboxylase complex T subunit 1.7 9.7 8.5 5.3
catabolism and transport SDL1 L-serine dehydratase 5.8 15.8 22.2 24.4
Ion homeostasis 2(7) ISU2 Synthesis of iron-sulfur proteins 10.0 14.4 19.2 21.5
FRE5 Putative ferric reductase 1.9 3.1 5.7 4.5
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Category Number of genes Gene Function 10 min
Fold change 
30 min 60 min 120 min
Transporter and targeting 7(28) ARN1 Siderophore-iron transporter 1.6 3.3 6.0 6.5
ARN2 Siderophore-iron transporter 1.9 2.9 5.0 9.7
ATR1 Major facilitator drug efflux pump 2.0 4.5 7.0 4.8
FLR1 Major facilitator drug transporter 2.0 7.9 13.5 11.3
MCH4 Transporter with similarity to mammalian 3.9 4.4 4.5 4.3
onocarboxylate permeases
SSU1 Major facilitator sulfite pump 2.3 2.9 9.3 10.1
YHR048W Drug transporter 3.5 13.0 21.0 20.6
Protein folding and modification 1(13) HSP31 Heat-shock protein 31 2.8 5.9 5.2 4.4
Response to variable stress 1(8) YAP2 Basic leucine zipper transcription factor 3.5 4.1 3.7 4.9
Cellular organisation 5(33) DAN4 Cell wall mannoprotein 2.9 3.3 4.9 4.9
and biogenesis HUG1 Meclp-mediated checkpoint pathway 0.9 0.9 5.3 65.3
PKH2 Serine/threonine protein kinase involved in cell wall 2.1 3.1 5.5 7.9integrity
SDP1 MAP kinase phosphatase involved in cell wall 11.3 9.3 5.6 15.2integrity
YOL155C Involved in cell wall integrity 1.5 1.8 5.5 7.0
DNA structure, replication, 1 (14) DDR48 DNA damage-responsive protein 3.8 4.4 4.1 4.2
transcription and translation
Other 2(18) ARR2 Arsenate reductase 4.6 14.2 26.5 32.9
YNR064C Epoxide hydrolase 15.3 52.8 70.7 67.2
Unknown genes 12(121)
Total 45 (346)
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B. Genes repressed after NO donor treatment
Category Nfumber a 3 of genes Gene Function 10 min
Fold change 
30 min 60 min 120 min
Response to oxidative stress 3 (4) CCP1 Cytochrome c peroxidase 1.3 0.3 0.1 0.1
CTA1a Catalase A 1.1 0.5 0.3 0.4
GRX4 Glutaredoxin 0.5 0.4 0.2 0.2
Electron transfer and ADP/ATP 24 (31) CBP4 Cytochrome b mRNA processing 1.4 0.8 0.3 0.3
translocator COQ2 Ubiquinone biosynthesis 0.5 0.4 0.4 0.3
COX4 Cytochrome c oxidase subunit 4 0.7 0.4 0.4 0.3
COX5A Cytochrome c oxidase subunit 5a 0.6 0.2 0.2 0.2
COX6 Cytochrome c oxidase subunit 6 0.7 0.5 0.3 0.4
C Y B t Cytochrome b2 0.8 0.1 0.1 0.1
CYC1 I so-1-cytochrome c 0.8 0.05 0.02 0.01
CYC7* lso-2-cytochrome c 2.4 0.5 0.2 0.4
CYT1 Cytochrome c1 0.5 0.2 0.1 0.1
HEM15 Ferrochelatase 1.7 0.4 0.3 0.2
HMX1* Heme-binding peroxidase 0.1 0.1 0.1 0.1
NDI1 NADH:ubiquinone oxidoreductase 1.1 0.3 0.1 0.1
PET309 Translational activator for the COX1 mRNA 0.5 0.4 0.4 0.3
QCR1 be! complex core subunit 0.8 0.4 0.3 0.2
QCR2 bci complex subunit 2 0.9 0.3 0.2 0.1
QCR6 bc^  complex subunit 6 0.6 0.3 0.2 0.2
QCR9 bci complex subunit 9 0.8 0.4 0.3 0.4
RIP1 bCi complex Rieske iron-sulfur protein 0.8 0.2 0.1 0.1
SDH1 Succinate dehydrogenase flavoprotein subunit 0.7 0.2 0.1 0.1
SDH2 Succinate dehydrogenase iron-sulfur protein subunit 0.7 0.1 0.1 0.1
SDH3 Succinate dehydrogenase cytochrome b subunit 0.8 0.3 0.2 0.1
SDH4 Succinate dehydrogenase membrane anchor 0.9 0.4 0.2 0.1
SUE1a Degradation of unstable forms of cytochrome c 0.6 0.3 0.2 0.4
YOR356W Oxidoreductase activity 0.6 0.1 0.1 0.05
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Category Number of genes Gene Function 10 min
Fold change 
30 min 60 min 120 min
Glycolysis, gluconeogenesis and 1 (13) AC01 Aconitase 0.5 0.1 0.3 0.7
Peroxisome, fatty acid and lipid 8(18) ACH1 Acetyl-CoA hydrolase 1.5 0.3 0.2 0.3
metabolism CYB5 Cytochrome b5 0.1 0.1 0.1 0.1
ERG7 Lanosterol synthase 0.5 0.2 0.3 0.2
FAS2 Alpha subunit of fatty acid synthetase 0.7 0.5 0.4 0.2
HMG1 HMG-CoA reductase isozyme 0.4 0.2 0.2 0.2
HNM1 Choline transporter 0.4 0.3 0.3 0.3
MVD1 Mevalonate pyrophosphate decarboxylase 0.5 0.3 0.3 0.3
OLE1 Fatty acid desaturase 0.3 0.3 0.7 0.8
Amino acid metabolism, 4(12) GLT1 Glutamate synthase 0.8 0.2 0.3 0.3
catabolism and transport LEU9 Alpha-isopropylmalate synthase II 0.4 0.2 0.3 0.3
PUT1a Proline oxidase 0.9 0.6 1.1 0.1
PUT4* Proline permease 0.4 0.03 0.04 0.04
Ion homeostasis 1(4) CCC1 Homeostasis of calcium, iron and manganese ions 0.8 0.4 0.4 0.3
Transporter and targeting 3(13) AT018 Acetate transporter 1.8 0.3 0.3 0.3
EMP70 Transporter activity 0.7 0.4 0.5 0.3
UBX6* Ubiquitin regulatory X 0.9 0.8 0.3 0.3
Protein folding and modification 1(3) PTR2 Peptide transporter 0.9 0.5 0.3 0.2
Cellular organisation 5(27) KTR6 Probable mannosylphosphate transferase 0.8 0.4 0.3 0.3
and biogenesis
NCS2 Role in urmylation and invasive/pseudohyphal 02 0.2 0.4 0.3growth
SCM4 Potential regulatory effector of CDC4 function 0.2 0.2 0.1 0.2
SST2 GTPase-activating protein for Gpalp 0.9 0.4 0.3 0.3
SUR7 Involved in sporulation 0.8 0.6 0.3 0.05
5. Transcriptional changes induced 
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Category Number of genes Gene Function 10 min
Fold change 
30 min 60 min 120 min
DNA structure, replication, 11 (195) CLU1 Involved in mitochondrial organisation 0.9 0.5 0.3 0.2
transcription and translation DBP10 Protein involved in ribosome biogenesis 0.3 0.4 0.6 0.5
GCD10 Subunit of tRNA methyltransferase 0.4 0.2 0.6 0.5
H P A t Histone acetyltransferase 0.5 0.3 0.2 0.3
HTB2 Histone H2B 0.9 0.4 0.4 0.2
MEF1 Mitochondrial elongation factor 1.4 1.1 0.3 0.2
NOP7 Protein involved in ribosome biogenesis 0.5 0.1 0.5 0.4
PUS2 Putative pseudouridine synthase 1 0.4 0.4 0.2
RPC34 RNA polymerase III subunit C34 0.3 0.3 0.8 0.6
RRP3 Ribosomal RNA processing 0.3 0.4 0.6 0.5
RSM24 Ribosomal small subunit of mitochondria 1 0.8 0.4 0.3
Other 5(14) DUR1.2 Urea amidolyase 0.8 0.3 0.4 0.2
LIP5 Probable lipoic acid synthase 0.8 0.4 0.3 0.3
MDV1 Mitochondrial fission 0.7 0.5 0.4 0.2
MIS1 Mitochondrial Cr tetrahydrofolate synthase 0.6 0.3 0.4 0.3
PCS6(f AMP-binding protein 0.8 0.5 0.4 0.3
Unknown genes 6(49) _
Total 72 (385)
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Table 5.5. Expression changes of known and putative Haplp and Roxlp-regulated genes after NO 
donor and myxothiazol treatment.
The list of known and putative Haplp-regulated genes is taken from (Ter Linde and Steensma, 2002). “+” 
= upregulated, = repressed. The fold change values after treatment with 3 mM DETA NONOate are 
given. The number o f replicate chips examined for each time point is given in 2.5.1.6.
Fold change 
10 min
h
30 min 60 min 120 min myxothiazol
Known Haplp-regulated genes
CTT1 unchanged
CYB2 0.79 0.09 0.07 0.10 +
CYC1 0.79 0.05 0.02 0.01 unchanged
CYC7 2.36 0.52 0.19 0.41 +
CYT1 0.50 0.17 0.08 0.07 unchanged
DLD1 unchanged
ERG9 unchanged
ERG11 unchanged
HAP1 2.65 2.86 4.47 2.46 unchanged
HMG1 0.37 0.23 0.23 0.22 -
HYP2 0.62 0.48 0.35 0.37 unchanged
QCR1 0.77 0.38 0.27 0.18 unchanged
QCR2 0.86 0.29 0.17 0.14 unchanged
ROX1 unchanged
SOD2 unchanged
YHB1 unchanged
Putative Haplp-regulated genes (7 other candidates unchanged)
CYB5 0.07 0.07 0.06 0.07 unchanged
GFD2 0.11 0.07 0.23 0.18 -
HMX1 0.13 0.09 0.07 0.13 +
HPA2 0.50 0.31 0.20 0.32 +
MLS1 0.76 0.87 1.53 4.39 unchanged
PCK1 1.03 0.47 0.32 0.33 unchanged
PUT1 0.85 0.62 1.12 0.14 +
PUT4 0.35 0.03 0.04 0.04 +
REG2 4.53 2.93 1.86 0.49 unchanged
SCM4 0.23 0.19 0.13 0.18 unchanged
STL1 0.41 0.07 0.12 0.08 -
Known Roxlp-regulated genes
AAC3 0.83 2.57 3.72 5.86 +
ANB1 1.03 2.45 8.23 22.40 +
ATF1 unchanged
COX5B 3.36 6.93 8.31 8.91 +
HEM13 unchanged
HMG2 unchanged
NCP1 unchanged
SUT1 unchanged
Putative Roxlp-regulated genes (23 other candidates unchanged)
DIP5 3.05 0.64 1.27 2.29 +
FIT2 1.83 2.93 4.08 5.17 +
FIT3 1.74 2.80 3.69 4.19 unchanged
ISU2 9.95 14.37 19.18 21.48 unchanged
RTA1 1.07 1.60 1.68 4.82 unchanged
SCM4 0.23 0.19 0.13 0.18 unchanged
SPI1 6.03 8.87 5.05 12.34 +
YAL028W 4.60 5.14 3.52 4.37 +
YGR066C 7.15 3.00 5.60 10.51 unchanged
YGR035C 1.31 1.79 4.12 2.15 -
YHR048W 3.47 13.02 20.99 20.58 unchanged
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This work was intended to address two separate areas, with the mitochondrial 
respiratory chain and the yeast Saccharomyces cerevisiae as central themes. First, the 
assembly of the respiratory chain enzyme cytochrome oxidase was investigated, using 
yeast as a model system. Second, the nature of the antimicrobial effect of nitric oxide 
(NO) and its derivatives reactive nitrogen species (RNS) was assessed in yeast.
6.1. CYTOCHROME OXIDASE ASSEMBLY
Cytochrome oxidase takes the form of a dimer, and in yeast each monomer is composed 
of 11 subunits of dual genetic origin. Added complexity comes from the presence of 
several metal cofactors and the integral membrane location of the assembled enzyme. It 
is therefore unsurprising that its assembly has been found to require a vast array of 
assembly factors (Table 1.2). Much progress has been made in identifying the 
mechanisms involved in insertion of subunits into the IMM and assembly of the 
cofactors. However, the processes by which the subunits themselves interact with each 
other to form the assembled enzyme complex are only just beginning to be elucidated. 
In the human system analysis of cells with defective assembly has led to the 
identification of assembly subcomplexes, providing some information on the sequential 
interaction between subunits (Nijtmans et al., 1998; Williams et al., 2004) (Figure 6.1).
Yeast have long been used as a model organism to investigate respiratory chain 
function, and the majority of the assembly factors known to be required for cytochrome 
oxidase assembly were first identified in yeast. However, the use of yeast in 
investigating the sequential assembly process of cytochrome oxidase has been limited 
by the efficient degradation of unassembled subunits, in particular the core subunits, by 
AAA proteases when assembly is impaired (Pearce and Sherman, 1995; Guelin et al., 
1996). There has only been one previous report of cytochrome oxidase subassemblies in 
yeast. Church et al. identified three subcomplexes, two containing the nuclear subunits 
Cox7p, Cox7ap and Cox8p, with or without the chaperone PetlOOp, and one containing 
Cox5ap and Cox6p, by sucrose gradient centrifugation and immunoprecipitation 
(Church et al., 2005). However, prior to the work described in this thesis no 
subassemblies containing the core mitochondrially-encoded subunits had been identified 
in yeast.
6.1.1. Mutations in COX2 abolishing assembly
With a view to elucidating the involvement of the core subunit Cox2p in the assembly 
process, I analysed yeast strains with mutations in the COX2 gene, causing amino acid 
alterations in the C-terminal soluble domain of Cox2p. Most of the mutations
179
6. Conclusions and future directions
completely abolished cytochrome oxidase assembly, reflecting the central location of 
Cox2p in the enzyme complex. To try to gain more information on the mutants I 
generated several revertant strains with additional mutation in the nuclear genome. The 
nature of the reversions could provide useful information about the mechanism by 
which the original mutation prevents assembly. Although I sequenced several candidate 
genes to try to identify the locations of the nuclear reversions, I was unsuccessful in 
locating them. A more profitable approach might be to construct genomic libraries from 
the revertant strains and transform them into the original mutant strains, select for those 
clones which have regained respiratory competence, and identify the genes responsible.
It may also be interesting to assess whether translocation of the C-terminal 
domain occurs in these mutants. C-terminal translocation is thought to involve the 
assembly factors Coxl8p, Mss2p and Pntlp (He and Fox, 1999; Broadley et al., 2001; 
Saracco and Fox, 2002). It is not clear whether it occurs before or after formation of the 
Cua site of Cox2p. The mutations could impair the binding of copper, or alter 
interaction with assembly factors, preventing translocation. Fox and colleagues have 
developed a system whereby a synthetic yeast mitochondrial gene ARG8 m is fused to 
COX2 resulting in a fusion protein with Arg8mp attached to the C-terminus of Cox2p 
(He and Fox, 1999). Soluble nuclear encoded Arg8p is normally imported into the 
matrix, where it participates in arginine biosynthesis. In the fusion protein Arg8p is 
exported to the IMM, and is unable to participate. If the nuclear-encoded Arg8p protein 
is nonfunctional, export of Arg8mp to the IMM will cause an Arg' phenotype, hence 
defects in Cox2p C-terminal export can be identified by an Arg+ phenotype.
6.1.2. Subcomplexes of cytochrome oxidase
Blue native electrophoresis allows separation of protein complexes in non-denaturing 
conditions (Schagger and von Jagow, 1991). I applied this technique to the separation of 
complexes present in mitochondrial membrane preparations of yeast, and used 
antibodies recognising subunits of cytochrome oxidase to try to identify subcomplexes 
of the enzyme. In wild type yeast I was able to identify one subcomplex of particular 
interest, containing Cox7p and/or Cox7ap (the antiserum used recognised both of these 
co-migrating subunits) (Figure 3.6). Due to the extent of migration of this subcomplex it 
seems likely that other proteins are associated with it, however the subcomplex did not 
contain any other cytochrome oxidase subunits (although I did not probe for Cox6bp). It 
is therefore unlikely to correspond to the complex identified by Church et al. containing 
Cox7p, Cox7ap and Cox8p (with or without PetlOOp) (Church et al., 1996), although it
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could be related to it, and it may be interesting to probe for the presence of PetlOOp. 
Other chaperone proteins (see Table 1.2) could also be associated with the subcomplex.
Unusually, two of the COX2 mutants screened (G156E and R159K) allowed 
partial assembly of cytochrome oxidase, permitting identification of a further 
subcomplex by blue native electrophoresis, this time containing core cytochrome 
oxidase subunits (Figure 3.6). The complex detected contained Coxlp, Cox3p, Cox5p 
and Cox6p, but not Cox2p, Cox4p, Cox6ap, Cox7p, Cox7ap or Cox8p. This novel 
subcomplex is likely to represent the degradation product of a subassembly containing 
the core subunits Coxlp, Cox2p and Cox3p, together with the nuclear subunits Cox5p 
and Cox6p. The existence of such a subcomplex is in agreement with the current model 
for assembly of mammalian cytochrome oxidase (Figure 6.1). Mammalian COX1, 
COX4 and COX5A, the equivalents of yeast Coxlp, Cox5p and Cox6p, respectively, 
are believed to interact first to form a subcomplex S2. Since Cox2p and Cox3p are core 
subunits, they would be expected to associate with S2 soon afterwards. It would be 
useful to perform a pulse chase experiment to compare the stability of Cox2p in the 
G156E and R159K mutants with that of the wild type Cox2p and the Cox2p in the 
assembly-abolished mutants. It might be expected that while Cox2p in the other mutants 
would be degraded rapidly, the G156E or R159K mutated Cox2p would persist for 
longer, although not as long as wild type Cox2p.
6.1.3. Perspectives
The residues R159 and G156 of COX2 are conserved between species (Figure 6.2). 
Together with the similar phenotype resulting from mutation at both of these residues, 
this suggests that this region of Cox2p has a particular role in assembly. Interestingly, 
McFarland et al. identified a human mutation L135P at the equivalent residue to yeast 
L I60, another highly conserved amino acid in this region (McFarland et al., 2004). The 
mutation caused rhabdomyolysis, the breakdown of muscle fibers with leakage of 
potentially toxic cellular contents into the circulation. The assembly defect caused by 
mutation of the nearby residues R159 and G156 in yeast in this conserved region may 
provide some clues as to the molecular defect in this patient. It seems likely that the 
human mutation could cause an assembly problem in cytochrome oxidase.
In conclusion, this work has demonstrated that yeast are a valuable model for 
further elucidation of the cytochrome oxidase assembly pathway. Other cytochrome 
oxidase mutant strains should now be analysed in a similar way to that described here,
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in an attempt to identify further subassemblies which could provide information on the 
assembly process.
6.2. ANTIMICROBIAL EFFECT OF NO/RNS
NO is released in high concentrations by macrophages, and RNS together with ROS 
form the first line of host cell defence against pathogens. Release of NO is an important 
mediator of the activity of macrophages against several pathogenic fungi. Host 
resistance increases with iNOS expression and inhibition of NOS exacerbates infection 
(see for example (Lane et al., 1994; Lovchik et al., 1995)). The second part of my thesis 
investigated the antimicrobial action of NO/RNS, using the effect of the NO donor 
DETA NONOate on yeast as a model. I first assessed the effect of NO/RNS on yeast 
proliferation and on the cytochromes of the respiratory chain. I then measured the 
genomic response to NO/RNS to try and determine the nature of the stress sensed by the 
cells on exposure, and the factors which mediate the response to this stress. I also tried 
to assess whether ROS contributed significantly to the stress, and whether several 
candidate transcription factors were involved in mediating the responses to NO/RNS.
6.2.1. Yeast are extremely resistant to NO/RNS
Yeast contain a highly efficient NO oxidoreductase, which makes cells extremely 
resistant to NO/RNS even at high concentration (Figure 4.1, Figure 4.2A). To allow 
identification of other NO/RNS defence systems I therefore performed all my analyses 
in strains lacking the YHB1 gene. However, even in the absence of Yhblp yeast were 
very resistant to treatment. Very high doses of NO donor were required to affect cell 
proliferation; 0.1 mM and 1 mM of DETA NONOate had little effect. These results are 
in agreement with previous reports on the sensitivity of yeast growth to this particular 
NO donor (Liu et al., 2000; Matsumoto et al., 2003). Furthermore, even high doses of 
DETA NONOate did not cause cell death in yeast: a cytostatic rather than cytotoxic 
effect was observed. A similar result was also observed in the pathogen fungus H  
capsulatum using an alternative NO donor DPTA NONOate (Nittler et al., 2005). When 
mammalian cells are subjected to similar doses a clear deleterious effect is observed. 
For example, in a human breast cancer cell line incubation with 0.1 mM DETA 
NONOate (concentration of 0.5 pM NO in the growth medium) led to cytostasis by 12 
hours, followed by cytotoxicity (Pervin et al., 2001). Mammalian cells are highly 
susceptible to the high concentrations of NO generated by macrophages, however the 
macrophages themselves are relatively resistant, allowing them to persist to carry out 
their physiological functions. Activated macrophages synthesising NO seem to have an
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atypical apoptotic cascade which makes the cell resistant to apotosis in the presence of 
NO (Bosca et al., 2005). Yeast also seem to be particularly resistant to NO/RNS, and 
this is not just because of Yhblp, suggesting that, in addition to Yhblp, yeast have other 
effective defence strategies against NO/RNS which make them particularly insensitive 
to these compounds.
6.2.3. General considerations about the microarray analysis
The analysis of global gene expression after NO donor treatment was intended to give 
clues as to the nature of the stress sensed by cells on exposure, on the defence 
mechanisms used to negate this stress, or repair or remove the damage caused by it.
When interpreting the microarray data it must be remembered that the 
correlation between mRNA and protein levels is not always straightforward. Post- 
translational mechanisms of control at the level of translation rate and protein stability 
mean that the relationship between the two can be variable. A study by Gygi et al. 
determined the relationship between mRNA and protein levels for 106 yeast genes 
(Gygi et al., 1999). A general trend of increased protein levels resulting from increased 
mRNA levels was found, but for genes with low mRNA or protein levels the correlation 
was much less apparent. The same group also looked at the correlation between mRNA 
and protein expression changes induced by growth of yeast on two different carbon 
sources, and found that, while in many cases changes in mRNA level corresponded with 
changes at the protein level, a significant number of changes did not show correlation 
(Griffin et al., 2002). So, while measurement of mRNA changes cannot give definitive 
conclusions as to the corresponding protein levels, they will frequently show correlation 
and can certainly identify trends. The next step regarding the microarray data would be 
to assess the protein levels of some of the genes exhibiting an interesting response to 
treatment to see if the transcript changes are translated into alteration at the protein 
level.
On a separate but related point, it must be considered that other mechanisms of 
enzyme regulation exist apart from modification of mRNA level. Activity of enzymes 
can be regulated by covalent modification (for example phosphorylation), or by 
subcellular distribution. Microarray data does not provide information relating to this, 
therefore there are likely to be other mechanisms of defence against RNS that have not 
been identified in this study. For example, the MnSOD of potato mitochondria 
(Bykovaet al., 2003) and pig heart mitochondria (Hopper et al., 2006) have been shown 
to be phosphorylated. Dephosphorylation of MnSOD on incubation with calcium
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correlated with an increase in MnSOD activity, suggesting a potential link between 
phosphorylation and activity (Hopper et al., 2006). Therefore an involvement of 
superoxide dismutase in the response to RNS stress cannot be excluded solely on the 
basis of an absence of induction in the microarray data. Additionally, NO can lead to S- 
nitrosation of cysteine thiols, which has been implicated in protein regulation (Hess et 
al., 2005).
6.2.4. Targets of NO/RNS and mechanisms of defence
Incubation with NO donor had a severe effect on the cytochrome oxidase content of 
yeast cells. NO donor also had an initial effect on other cytochromes, but the levels of 
these returned to normal over the period tested. The decrease in cytochrome oxidase 
content was observed only in dividing cells, not non-dividing cells, suggesting that 
NO/RNS was somehow interfering in the assembly of cytochrome oxidase. The 
microarray analysis showed that expression of several respiratory chain genes was 
repressed on NO donor treatment, however, this was not confined to cytochrome 
oxidase, therefore cannot fully explain the severe decrease in content observed, 
suggesting instead that NO/RNS interferes in some way with the physical assembly of 
the enzyme complex. It would be interesting to analyse the subunit profile of 
cytochrome oxidase after NO donor treatment, as performed for the COX2 mutants in 
Chapter 3. A decrease in respiratory chain complexes would not affect the viability of S. 
cerevisiae because in the presence of NO, an inhibitor of cytochrome oxidase, the cells 
would have presumably switched to fermentation. However, in pathogens relying more 
heavily on respiration, the decrease in cytochromes could have a more deleterious 
effect.
When cell proliferation was diminished due to the absence of a respiratory 
chain, or an inhibited respiratory chain, addition of NO donor caused a further inhibition 
of cell proliferation, indicating that mechanisms other than simple inhibition of the 
respiratory chain must also be in operation. RNS can interact with and damage several 
protein moieties, and are likely to react with numerous proteins and other cellular 
constituents. This might cause a general cell stress which would slow growth rate while 
cells attempted to repair the damage. A large number of genes of the category “DNA 
structure, replication, transcription and translation” were repressed on incubation with 
NO donor, many linked with the response to sudden environmental change associated 
with growth arrest. However, the repression of such genes was largely transient, 
suggesting that this would not explain the prolonged growth inhibition.
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Proteins with a more specific involvement in cell growth could be targets of 
RNS. One target pathway could be the biosynthesis of ergosterol, an essential 
constituent of the yeast cell wall. In the microarray analysis the expression of several 
genes involved in ergosterol biosynthesis was downregulated. Furthermore, NO may be 
able to inhibit those enzymes of the ergosterol biosynthetic pathway which contain 
cytochrome P450. A preliminary experiment to test the effect of addition of ergosterol 
to the growth medium did not demonstrate relief of the growth inhibition caused by NO 
donor. Nevertheless, it would be interesting to measure the ergosterol content in NO 
donor-treated cells, to see whether the decrease in gene expression or potential 
inhibition of the biosynthetic enzymes led to a decrease in ergosterol content. Another 
possible target is ribonucleotide reductase, the rate-limiting step in DNA synthesis. NO 
has been previously shown to have an inhibitory effect on this enzyme (Kwon et al., 
1991). If non-functional, the synthesis of new DNA, and therefore cell proliferation, 
would be impaired. To test this deoxyribonucleosides could be added to the cell culture 
to see whether this leads to any decrease in the growth inhibition caused by NO donor.
The microarray data provides many other clues to the mechanism of inhibition 
of proliferation. As might be expected, upregulation of genes involved in removal of 
reactive species was observed. Several members of the peroxiredoxin and phospholipid 
hydroperoxide glutathione peroxidase family were upregulated. These enzymes are 
involved in the removal of hydrogen peroxide, alkyl hydroperoxides, and peroxynitrite. 
More prevalent than induction of genes involved in detoxification of RNS themselves 
was the upregulation of genes involved in the repair of cell damage. In particular several 
enzymes which could be implicated in the removal of lipid epoxides were highly 
upregulated, including the phospholipid hydroperoxide glutathione peroxidase family 
mentioned above, an epoxide hydrolase and several putative aryl alcohol 
dehydrogenases. In addition, the glutathione detoxification system, which may facilitate 
removal of toxic material from the cell, seemed to be activated, and enzymes of the 
DNA repair system were induced. Furthermore, genes involved in iron homeostasis 
were altered, perhaps in response to breakdown of iron-sulfur clusters.
Three papers have been published recently assessing gene expression changes in 
fungi in response to nitrosative stress. Firstly, Sarver and DeRisi studied the effect of 
the NO donor DPTA NONOate and NO gas on S. cerevisiae (Sarver and DeRisi, 2005). 
As in this study, the majority of the gene changes were associated with the general 
stress response. The study focused on a strong and long lasting induction of YHB1, 
SSU1 (sulfite transporter), YNR064C (epoxide hydrolase) and two homologous ORFs
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YNL335W and YFL061W. The transcription factor Fzflp was shown to be involved in 
the regulation of these transcripts. The transcripts (with the obvious exception of YHB1) 
were also upregulated by NO donor treatment in my study. Secondly, Nittler et al. 
assessed the response to nitrosative stress caused by DPT A NONOate and GSNO in the 
pathogenic fungus H. capsulatum (Nittler et al., 2005). Several sets of genes were 
induced, including those involved in iron acquisition and DNA repair. Finally, 
Hromatka et a l looked at the effect of DPT A NONOate on another pathogenic fungus 
C. albicans (Hromatka et al., 2005). A large number of respiratory chain genes were 
repressed after treatment, as was also observed in my study.
The work described in this thesis seems to fit well with these reports, suggesting 
that nitrosative stress activates the same defence systems in S. cerevisiae and pathogenic 
fungi. It also expands on the data, in particular by assessing the involvement of several 
different transcription factors in the response to nitrosative stress, and the contribution 
of ROS and inhibition of the respiratory chain. It would now be interesting to generate 
strains with deletion of some of those genes found to be involved in the response to 
NO/RNS, and determine their sensitivity to NO donor. It may be that deletion of these 
genes potentiates the inhibition of cell proliferation caused by NO/RNS.
6.2.5. Involvement of ROS in the effect of NO/RNS
ROS are involved in the generation of some RNS. Additionally, NO increases the 
synthesis of ROS through inhibition of the respiratory chain (Poderoso et al., 1996). 
Previous studies in yeast did not find evidence for a major contribution of ROS in the 
antimicrobial effect of NO. Jakubowski et al. found only minor differences in growth 
inhibition caused by the NO donor GSNO on strains with deletions of antioxidant 
defence genes (Jakubowski et al., 1999). Chiang et al. found that the toxicity of NO was 
enhanced under aerobic conditions, but this was not due to the action of hydrogen 
peroxide or superoxide (Chiang et al., 2000). However, these studies did not utilise 
strains with deletion of YHB1 so effects could have been overlooked. To clarify this, I 
reassessed the involvement of ROS in the antimicrobial effect of NO donor.
The majority of my data points away from a major involvement of ROS, at the 
level of both cell growth and gene expression. In the absence of a functional respiratory 
chain a high concentration of NO donor caused inhibition of cell proliferation; since the 
respiratory chain is the major site of ROS production this suggests that ROS do not 
provide a major contribution to the inhibition. Furthermore, deletion of genes encoding 
enzymes involved in the removal of ROS (superoxide dismutase, catalase and
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cytochrome c peroxidase) did not alter the extent of inhibition of yeast growth by NO 
donor. However, double deletions (for example both SOD1 and SOD2 genes) were not 
assessed and it is possible that compensatory mechanisms could be involved. Notably 
absent in the transcriptional response to NO/RNS was the induction of these ROS 
defence genes, which are highly induced in the presence of hydrogen peroxide (Gasch et 
al., 2000; Causton et al, 2001). This lack of induction on NO donor treatment would 
suggest that the cell recognises RNS stress as distinct from ROS stress, and may also 
suggest that ROS do not have a major involvement in the RNS-induced stress. In the 
absence of a respiratory chain the overall gene expression response to NO donor was 
similar to the response observed in control cells, suggesting that the stress sensed was 
similar whether or not ROS were generated by the respiratory chain. However, several 
genes involved in the removal of peroxides were induced by NO donor treatment, and 
many of the genes upregulated were also upregulated by hydrogen peroxide (Gasch et 
al., 2000; Causton et al, 2001), suggesting that RNS stress does shares some features 
with oxidative stress. Furthermore, the transcription factor Yaplp, mediator of the 
response to oxidative stress, was involved in the expression alteration of 23% of genes.
In summary, the evidence does not exclude involvement of ROS in the RNS- 
induced stress, but suggests that a significant part of the stress does not involve the 
contribution of ROS and is specific to RNS. As discussed earlier it cannot be excluded 
that post-translational events affecting the activity of proteins involved in ROS 
metabolism could occur, and I have not investigated this.
6.2.6. Downregulation of Haplp-activated genes by NO donor
The most striking observation made from the transcriptional analysis was the repression 
of a large number of respiratory chain genes and genes involved in fatty acid and sterol 
synthesis after NO donor treatment. In yeast, in aerobic conditions, the presence of 
heme liberates the transcription factor Haplp from the complex (HMC) it forms with 
other proteins, enabling it to activate transcription of aerobic genes encoding proteins 
involved in the respiratory chain, and heme, sterol and fatty acid synthesis. One of the 
major genes activated is ROX1, the product of which represses transcription of several 
hypoxic genes. The microarray data showed that a large number of genes under the 
control of Haplp were expressed at a lower level after addition of NO donor, 
resembling the situation in anaerobiosis, suggesting that Haplp may be, directly or 
indirectly, affected by NO/RNS.
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In mammalian cells the major transcription factor involved in the response to 
oxygen concentration is the heterodimeric HIF-1 (hypoxia-inducible factor-1). In low 
oxygen concentrations HIF-1 binds to promoters of hypoxia-inducible genes to activate 
transcription. One component of the heterodimeric protein is HIF-1 a, the stability of 
which is regulated in response to oxygen concentration (Wang et al., 1995; Huang et al., 
1996). In conditions of low oxygen the activity of a family of prolyl hydroxylases is 
inhibited and HIF-1 a accumulates to form an active dimer with HIF-1/? and activate 
expression of hypoxic genes (Ivan et al., 2005; Jaakkola et al., 2005). NO and other 
respiratory chain inhibitors have been shown to prevent the stabilisation of HIF-1 a 
during hypoxia (Hagen et al., 2003). This is due to a lack of inhibition of prolyl 
hydroxylase, possibly due to the increased availability of oxygen, which has not been 
consumed by the respiratory chain. However, high concentrations of NO have the 
converse effect and stabilise HIF-1 a, even at high oxygen concentration (Mateo et al., 
2003), allowing it to activate transcription of hypoxic genes. This stabilisation is 
independent of the respiratory chain, and has been suggested among other things to be 
due to S-nitrosation of thiols in HIF-1 a or inactivation of prolyl hydroxylase by NO. It 
seems therefore that in mammalian cells high concentrations of NO cause the cell to 
sense a hypoxic state and activate hypoxic genes. In yeast, NO seems to have a similar 
effect in preventing the transcription of aerobic genes.
I attempted to determine whether Haplp activity was decreased after NO donor 
treatment, however, the /?-galactosidase assay I used was unsuitable. The gene 
expression profile, though, strongly suggests that Haplp is affected in some way by 
NO/RNS. One possible hypothesis could be that NO/RNS might affect Haplp by 
interfering with heme synthesis, thereby decreasing heme levels and preventing Haplp 
release from the inhibitory HMC. The mammalian equivalent of Heml5p, catalysing the 
final step of heme biosynthesis, is inhibited by NO through destruction of its iron-sulfur 
centre, though the yeast enzyme does not contain this cluster and is unaffected by NO 
(Sellers et al., 1996). However, several heme biosynthetic enzymes contain cytochrome 
P450, and NO has been shown to inhibit members of this superfamily. I made a 
preliminary attempt to assess the effect on transcription of adding a heme precursor to 
the NO donor-treated cells and found no differences, but further investigation would be 
required to confirm this result, and it would be interesting to pursue this hypothesis 
further. Any decrease in heme synthesis might also be expected to result in a decrease in 
the levels of heme-containing proteins, including components of the respiratory chain as 
well as other proteins, possibly contributing to the decreased cell proliferation.
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If alteration of heme level was discounted as a mechanism of Haplp inactivation 
by NO donor, it might be possible that RNS could act directly on Haplp. The DNA- 
binding domain of Haplp is a Zn2Cys6 binuclear cluster domain. S-nitrosation at the 
cysteine residues may disrupt the coordination of zinc and hamper binding to DNA, 
thereby preventing the activity of Haplp. Treatment of K. lactis with NO caused a 
decrease in DNA binding activity of the LAC9 transcription factor, which contains a 
Zn2Cys6 domain (Kronke et al., 1994). Alternatively, perhaps NO/RNS could affect the 
other proteins of the HMC, which include Hsp90p, Ydjlp, Hsp70p and Sro9p (Hon et 
al., 2001) to prevent release of Haplp.
6.2.7. Conclusions
In summary, yeast are highly resistant to the effects of NO/RNS, and antimicrobial 
effects are observed only with high concentrations of NO donor. The main defence 
mechanism against NO is the NO oxidoreductase Yhblp. However, yeast also seem to 
contain several other defence mechanisms to counteract the damage caused by 
NO/RNS. These include enzymes which detoxify peroxides, in particular lipid epoxides, 
and enzymes involved in iron homeostasis and repair of DNA damage. RNS also seem 
to affect cytochrome levels, in particular cytochrome oxidase. The majority of the RNS- 
induced stress observed did not appear to rely on the presence of ROS. The pattern of 
gene expression induced by NO/RNS points to involvement of the oxygen-responsive 
transcription factor Haplp. This work could provide valuable information on the 
strategies used by pathogens to defend against the antimicrobial action of RNS.
6.3. FINAL REMARKS
This thesis illustrates the versatility of the yeast Saccharomyces cerevisiae as a model 
organism which can be utilised in the investigation of subjects relevant to both higher 
and lower eukaryotes. In particular, S. cerevisiae is exceptionally useful in the 
investigation of matters relating to respiration, due to its capacity to remain viable even 
in the absence of a functional respiratory chain.
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Figure 6.1. Mammalian cytochrome oxidase assembly pathway.
Several assembly subcomplexes have been identified in human cells (Nijtmans et al., 1998; Williams et 
al., 2004). Yeast counterparts o f some of the human subunits are given in parenthesis.
Y e a s t V I P D E L L E E G Q L R L L D T D T S M V V P
Human M L P P L F L E P G D L R L L D V D N R V V L P
Mouse M I P T N D L K P G E L R L L E V D N R V V L P
R a t M I P T N D L K P G E L R L L E V D N R V V L P
B o v i n e M I P T S E L K P G E L R L L E V D N R V V L P
Xenopus M I P T N D L T P G Q F R L L E V D N R M V V P
Figure 6.2. Sequence comparison of the COX2 gene showing the conserved residues G156 and R159.
Sequences were obtained from NCBI and alignment was made using ClustalW 
(http://www.ebi.ac.uk/clustalw/)
190
Reference list
REFERENCE LIST
191
Reference list
Aggeler,R. and Capaldi,R.A. (1990). Yeast cytochrome c oxidase subunit VII is 
essential for assembly of an active enzyme. Cloning, sequencing, and characterization 
of the nuclear-encoded gene. J. Biol. Chem. 265, 16389-16393.
Alderton,W.K., Cooper,C., and Knowles,R.G. (2001). Nitric oxide synthases: structure, 
function and inhibition. Biochem. J. 357, 593-615.
Altamura,N., Capitanio,N., Bonnefoy,N., Papa,S., and Dujardin,G. (1996). The 
Saccharomyces cerevisiae OXA1 gene is required for the correct assembly of 
cytochrome c oxidase and oligomycin-sensitive ATP synthase. FEBS Lett. 382, 111- 
115.
Aulak,K.S., Miyagi,M., Yan,L., West,K.A., Massilon,D., Crabb,J.W., and Stuehr,D.J.
(2001). Proteomic method identifies proteins nitrated in vivo during inflammatory 
challenge. Proc. Natl. Acad. Sci. USA 98, 12056-12061.
Avery,A.M. and Avery,S.V. (2001). Saccharomyces cerevisiae expresses three 
phospholipid hydroperoxide glutathione peroxidases. J. Biol. Chem. 276, 33730-33735.
Balatri,E., Banci,L., Bertini,I., Cantini,F., and Ciofi-Baffoni,S. (2003). Solution 
structure of S co l: A thioredoxin-like protein involved in cytochrome c oxidase 
assembly. Structure 11, 1431-1443.
Ballinger,S.W., Patterson,C., Yan,C.N., Doan,R., Burow,D.L., Young,C.G., 
Yakes,F.M., Van Houten,B., Ballinger,C.A., Freeman,B.A., and Runge,M.S. (2000). 
Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and 
dysfunction in vascular endothelial and smooth muscle cells. Circ. Res. 8 6 , 960-966.
Barrientos,A., Barros,M.H., Valnot,I., Rotig,A., Rustin,P., and Tzagoloff,A. (2002). 
Cytochrome oxidase in health and disease. Gene 286, 53-63.
Barros,M.H., Nobrega,F.G., and Tzagoloff,A. (2001). Involvement of mitochondrial 
ferredoxin and Coxl5p in hydoxlation of heme O. FEBS Lett. 492, 133-138.
192
Reference list
Barros,M.H., Johnson,A., and Tzagoloff,A. (2004). COX23, a homologue of COX24, is 
required for cytochrome oxidase assembly. J. Biol. Chem. 279, 31943-31947.
Barros,M.H., Myers,A.M., Van Driesche,S., and Tzagoloff,A. (2006). COX24 codes for 
a mitochondrial protein required for processing of the COX1 transcript. J. Biol. Chem. 
281, 3743-3751.
Basrai,M.A., Velculescu,V.E., Kinzler,K.W., and Hieter,P. (1999). NORF5/HUG1 is a 
component of the MEC1 -mediated checkpoint response to DNA damage and replication 
arrest in Saccharomyces cerevisiae. Mol. Cell. Biol. 79, 7041-7049.
Bauer,M., Behrens,M., Esser,K., Michaelis,G., and Pratje,E. (1994). PET1402, a 
nuclear gene required for proteolytic processing of cytochrome oxidase subunit 2 in 
yeast. Mol. Gen. Genet. 245, 272-278.
Beckman,J.S., Beckman,T.W., Chen,J., Marshall,P.A., and Freeman,B. (1990). 
Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial 
injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87, 1620-1624.
Beckman,J.S., Ischiropoulos,H., Zhu,L., van der Woerd,M., Smith,C., Chen,J.,
Harrison,J., Martin,J.C., and Tsai,M. (1992). Kinetics of superoxide dismutase- and 
iron-catalysed nitration of phenolics by peroxynitrite. Arch . Biochem. Biophys. 298, 
438-445.
Beers,J., Glerum,D.M., and Tzagoloff,A. (1997). Purification, characterisation, and 
localization of yeast Coxl7p, a mitochondrial copper shuttle. J. Biol. Chem. 272, 
33191-33196.
Behrens,M., Michaelis,G., and Pratje,E. (1991). Mitochondrial inner membrane 
protease 1 of Saccharomyces cerevisiae shows sequence similarity to the Escherichia 
coli leader peptidase. Mol. Gen. Genet. 228, 167-176.
Beltran,B., Orsi,A., Clementi,E., and Moncada,S. (2000). Oxidative stress and S- 
nitrosylation of proteins in cells. British. J. Pharmacol. 129, 953-960.
193
Reference list
Billinton,N. and Knight,A. W. (2001). Seeing the wood through the trees: A review of 
techniques for distinguishing green fluorescent protein from endogenous 
autofluorescence. Anal. Biochem. 291, 175-197.
Bisson,R., Steffens,G.C.M., Capaldi,R.A., and Buse,G. (1982). Mapping of the 
cytochrome c binding site on cytochrome c oxidase. FEBS Lett. 144, 359-363.
Biteau,B., Labarre,J., and Toledano,M.B. (2003). ATP-dependent reduction of cysteine- 
sulphinic acid by S', cerevisiae sulphiredoxin. Nature 425, 980-984.
Bolanos,J.P., Peuchen,S., Heales,S.J.R., Land,J.M., and Clark,J.B. (1994). Nitric oxide- 
mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. 
Neurochem. 63, 910-916.
Borutaite,V., Budriunaite,A., and Brown,G.C. (2000). Reversal of nitric oxide-, 
peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or 
complex I activity by light and thiols. Biochim. Biophys. Acta 1459, 405-412.
Bosca,L., Zeini,M., Traves,P.G., and Hortelano,S. (2005). Nitric oxide and cell viability 
in inflammatory cells: a role for NO in macrophage function and fate. Toxicol. 208 249- 
258.
Bourges,I., Horan,S., and Meunier,B. (2005). Effect of inhibition of the bc\ complex on 
gene expression profile in yeast. J. Biol. Chem. 280, 29743-29749.
Boveris,A. and Cadenas,E. (1975). Mitochondrial production of superoxide anions and 
its relationship to the antimycin insensitive respiration. FEBS Lett. 54, 311-314.
Boveris,A., Cadenas,E., and Stoppani,A.O. (1976). Role of ubiquinone in the 
mitochondrial generation of hydrogen peroxide. Biochem. J. 156, 435-444.
Bratton,M., Mills,D., Castleden,C.K., Hosier,J., and Meunier,B. (2003). Disease-related 
mutations in cytochrome c oxidase studied in yeast and bacterial models. Eur. J. 
Biochem. 270, 1-9.
194
Reference list
Broadley,S.A., Demlow,C.M., and Fox,T.D. (2001). Peripheral mitochondrial inner 
membrane protein, Mss2p, required for export of the mitochondrially coded Cox2p C 
tail in Saccharomyces cerevisiae. Mol. Cell. Biol. 21, 7663-7672.
Brookes,P.S., Pinner,A., Ramachanran,A., Coward,L., Barnes,S., Kim,H., and Darley- 
Usmar,V.M. (2002). High throughput two-dimensional blue-native electrophoresis: a 
tool for functional proteomics of mitochondria and signaling complexes. Proteomics 2, 
969-977.
Brown,G.C. and Cooper,C.E. (1994). Nanomolar concentrations of nitric oxide 
reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome 
oxidase. FEBS Lett. 356, 295-298.
Brown,G.C. (1995a). Nitric oxide regulates mitochondrial respiration and cell functions 
by inhibiting cytochrome oxidase. FEBS Lett. 369, 136-139.
Brown,G.C. (1995b). Reversible binding and inhibition of catalase by nitric oxide. Eur. 
J. Biochem. 232, 188-191.
Brown,G.C., Foxwell,N., and Moncada,S. (1998). Transcellular regulation of cell 
respiration by nitric oxide generated by activated macrophages. FEBS Lett. 439, 321 - 
324.
Brown,N.G., Costanzo,M.C., and Fox,T.D. (1994). Interaction among three proteins 
that specifically activate translation of the mitochondrial COX3 mRNA in 
Saccharomyces cerevisiae. Mol. Cell. Biol. 14, 1045-1053.
Brown,S., Colson,A.-M., Meunier,B., and Rich,P.R. (1993). Rapid screening of 
cytochromes of respiratory mutants of Saccharomyces cerevisiae -  application to the 
selection of strains containing novel forms of cytochrome c oxidase. Eur. J. Biochem. 
213, 137-145.
195
Reference list
Butzer,U., Weidenbach,H., Gansauge,S., Gansauge,F., Beger,H.G., and Nussler,A.K. 
(1999). Increased oxidative stress in the RAW 264.7 macrophage cell line is partially 
mediated via the S-nitrosothiol-induced inhibition of glutathione reductase. FEBS Lett. 
445, 274-278.
Bykova,N.V., Egsgaard,H. and Moller,I.M. (2003). Identification of 14 new 
phosphoproteins involved in important plant mitochondrial processes. FEBS Lett. 540, 
141-146.
Cadenas,E., Boveris,A., Ragan,C.I., and Stoppani,A.O.M. (1977). Production of 
superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and 
ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. 
Biophys. 180,248-257.
Calder,K.M. and McEwen,J.E. (1990). Nucleotide sequence of the gene encoding 
cytochrome c oxidase subunit VII from Saccharomyces cerevisiae. Nucl. Acid. Res. 18, 
1632.
Carlson,C.G., Barrientos,A., Tzagoloff,A., and Glerum,D.M. (2003). COX16 encodes a 
novel protein required for the assembly of cytochrome oxidase in Saccharomyces 
cerevisiae. J. Biol. Chem. 278, 3770-3775.
Carr,H.S. and Winge,D.R. (2003). Assembly of cytochrome c oxidase within the 
mitochondrion. Acc. Chem. Res 36, 309-316.
Carr,H.S., Georges,G.N., and Winge,D.R. (2002). Yeast Coxl 1, a protein essential for 
cytochrome c oxidase assembly, is a Cu (I)-binding protein. J. Biol. Chem. 277, 31237- 
31242.
Cassina,A. and Radi,R. (1996). Differential inhibitory action of nitric oxide and 
peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 328, 309- 
316.
196
Reference list
Castro,L.A., Robalinho,R.L., Cayota,A., Meneghini,R., and Radi,R. (1998). Nitric oxide 
and peroxynitrite-dependent aconitase inactivation and iron-regulatory protein-1 
activation in mammalian fibroblasts. Arch . Biochem. Biophys. 359, 215-224.
Caughey,W.S., Smythe,G.A., O'Keeffe,D.H., Maskasky,J.E., and Smith,M.L. (1975). 
Heme A of cytochrome oxidase. Structure and properties: comparisons with hemes B,
C, and S and derivatives. J. Biol. Chem. 250, 7602-7622.
Causton,H.C., Ren,B., Koh,S.S., Harbison,C.T., Kanin,E., Jennings,E.G., Lee,T.I., 
True,H.L., Lander,E.S., and Young,R. A. (2001). Remodelling of yeast genome 
expression in response to environmental changes. Mol. Biol. Cell 12, 323-337.
Chacinska,A., Pfannschmidt,S., Wiedemann,N., Kozjak,V., Sanjuan Szklarz,L.K., 
Schulze-Specking A, Truscott KN, Guiard B, Meisinger C, and Pfanner N. (2004). 
Essential role of Mia40 in import and assembly of mitochondrial intermembrane space 
proteins. EMBO J. 23, 3735-3746.
Chae,H.Z., Chung,S.J., and Rhee,S.G. (1994). Thioredoxin-dependent peroxide 
reductase from yeast. J. Biol. Chem. 269, 27670-27678.
Chiang,K.T., Switzer,C.H., Akali,K.O., and Fukuto,J.M. (2000). The role of oxygen and 
reduced oxygen species in nitric oxide-mediated cytotoxicity: studies in yeast 
Saccharomyces cerevisiae model system. Toxicol. Appl. Pharmacol. 167, 30-36.
Chinenov,Y.V. (2004). Cytochrome c oxidase assembly factors with a thioredoxin fold 
are conserved among prokaryotes and eukaryotes. J. Mol. Med. 78, 239-242.
Church,C., Chapon,C., and Poyton,R.O. (1996). Cloning and characterization of 
PET100, a gene required for the assembly of yeast cytochrome c oxidase. J. Biol. Chem. 
271, 18499-18507.
Church,C., Goehring,B., Forsha,D., Wazny,P., and Poyton,R.O. (2005). A role for 
PetlOOp in the assembly of yeast cytochrome c oxidase. Interaction with a subassembly 
that accumulates in a petlOO mutant. J. Biol. Chem. 280, 1854-1863.
197
Reference list
Cleeter,M.W.J., Cooper,J.M., Darley-Usmar,V.M., Moncada,S., and Schapira,A.H.V. 
(1994). Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the 
mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative 
diseases. FEBS Lett. 345, 50-54.
Clementi,E., Brown,G.C., Feelisch,M., and Moncada,S. (1998). Persistent inhibition of 
cell respiration by nitric oxide. Proc. Natl. Acad. Sci. USA 95, 7631-7636.
Cohen,B.A., Pilpel,Y., Mitra,R.D., and Church,G.M. (2002). Discrimination between 
paralogs using microarray analysis: Application to the Yaplp and Yap2p transcription 
network. Mol Biol Cell. 13, 1608-1614.
Collinson,E.J. and Grant,C.M. (2003). Role of yeast glutaredoxins as glutathione S- 
transferases. J. Biol. Chem. 278, 22492-22497.
Collinson,E.J., Wheeler,G.L., Garrido,E.O., Avery,A.M., Avery,S.V., and Grant,C.M.
(2002). The yeast glutaredoxins are active as glutathione peroxidases. J. Biol. Chem. 
277, 16712-16717.
Conde,J. and Fink,G.R. (1976). A mutant of Saccharomyces cerevisae defective for 
nuclear fusion. Proc. Natl. Acad. Sci. USA 73, 3651-3655.
Cooper,C.E. (1999). Nitric oxide and iron proteins. Biochim. Biophys. Acta 1411, 290- 
309.
Costanzo,M.C. and Fox,T.D. (1986). Product of Saccharomyces cerevisiae nuclear gene 
PET494 activates translation of a specific mitochondrial mRNA. Mol Cell Biol. 6, 
3694-3703.
Costanzo,M.C., Seaver,E.C., and Fox,T.D. (1986). At least two nuclear gene products 
are specifically required for translation of a single yeast mitochondrial mRNA. EMBO 
J. 5, 3637-3641.
198
Reference list
Cruciat,C.-M., Brunner,S., Baumann,F., Neupert,W., and Stuart,R.A. (2000). The 
cytochrome bc\ and cytochrome c oxidase complexes associate to form a single 
supracomplex in yeast mitochondria. J. Biol. Chem. 275, 18093-18098.
Cumsky,M.G., Ko,C., Trueblood,C.E., and Poyton,R.O. (1985). Two nonidentical 
forms of subunit V are functional in yeast cytochrome c oxidase. Proc. Natl. Acad. Sci. 
USA 82, 2235-2239.
Das,T.K., Pecoraro,C., Tomson,F.L., Gennis,R.B., and Rousseau,D.L. (1998). The post- 
translational modification in cytochrome c oxidase is required to establish a functional 
environment of the catalytic site. Biochemistry 37, 14471-14476.
De Freitas,J.M., Liba,A., Meneghini,R., Valentine,J.S., and Gralla,E.B. (2000). Yeast 
lacking Cu-Zn superoxide dismutase show altered iron homeostasis. Role of oxidative 
stress in iron metabolism. J. Biol. Chem. 275, 11645-11649.
De Groote,M.A., Ochsner,U.A., Shiloh,M.U., Nathan,C., McCord,J.M., Dinaeur,M.C., 
Libby,S.J., Vazquez-Torres,A., Xu,Y., and Fang,F.C. (1997). Periplasmic superoxide 
dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric 
oxide synthase. Proc. Natl. Acad. Sci. USA 94, 13997-14001.
Dedon,P.C. and Tannenbaum,S.R. (2004). Reactive nitrogen species in the chemical 
biology of inflammation. Arch. Biochem. Biophys. 423, 12-22.
Delneri,D., Gardner,D.C.J., and Oliver,S.G. (1999a). Analysis of the seven-member 
AAD gene set demonstrates that genetic redundancy in yeast may be more apparent 
than real. Genetics 153, 1591-1600.
Delneri,D., Gardner,D.C.J., Bruschi,C.V., and Oliver,S.G. (1999b). Disruption of seven 
hypothetical aryl alcohol dehydrogenase genes from Saccharomyces cerevisae and 
construction of a multiple knock-out strain. Yeast 15, 1681-1689.
Denninger,J.W. and Marietta,M.A. (1999). Guanylate cyclase and the NO/cGMP 
signaling pathway. Biochim. Biophys. Acta 1411, 334-350.
199
Reference list
DeRisi,J.L., Lyer,V.R., and Brown,P.O. (1997). Exploring the metabolic and genetic 
control of gene expression on a genomic scale. Science 278, 680-686.
Dickinson,E.K., Adams,D.L., SchonJE., and Glerum,D.M. (2000). A human SC02 
mutation helps define the role of Scolp in the cytochrome oxidase assembly pathway. J. 
Biol. Chem. 275, 26780-26785.
Dimmeler,S., Lottspeich,F., and Brune,B. (1992). Nitric oxide causes ADP-ribosylation 
and inhibition of glyceraldehyde-3- phosphate dehydrogenase. J. Biol. Chem. 267, 
16771-16774.
Dowhan,W., Bibus,C.R., and Schatz,G. (1985). The cytoplasmically-made subunit IV is 
necessary for assembly of cytochrome c oxidase in yeast. EMBO J. 4, 179-184.
Drapier,J.-C. and Hibbs,J.B. (1986). Murine cytotoxic activated macrophages inhibit 
aconitase in tumor cells. J. Clin. Invest. 78, 790-797.
Elfstrom,L.T. and Widersten,M. (2005). The Saccharomyces cerevisiae ORF YNR064c 
protein has characteristics of an 'orphaned' epoxide hydrolase. Biochim. Biophys. Acta 
1748, 213-221.
Epstein,C.B., Waddle,J.A., Hale IV,W., Dave,V., Thornton,J., Macatee,T.L.,
Gamer,H.R., and Butow,R.A. (2001). Genome-wide responses to mitochondrial 
dysfunction. Mol. Biol. Cell 12, 297-308.
Estruch,F. and Carlson,M. (1993). Two homologous zinc finger genes identified by 
multicopy suppression in a SNF1 protein kinase mutant of Saccharomyces cerevisiae. 
Mol Cell Biol. 13, 3872-3881.
Funes,S., Nargang,F.E., Neupert,W., and Herrmann,J.M. (2004). The Oxa2 protein of 
Neurospora crassa plays a critical role in the biogenesis of cytochrome oxidase and 
defines a ubiquitous subbranch of the Oxal/YidC/Alb3 protein family. Mol. Biol. Cell 
15, 1853-1861.
200
Reference list
Fytlovich,S., Gervais,M., Agrimonti,C., and Guiard,B. (1993). Evidence for an 
interaction between the CYP1 (HAP1) activator and a cellular factor during heme- 
dependent transcriptional regulation in the yeast Saccharomyces cerevisiae. EMBO J. 
72, 1209-1218.
Gardner,P.R., Costantino,G., Szabo,C., and Salzman,A.L. (1997). Nitric oxide 
sensitivity of the aconitases. J. Biol. Chem. 272, 25071-25076.
Gardner,P.R., Gardner,A.M., Martin,L.A., Dou,Y., Li,T., Olson,J.S., Zhu,H., and 
Riggs,A.F. (2000). Nitric-oxide dioxygenase activity and function of flavohemoglobins. 
Sensitivity to nitric oxide and carbon monoxide inhibition. J. Biol. Chem. 275, 31581- 
31587.
Gasch,A.P., Spellman,P.T., Kao,C.M., Carmel-Harel,0., Eisen,M.B., Storz,G., 
Botstein,D., and Brown,P.O. (2000). Genomic expression programs in the response of 
yeast cells to environmental changes. Mol. Biol. Cell 11, 4241-4257.
Geng,Y., Hansson,G.K., and Holme,E. (1992). Interferon-gamma and tumor necrosis 
factor synergize to induce nitric oxide production and inhibit mitochondrial respiration 
in vascular smooth muscle cells. Circ. Res. 71, 1268-1276.
Ghafourifar,P. and Richter,C. (1997). Nitric oxide synthase activity in mitochondria. 
FEBS Lett. 418, 291-296.
Gietz,R.D. and Woods,R.A. (2002). Transformation of yeast by lithuim acetate/single 
stranded carrier DNA/polyethylene glycol method. Methods Enzymol. 350, 87-96.
Glerum,D.M., Koemer,T.J., and Tzagoloff,A. (1995). Cloning and characterization of 
COX14, whose product is required for assembly of yeast cytochrome oxidase. J. Biol. 
Chem. 270, 15585-15590.
Glerum,D.M., Shtanko,A., and Tzagoloff,A. (1996a). Characterization of COX 17, a 
yeast gene involved in copper metabolism and assembly of cytochrome oxidase. J. Biol. 
Chem. 277, 14504-14509.
201
Reference list
Glerum,D.M., Shtanko,A., and Tzagoloff,A. (1996b). SC01 and SC02 act as high copy 
suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae.
J. Biol. Chem. 277, 20531-20535.
Glerum,D.M. and Tzagoloff,A. (1997). Submitochondrial distributions and stabilities of 
subunits 4, 5 and 6 of yeast cytochrome oxidase in assembly defective mutants. FEBS 
Lett. 412, 410-414.
Gou,H., Wei,J., and Kuo,P.C. (2001). Nitric oxide inhibits expression of cytochrome b 
in endotoxin-stimultaed murine macrophages. Biochem. Biophys. Res. Comm. 289, 
993-997.
Griffin,T.J., Gygi,S.P., Ideker,T., Rist,B., Eng,J., Hood,L., and Aebersold,R. (2002). 
Complementary profiling of gene expression at the transcriptome and proteome levels 
in Saccharomyces cerevisiae. Mol. Cell Proteom. 1, 323-333.
Groot Koerkamp,M., Rep,M., Bussemaker,H.J., Hardy,G.P.M.A., Mul,A., Piekarska,K., 
Al-Khalili Szigyarto,C., Teixeira de Mattos,J.M., and Tabak,H.F. (2002). Dissection of 
transient oxidation stress response in Saccharomyces cerevisiae by using DNA 
microarrays. Mol. Biol. Cell 13, 2783-2794.
Gross,W.L., Bak,M.I., Ingwall,J.S., Arstall,M.A., Smith,T.W., Balligand,J.L., and 
Kelly,R.A. (1996). Nitric oxide inhibits creatine kinase and regulates rat heart 
contractile reserve. Proc. Natl. Acad. Sci. USA 93, 5604-5609.
Guarente,L. and Ptashne,M. (1981). Fusion of Escherichia coli LacZ to the cytochrome 
c gene of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 78, 2199-2203.
Guelin,E., Rep,M., and Grivell,L.A. (1996). Afg3p, a mitochondrial ATP-dependent 
metalloprotease, is involved in degradation of mitochondrially-encoded Coxl, Cox3, 
Cob, Sub6, Sub8 and Sub9 subunits of the inner membrane complexes III, IV and V. 
FEBS Lett. 381, 42-46.
Gygi,S.P., Rochon,Y., Franza,B.R., and Aebersold,R. (1999). Correlation between 
protein and mRNA abundance in yeast. Mol Cell Biol. 19, 1720-1730.
2 0 2
Reference list
Hagen,T., Taylor,C.T., Lam,F., and Moncada,S. (2003). Redistribution of intracellular 
oxygen in hypoxia by nitric oxide: effect on HIFla. Science 302, 1975-1978.
Haltia,T., Finel,M., Harms,N., Nakari,T., Raitio,M., Wikstrom,M., and Saraste,M. 
(1989). Deletion of the gene for subunit III leads to defective assembly of bacterial 
cytochrome oxidase. EMBO J. 8, 3571-3579.
Hamel,P., Lemaire,C., Bonnefoy,N., Brivet-Chevillotte,P., and Dujardin,G. (1998). 
Mutations in the membrane anchor of yeast cytochrome c\ compensate for the absence 
of Oxalp and generate carbonate-extractable forms of cytochrome c\. Genetics 150, 
601-611.
Hanke,C.J., Drewett,J.G., Myers,C.R., and Campbell,W.B. (1998). Nitric oxide inhibits 
aldosterone synthesis by a guanylyl cyclase-independent effect. Endocrinology 139, 
4053-4060.
Harris,N., Costa,V., MacLean,M., Mollapour,M., Morades-Ferreira,P., and Piper,P. 
(2003). MnSOD overexpression extends the yeast chronological (Go) life span but acts 
independently of Sir2p histone deacetylase to shorten the replicative life span of 
dividing cells. Free Rad. Biol. Med. 34, 1599-1606.
Harris,N., Bachler,M., Costa,V., Moradas-Ferreira,P., and Piper,P.W. (2005). 
Overexpressed Sodlp acts either to reduce or to increase the lifespans and stress 
resistance of yeast, depending on whether it is Cu2+-deficient or an active Cu,Zn- 
superoxide dismutatse. Aging Cell 4, 41-52.
Hausladen,A. and Fridovich,I. (1994). Superoxide and peroxynitrite inactivate 
aconitases, but nitric oxide does not. J. Biol. Chem. 269, 29405-29408.
Hausladen,A., Gow,A.J., and Stamler,J.S. (1998). Nitrosative stress: Metabolic pathway 
involving the flavohemoglobin. Proc. Natl. Acad. Sci. USA 95, 14100-14105.
He,S. and Fox,T.D. (1997). Membrane translocation of mitochondrially coded Cox2p: 
Distinct requirements for export of N and C termini and dependence on the conserved 
protein Oxalp. Mol. Biol. Cell 8, 1449-1460.
203
Reference list
He,S. and Fox,T.D. (1999). Mutations affecting a yeast mitochondrial inner membrane 
preotein, Pntlp, block export of a mitochondrially synthesised fusion protein from the 
matrix. Mol. Cell. Biol. 19, 6598-6607.
Heales,S.J., Bolanos,J.P., Land,J.M., and Clark,J.B. (1994). Trolox protects 
mitochondrial complex IV from nitric oxide-mediated damage in astrocytes. Brain Res. 
668, 243-245.
Heaton,D.N., George,G.N., Garrison,G., and Winge,D.R. (2001). The mitochondrial 
copper metallochaperone Cox 17 exists as an oligomeric, polycopper complex. 
Biochemistry 40, 743-751.
Hell,K., Herrmann,J., Pratje,E., Neupert,W., and Stuart,R.A. (1997). Oxalp mediates 
the export of the N- and C-termini of pCoxII from the mitochondrial matrix to the 
intermembrane space. FEBS Lett. 418, 367-370.
Hell,K., Herrmann,J.M., Pratje,E., Neupert,W., and Stuart,R.A. (1998). Oxalp, an 
essential component of the N-tail protein export machinery in mitochondria 
Proc. Natl. Acad. Sci. USA 95, 2250-2255.
Hell,K., Tzagoloff,A., Neupert,W., and Stuart,R.A. (2000). Identification of Cox20p, a 
novel protein involved in the maturation and assembly of cytochrome oxidase subunit 2. 
J. Biol. Chem. 275, 4571-4578.
Hell,K., Neupert,W., and Stuart,R.A. (2001). Oxalp acts as a general membrane 
insertion machinery for proteins encoded by mitochondrial DNA. EMBO J. 20, 1281 - 
1288.
Henry,Y., Lepoivre,M., Drapier,J.C., Ducrocq,C., Boucher,J.L., and Guissani,A. (1993). 
EPR characterisation of molecular targets for NO in mammalian cells and organelles. 
FASEB J. 7, 1124-1134.
Herrmann,J.M. and Bonnefoy,N. (2004). Protein export across the inner membrane of 
mitochondria: The nature of translocated domains determines the dependence on the 
Oxal translocase. J. Biol. Chem. 279, 2507-2512.
204
Reference list
Hess,D.T., Matsumoto,A., Kim,S.-0., Marshall,H.E., and Stamler,J.S. (2005). Protein 
S-nitrosylation: Purview and parameters. Nature Rev. Mol. Cell Biol. 6, 150-166.
Hibbs,J.B., Jr., Vavrin,Z., and Taintor,R.R. (1987). L-arginine is required for expression 
of the activated macrophage effector mechanism causing selective metabolic inhibition 
in target cells. J. Immunol. 138, 550-565.
Hiltunen,J.K., Mursula,A.M., Rottensteiner,H., Wierenga,R.K., Kastaniotis,A.J., and 
Gurvitz,A. (2003). The biochemistry of peroxisomal 13-oxidation in the yeast 
Saccharomyces cerevisiae. FEMS Microbiol. Rev. 27, 35-64.
Hiser,L., Di Valentin,M., Hamer,A.G., and Hosier,J.P. (2000). Coxl lp is required for 
stable formation of the Cub and magnesium centers of cytochrome c oxidase. J. Biol. 
Chem. 275, 619-623.
Hiser,L. and Hosier, J.P. (2002). Heme A is not essential for assembly of the subunits of 
cytochrome c oxidase of Rhodobacter sphaeroides. J. Biol. Chem. 276, 45403-45407.
Hon,T., Dodd,A., Dirmeier,R., Gorman,N., Sinclair,P.R., Zhang,L., and Poyton,R.O.
(2003). A mechanism of oxygen sensing in yeast. Multiple oxygen-responsive steps in 
the heme biosynthetic pathway affect Hapl activity. J. Biol. Chem. 278, 50771-50780.
Hon,T., Lee,H.C., Hach,A., Johnson,J.L., Craig,E.A., Erdjument-Bromage,H., 
Tempst,P., and Zhang,L. (2001). The Hsp70-Ydjl molecular chaperone represses the 
activity of the heme activator protein Hapl in the absence of heme. Mol. Cell Biol. 21 
7923-7932.
Hopper,R.K., Carroll,S., Aponte,A.M., Johnson,D.T., French,S., Shen,R.-F., 
Witzmann,F.A., Harris.,R.A., and Balaban,R.S. (2006). Biochemistry 45, 2524-2536.
Homg,Y.C., Cobine,P.A., Maxfield,A.B., Carr,H.S., and Winge,D.R. (2004). Specific 
copper transfer from the Cox 17 metallochaperone to both Scol and Coxl 1 in the 
assembly of yeast cytochrome c oxidase. J. Biol. Chem. 279, 35334-35340
205
Reference list
Hrabie,J.A. and Klose,J.R. (1993). New nitric oxide-releasing zwitterions derived from 
polyamines. J. Org. Chem. 58, 1472-1476.
Hromatka,B.S., Noble,S.M., and Johnson,A.D. (2005). Transcriptional response of 
Candida albicans to nitric oxide and the role of the YHB1 gene in nitrosative stress and 
virulence. Mol. Biol. Cell. 16, 4814-4826.
Huang,L.E., Arany,Z., Livingston,D.M., and Bunn,H.F. (1996). Activation of hypoxia- 
inducible transcription factor depends primarily on redox-sensitive stabilisation of its a- 
subunit. J Biol. Chem. 271, 32253-32259.
Ignarro,L.J., Buga,G.M., Wood,K.S., Byms,R.E., and Chaudhuri,G. (1987). 
Endothelium-derived relaxing factor produced and released from artery and vein is 
nitric oxide. Proc. Natl. Acad. Sci. USA 84, 9265-9269.
Inoue,Y., Matsuda,T., Sugiyama,K., Izawa,S., and Kimura,A. (1999). Genetic analysis 
of glutathione peroxidase in oxidative stress response of Saccharomyces cerevisiae. J. 
Biol. Chem. 274, 27002-27009.
Ischiropoulos,H. (1998). Biological tyrosine nitration: A pathophysiological function of 
nitric oxide and reactive oxygen species. Arch . Biochem. Biophys. 356, 1-11.
Ivan,M., Kondo,K., Yang,H., Kim,W., Valiando,J., Ohh,M., Salic,A., Asara,J.M., 
Lane,W.S., and Kaelin Jr, W.G. (2001). HIFalpha targeted for VHL-mediated 
destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464- 
468.
Iwata,S., Ostermeier,C., Ludwig,B., and Michel,H. (1995). Structure at 2.8 A resolution 
of cytochrome c oxidase from Paracoccus denitrificans. Nature 376, 660-669.
Jaakkola,P., Mole,D.R.,Tian,Y.M., Wilson,M.I., Gielbert,J., Gaskell,S.J., 
Kriegsheim,AV.,Hebestreit,H.F., Mukherji,M., Schofield,C.J., Maxwell,P.H., 
Pugh,C.W., and Ratcliffe,P.J. (2001). Targeting of HIF-alpha to the von Hippel-Lindau 
ubiquitylation complex by Ch-regulated prolyl hydroxylation. Science 292, 468-472.
206
Reference list
Jaksch,M., Paret,C., Stucka,R., Hom,N., Muller-Hocker,J., Horvath,R., Trepesch,N., 
Stecker,G., Freisinger,P., Thirion,C., Muller,J., Lunkwitz,R., Rodel,G.,
Jakubowski,W., Bilinski,T., and Bartosz,G. (1999). Sensitivity of antioxidant-deficient 
yeast Saccharomyces cerevisae to peroxynitrite and nitric oxide. Biochim. Biophys. 
Acta 1472, 395-398.
Jelinsky,S.A. and Samson,L.D. (1999). Global response of Saccharomyces cerevisiae to 
an alkylating agent. Proc. Natl. Acad. Sci. USA 96, 1486-1491.
Kadenbach,B., Napiwotzki,J., Frank,V., Arnold,S., Exner,S., and Hiittemann,M. (1998). 
Regulation of energy transduction and electron transfer in cytochrome c oxidise by 
adenine nucleotides. J. Bioenerg. Biomemb. 30, 25-34.
Khalimonchuk,0., Ostermann,K., and Rodel,G. (2005). Evidence for the association of 
yeast mitochondrial ribosomes with Coxl lp, a protein required for the Cub site 
formation of cytochrome c oxidase. Curr. Genet. 47, 223-233.
Kim,S.O., Orii,Y., Lloyd,D., Hughes,M.N., and Poole,R.K. (1999). Anoxic function for 
the Escherichia coli flavohaemoglobin (Hmp): Reversible binding of nitric oxide and 
reduction to nitrous oxide. FEBS Lett. 445, 389-394.
King,P.A., Anderson,V.E., Edwards,J.O., Gustafson,G., Plumb,R.C., and Suggs,J.W. 
(1992). A stable solid that generates hydroxyl radical upon dissolution in aqueous 
solutions: Reaction with proteins and nucleic acid. J. Am. Chem. Soc 114, 5430-5432.
Kirichenko,A., Vygodina,T., Mkrtchyan,M., and Konstantinov,A. (1998). Specific 
cation binding site in mammalian cytochrome oxidase. FEBS Lett. 423, 329-333.
Klebanoff,S.J. (1971). Intraleukocytic microbicidal defects. Ann. Rev. Med. 22, 39-62.
Kloeckener-Gruissem,B., McEwen,J.E., and Poyton,R.O. (1988). Identification of a 
third nuclear protein-coding gene required specifically for posttranscriptional expression 
of the mitochondrial COX3 gene in Saccharomyces cerevisiae. J. Bacteriol. 130, 1399- 
1402.
207
Reference list
Knight,A.W., Goddard,N.J., Fielden,P.R., Barker,M.G., Billinton,N., and 
Walmsley,R.M. (1999). Fluorescence polarisation of green fluorescent protein (GFP). A 
strategy for improved wavelength discrimination for GFP determinations. Anal. 
Commun. 36, 113-117.
Konorev,E.A., Hogg,N., and Kalyanaraman,B. (1998). Rapid and irreversible inhibition 
of creatine kinase by peroxynitrite. FEBS Lett. 427, 171-174.
Krems,B., Charizanis,C., and Entian,K.D. (1996). The response regulator-like protein 
Pos9/Skn7 of Saccharomyces cerevisiae is involved in oxidative stress resistance.
Curr. Genet. 29, 327-334.
Kronke,K.D., Fehsel,K., Schmidt,T., Zenke,F.T., Dasting,I., Wesener,J.R., 
Bettermann,H., Breunig,K.D., and Kolb-Bachofen,V. (1994). Nitric oxide destroys zinc- 
sulfur clusters including zinc release from metallothoinein and inhibition of the zinc 
finger-type yeast transcription activator LAC9. Biochim. Biophys. Res. Comm. 200, 
1105-1110.
Krummeck,G. and Rodel,G. (1990). Yeast SCOl protein is required for a post- 
translational step in the accumulation of mitochondrial cytochrome c oxidase subunits I 
and II. Curr. Genet. 18, 13-15.
Kuge,S., Jones,N., and Nomoto,A. (1997). Regulation of yAP-1 nuclear localization in 
response to oxidative stress. EMBO J. 16, 1710-1720.
Kwon,M., Chong,S., Han,S., and Kim,K. (2003). Oxidative stresses elevate the 
expression of cytochrome c peroxidase in Saccharomyces cerevisiae. Biochim. Biophys. 
Acta 1623, 1-5.
Kwon,N.S., Stuehr,D.J., and Nathan,C.F. (1991). Inhibition of tumor cell ribonucleotide 
reductase by macrophage-derived nitric oxide. J. Exp. Med. 174, 761-767.
Lagunas,R. (1986). Misconceptions about the energy metabolism of Saccharomyces 
cerevisiae. Yeast 2, 211-228.
208
Reference list
LaMarche,A.E.P., Abate,M.I., Chan,S.H.P., and Trumpower,B.L. (1992). Isolation and 
characterization of COX 12, the nuclear gene for a previously unrecognized subunit of 
Saccharomyces cerevisiae cytochrome c oxidase. J. Biol. Chem. 2(57, 22473-22480.
Lancaster, J.R., Jr. (1994). Simulation of the diffusion and reaction of endogeneously 
produced nitric oxide. Proc. Natl. Acad. Sci. 91, 8137-8141.
Lane,T.E., Otero,G.C., Wu-Hsieh,B.A., and Howard,D.H. (1994). Expression of 
inducible nitric oxide synthase by stimulated macrophages correlates with their 
antihistoplasma activity. Infect. Immun. 62 1478-1479.
Lappalainen,P., Watmough,N.J., Greenwood,C., and Saraste,M. (1995). Electron 
transfer between cytochrome c and the isolated CuA domain: Identification of substrate- 
binding residues in cytochrome c oxidase. Biochemistry 34, 5824-5830.
Leary,S.C., Hill,B.C., Lyons,C.N., Carlson,C.G., Michaud,D., Kraft,C.S., Ko,K., 
Glerum,D.M., and Moyes,C.D. (2002). Chronic treatment with azide in situ leads to an 
irreversible loss of cytochrome c oxidase activity via holoenzyme dissociation. J. Biol. 
Chem. 277, 11321-11328.
Lee,J., Godon,C., Lagniel,G., Spector,D., Garin,J., Labarre,J., and Toledano,M.B.
(1999). Yapl and Skn7 control two specialized oxidative stress response regulons in 
Yeast. J. Biol. Chem. 274, 16040-16046.
Leeuwenburgh,C., Hardy,M.M., Hazen,S.L., Wagner,P., Oh-ishi,S., Steinbrecher,U.P., 
and Heinecke,J.W. (1997). Reactive nitrogen intermediates promote low density 
lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272, 1433-1436.
Lehrer-Graiwer,J., Firestein,B.L., and Bredt,D.L. (2000). Nitric oxide mediated 
induction of cytochrome c oxidase mRNA and protein in a mouse macrophage cell line. 
Neurosci. Lett. 288, 107-110.
Lemaire,C., Robineau,S., and Netter,P. (1998). Molecular and biochemical analysis of 
Saccharomyces cerevisiae coxl mutants. Current Genetics 34, 138-145.
209
Reference list
Lemaire,C., Hamel,P., Velours,J., and Dujardin,G. (2000). Absence of the 
mitochondrial AAA protease Ymelp restores F0-ATPase subunit accumulation in an 
oxal deletion mutant of Saccharomyces cerevisiae. J. Biol. Chem. 275, 23471-23475.
Lemaire,G., Alvarez-Pachon,F.-J., Beuneu,C., Lepoivre,M., and Petit,J.-F. (1999). 
Differential cytostatic effects of NO donors and NO producing cells. Free Rad. Biol, 
and Med. 26, 1274-1283.
Leonhard,K., Stiegler,A., Neupert,W., and Langer,T. (1999). Chaperone-like activity of 
the AAA domain of the yeast AAA Ymel AAA protease. Nature 398, 348-351.
Leonhard,K., Guiard,B., Pellecchia,G., Tzagoloff,A., Neupert,W., and Langer,T.
(2000). Membrane protein degradation by AAA proteases in mitochondria: Extraction 
of substrates from either membrane surface. Mol. Cell 5, 629-638.
Lepoivre,M., Flaman,J.M., Bobe,P., Lemaire,G., and Henry,Y. (1994). Quenching of 
the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to 
cytostasis induced in tumor cells by cytotoxic macrophages. J. Biol. Chem. 269, 21891- 
21897.
Li,L., Chen,O.S., Ward,D.M., and Kaplan,J. (2001). CCC1 is a transporter that mediates 
vacuolar iron storage in yeast. J. Biol. Chem. 276, 29515-29519.
Li,Z.-S., Szczypka,M., Lu,Y.-P., Thiele,D.J., and Rea,P.A. (1996). The yeast cadmium 
factor protein (YCF1) is a vacuolar glutathione S-conjugate pump. J. Biol. Chem. 271, 
6509-6517.
Lightowlers,R., Chrzanowska-Lightowlers,Z., Marusich,M., and Capaldi,R.A. (1991). 
Subunit function in eukaryote cytochrome c oxidase. A mutation in the nuclear-coded 
subunit IV allows assembly but alters the function and stability of yeast cytochrome c 
oxidase. J. Biol. Chem. 266, 7688-7693.
Liu,L., Zeng,M., Hausladen,A., Heitman,J., and Stamler,J.S. (2000). Protection from 
nitrosative stress by yeast flavohemoglobin. Proc. Natl. Acad. Sci. USA 97, 4672-4676.
2 1 0
Reference list
Liu,X., Miller,M.J.S., Joshi,M.S., Thomas,D.D., and Lancaster,J.R. (1998). Accelerated 
reaction of nitric oxide with O2 within the hydrophobic interior of biological 
membranes. Proc. Natl. Acad. Sci. USA 95, 2175-2179.
Liu,Y., Fiskum,G., and Schubert,D. (2002). Generation of reactive oxygen species by 
the mitochondrial electron transport chain. J. Neurochem. 80, 780-787.
Liu,Y.C., Sowdal,L.H., and Robinson,N.C. (1995). Separation and quantitation of 
cytochrome c oxidase subunits by mono-Q fast protein liquid chromatography and C l8 
reverse- phase high-performance liquid chromatography. Arch. Biochem. Biophys. 324, 
135-142.
Livak,K.J. and Schmittgen,T.D. (2001). Analysis of relative gene expression data using 
real-time quantitative PCR and the 2-A ACT method. Methods 25, 402-408.
Lode,A., Kuschel,M., Paret,C., and Rodel,G. (2000). Mitochondrial copper metabolism 
in yeast: Interaction between Scolp and Cox2p. FEBS Lett. 485, 19-24.
Lode, A., Paret,C., and Rodel,G. (2002). Molecular characterization of Saccharomyces 
cerevisiae Sco2p reveals a high degree of redundancy with Scolp. Yeast 19, 909-922.
Longo,V.D., Gralla,E.B., and Valentine,J.S. (1996). Superoxide dismutase activity is 
essential for stationary phase survival in Saccharomyces cerevisiae. J. Biol. Chem. 271, 
12275-12280.
Lovchik,J.A., Lyons,C.R., and Lipscomb,M.F. (1995). A role for gamma interferon- 
induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. 
Respir. Cell Mol. Biol. 13, 116-124.
Lupetti,A., Danesi,R., Campa,M., Tacca,M.D., and Kelly,S. (2002). Molecular basis of 
resistance to azole antifungals. Trends Mol. Med. 8, 76-81.
MacMicking,J., Xie,Q.W., and Nathan,C. (1997). Nitric oxide and macrophage 
function. Ann. Rev. Immunol. 15, 323-350.
211
Reference list
Maneg,0., Malatesta,F., Ludwig,B., and Drosou,V. (2004). Interaction of cytochrome c 
with cytochrome oxidase: two different docking scenarios. Biochim. Biophys. Acta 
1655, 274-281.
Manthey,G.M. and McEwan,J.E. (1995). The product of the nuclear gene PET309 is 
required for translation of mature mRNA and stability of production of intron- 
containing RNAs derived from the mitochondrial COX1 locus of Saccharomyces 
cerevisiae. EMBO J. 14, 4031-4043.
Marietta,M.A., Yoon,P.S., Iyengar,R., Leaf,C.D., and Wishnok,J.S. (1988). 
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an 
intermediate. Biochemistry 27, 8706-8711.
Martinez-Pastor,M.T., Marchler,G., Schuller,C., Marchler-Bauer,A., Ruis,H., and 
Estruch,F. (1996). The Saccharomyces cerevisiae zinc finger proteins Msn2p and 
Msn4p are required for transcriptional induction through the stress response element 
(STRE). EMBO J. 15, 2227-2235.
Mastroeni,P., Vazquez-Torres,A., Fang,F.C., Xu,Y., Khan,S., Hormaeche,C.E., and 
Dougan,G. (2000). Antimicrobial actions of the NADPH phagocyte oxidase and 
inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial 
proliferation and host survival in vivo. J. Exp. Med. 192, 237-248.
Mateo,J., Garcia-Lecea,M., Cadenas,S., Hernandez,C., and Moncada,S. (2003). 
Biochem. J. 376 537-544.
Matsumoto,A., Comatas,K.E., Liu,L., and Stamler,J.S. (2003). Screening for nitric 
oxide-dependent protein-protein interactions. Science 301, 657-661.
Maxfield,A.B., Heaton,D.N., and Winge,D.R. (2004). C oxl7 is functional when 
tethered to the mitochondrial inner membrane. J. Biol. Chem. 279, 5072-5080.
McCartney-Francis,N., Allen,J.B., Mizel,D.E., Albina,J.E., Xie,Q.W., Nathan,C.F., and 
Wahl,S.M. (1993). Suppression of arthritis by an inhibitor of nitric oxide synthase. J. 
Exp. Med. 178, 749-754.
2 1 2
Reference list
McEwan,J.E., Cumsky,M.G., Ko,C., Power,S.D., and Poyton,R.O. (2004). 
Mitochondrial membrane biogenesis: characterisation and use of pet mutants to clone 
the nuclear gene coding for subunit V of yeast cytochrome c oxidase. J. Cell Biochem. 
2 4 ,229-242.
McEwen,J.E., Hong,K.H., Park,S., and Preciado,G.T. (1993). Sequence and 
chromosomal localization of two PET  genes required for cytochrome c oxidase 
assembly in Saccharomyces cerevisiae. Curr. Genet. 23, 9-14.
McFarland,R., Taylor,R.W., ChinneryJP.F., Howell,N., and Turnbull,D.M. (2004). A 
novel sporadic mutation in cytochrome c oxidase subunit II as a cause of 
rhabdomyolysis. Neuromusc. Disord. 14 162-166.
McHale,M.W., Kroening,K.D., and Bemlohr,D.A. (1996). Identification of a class of 
Saccharomyces cerevisiae mutants defective in fatty acid repression of gene 
transcription and analysis of the frm2 gene. Yeast 12, 319-331.
Meister,A. (1988). Glutathione metabolism and its selective modification. J. Biol. 
Chem. 263, 17205-17208.
Meunier,B., Lemarre,P., and Colson,A.M. (1993). Genetic screening in Saccharomyces 
cerevisiae for large numbers of mitochondrial point mutations which affect structure 
and function of catalytic subunits of cytochrome-c oxidase. Eur. J. Biochem. 213, 129- 
135.
Meunier,B. and Rich,P.R. (1998). Quantitation and characterisation of cytochrome c 
oxidase in complex systems. Anal. Biochem. 260, 237-243.
Meunier,B. and Rich,P.R. (1998). Second-site reversion analysis is not a reliable 
method to determine distance in membrane proteins: an assessment using mutations in 
yeast cytochrome c oxidase subunits I and III. J. Mol. Biol. 283, 727-730.
Meunier,B. (2001). Site-direct mutations in the mitochondrially-encoded subunits I and 
III of yeast cytochrome oxidase. Biochem. J. 354, 407-412.
213
Reference list
Meunier,B. and Taanman,J.-W. (2002). Mutations of cytochrome c oxidase subunits 1 
and 3 in Saccharomyces cerevisiae: Assembly defect and compensation. Biochim. 
Biophys. Acta 1554, 101-107.
Michel,H., Behr,J., Harrenga,A. and Knnt,A. (1998). Cytochrome c oxidase: structure 
and spectroscopy. Ann. Rev. Biophys. Biomol. Struct. 27, 329-356.
Miller,B.R. and Cumsky,M.G. (1993). Intramitochondrial sorting of the precursor to 
yeast cytochrome c oxidase subunit Va. J. Cell. Biol. 727, 1021-1029.
Minamiyama,Y., Takemura,S., Imaoka,S., Funae,Y., Tanimoto,Y., and Inoue,M.
(1997). Irreversible inhibition of cytochrome P450 by nitric oxide. J. Pharmacol. Exp. 
Ther. 283, 1479-1485.
Mitchell,P., and Moyle,J. (1967). Chemiosmotic hypothesis of oxidative 
phosphorylation. Nature 272, 137-139.
Moncada,S., Palmer,R.M.J., and Higgs,E.A. (1991). Nitric oxide: physiology, 
pathophysiology, and pharmacology. Pharmac. Rev. 43, 109-142.
Moncada,S. and Erusalimsky,J.D. (2002). Does nitric oxide modulate mitochondrial 
energy generation and apoptosis? Nature Rev. Mol. Cell Biol. 3, 214-220.
Moradas-Ferreira,P., Costa,V., Piper,P.W., and Mager,W. (1996). The molecular 
defences against reactive oxygen species in yeast. Mol. Microbiol. 79, 651-658.
Moreno,J.J. and Pryor,W.A. (1992). Inactivation of al-proteinase inhibitor by 
peroxynitrite. Chem. Res. Toxicol. 5, 425-431.
Morgan,B.A., Banks,G.R., Toone,W.M., Raitt,D., Kuge,S., and Johnston,L.H. (1997). 
The Skn7 response regulator controls gene expression in the oxidative stress response of 
the budding yeast Saccharomyces cerevisiae. EMBO J. 76, 1035-1044.
214
Reference list
Morgan,E.T., Ullrich,V., Daiber,A., Schmidt,P., Takaya,N., Shoun,H., McGiff,J.C., 
Okeyan,A., Hanke,C.J., Campbell,W.B., Park,C.-S., Kang,J.-S., Yi,H.-G., Cha,Y.-N., 
Mansuy,D., and Boucher,J.-L. (2001). Cytochromes P450 and flavin monooxygenases - 
targets and sources of nitric oxide. Drug Metab. Dispos. 29, 1366-1376.
Mukhopadhyay,R. and Rosen,B.P. (1998). Saccharomyces cerevisiae ACR2 gene 
encodes an arsenate reductase. FEMS Microbiol. Lett. 168, 127-136.
Mulero,J.J. and Fox,T.D. (1993). Alteration of Saccharomyces cerevisiae COX2 mRNA 
5'-untranslated leader by mitochondrial gene replacement and functional interaction 
with the translational activator protein PET111. Mol. Biol. Cell. 4, 1327-1335.
Naithani,S., Saracco,S.A., Butler,C.A., and Fox,T.D. (2003). Interactions among COX1, 
COX2, and COX3 mRNA-specific translational activator proteins on the inner surface 
of the mitochondrial inner membrane of Saccharomyces cerevisiae. Mol. Biol. Cell 14, 
324-333.
Nakai,T., Yasuhara,T., Fujiki,Y., and Ohashi,A. (1995). Multiple genes, including a 
member of the AAA family, are essential for degradation of unassembled subunit 2 of 
cytochrome c oxidase in yeast mitochondria. Mol. Cell. Biol. 15, 4441-4452.
Nathan,C.F. and Root,R.K. (1977). Hydrogen peroxide release from mouse peritoneal 
macrophages. J. Exp. Med. 146, 1648-1662.
Netto,L.E.S., Chae,H.Z., Kang,S.W., Rhee,S.G., and Stadtman,E.R. (1996). Removal of 
hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its 
antioxidant properties. TSA possesses thiol peroxidase activity. J. Biol. Chem. 271, 
15315-15321.
Nicoletti,V.G., Caruso,A., Tendi,E.A., Privitera,A., Console,A., Calabrese,V., 
Spadaro,F., Ravagna,A., Copani,A., and Giuffrida-Stella,A.M. (1998). Effect of nitric 
oxide synthase induction on the expression of mitochondrial respiratory chain enzyme 
subunits in mixed cortical and astroglial cell cultures. Biochimie 80, 871-881.
215
Reference list
Nijtmans,L.G.J., Spelbrink,J.N., Van G a l e n , Z w a a n , M . ,  Klement,P., and Van 
den Bogert,C. (1995). Expression and fate of the nuclearly encoded subunits of 
cytochrome-c oxidase in cultured human cells depleted of mitochondrial gene products. 
Biochim. Biophys. Acta 1265, 117-126.
Nijtmans,L.G.J., Taanman,J.-W., Muijsers,A.O., Speijer,D., and Van den Bogert,C.
(1998). Assembly of cytochrome c oxidase in cultured human cells. Eur. J. Biochem. 
254, 389-394.
Nittis,T., George,G.N., and Winge,D.R. (2001). Yeast Scol, a protein essential for 
cytochrome c oxidase function, is a Cu (I)-binding protein. J. Biol. Chem. 276, 42520- 
42526.
Nittler,M.P., Hocking-Murray,D., Foo,C.K., and Sil,A. (2005). Identification of 
Histoplasma capsulatum transcripts induced in response to reactive nitrogen species. 
Mol. Biol. Cell 16, 4792-4813.
Nobrega,M.P., Bandeira,S.C.B., Beers,J., and Tzagoloff,A. (2002). Characterisation of 
COX 19, a widely distributed gene required for expression of mitochondrial cytochrome 
oxidase. J. Biol. Chem. 277, 40206-40211.
Nunnari,J., Fox,T.D., and Walter.P (1993). A mitochondrial protease with two catalytic 
subunits of overlapping specificities. Science 262, 1997-2004.
0'Connor-Cox,E., Mochaba,F.M., Lodolo,E.J., Majara,M., and Axcell,B. (1997). 
Methylene blue staining: use at your own risk. Tech. Q. Master Brew. Assoc. Am. 34, 
306-312.
O'Donnell,V.B., Chumley,P.H., Hogg,N., Bloodsworth,A., Darley-Usmar,V., and 
Freeman,B. A. (1997). Nitric oxide inhibition of lipid peroxidation: Kinetics of reaction 
with lipid peroxyl radicals and comparison with a-tocopherol. Biochemistry 36, 152lb- 
15223.
216
Reference list
Ostermeier,C., Harrenga,A., Ermler,U., and Michel,H. (1997). Structure at 2.7 A 
resolution o f the Paracoccus denitrificans two-subunit cytochrome coxidase complexed 
with an antibody Fv fragment. Proc. Natl. Acad. Sci. USA 94, 10547-10553.
Otsuka,M., Mizuno,Y., Yoshida,M., Kagawa,Y., and Ohta,S. (1988). Nucleotide 
sequence o f cDNA encoding human cytochrome oxidase subunit IVc. Nuc. Acid. Res. 
16, 10916.
Packer,M.A., Porteous,C.M., and Murphy,M.P. (1996). Superoxide production by 
mitochondria in the presence o f nitric oxide forms peroxynitrite. Biochem. Mol. Biol. 
Int. 40, 527-534.
Padgett,C.M. and Whorton,A.R. (1995). S-nitrosoglutathione reversibly inhibits 
GAPDH by S-nitrosylation. Am. J. Physiol. Cell Physiol 269, C739-C749.
Palmer,R.M.J., Ferrige,A.G., and Moncada,S. (1987). Nitric oxide release accounts for 
the biological activity of endothelial-derived relaxing factor. Nature 327, 524-526.
Paradies,G., Petrosillo,G., Pistolese,F., and Ruggiero,M. (2000). The effect of reactive 
oxygen species generated from the mitochondrial electron transport chain on the 
cytochrome c oxidase activity and on the cardiolipin content in bovine heart 
submitochondrial particles. FEBS Lett. 466, 323-326.
Paret,C., Ostermann,K., Krause-Buchholz,U., Rentzsch,A., and Rodel,G. (1999). 
Human members of the SCOl gene familyxomplementation analysis in yeast and 
intracellular localization. FEBS Lett. 447, 65-70.
Park,S.G., Cha,M.K., Jeong,W., and Kim,I.H. (2000). Distinct physiological functions 
of thiol peroxidase isoenzymes in Saccharomyces cerevisiae. J. Biol. Chem. 275, 5723- 
5732.
Patterson,T.E. and Poyton,R.O. (1986). Cox8, the structural gene for yeast cytochrome 
c oxidase subunit VIII. DNA sequence and gene disruption indicate that subunit VIII is 
required for maximal levels of cellular respiration and is derived from a precursor which 
is extended at both its NH2 and COOH termini. J. Biol. Chem. 261, 17192-17197.
217
Reference list
Pearce,D. A. and Sherman,F. (1995). Degradation of cytochrome oxidase subunits in 
mutants of yeast lacking cytochrome c and suppression of the degradation by mutation 
of ymel. J. Biol. Chem. 270, 20879-20882.
Pearce,L.L., Epperly,M.W., Greenberger,J.S., Pitt,B.R., and Peterson,J. (2001). 
Identification of respiratory complexes I and III as mitochondrial sites of damage 
following exposure to ionizing radiation and nitric oxide. Nitric Oxide 5, 128-136.
Pelzer,W., Muhlenhoff,U., Diekert,K., Siegmund,K., Kispal,G., and Lill,R. (2000). 
Mitochondrial Isa2p plays a crucial role in the maturation of cellular iron-sulfur 
proteins. FEBS Lett. 476, 134-139.
Perez-Martinez,X., Broadley,S.A., and Fox,T.D. (2003). Mss51p promotes 
mitochondrial Coxlp synthesis and interacts with newly synthesized Coxlp. EMBO J. 
22, 5951-5961.
Pervin,S., Singh,R., Gau,C.-L., Edamatsu,H., Tamanoi,F., and Chaudhuri,G. (2001). 
Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by 
famesyltransferase inhibitor: implications in breast cancer. Cane. Res. 61, 4701-4706.
Peterson,G.L. (1977). A simplification of the protein assay method of Lowry et al. 
which is more generally applicable. Anal. Biochem. 83, 346-356.
Petruzzella,V., Tiranti,V., Fernandez,P., Ianna,P., Carrozzo,R., and Zeviani,M. (1998). 
Identification and characterization of human cDNAs specific to BCS1, PET112, SCOl, 
COX 15, and COX11, five genes involved in the formation and function of the 
mitochondrial respiratory chain. Genomics 54, 494-504.
Pfanner,N. and Geissler,A. (2001). Versatility of the mitochondrial protein import 
machinery. Nat. Rev. Mol. Cell Biol. 2, 339-349.
Pfeiffer,K., Gohil,V., Stuart,R.A., Hunte,C., Brandt,U., Greenberg,M.L., and 
Schagger,H. (2003). Cardiolipin stabilizes respiratory chain supercomplexes J. Biol. 
Chem. 278, 52873-52880.
218
Reference list
Piper,P. W. (1999). Yeast superoxide dismutase mutants reveal a pro-oxidant action of 
weak organic food preservatives. Free Rad. Biol. Med. 27, 1219-1227.
Poderoso,J.J., Carreras,M.C., Lisdero,C., Riobo,N., Schopfer,F., and Boveris,A. (1996). 
Nitric oxide inhibits electron transfer and increases superoxide radical production in rat 
heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328, 85- 
92.
Poole,R.K. and Hughes,M.N. (2000). New functions for the ancient globin family: 
Bacterial responses to nitric oxide and nitrosative stress. Mol. Microbiol. 36, 775-783.
Poyton,R.O. and Burke,P. V. (1992). Oxygen regulated transcription of cytochrome c 
and cytochrome c oxidase genes in yeast. Biochim. Biophys. Acta 1101, 252-256.
Pratje,E., Mannhaupt,G., Michaelis,G., and Beyreuter,K. (1983). A nuclear mutation 
prevents processing of a mitochondrially encoded membrane protesin in Saccharomyces 
cerevisiae. EMBO J. 2, 1049-1054.
Preuss,M., Leonhard,K., Hell,K., Stuart,R.A., Neupert,W., and Herrmann,J.M. (2001). 
Mbal, a novel component of the mitochondrial protein export machinery of the yeast 
Saccharomyces cerevisiae. J. Cell Biol. 153, 1085-1096.
Preuss,M., Ott,M., Funes,S., Luirink,J., and Herrmann,J.M. (2005). Evolution of 
mitochondrial oxa proteins from bacterial YidC: Inherited and acquired functions of a 
conserved protein insertion machinery. J. Biol. Chem. 280, 13004-13011.
Proshlyakov,D.A., Pressler,M.A., DeMaso,C., Leykam,J.F., DeWitt,D.L., and 
Babcock,G.T. (2000). Oxygen activation and reduction in respiration: involvement of 
redox-active tyrosine 244. Science 290, 1588-1591.
Pryor, W. A. and Lightsey,J.W. (1981). Mechanisms of nitrogen dioxide reactions: 
initiation of lipid peroxidation and the production of nitrous acid. Science 214, 435-437.
219
Reference list
Q u a r o n i ,L .G . ,  Seward,H.E., McLean,K.J., Girvan,H.A., Ost,T.W.B., Noble,M.A., 
Kelly,S.M., Price,N.C., Cheesman,M.R., Smith,W.E., and Munro,A.W. (2004). 
Interaction of nitric oxide with cytochrome P450 BM3. Biochemistry 43, 16416-16431.
Radi,R., Beckman,J.S., Bush,K.M., and Freeman,B.A. (1991a). Peroxynitrite oxidation 
of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 
266, 4244-4250.
Radi,R., Beckman,J.S., Bush,K.M., and Freeman,B.A. (1991b). Peroxynitrite-induced 
membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. 
Arch. Biochem. Biophys. 288, 481-487.
Radi,R., Rodriguez,M., Castro,L., and Telleri,R. (1994). Inhibition of mitochondrial 
electron transport by peroxynitrite. Arch. Biochem. Biophys. 308, 89-95.
Rahman,S., Taanman,J.-W., Cooper,J.M., Nelson,I., Hargreaves,I., Meunier,B.,
Hanna,M.G., Garcia,J., Capaldi,R.A., Lake,B.D., Leonard,J.V., and Shapira,A.H.V.
(1999). A mis-sense mutation of cytochrome oxidase subunit II causes defective 
assembly and myopathy. Am. J. Hum. Genet. 65, 1030-1039.
Ramachandran,A., Ceaser,E., and Darley-Usmar,V. (2004). Chronic exposure to nitric 
oxide alters the free iron pool in endothelial cells: Role of mitochondrial respiratory 
complexes and heat shock proteins. Proc. Natl. Acad. Sci. USA 101, 384-389.
Ramil,E., Agrimonti,C., Shechter,E., Gervais,M., and Guiard,B. (2000). Regulation of 
the CYB2 gene expression: transcriptional co-ordination by the Haplp, Hap2/3/4/5p 
and Adrlp transcription factors. Mol. Microbiol. 37 1116-1132.
Rasmussen,A.K., Chatterjee,A., Rasmussen,L.J., and Singh,K.K. (2003). Mitochondria- 
mediated nuclear mutator phenotype in Saccharomyces cerevisiae. Nuc. Acid. Res. 31, 
3909-3917.
Rep,M., Nooy,J., Guelin,E., and Grivell,L.A. (1996). Three genes for mitochondrial 
proteins suppress null-mutations in both Afg3 and Real when over-expressed. Curr. 
Genet. 30, 206-211.
2 2 0
Reference list
Rich,P.R., Jiinemann,S., and Meunier,B. (1998). Protonmotive mechanism of haem- 
copper oxidases. J. Bioenerg. Biomemb. 30, 131-138.
Riobo,N.A., Clementi,E., Melani,M., Boveris,A., Cadenas,E., Moncada,S., and 
Poderoso,J.J. (2001). Nitric oxide inhibits mitochondrial NADH: ubiquinone reductase 
activity through peroxynitrite formation. Biochem. J. 359, 139-145.
Roberts,E-S., Lin,H., Crowley,J.R., Vuletich,J.L., Osawa,Y., and Hollenberg,P.F.
(1998). Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic 
activity of cytochrome P450 2B1. Chem. Res. Toxicol. 11, 1067-1074.
Rodrigues-Pousada,C.A., Nevitt,T., Menezes,R., Azevedo,D., Pereira,J., and Amaral,C.
(2004). Yeast activator proteins and stress response: an overview. FEBS Lett. 567, 80- 
85.
Roy,B., Lepoivre,M., Henry, Y., and Fontecave,M. (1995). Inhibition of ribonucleotide 
reductase by nitric oxide derived form thionitrites: reversible modification of both 
subunits. Biochemistry 34, 5411-5418.
Saint-Georges,Y., Hamel,P., Lemaire,C., and Dujardin,G. (2001). Role of positively 
charged transmembrane segments in the insertion and assembly of mitochondrial inner- 
membrane proteins. Proc. Natl. Acad. Sci. USA 98, 13814-13819.
Salviati,L., Hemendez-Rosa,E., Walker,W.F., Sacconi,S., DiMauro,S., Schon,E.A., and 
Davidson,M.M. (2002). Copper supplementation restores cytochrome c oxidase activity 
in cultured cells from patients with SC02 mutations. Biochem. J. 363, 321-327.
Saracco,S.A. and Fox,T.D. (2002). Coxl8p is required for export of the mitochondrially 
encoded Saccharomyces cerevisiae Cox2p C-tail and interacts with Pntlp and Mss2p in 
the inner membrane. Mol. Biol. Cell 13, 1122-1131.
Sarti,P., Giuffre,A., Barone,M.C., Forte,E., Mastronicola,D., and Brunori,M. (2003). 
Nitric oxide and cytochrome oxidase: reaction mechanisms from the enzyme to the cell. 
Free Rad. Biol. Med. 34, 509-520.
221
Reference list
Sarver,A. and DeRisi,J. (2005). Fzflp regulates an inducible response to nitrosative 
stress in Saccharomyces cerevisiae. Mol. Biol. Cell. 16, 4781-4791.
Schagger,H. and von Jagow,G. (1991). Blue native electrophoresis for isolation of 
membrane protein complexes in enzymatically active form. Anal. Biochem. 199, 223- 
231
Schagger,H. and Pfeiffer,K. (2000). Supercomplexes in the respiratory chains of yeast 
and mammalian mitochondria. EMBO J. 19, 1777-1783.
Schilke,B., Voisine,C., Beinert,H., and Craig,E. (1999). Evidence for a conserved 
system for iron metabolism in the mitochondria of Saccharomyces cerevisiae. Proc. 
Natl. Acad. Sci. USA 96, 10206-10211.
Schmidt,B., McCracken,J., and Ferguson-Miller,S. (2003). A discrete water exit 
pathway in the membrane protein cytochrome c oxidase. Proc. Natl. Acad. Sci. USA 
100, 15539-15542.
Schmitt,A.P. and McEntee,K. (1996). Msn2p, a zinc finger DNA-binding protein, is the 
transcriptional activator of the multistress response in Saccharomyces cerevisiae. Proc. 
Natl. Acad. Sci. USA 93, 5777-5782.
Schmitt,M.E., Brown,T.A., and Trumpower,B. (1990). A rapid and simple method for 
preparation of RNA from Saccharomyces cerevisiae. Nuc. Acid. Res. 18, 3091-3092.
Sedlak,M. and Robinson,N.C. (1999). Phospholipase A2 digestion of cardiolipin bound 
to bovine cytochrome c oxidase alters both activity and quaternary structure. 
Biochemistry 38, 14966-14972.
Sellers, V.M., Johnson,M.K. and Dailey,H. A. (1996). Function of the [2Fe-2S] cluster in 
mammalian ferrochelatase: a possible role as a nitric oxide sensor. Biochemistry 35, 
2699-1704.
Sharpe,M. A. and Cooper,C.E. (1998). Interaction of peroxynitrite with mitochondrial 
cytochrome oxidase. J. Biol. Chem. 273, 30961-30972.
2 2 2
Reference list
Shergill,J.K., Cammack,R., Cooper,C.E., Cooper,J.M., Mann,V.M., and 
Schapira,A.H.V. (1996). Detection of nitrosyl complexes in human substantia nigra, in 
relation to Parkinson's disease. Biochim. Biophys. Res. Commun. 228, 298-305.
Shoubridge,E.A., and Lochmuller,H. (2001). Cytochrome oxidase deficiency due to 
mutations in SC02, encoding a mitochondrial copper-binding potein, is rescued by 
copper in human myoblasts. Hum. Mol. Genet. 10, 3025-3035.
Siep,M., van Oosterum,K., Neufeglise,H., van der Spek,H., and Grivell,L.A. (2000). 
Mss51p, a putative translational activator of cytochrome c oxidase subunit-1 (COX1) 
mRNA, is required for synthesis of Coxlp in Saccharomyces cerevisiae. Curr.Genet. 
37,213-220.
Slonimski,P.P. and Tzagoloff,A. (1976). Localisation in yeast mitochondrial DNA of 
mutations expressed in a deficiency of cytochrome oxidase and/or coenzyme QH2- 
cytochrome c reductase. Eur. J. Biochem. 61, 27-41.
Smith,D., Gray,J., Mitchell,L., Antholine,W.E., and Hosier,J.P. (2005). Assembly of 
cytochrome-c oxidase in the absence of assembly protein Surflp leads to loss of the 
active site heme. J. Biol. Chem. 280, 17652-17656.
Souza,J.M. and Radi,R. (1998). Glyceraldehyde-3-phosphate dehydrogenase 
inactivation by peroxynitrite. Arch. Biochem. Biophys. 360, 187-194.
Souza,R.L., Green-Willms N.S., Fox T.D., Tzagoloff A., and Nobrega F.G. (2000). 
Cloning and characterization of COX 18, a Saccharomyces cerevisiae PET gene 
required for the assembly of cytochrome oxidase. J. Biol. Chem. 275, 14898-14902.
Speno,H., Taheri,M.R., Sieburth,D., and Martin,C.T. (1995). Identification of essential 
amino acids within the proposed CuA binding site in subunit II of cytochrome c oxidase. 
J. Biol. Chem. 270, 25363-25369.
Srinivasan,C., Liba,A., Imlay,J.A., Valentine,J.S., and Gralla,E.B. (2000). Yeast lacking 
superoxide dismutase(s) show elevated levels of "free iron" as measured by whole cell 
electron paramagnetic resonance. J. Biol. Chem. 275, 29187-29192.
223
Reference list
Stachowiak,0., Dolder,M., Wallimann,T., and Richter,C. (1998). Mitochondrial 
creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. 
J. Biol. Chem. 273, 16694-16699.
Susswein,A.J., Katzoff,A., Miller,N., and Hurwitz,I. (2004). Nitric oxide and memory. 
Neuroscientist 10, 153 -162.
Szyrach,G., Ott,M., Bonnefoy,N., Neupert,W., and Herrmann,J.M. (2003). Ribosome 
binding to the Oxal complex facilitates co-translational protein insertion in 
mitochondria. EMBO J. 22, 6448-6457.
Taanman,J.W. and Capaldi,R.A. (1992). Purification of yeast cytochrome c oxidase 
with a subunit composition resembling the mammalian enzyme. J. Biol. Chem. 267, 
22481-22485.
Taanman,J.-W. and Capaldi,R.A. (1993). Subunit Via of yeast cytochrome c oxidase is 
not necessary for assembly of the enzyme complex but modulates the enzyme activity. 
Isolation and characterization of the nuclear-coded gene. J. Biol. Chem. 268, 18754- 
18761.
Taanman,J.-W. (1997). Human cytochrome c oxidase: Structure, function and 
deficiency. J. Bioenerg. Biomemb. 29, 151-163.
Taanman,J.-W., Bodnar,A.G., Cooper,J.M., Morris,A.A.M., Clayton,P.T., Leonard,J.V., 
and Schapira,A.H.V. (1997). Molecular mechanisms in mitochondrial DNA depletion 
syndrome. Hum. Mol. Genet. 6, 935-942.
Tamir,S., Burney,S., and Tannenbaum,S.R. (1996). DNA damage by nitric oxide.
Chem. Res. Toxicol. 9, 821-827.
Tatoyan,A. and Giulivi,C. (1998). Purification and characterisation of a nitric-oxide 
synthase from rat liver mitochondria. J. Biol. Chem. 273, 11044-11048.
224
Reference list
Tauer,R., Mannhaupt,G., Schnall,R., Pajic,A., Langer,T., and Feldmann,H. (1994). 
YtalOp, a member of a novel ATPase family in yeast, is essential for mitochondrial 
function. FEBS Lett. 353, 197-200.
Ter Linde,J.J., Liang,H., Davis,R.W., Steensma,H.Y., van Dijken,J.P., and Pronk,J.T.
(1999). Genome-wide transcriptional analysis of aerobic and anaerobic chemostat 
cultures of Saccharomyces cerevisiae. J. Bacteriol. 181, 7409-7413.
Ter Linde,J.J. and Steensma,H.Y. (2002). A microarray-assisted screen for potential 
Hapl and Roxl target genes in Saccharomyces cerevisiae. Yeast 19, 825-840.
Terziyska,N., Lutz,T., Kozany,C., Mokranjac,D., Mesecke,N., Neupert,W.,
Herrmann,J.M., and Hell,K. (2005). Mia40, a novel factor for protein import into the 
intermembrane space of mitochondria is able to bind metal ions. FEBS Lett. 579, 179- 
184.
Thomas,J.W., Calhoun,M.W., Lemieux,L.J., Puustinen,A., Wikstrom,M., Alben,J.O., 
and Gennis,R.B. (1994). Site-directed mutagenesis of residues within helix VI in 
subunit I of the cytochrome bo3 ubiquinol oxidase from Escherichia coli suggests that 
tyrosine 288 may be a Cub ligand. Biochemistry 33, 13013-13021.
Torello,A.T., Overholtzer,M.H., Cameron,V.L., Bonnefoy,N., and Fox,T.D. (1997). 
Deletion of the leader peptide of the mitochondrially encoded precursor of 
Saccharomyces cerevisiae cytochrome c oxidase subunit II. Genetics 145, 903-910.
Tsukihara,T., Aoyama,H., Yamashita,E., Tomizaki,T., Yamaguchi,H., Shinzawa- 
Itoh,K., Nakashima,R., Yaono,R., and Yoshikawa,S. (1995). Structures of metal sites of 
oxidized bovine heart cytochrome c oxidase at 2.8 A. Science 269, 1069-1074.
Tsukihara,T., Aoyama,H., Yamashita,E., Tomizaki,T., Yamaguchi,H., Shinzawa- 
Itoh,K., Nakashima,R., Yaono,R., and Yoshikawa,S. (1996). The whole structure of the 
13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272, 1136-1144. 
Turrens,J.F. and Boveris,A. (1980). Generation of superoxide anion by the NADH 
dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421-427.
225
Reference list
Tzagoloff,A., Capitanio,N., Nobrega,M.P., and Gatti,D. (1990). Cytochrome oxidase 
assembly in yeast requires the product of COX11, a homolog of the P. denitrificans 
protein encoded by ORF3. EMBO J. 9, 2759-2764.
Tzagoloff,A., and Dieckmann,C.L. (1990). PET genes of Saccharomyces cerevisiae. 
Microbiol. Rev. 54, 211-225.
Tzagoloff,A., Nobrega,M., Gorman,N., and Sinclair,P. (1993). On the functions of the 
yeast COXIO and COX11 gene products. Biochem. Mol. Biol. Int. 31, 593-598.
van Gelder,B., and Slater,E.C. (1962). The extinction coefficient of cytochrome c. 
Biochim. Biophys. Acta 58, 893-595.
van Loon,A.P.G.M., Pesold-Hurt,B., and Schatz,G. (1986). A yeast mutant lacking 
mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc. Natl. 
Acad. Sci. USA 83, 3820-3824.
Veal,E.A., Ross,S.J., Malakasi,P., Peacock,E., and Morgan,B.A. (2003). Ybpl is 
required for the hydrogen peroxide-induced oxidation of the Yapl transcription factor.
J. Biol. Chem. 278, 30896-30904.
Vesela,K., Hansikova,H., Tesarova,M., Martasek,P., Elleder,M., Houstek,J., and 
Zeman,J. (2004). Clinical, biochemical and molecular analyses of six patients with 
isolated cytochrome c oxidase deficiency due to mutations in the SC02 gene. Acta 
Paediatr. 93, 1312-1317.
Wang,G.L., Jiang,B.H., Rue,E.A. and Semenza,G.L. (1995). Hypoxia-inducible factor 1 
is a basic-helix-loop-helix-PAS heterodimer regulated by cellular 0 2 tension. Proc. Natl. 
Acad. Sci. USA 92, 5510-5514.
Wei,J., Guo,H., and Kuo,P.C. (2002). Endotoxin-stimulated nitric oxide production 
inhibits expression of cytochrome c oxidase in ANA-1 murine macrophages. J. 
Immunol. 168, 4721-4727.
226
Reference list
Welter,R., Yu,L., and Yu.C-.A. (1996). The effects of nitric oxide on electron transport 
complexes. Arch. Biochem. Biophys. 331, 9-14.
Wennmalm,A., Benthin,G., Edlund,A., Jungersten,L., Kieler-Jensen,N., Lundin,S., 
Westfelt,U.N., Petersson,A.S., and Waagstein,F. (1993). Metabolism and excretion of 
nitric oxide in humans. An experimental and clinical study. Circ. Res. 73, 1121-1127.
Wikstrom,M., Morgan, J.E., and Verkhovsky,M.I. (1998). On the mechanism of proton 
translocation by respiratory enzyme. J. Bioenerg. Biomemb. 30, 139-145.
Wikstrom,M. (2000) Proton translocation by cytochrome c oxidase: a rejoinder to recent 
criticism. Biochemistry 39, 3515-9.
Williams,S.L., Valnot,I., Rustin,P., and Taanman,J.-W. (2004). Cytochrome c oxidase 
subassemblies in fibroblast cultures from patients carrying mutations in COX 10, SCOl, 
or SURF1. J. Biol. Chem. 279, 7462-7469.
Witt,H., Zickermann,V., and Ludwig,B. (1995). Site-directed mutagenesis of 
cytochrome c oxidase reveals two acidic residues involved in the binding of cytochrome 
c. Biochim. Biophys. Acta 1230, 74-76.
Wolosker,H., Panizzutti,R., and Engelender,S. (1996). Inhibition of creatine kinase by 
S-nitrosoglutathione. FEBS Lett. 392, 274-276.
Wong,C.-M., Zhou,Y., Ng,R.W.M., Kung,H., and Jin,D.-Y. (2002a). Cooperation of 
yeast peroxiredoxins Tsalp and Tsa2p in the cellular defense against oxidative and 
nitrosative stress. J. Biol. Chem. 277, 5385-5394.
Wright,R.M., Dircks,L.K., and Poyton,R.O. (1986). Characterization of COX9, the 
nuclear gene encoding the yeast mitochondrial protein cytochrome c oxidase subunit 
Vila. Subunit Vila lacks a leader peptide and is an essential component of the 
holoenzyme. J. Biol. Chem. 261, 17183-17191.
227
Reference list
Yakes,F.M. and Van Houten,B. (1997). Mitochondrial DNA damage is more extensive 
and persists longer than nuclear DNA damage in human cells following oxidative stress. 
Proc. Natl. Acad. Sci. USA 94, 514-519.
Yamamoto,T., Maruyama,W., Kato,Y., Yi,H., Shamoto-Nagai,M., Tanaka,M., Sato,Y., 
and Naoi,M. (2002). Selective nitration of mitochondrial complex I by peroxynitrite: 
Involvement in mitochondria dysunction and cell death of dopaminergic SH-SY5Y 
cells. J. Neural. Transm. 109, 1-13.
Yun,C.-W., Ferea,T., Rashford,J., Ardon,0., Brown,P.O., Botstein,D., Kaplan,J., and 
Philpott,C.C. (2000). Desferrioxamine-mediated iron uptake in Saccharomyces 
cerevisiae. Evidence for two pathways of iron uptake. J. Biol. Chem. 275, 10709-10715.
Zhang,L. and Guarente,L. (1994). HAP1 is nuclear but is bound to a cellular factor in 
the absence of heme. J. Biol. Chem. 269, 14643-14647.
Zhang,L., Hach,A., and Wang,C. (1998). Molecular mechanism governing heme 
signaling in yeast: A higher-Order complex mediates heme regulation of the 
transcriptional activator HAP1. Mol. Cell. Biol. 18, 3819-3828.
Zhang,M., Mileykovskaya,E., and Dowhan,W. (2002). Gluing the respiratory chain 
together. Cardiolipin is required for supercomplex formation in the inner mitochondrial 
membrane. J. Biol. Chem. 277, 43553-43556.
Zhen,Y., Hoganson,C.W., Babcock,G.T., and Ferguson-Miller,S. (1999). Definition of 
the interaction domain for cytochrome c on cytochrome c oxidase. I. Biochemical, 
spectral, and kinetic characterization of surface mutants in subunit II of Rhodobacter 
sphaeroides cytochrome aa^. J. Biol. Chem. 274, 38032-38041.
228
Appendices
APPENDICES
229
Appendix I: Reprint o f  paper published in the Biochemical Journal
Biochem. J. (2005) 390, 70 3 -7 0 8  (Printed in Great Britain) doi:10.1042/BJ20050598 7 03
Analysis of COX2 mutants reveals cytochrome oxidase subassemblies 
in yeast
Susannah HORAN*, Ingrid BOURGES*, Jan-Willem TAANMANf and Brigitte MEUNIER*1
2005 Biochemical Society
230
Appendix I: Reprint o f  paper published in the Biochemical Journal
704 S. Horan and others
©  2005 Biochemical Society
231
Appendix I: Reprint o f  paper published in the Biochemical Journal
Cytochrome oxidase subassemblies 705
©  2005 Biochemical Society
232
Appendix I: Reprint o f  paper published in the Biochemical Journal
706 S. Horan and others
©  2005 Biochemical Society
233
Appendix I: Reprint o f  paper published in the Biochemical Journal
Cytochrome oxidase subassemblies 707
2005 Biochemical Society
234
Appendix I: Reprint o f  paper published in the Biochemical Journal
708 S. Horan and others
©  2005 Biochemical Society
235
Appendix II: Reprint o f  paper published in the Journal o f Biological Chemistry
OFlBlOLOGIC^  9 HEM,1STRY Vol. 280, No. 33, Issue of August 19, pp. 29743-29749, 2005
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
Effect of Inhibition of the bcx Complex on Gene Expression 
Profile in Yeast*^
Received for publication, May 31, 2005 
Published, JB C  Papers in  Press, Ju n e  20, 2005, DOI 10.1074/jbc.M505915200
Ingrid Bourges, Susannah Horan, and Brigitte Meunier^
This paper is available on line at http://www.jbc.org Supplemental Material can be found at: http://www.jbc.org/cgi/content/full/M505915200/DC129743
236
Appendix II: Reprint o f  paper published in the Journal of Biological Chemistry
2 9 7 4 4 Inhib ition  o f  bcj Complex and  Gene Expression Changes
237
Appendix II: Reprint o f  paper published in the Journal o f Biological Chemistry
Inh ib ition  o f bc j  Complex and  Gene Expression Changes 29745
238
Appendix II: Reprint o f paper published in the Journal of Biological Chemistry
2 9 7 4 6 Inhibition o f be j Complex and Gene Expression Changes
239
Appendix II: Reprint o f  paper published in the Journal o f Biological Chemistry
Inhib ition  o f  be2 Complex and  Gene Expression Changes 29747
240
Appendix II: Reprint o f  paper published in the Journal o f Biological Chemistry
29748 Inh ib ition  o f  bcj Complex and Gene Expression Changes
241
Appendix II: Reprint o f  paper published in the Journal o f Biological Chemistry
Inhib ition  o f  bcj Complex and Gene Expression Changes 29749
242
Appendix III: Reprint o f  paper published in Yeast
Y e a s t
Yeast 2006; 2 3 :5 1 9 -5 3 5 .
Published online in W iley InterScience (www.interscience.wiley.com). D O I: 10 .1002/yea. 1372 
Research Article
Transcriptional response to nitrosative stress in 
Saccharomyces cerevisiae
Susannah H o ran 1, Ingrid B ourges1 and Brigitte M eunier1,2*
Copyright © 2006 John Wiley & Sons, Ltd.
243
Appendix III: Reprint o f  paper published in Yeast
520 S. Horan, I. Bourges and B. Meunier
Copyright © 2006 John Wiley & Sons. Ltd. Yeast 2006; 23:519-535.
244
Appendix III: Reprint o f  paper published in Yeast
Gene expression changes on RNS treatm ent of yeast 521
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23:519-535.
245
Appendix III: Reprint o f  paper published in Yeast
522 S. Horan, I. Bourges and B. Meunier
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23:519-535.
246
Appendix III: Reprint o f paper published in Yeast
Gene expression changes on RNS treatment of yeast 523
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 5 19-535.
247
Appendix III: Reprint o f paper published in Yeast
524 S. Horan, I. Bourges and B. Meunier
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 519-535.
248
Appendix III: Reprint o f  paper published in Yeast
Gene expression changes on RNS treatment of yeast 525
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23:519-535.
249
Appendix III: Reprint o f paper published in Yeast
526 S. Horan, I. Bourges and B. Meunier
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 519-535.
250
Appendix III: Reprint o f  paper published in Yeast
Gene expression changes on RNS treatment of yeast 527
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 5 19-535.
251
Appendix III: Reprint o f  paper published in Yeast
528 S. Horan, I. Bourges and B. Meunier
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23:519-535.
252
fio
toUi
O
A
3A
A
X■o
Atfltfl
0*
3
O
3"V
3OQ
Av>
0
3
JOz
(/)
rt-
A
ft
3
A
3r t
O■*»
A
»W)
>
13
13
a
3Q.
a
13
O•-t>
T3
•3A"I
13
3O*
arA
CL
*<
AP
1/1Kl»o
Copyright 
© 
2006 
John 
W
iley 
& 
Sons, Ltd. 
Yeast 2006; 23: 5
19-535.
(aiwo
(/)
Xo
3
3
09Oc
wAw
ft
3Q.
xA
C
3
a ’
Appendix 
III: Reprint of paper published 
in 
Y
east
tot-fl
oft
3ft
ftx■o■nft</>W)
0*
3
P>
300ftu>
O
3
JO
Z
V)
e t
ft
ft
3ft
3
-<ft
P>u»
>TJ
T3
f t3a.
jo<t
5'
o
*-*>
Xi
■o
f t
~accr
Vicr
f tel­
s'
-<
f t
p
U1w
Appendix III: Reprint o f paper published in Yeast
532 S. Horan, I. Bourges and B. Meunier
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 5 19-535.
256
Appendix III: Reprint o f paper published in Yeast
Gene expression changes on RNS treatment of yeast 533
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23; 5 19—535.
257
Appendix III: Reprint o f paper published in Yeast
534 S. Horan, I. Bourges and B. Meunier
Copyright © 2006 John Wiley & Sons, Ltd. Yeast 2006; 23: 519-535.
258
Appendix III: Reprint o f paper published in Yeast
Gene expression changes on RNS treatment of yeast 535
Copyright © 2006 John Wiley & Sons, Ltd.
259
Yeast 2006; 23:519-535.
